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SUMMARY
This study has examined the effect of purines and 
pyrimidines on the rat superior cervical ganglion in 
vitro. Using an extracellular recording technique”Tt was 
found adenosine and its analogues produced concentration 
dependent hyperpolarisations. In contrast pyrimidines 
such as UTP and the P2-purinoceptor agonist alpha,beta- 
methylene adenosine triphosphate depolarised, via a 
methylxanthine independent mechanism.
A mechanism for the uptake and degradation of adenosine in 
the ganglion was evident as the effects of adenosine were 
enhanced in the presence of adenosine uptake inhibitors or 
in the presence of an adenosine deaminase inhibitor. The 
deaminated metabolite of adenosine, i.e. inosine was 
inactive.
The ionic mechanism for the adenosine-induced hyperpolari­
sation was examined by altering the extracellular cation 
concentrations and the use of selective ion channel 
antagonists. The hyperpolarisation to adenosine was not 
antagonised by inorganic or dihydropyridine calcium 
channel antagonists, suggesting adenosine did not alter 
Ca entry. The response to adenosine was resistant to 
antagonism of sodium and chloride channels and the 
inhibition of Na+/K+ ATPase and Na+/K+/Cl“ co­
transporters, but was sensitive to changes in 
extracellular K+ concentration. The hyperpolarisation to 
adenosine was enhanced in reduced external potassium 
solution or the presence of low concentrations of TEA 
suggesting adenosine may increase potassium conductance.
The response to muscarinic agonists and not other agonists 
was selectively reduced by adenosine but not by all 
purines or pyrimidines. The depression of muscarine was 
selective for the depolarisation and not the 
hyperpolarisation.
Both the relative order of potency of adenosine and its 
analogues to hyperpolarise and depress the response to 
muscarine were indicative of the presence of purinoceptors 
of the A1 subtype on the rat SCG. Studies to confirm the 
nature of the adenosine receptor using two selective Al- 
adenosine receptor antagonists. 1,3-dipropyl-8- 
cyclopentylxanthine and xanthine amine congener produced 
an apparently non-competitive inhibition. This may 
indicate the presence of two receptor subtypes. However, 
a selective A2 adenosine receptor antagonist 3,7-dimethy- 
1-propargyl-xanthine did not alter the inhibition of 
muscarinic responses or the hyperpolarisation caused by 
purines.
XI
The biochemical mechanism responsible for the 
hyperpolarisation to adenosine remains elusive. Cyclic 
adenosine monophosphate phosphodiesterase inhibitors Ro 
20-1724 and denbufylline and an adenylate cyclase 
inhibitor, SQ 22,536, reduced the hyperpolarisation to 
purines but not the depression of the response to 
muscarine. However, agents known to increase cAMP levels 
in the ganglion did not dramatically alter the response to 
adenosine suggesting the responses to adenosine are not 
mediated by a change in cyclic nucleotide levels. The 
ability of phorbol esters to enhance the response to 
adenosine suggests that protein kinase C is involved in 
the interaction of adenosine with muscarine. An 
interaction with the arachidonic acid cascade pathway was 
suggested by the inhibition of the hyperpolarisation to 
adenosine by a selective lipoxygenase inhibitor.
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CHAPTER ONE 
GENERAL INTRODUCTION
Chapter 1 
INTRODUCTION
1. THE RAT SUPERIOR CERVICAL GANGLION.
The autonomic nervous system (ANS) is an efferent outflow 
from the brain and spinal cord having a thoracolumbar or 
sympathetic and a parasympathetic division, the latter 
comprised of cranial and sacral components. In part the 
sympathetic nervous system of the rat consists of a series 
of ganglia on each side of the vertebral column. At the 
cervical level the ganglia are distinguished by their 
positions, namely the superior, middle and inferior 
ganglia. The superior cervical ganglion (SCG) provides 
sympathetic innervation to the pineal gland, median 
eminance, cephalic blood vessels, the choroid plexus, 
carotid body, the neurohypophysis, and thyroid and 
parathyroid glands. In keeping with the homeostatic role 
of the autonomic nervous system the SCG is involved in 
neuroendocrine intergration, and removal of the SCG causes 
several neurodendocrine and behavioural changes in mammals 
(Cardinali, Vacas & Gejman, 1981). Several effects arise 
from the interruption of neuronal connections originating 
in the SCG including modified water balance, drinking and 
feeding behaviour in rats, alteration of photoperiodic 
control of reproduction in mammals and modifications to 
adenohypophysial, thyroid, parathyroid and calcitonin 
release in rats (Cardinali et al., 1981; Cardinali, Romeo 
& Vacas, 1987).
The input to the ganglion cells is nearly all unmyelinated 
cholinergic axons having their origin in the spinal cord, 
and preganglionic sympathetic fibres project to adrenergic 
cell bodies and dendrites of the rat SCG (Hedger & Weber, 
1976). The ganglion is complicated in structure and the
2nerve cells that give rise to the postganglionic fibres 
are multipolar with numerous dendrites, of varying sizes 
and staining characteristics, and are almost entirely 
enclosed by satellite cells. Most autonomic ganglia have 
a variable number of small cells which have a high content 
of catecholamines, as detected by formaldehyde-induced 
fluorescence, i.e. small intensely fluorescent (SIF) cells 
(for review see Williams & Jew, 1983) and chromaffin type 
cells are often in close contact to ganglion cells or 
capillaries.
It is unlikely that the SCG exist solely for relaying 
nerve inpulses as anatomical and electrophysiological 
studies have shown complicated interactions between 
different cells (Williams & Jew, 1983). In the guinea-pig 
each postganglionic neurone is multiply-innervated by an 
average of four spinal cord segments (Nja & Purves, 1977) 
and the number of axons leaving the ganglion is greater 
than those innervating the tissue. The pre- to 
postganglionic fibre ratios of the SCG is reported to be 
species dependent and to be between 1-11 and 1-30. There 
is good evidence that SCG may be subdivided into regions 
of neurones that project to specific target organs (for 
review see Dail & Barton, 1983). Nja & Purves (1977) 
demonstrated that stimulation of the ventral roots 
produces an effector response, with the upper spinal cord 
segments (T1 to T3) controlling pupillary dilation and 
more caudal cord segments (T3 to T5) controlling 
piloerection on the face and neck and vasoconstriction of 
the ear.
A number of substances including acetylcholine (ACh), 
dopamine (DA), noradrenaline (NA), 5-hydroxytryptamine 
(5HT), gamma-aminobutyric acid (GABA), hormones and 
purines have been reported to function as 
neurotransmitters or neuromodulators of the SCG. The
5presence of catecholamines and in particular DA, in SCG 
has led to the suggestion by some researchers that they 
could be the neurotransmitter released by interneurones, 
and may generate the slow inhibitory postsynaptic 
potential (sIPSP) (Eccles & Libet, 1961). This hypothesis 
has been the subject of much controversy, and in the rat 
SCG little evidence for a catecholamine mediated 
hyperpolarisation has been found (Newberry,Priestley & Woodruff
1987). However the presence of a wide range of other 
substances within ganglion cells, such as histamine 
(Christian, Undem & Weinrech, 1989) and 5HT 
(Hadjiconstantinou, Potter & Neff, 1982), implies that 
they may have a neuromodulatory role consistent with the 
concept of integration of neuronal signals by the SCG.
Therefore signals entering the SCG, instead of being 
relayed to effector organs via monosynaptic processes, may 
be modulated at both pre- and postsynaptic sites in a 
highly complex manner (Kuba & Koketsu, 1978).
1.1 Role of cholinergic transmission in the rat SCG
Synaptic transmission has been investigated in 
considerable detail in sympathetic ganglia. Both the 
rabbit and rat SCG are well established and popular 
preparations for the study of the cholinergic synapse and 
are of particular interest because three distinct 
cholinergic potentials can be evoked in rabbit (Eccles,
1952; Eccles & Libet, 1961) and rat SCG (Dunant & Dolivo,
1967; Dunn & Karczmar, 1980; Newberry & Connolly, 1989).
In order of latency, the potentials are the fast 
excitatory postsynaptic potential (fSPSP), the sIPSP and 
the slow excitatory postsynaptic potential (sEPSP). The 
fEPSP is mediated by nicotinic receptors, as shown by its 
sensitivity to d-tubocuarine (dTC) and hexamethonium (C6), 
and the slow potentials are both muscarinic, since they 
are antagonised by atropine (Eccles & Libet, 1961). It is
4thought the fEPSP provides a mechanism for the rapid 
transfer of frequency-coded information through the 
synapse (Brown, 1983; Birks & Iscoff, 1988) whereas the 
major role of the muscarinic processes appears to be a 
facilitation or reinforcement of neuronal activity over 
prolonged periods (Libet, Kobayashi & Tanka, 1975).
The actions of muscarinic agents on isolated rat SCG are 
similar to the effects produced by ACh in the presence of 
nicotinic receptor antagonists. The predominant effect 
seen is a slow muscarinic depolarisation recorded as a 
corresponding extracellular late negative (LN) surface 
potential (see Eccles, 1952; Eccles & Libet, 1961). The 
LN potential, termined the sEPSP by Libet (1964; 1967), 
was recorded with intracellular microelectrodes in the 
rabbit SCG in 1968. Muscarinic stimulation can also 
produce a slow muscarinic hyperpolarisation (corresponding 
to the sIPSP, see Eccles, 1952) and/or postsynaptic 
repetitive firing both of which are clearly seen upon 
repetitive stimulation in the presence of an 
anticholinesterase (antiChE) agent (Voile, 1966).
The results of many pharmacological and biochemical 
techniques suggest that muscarinic receptors are 
heterogenous as discriminated by pirenzepine (PIR)
(Hammer, Bernie, Birdstall, Burgen & Holme, 1980; Hammer & 
Giachetti, 1982, see also Levine, Birdstall, North,
Holman, Wantanabe & Iversen, 1988). There are at least 
three different pharmacologically identifiable types of 
muscarinic receptors and at least five different molecular 
forms have been discovered (Bonner, 1988) and two 
concomitant nomenclatures are used to describe these 
receptors. The three pharmacologically defined muscarinic 
receptors are represented by a capital M and include Ml, 
which has a high affinity for pirenzepine; M2 which has a 
high affinity for AFDX-116 (full chemical name: ll-((2-
(diethylamino)methy1)-1-piperidinyl) acetyl)-5,11-dihydro- 
6H-pyrido(2,3-b)benzodiazepine-2-one) or gallamine and M3, 
which has a high affinity for 4-diaphenyl acetoxy-N- 
methylpiperidine methiodide (4DAMP) or hexahydro- 
siladifenidol (HHSD). The five molecular forms are 
denoted by Bonner and colleagues (Bonner, Buckley, Young & 
Brann, 1987; Bonner, Young, Brann & Buckley, 1988) as ml, 
m2, m3, m4 and m5. It has been found that the properties 
of ml, m2 and m3 receptors show a good correlation with 
Ml, M2 and M3 subtypes. Four of the five muscarinic 
receptors identified by Bonner in the rat (ml, m2, m3 and 
m4) are homologous with four muscarinic receptors (Hml, 
Hm2, Hm3 and Hm4) described by Peralta, Ashkenazi,
Winslow, Smith, Ramachandran & Capon (1987) in human 
brain. However the nomenclature used by these 
investigators is different and Hm4 and Hm3 correspond to 
m3 and m4 respectively.
It is believed that stimulation of muscarinic receptors 
activates intracellular responses due to the interaction 
with guanosine triphosphate (GTP) binding proteins (G- 
proteins), which bind guanine nucleotides and act as 
intermediaries in the transduction of the agonist receptor 
binding and the intracellular signal that produces the 
response.
It has been suggested that the different muscarinic 
receptor subtypes are functionally specialised so that Ml 
receptors and M2 receptors are preferentially coupled to 
the activation of phosphatidylinositol turnover (PIT) and 
the inhibition of adenylate cyclase (AC) respectively 
(Peralta et al., 1987) and that ml, m3 and m5 receptors 
couple primarily with Gp and in some cases with Gs, 
whereas M2 and M4 receptors are mainly coupled to Gi and 
Gk (Peralta et al., 1988; Kim, Lewis, Graziadei, Neer, 
Bar-Sagi & Clapham, 1989). However other research groups
6have argued there is considerable overlap between the 
receptor subtypes both in terms of coupling to G proteins 
and intracellular messengers, and these differences may 
account for the unreliability of any classification of 
muscarinic receptors based purely on the basis of G- 
protein coupling or the production of a second messenger 
(see Peralta et al,, 1987; and Chapter 5, for further 
discussion).
Concomitant with the development of Ml and M2 selective 
muscarinic antagonists these compounds have been applied 
to the SCG to discover if the sEPSP and sIPSP are mediated 
via Ml and M2 receptors respectively. Pirenzepine has 
been shown to be a potent antagonist of ganglionic 
depolarisation produced by muscarinic agonists in the rat 
SCG (Brown, Forward & Marsh, 1980) and selectively 
depressed the sEPSP in rabbit SCG (Ashe & Yarosh, 1984).
In contrast the M2 receptor antagonists, gallamine 
selectively reduced the sIPSP of the rabbit (Ashe &
Yarosh, 1984) and rat SCG (Newberry & Connolly, 1989). 
Further support for an M2 receptor mediated cholinergic 
hyperpolarisation was provided by the selective antagonism 
of the sIPSPs of both rabbit and rat SCG by a selective M2 
antagonist, AFDX-116 (see Mochida & Kobayashi, 1988 and 
Newberry & Connolly, 1989 respectively). Thus the slow 
synaptic depolarising potential of the rat SCG is mediated 
by the interaction of ACh with pharmacologically distinct 
muscarinic binding sites which are similar to those of the 
cerebral cortex (McCormick & Prince, 1986; North, 1986) 
are mediated by Ml receptors.
The ionic mechanism of the fEPSP is similar to that for 
the end plate potential at the neuro-muscular junction 
(for comparison see Fig. 4 in Kuba & Koketsu, 1978), and 
involves increases in the membrane conductance to sodium 
(gNa), potassium (gK) and calcium (gCa). In contrast the
ionic mechanism of the slow potentials are not fully 
resolved (Kobayashi and Libet, 1970) but studies on 
voltage-clamped amphibian neurones have revealed that the 
inward (depolarising) current occurs primarily due to an 
inhibition of a time and voltage dependent potassium 
current termed the *M-current* (Im, see Adams & Brown,
1982). Im has been found to be present in mammalian 
sympathetic neurones and Im of the rat SCG is reduced by a 
number of substances including ACh, angiotensin (Constanti 
& Brown, 1981), luteinizing hormone releasing factor 
(LHRH) and uridine triphosphate (UTP) (Adams, Brown & 
Constanti, 1982a).
It is believed that Im the predominant current involved 
in depolarisation of the rat SCG to muscarine (Brown,
1988) although other currents may also be involved.
Studies by Brown & Selyanko (1985a,b) have revealed at 
least three components of the response to muscarinic 
agonists; an inward current resulting from Im inhibition, 
and a simultaneous outward current (Ix) due to voltage 
independent resting current, apparently carried in part by 
Cl” and an occasional late inward current associated with 
an increased membrane conductance. Other researchers have 
found the responses recorded via extra- and intracellular 
electrodes to muscarine are complex and depends upon the 
concentration of muscarine applied (Hashiguchi, Kobayashi, 
Tosaka & Libet, 1982; Mochida & Kobayashi, 1986a,b; 
personal observation; Newberry & Gilbert, 1989a), the 
extracellular concentration of calcium ([Ca^+ ]e) (Tokimasa 
& Akasu, 1990) and the neuronal resting membrane potential 
(RMP) (Adams et al., 1982; Jones, 1989).
The sIPSP is considered to be mediated by an opening of K+ 
channels (Horn & Dodd, 1981; Dodd & Horn, 1983; Cole & 
Shinnick-Gallagher, 1984), although the ionic movements 
involved in the hyperpolarisation of the rat SCG by
8muscarinic agents do not appear to have been determined, 
but are likely to involve an increased K+ efflux.
1.2 PURINES
1.2.1 Historical perspective and overview
In 1929 Drury and Szent-Gyorgi reported on the profound 
physiological properties of purine nucleotides which 
included hypotension and bradycardia of dog and guinea-pig 
hearts and these effects were attributed to the adenosine 
monophosphate (AMP) content of the extracts used. In 
further experiments the injection of adenosine extracted 
from yeast produced identical but more potent effects when 
injected into animals. During hypoxia or post-ischaemic 
hyperaemia, adenosine 5'-triphosphate (ATP) may have a 
dominant role as a more potent coronary vasodilator to 
dilate blood vessels directly or after metabolism to 
adenosine. The important role of adenosine in the 
regulation of the cardiovascular system has been reviewed 
by Berne (1964; 1980).
Since the seminal work of Drury and Szent-Gyorgi (1929) 
many physiological roles have been proposed for adenosine 
and adenine nucleotides of which the modulation of 
synaptic transmission is probably the most validated. The 
concept of purines as neuromodulators and neuro­
transmitters has developed over the last two or three 
decades, and has been reviewed by Burnstock (1978, 1985) 
and Stone (1981a, 1989). The physiological and 
pharmacological effects of adenine nucleotides are often 
different to those of the parent molecule adenosine (Fig. 
1), and separate receptors for each compound have been 
distinguished (Burnstock, 1978).
Most cell types have been found to respond to adenosine, 
and a search for drugs that can selectively modify the 
actions of adenosine has resulted in intensive 
pharmaceutical research to discover new therapeutic 
agents. The potential use of these agents include the 
treatment of asthma and apnoea as respiratory stimulants; 
as cognitive enhancers and as cardiotonics and renal 
modulators (Daly, 1982; Williams & Jarvis, 1988; Bowmer & 
Yates, 1989).
1.2.2 Role of ATP as a neurotransmitter
It is believed that adenosine may function as a general 
modulator of cell physiology, while ATP functions as a 
neurotransmitter for some tissues. The first suggestion 
that ATP might be a neurotransmitter came from Holton & 
Holton in 1954, who presented evidence for release of ATP 
from collateral branches of primary afferent sensory 
fibres during antidromic stimulation, to cause 
vasodilatation of constricted rabbit ear vessels. 
Subsequent studies showed that antidromic stimulation of 
the great auricular nerve was accompanied by ATP release 
(Holton, 1959).
In the early 1960*s, Burnstock and his colleagues recorded 
inhibitory junction potentials in intestinal smooth muscle 
in response to stimulation of non-adrenergic non- 
cholinergic (NANC) nerves. In 1972 Burnstock proposed 
that the principal active substance released from these 
NANC nerves was ATP and he proposed the term "purinergic 
nerve". Subsequent experiments have produced evidence in 
favour of the release of ATP with neurotransmitters to 
function as a co-transmitter including observations on the 
synthesis, storage, release, receptor interaction and 
metabolism of ATP (see Burnstock 1985). Evidence from 
other groups has supported the concept that ATP can be
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released from synaptic vesicles by itself or with ACh or 
noradrenaline (Fedan, Hogaboom, O'Donnell, Colby & 
Westfall, 1981; Sneddon, Westfall & Fedan, 1982; Stjarne & 
Astrand, 1985).
The direct effects of ATP on postjunctional sites i.e. the 
P2 purinoceptor, have been reviewed by Burnstock (1972); 
Stone (1981a,b) and Gordon (1986). As well as being a 
neurotransmitter it has been postulated that ATP is a 
neuromodulator because it influences responses produced by 
classical neurotransmitters such as ACh in the rat 
diaphragm (Ewald, 1976), the frog skeletal muscle end- 
plate (Akasu, Hirai & Koketsu, 1981), sympathetic ganglia 
(Silinsky & Ginsborg, 1983; Akasu, Hirai & Koketsu, 1982, 
1983a), noradrenaline in the rat vas deferens (French & 
Scott, 1983) and GABA in the bullfrog spinal ganglion 
(Morita, Katayama, Koketsu & Akasu, 1984).
1.2.3 Purine receptor classification
Burnstock in 1978 suggested that the actions of ATP and AD 
could be attributed to different subtypes of purinergic 
receptor i.e. those preferring adenosine and sensitive to 
antagonism by methylxanthines such as caffeine and 
theophylline (THEO), namely the PI purinoceptors, and the 
other preferring adenine nucleotides and insensitive to 
methylxanthines, the P2 purinoceptors, (ATP receptors). 
Since then a more elaborate classification of both PI and 
P2 receptor subtypes has developed with the introduction 
of more selective agonists and antagonists. Table 1 
summarises the classification, properties and nomenclature 
that will be used here.
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1.2.3.1 Properties of P2 purinoceptors.
P2 receptors have been subclassified into four main 
categories (Gordon, 1986) of which the P2x and P2y are 
fairly well characterised (Burnstock & Kennedy, 1985).
This subdivision is based on the potency of ATP agonists, 
antagonism by an arylazidoaminopropionyl-ATP (ANAPP3), 
receptor distribution and the physiological consequences 
of receptor occupation (table 1). P2 purinoceptors are 
located largely postjunctionally. These receptors are 
more sensitive to ATP, are not antagonised by 
methylxanthines, do not in general alter adenylate cyclase 
activity and can lead to the generation of prostaglandin 
(PG).
The majority of the research on P2 purinoceptors has been 
carried out on smooth muscles where the stimulation of P2x 
purinoceptors tends to produce a contraction whereas 
stimulation of P2y purinoceptors generally has an 
inhibitory or relaxant effect on smooth muscle. The 
excitatory P2x purinoceptor appear to be involved in 
cotransmission of ATP and NA from sympathetic perivascular 
nerves. These receptors are selectively antagonised by 
ANAPP3 or suramin and desensitised by alpha,beta- 
methylene-ATP.
From a study of many smooth-muscle preparations it is 
thought that the activation of P2 receptors by ADP and ATP 
alters potassium or calcium ion flux. Activation of P2y- 
receptors can stimulate G-protein coupled phospholipase C 
(PLC) activation, while P2x-receptor activation mediates 
calcium (Ca^+) influx into cells. Until very recently 
(see Williams & Jarvis, 1988; Williams & Cusack, 1990) P2 
receptor antagonists have proven rather unselective and 
the classification of P2 receptors, like that of PI 
purinoceptors is dependant on the development of selective
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antagonists. Putative selective P2 purinoceptor 
antagonists include a photoaffinity analogue of ATP,
ANAPP3 (selective for the P2x purinoceptor) and more 
recently competitive antagonists suramin and beta, gamma- 
dichloromethylene-ATP.
In some tissues exogenous ATP is rapidly degraded to 
active compounds such as ADP, AMP and adenosine, which can 
then interact with other purine receptors and complicate 
the interpretation of experimental results. To avoid such 
complexities, slowly degradable analogues of ATP have been 
synthesised, by joining the bridge oxygens to a phosphate 
in ATP by a methylene group, producing a
methylenephosphonate linkage that is relatively stable to 
enzymatic hydrolysis. The incorporation of the methylene 
group into ATP between the innermost phosphates produces 
alpha, beta-methylene-ATP (c*,j$-MeATP). This is slowly 
degraded to od,p-MeADP, which is not degraded further. The 
incorporation of a methylene group between the outer 
phosphates produces beta, gamma-metylene-ATP (P,y Me-ATP), which is 
reported to be completely resistant to dephophorylation by 
ectoenzymes such as 5 *-nucleotidase (Hourani, Welford &
Cusack, 1985; Welford, Cusack & Hourani, 1986),
1.2.3.2 Properties of PI purinoceptors
Most responses to adenosine have been attributed to an 
action on extracellular adenosine receptors, which are 
located on the outer face of the plasma membrane (Huang &
Daly, 1974). It has been found with only a few exceptions 
(see Collis & Pettinger, 1982; Moody, Meghj & Burnstock,
1984) that the adenosine receptor has no significant 
affinity for adenine nucleotides (Bruns, 1980a; Satchell,
1984), and conversely that ADP and ATP receptors have 
little or no affinity for adenosine (Burnstock, 1972). It 
is reported that all adenosine receptors are antagonised
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by theophylline, although some require rather high 
concentrations, whereas the responses mediated by ADP and 
ATP i.e., P2 purinoceptors are unaffected by theophylline.
1.2.3.3 The flP-sitelf an intracellular site of action for 
adenosine
In addition to an action at extracellular adenosine 
receptors, adenosine can inhibit adenylate cyclase by 
interacting with an intracellular "P-site", that appears 
to be located on the catalytic subunit of adenylate 
cyclase (Premont, Guillon & Bockaert, 1979). The P site 
has a low affinity for adenosine, in the high micromolar 
range and is not blocked by methylxanthines (Bruns,
1980b).
The ability of adenosine to stimulate cAMP production in- 
some cells and inhibit cAMP production in others, gave 
rise to a subdivision of PI purinoceptors into Ri and Ra 
receptors, by Londos, Cooper & Wolff (1980) and into Al 
and A2 respectively, by Van Calker, Muller & Hamprecht 
(1979). In many instances PI receptors control adenylate
cyclase activity but not all, and the subdivision of the
PI receptors has been adopted not on the interaction with
a secondary messenger, but on the relative order of
potency of a series of adenosine analogues (for discussion 
see Stone, 1985a, and Hamprecht & Van Calker, 1985). The 
classification of any receptor only in terms of agonist 
potency can produce anomalies and complicate the 
interpretation of experimental data (for discussion see 
Collis, 1985) but it is a simple and effective method for 
categorising a physiological response to a particular 
adenosine receptor, until truly selective antagonists are 
available.
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From the data derived from extensive binding studies by 
Bruns, Lu & Pugsley (1986) and other researchers a 
detailed view of the adenosine receptor environment has 
been constructed and these structure activity 
relationships, have proved useful in classifying the 
actions of adenosine agonists on a particular response 
e.g., the correlation of hypomobility effects of adenosine 
analogues in mice by Durcan & Morgan (1989) and the 
binding of A2 receptor ligands. More recently it has been 
demonstrated that the Al and A2 receptors for adenosine 
are distinct proteins of different molecular weights (Mr 
38000 and 45000 respectively) and that each displays the 
appropriate pharmacological profile (Stiles & Jacobson, 
1988; Barrington, Jacobson, Hutchinson, Williams & Stiles,
1989). Research is currently in progress to purify the Al 
adenosine receptor in order to study its properties and 
obtain amino acid sequence data and clone the receptor 
gene. As with other 'cloned receptors' these experiments 
should allow the transfection, and expression of the 
adenosine receptor into a suitable cell line, to study of 
the intracellular transduction mechanism.
There is increasing evidence suggesting purines can 
modulate cholinergic transmission in the autonomic nervous 
system (Siggins, Gruol, Padjen & Forman, 1977; Burnstock, 
Cocks, Crowe & Kasakov, 1978 ,; DeGroat & Booth 1980;
Akasu et al., 1981, 1982, 1983a,b; Silinsky & Ginsborg,
1983) and these actions are discussed in detail in chapter 
5. The presence of purinergic nerves has been described 
in peripheral systems including perivascular nerves and 
ATP rather than adenosine is considered to be the 
neurotransmitter in such nerves (Burnstock, 1978).
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1*2.4 The actions of purines in sympathetic ganglia
Consistent with the idea that purinergic nerves release 
ATP was the finding by Silinsky & Ginsborg (1983) who 
reported ATP and not adenosine inhibited the release of 
ACh from preganglionic nerves of frog lumbar sympathetic 
ganglia. As the inhibition of ACh release by ATP was 
antagonised by 2mM theophylline and ACh release was 
unaffected by the P2x selective agonist alpha,beta-MeATP, 
Silinsky & Ginsborg (1983) concluded the receptor 
responsible for the inhibitory effects of ATP was not a 
PI or P2 purinoceptor. Perhaps this ganglion contains a 
theophylline sensitive P2 receptor, however with hindsight 
it would be useful to study the inhibition of ACh using 
more selective agonists e.g. 2-methylthioadenosine 
triphosphate (2MeS-ATP), and more selective antagonists 
e.g. 8-phenyltheophylline (8PT) to determine if the 
effects of theophylline are due to receptor antagonism or 
indirect via an increase in intracellular calcium 
([Ca^+ ]i) and/or cAMP.
In contrast to Sklinisky & Ginsborg (1983), Akasu and his 
colleagues published an elegant set of experiments showing 
that PI purinergic transmission can occur in some 
autonomic ganglia. Akasu, Shinnick-Gallagher & Gallagher 
(1984), were able to mimic the slow hyperpolarising 
synaptic potentials i.e. the sIPSP of cat vesical 
parasympathetic ganglia, by applying exogenous adenosine. 
Both the sIPSP and adenosine hyperpolarisation were 
depressed by caffeine and adenosine deaminase (ADA), and 
potentiated by dipyridamole (DIP), an adenosine uptake 
inhibitor. The sIPSP and the hyperpolarisation induced by 
adenosine had a similar reversal potential of about -93 mV 
suggesting the activation of an outward K+ current. A 
study by Kato, Katz & Collier (1974), failed to detect the 
release of tritiated ([%]) ATP ([%]ATP) during
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preganglionic stimulation of cat SCG prelabelled with 
tritiated adenosine (3[H]-AD), suggesting ATP is not released 
upon electrical stimulation of these nerves. However the 
incorporation, release and metabolism of 3[H]-AD by cat SCG 
was not determined in the above study. Thus the possiblity 
that in vivo cat SCG neurones release adenosine and/or ATP 
which is rapidly metabolised to adenosine which modulates 
synaptic transmission has yet to be assessed.
Release of adenosine may occur via presynaptic (Silinsky,
1975) or postsynaptic sites (Fredholm, Fried & Hedqvist,
1982) and it has been suggested that adenosine may be a 
retrograde inhibitor of synaptic transmission (Israel,
Lesbats, Manaranche, Menunier & Franchon, 1980). Thus ACh 
released alone or with a cotransmitter
could activate the postsynaptic region to 
release adenosine, which may inhibit further ACh release.
The spontaneous release of purines has been observed when 
ganglia are labelled with tritiated adenosine (^[H]-AD) 
both in culture (Wolinsky & Patterson, 1985), and for 
intact rat SCG (McCaman & McAfee, 1986) and frog 
paravertebral ganglia (Rubio, Bencherif & Berne, 1988).
Purine release was increased by brief exposure to high 
potassium (Wolinsky & Patterson, 1985; McCaman & McAfee,
1986; Rubio et al., 1988). Intact rat SCG also increased 
their release of 3[H]-purines during presynaptic 
electrical stimulation and hypoxia, suggesting purines may 
be involved in the physiological response to stress.
It is interesting that Bencherif, Rubio & Berne (1986) 
found orthodromic stimulation of both frog and rabbit 
sympathetic ganglia, caused concurrent release of both 
3[H]-AD and ^[H]-ACh. Even more interesting is the report 
that ^[H]-purines, of which 60% was ^[H]-AD, are 
spontaneously released from the postsynaptic structures of 
the frog ganglion. The rate of release of ^[H]-purines 
was increased by both antidromic stimulation and the 
application of carbachol, but the relative proportion of
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3[H]-AD was constant, suggesting 3[H]-AD was released 
directly and not as a consequence of the extracellular 
metabolism of ^[H]-AD. Rubio and colleagues concluded 
that the primary release of adenosine was from the 
postsynaptic structures during synaptic activation.
It is tempting to regard the results of Rubio and 
colleagues as evidence for a role of adenosine as a 
retrograde inhibitor of synaptic transmission (Israel et 
al., 1980), but the results of Silinksy & Ginsborg (1983) 
are at variance with this idea. Silinsky & Ginsborg 
(1983) found ATP and not adenosine inhibited the release 
of ACh from preganglionic nerves of the frog lumbar 
sympathetic ganglia. An alternative mode of action of 
postsynaptically released adenosine would be to depress 
the postsynaptic response to ACh. During sustained nerve 
activity the level of adenosine would rise dramatically, 
due to both the degradation of ATP to adenosine and the 
postsynaptic release of adenosine upon depolarisation, 
leading to the activation of postsynaptic adenosine 
receptors and depression of the postsynaptic response to 
ACh.
1.2.4.1 Can purines alter the postsynaptic response of
ganglia to neurotransmitters?
There are a few reports that provide good evidence that 
purines can alter both pre- and postsynaptic events of 
sympathetic ganglia. ATP was found to modulate the 
postsynaptic response of bullfrog sympathetic neurones to 
ACh (Akasu & Koketsu, 1985) and GABA (Morita et al., 1984) 
and may arise from an increased sensitivity of the 
nicotinic receptors due to an action of ATP on an 
allosteric site of the ACh receptor-ion channels (Akasu & 
Koketsu, 1985).
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1.2.4.2 Effect of purines on the rat SCG.
Both Henon & McAfee (1983b) and Alkadi et al. (1984) 
reported that adenosine and its analogues decreased 
synaptic transmission in the isolated rat SCG by reducing 
the height of the compound action potential (CAP). Henon 
& McAfee (1985) concluded "these agents are presumed to 
act presynaptically since they do not affect postsynaptic 
responses to exogenous cholinergic agonists". At high 
frequencies of stimulation adenosine facilitated 
ganglionic transmission during repetitive stimulation of 
the preganglionic nerve (Henon & McAfee, 1983a,b). It was 
postulated that adenosine functions as a "high pass 
filter", inhibiting single or weak synaptic inputs but 
facilitated transmission of higher frequency events,
(Henon & McAfee, 1985) and this action would be 
appropriate as a mechanism for boosting synaptic 
transmission in times of stress.
Using intracellular electrodes, Henon & McAfee (1983a) 
found that adenosine (l-200uM) produced small (1-4 mV) 
transient hyperpolarisations, which were not dose-related 
and inconsistent in different trials on the same cell. In 
contrast the application of adenosine during the 
intracellular generation of postganglionic action 
potentials inhibited three Ca^+ dependent potentials, 
namely, a) a shoulder on the falling phase of the action 
potential (AP); b) an after-hyperpolarisation (AHP) and c) 
a regenerative Ca^+ spike (recorded in tetrodotoxin (TTX) 
and tetraethylammonium (TEA)). The potency order for 
inhibition of Ca^+ currents was R(-)-Phenylisopropyl- 
adenosine (R-PIA) > 2 chloro-adenosine (2CA) > adenosine 
(AD) > cyclic adenosine-5-monophosphate (cAMP). The 
effects of adenosine and 2CA were antagonised by 
theophylline, suggesting an external PI purinoceptor, but 
Henon & McAfee did not assign a receptor subtype. These
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researchers concluded that the adenosine hyperpolarisation 
"does not appear to be an important mechanism in 
sympathetic ganglia” and that adenosine directly inhibits 
postganglionic inward Ca^+ currents. These results have 
been cited and interpreted by Ribeiro & Sebastiao (1986) 
to provide support to the concept of a third adenosine 
receptor, which is linked to decreased calcium entry.
1.3 AIMS OF THESIS
The studies reviewed above suggest that purines such as 
adenosine and ATP may function to modulate the 
postsynaptic sensitivity of the rat SCG. It is the aim of 
this thesis to answer the following questions:
1. Do purines and pyrimidines alter the membrane 
potential of the rat SCG and what receptors are 
responsible for any potential changes?
2. Do purines and pyrimidines modulate the postsynaptic
sensitivity of the rat SCG to other agents?
3. Does adenosine alter the membrane potential of the 
rat SCG by inhibiting the entry of extracellular 
calcium.
4. What biochemical events mediate the actions of
adenosine? Does adenosine function via an
intracellular messenger to affect cyclic nucleotide 
metabolism.
20
Plate 1. Photograph of an isolated superior cervical 
ganglion of the rat showing the major nerve trunks.
The postganglionic nerve trunks are denoted by ICN for the 
internal carotid nerve and ECN for the external carotid 
nerve. The cervical sympathetic trunk (CST) forms the 
preganglionic nerve input.
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Plate 2. Photograph of an isolated superior cervical 
ganglion of the rat in a 'Perspex1 recording chamber as 
used for recording direct current potentials between the 
perfused central chamber, containing the ganglion body and 
the right hand postganglionic chamber, containing the 
internal carotid nerve (ICN).
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Fig. 1 Structural formula of adenosine illustrating the 
nomenclature used in this thesis.
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Chapter Two EXPERIMENTAL METHODS 
Introduction
The rat SCG preparation has been extensively studied both 
iv vivo and in vitro and the pre- and post-ganglionic 
nerves are easily identified. Classically the ganglion is 
left in situ and is perfused through its normal 
vasculature and this method is most suited to large 
animals such as the cat or rabbit (for review see Collier 
& Kwok, 1982). In vivo the high metabolic activity of the 
rat SCG is maintained by the passage of nutrients and 
oxygen into a capillary plexus from its rich blood supply 
via the neck into both pre- and postganglionic nerve 
trunks•
The isolated superfused SCG has been described as the 
'poor mans microelectrode' by which it is meant that some 
indication of the effect of drugs on the resting membrane 
potential (RMP) can be inferred from changes in the 
polarity of the ganglion i.e., the change in direct 
current (d.c.) potential recording. The major difference 
between intracellular and extracellular recording 
techniques, is that an intracellular electrode records 
mainly the membrane potential from a single cell body, 
whereas both the sucrose and grease gap methods record the 
local field potential generated by the somas of the 
ganglion cells that span the gap and their initial axon 
segments and a part of the proximal axons.
The method adopted here was a modification of the sucrose- 
gap technique (Kosterlitz & Wallis, 1966; McAfee & 
Greengard, 1972) where a grease-gap is used instead of 
sucrose as the later technique requires the precise 
control of flow rates during the recording and changing 
the perfusate, to reduce flow artifacts. The grease gap
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as described here had similar properties to those reported 
by McAfee & Greengard (1972) but without the complications 
and confounding factors of the sucrose gap method. The 
grease-gap method can be used to record both the basal 
d.c. potential and synaptic potentials of superfused 
ganglia. The neurones of the rat SCG are isolated from 
their environment by a thick continuous capsule of 
connective tissue and this must be removed for in vitro 
experiments, to allow full penetration of drugs, oxygen 
and superfusate (see Watson, 1969). Desheathed rat SCG 
can be maintained in vitro for hours, with no change in 
morphological integrity (Sansone, Mclsaac & Tomasulo,
1982) and qualitatively similar responses to some drugs 
can be obtained even after overnight storage (Brown & 
Caulfield, 1979; personal observation). Thus the isolated 
rat SCG is fairly robust and useful ganglion for the 
analysis of the actions of drugs on neuronal tissue.
The major difference between intracellular and 
extracellular recording techniques, is that an 
intracellular electrode records mainly the membrane 
potential from a single cell body, whereas the grease gap 
records the local field potential generated by the 
membrane current generated from the somas of the ganglion 
cells that span the gap but also from their initial axon 
segments and a part of the proximal axons. The sucrose 
gap requires the precise control of flow rates during the 
recording and changing the perfusate, to reduce flow 
artifacts. The grease gap as described here had similar 
properties to those reported by McAfee & Greengard (1972) 
but without some of the complications and confounding 
factors of the sucrose gap.
A recent development has been the introduction of the 
isolated perfused rat sympathetic ganglion, as described 
by Birks & Isacoff (1988). The isolated perfused rat SCG
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appears to have some distinct advantages over the grease 
gap method as it allows the rapid access and equilibration 
of drugs and ions at the synaptic site and minimises the 
accumulation of potassium in the intracellular space, 
during electrical stimulation. However as this new 
technique was unreported until a substantial part of the 
experimental work for this thesis was completed, the 
results presented here are from experiments using the 
grease-gap method.
2.1 Drugs and solutions used
The compounds, names of chemical suppliers and 
abbreviations used in this study are listed in table 2.1. 
All other chemicals were obtained from British Drug Houses 
(BDH) Ltd or Fisons Ltd and were of "Analar" quality.
I am most grateful for the generous gifts of: 
methyIfurmethide (MeF) and dihydro-beta-erthroidine (DHBE) 
from Merck Sharp & Dohme, USA; pirenzepine and 
dipyridamole (DIP) from Thomae-Biberach/Riss, DGRM; AFDX- 
116 from Boeringer Ingelheim, Bracknell, U.K.; 4—(3— 
butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724) 
from Roche Products Ltd, Welwyn Garden City, U.K.; Dr. 
Barraclough of The Wellcome Foundation Ltd for erythro-6- 
amino-9-(2-hydroxy-3-nony1) purine hydrochloride (EHNA); 
Dr. R. Marshal of University of Wales, for Suramin, Dr. 
J.W. Daly of NIH for l-propargyl-3,7-dimethylXanthine 
(DMPX); Dr. N.J. DeSouza of Hoechst, India for forskolin 
(FSK); Dr. Lucania of the Squibb Institute for Medical 
Research, NJ, USA for SQ 22-536; May & Baker Ltd., 
Dagenham, U.K., for M&B 22948 and Professor Stone for 6- 
( 2 - h y d r o x y - 5-Nitrobenzyl-thioguanosine) (HNBTG), A23,187 
and N6-(9H-fluorenylmethyl) adenosine (PD 117,413).
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2.1.1 Composition of the physiological salt solution 
(PSS)
SCG preparations were normally perfused with a PSS which
had the following composition (mM) - NaCl, 125; NaHC03,
25; KC1, 5; KH2P04 , 1; MgS04 , 1; glucose, 10; CaCl2 , 2.5;
and all procedures were carried out using this PSS unless
stated differently in the text. Nominally calcium free
PSS (0Ca2+ PSS) contained no added CaCl2. It is expected
that a PSS without added calcium chloride, i.e. OmM Ca2+
PSS could have as much as 30uM free Ca2+ in solution, due 
2+to Ca leaching from glassware and contamination from 
chemicals used (Campbell, 1983). To reduce the calcium 
concentration to submicromolar concentration PSS was 
prepared without added calcium chloride and with 2mM EGTA, 
and is referred to as 0Ca2+/EGTA PSS. For a nominally 
potassium free PSS (0K+ PSS), KC1 was omitted and KH2P04 
was replaced with an equimolar concentration of Na2HP04 
(lmM). For nominally magnesium free PSS (0Mg2+ PSS), 
Mg2^04 was omitted and the magnesium concentration present 
was estimated from the manufacturer’s data as less than 
lluM. Phosphate and sulphate free PSS were made by 
replacing Mg2S04 by MgCl2 (lmM) and KH2P04 by KC1 (lmM). 
This PSS was used when calcium chloride was replaced by 
cobalt (C02+) chloride, cadmium (Cd2+) chloride, or barium 
(Ba2+) chloride.
HEPES PSS was prepared by replacing the NaHCO^ of the 
phosphate and sulphate PSS with 5mM HEPES. NaCl was 
replaced by LiCl (125mM) for Lithium-HEPES (Li-HEPES). 
Calcium was replaced by lanthanum for lanthanum-HEPES (La- 
HEPES). Sucrose at 20mM in PSS was used when comparing 
the response of adenosine to that in Li-PSS (lithium 
chloride lOmM added to PSS) to avoid changes in osmolarity 
(Sebastiao, 1989). Rubidium (Rb2+) at lmM was added to 
PSS to give a PSS containing lmM Rb. Rb-PSS was prepared
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by replacing 6mM potassium chloride with 6mM rubidium 
chloride. Low Cl PSS containing 8.5mM [Cl”]e was made by 
modifying PSS by replacing sodium chloride with sodium 
isethionate (at 125mM) and replacing potassium chloride by 
potassium hydrogen carbonate (5mM).
PSS were made fresh each day in double glass distilled 
water or milli-q (Millipore systems) water to prevent the 
precipitation of trace impurities. PSS solutions were 
oxygenated with 5% carbon dioxide/95% oxygen and HEPES 
solutions with pure oxygen for at least 30 minutes before 
use. Random checks of PSS with a pH meter or blood gas 
analyser indicated that a pH of 7.4 was maintained.
When necessary drugs were dissoved in PSS as lOmM stock 
solutions in 10 to 100 uL of hydrochloric acid (1 or 10 M) 
or sodium hydroxide (1 or 10 M) and stored as aliquots at 
-20°C. Drugs diluted in PSS did not alter the pH of the 
PSS perfused on to the ganglion. Cromakalim was made up 
as a stock solution (10mM) in 70% ethanol and lemakalim as 
a lOmM stock solution in 50% polyethylene glycol.
Where drugs were dissolved in solvents control responses 
for vehicles were determined and are described in table 
2.2. Changing from PSS to a new PSS often altered the 
d.c. potential and/or the response to adenosine (Table 
2.2) and therefore all experiments to examine the effect 
of drugs were performed using suitable control PSS of the 
same composition as the PSS containing drugs.
The effect of Ca2+ channel antagonists on the response to 
adenosine and the depression of muscarine was assessed by 
changing from the appropriate PSS containing metal ions or 
Ca2+ channel antagonists. Nickel (Ni+) chloride at 500uM 
or lanthanum (La3+) chloride at 20uM was added directly to 
PSS and for a lmM Ni-PSS nickel chloride replaced 2.5mM
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calcium chloride in PSS. Experiments using 
dihydropyridines (DHPs) were carried out with the tissue 
bath in the dark. The perfusate and associated equipment 
were kept in darkness apart from a safety lamp (Wratton 
series filter number 1, 60 watt bulb) placed about 1 meter 
and at 45 degrees to the tissue bath. DHPs were dissolved 
in absolute ethanol as lOmM stock solutions and diluted at 
lOOul stock solution per litre PSS. Ethanol did not alter 
the d.c. potential but did significantly reduce the 
response to adenosine (Table 2.2); the effects of 
incubation with DHPs were compared to control responses in 
PSS + ethanol (2mM).
2.2 DISSECTION AND ISOLATION OF THE SUPERIOR CERVICAL 
GANGLION
Male Wistar rats (120 to 390g) obtained from the animal 
houses of St. George’s Hospital Medical School (SGHMS) or 
SKB, were maintained at 22 + 1°C, on a 12 hour light/dark 
cycle, with food and water available ad libitum.
In a few preliminary experiments carried out at SGHMS rats 
were killed by a blow to the head and cervical dislocation 
rather than with a lethal dose of urethane. In all other 
experiments rats were injected with urethane (1.5- 
2.0g/kg), given intraperitoneally as a 25% w/v solution in 
saline. Rats in terminal anaesthesia were pinned, ventral 
side up. The thoracic cavity was opened and the aorta was 
cut to drain off the blood from the head and neck region. 
The skin of the neck region was cut longitudinally from 
the mid-thorax to the jaw, and removed. The overlying 
fatty tissue and underlying muscle was dissected away to 
expose the trachea and oesophagus, which were removed.
The common carotid arteries and vagus nerves were 
separated from the preganglionic cervical sympathetic
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trunk (CST). The ganglia were located by following the 
preganglionic sympathetic trunk to the carotid 
bifurcation. Under a binocular microscope (x 10), the 
preganglionic nerve was separated from the vagus and 
carotid artery, using watch makers No.5 forceps. The 
ganglia was cut away from the carotid artery at the level 
of the bifurcation by holding the connective tissue 
surrounding the ganglion or the external carotid nerve 
(ECN) and cutting underneath the ganglion body with 
iridectomy scissors. The postganglionic internal carotid 
nerve (ICN) which lies next to the internal carotid artery 
was gently cut free with iridectomy scissors and followed 
down the bony projection of the hyoid arch, as far as 
possible before cutting. At least 25mm of CST and 5mm of 
ICN was obtained by this method. The contralateral 
ganglion was removed from the animal within 5 minutes, 
while the first ganglion was maintained in about 30 mL PSS 
in a glass petri dish, kept in a moist saturated 
oxygenated chamber. The first ganglion was then placed in 
fresh PSS in a petri dish and the connective tissue sheath 
removed, with the aid of a dissecting microscope (x40), 
and the ganglion placed in the incubating chamber while 
the other ganglion was desheathed.
2.3 ELECTRICAL RECORDINGS 
2.3.1. Preparation of electrodes
Preformed disc electrodes (product code E202, 2mm dia x 
4mm deep, Clark Electromedical Instruments) were inserted 
into the top of a cut down plastic lmL Luer syringe. The 
electrodes were glued in place overnight, and were ready 
for use the next day. The tissue bath was designed to 
allow the electrodes to be easily removed for replacement 
and cleaning of the bath and electrodes (plate 2.2).
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Electrodes were either kept in place overnight, or when 
not used for a few days placed in a 20mL glass vial 
containing sterile saline. Before use each day electrodes 
were washed with PSS and allowed to equilibrate while the 
dissection was performed. The recordings of the d.c. 
potential taken at this time showed little drift in the 
base line, indicating the electrodes were satisfactory.
2.3.2 Extracellular d.c. recording
The tissue bath was based on a modification of the sucrose 
gap technique first described for use with rabbit SCG by 
Kosterlitz, Lees & Wallis (1968), and modified for use 
with the rat SCG, using insulating grease-sealed 
partitions by Brown & Marsh (1978) and Newberry, Priestley 
& Woodruff (1987).
Desheathed ganglia were mounted in a three compartment 
bath, with the ganglion body situated in the central 
chamber (bath volume about 500 uL) and the pre- and post­
ganglionic trunks protruding through lightly greased (High 
vacuum silicon grease, BDH) slots into the outer chambers 
as shown in plate 2.1. This was achieved by placing the 
nerve trunks above the slot of each of the lower barriers 
and lightly pressing down pregreased upper barriers onto 
the nerve trunks, in order to form an efficient electrical 
seal. All chambers were filled with PSS and perfusion of 
the central chamber started. The pre- and post-ganglionic 
chambers were covered with a piece of greased glass and 
the junction between the glass and the barriers greased to 
prevent differential evaporation of PSS. Pre-oxygenated 
perfusate passed through a heating coil to arrive at the 
tissue bath at 25 + 1°C (measured with a small 
thermocouple). Perfusate was run to waste via fibre wicks 
(Boots 3 star nappy liner) placed in between the barriers.
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The potential difference (p.d.) between the central 
chamber (earthed to reduce electrical noise) and the 
adjacent chamber was recorded i.e., for the SCG between 
the ganglion body and the ICN or ECN. The potential 
difference was filtered through a 1M ohm resistor and a
2.2 uF capacitor in parallel, to allow only d.c. 
potentials to be recorded. Preliminary monitoring of the 
recordings on an oscilloscope of the electrodes before and 
after filtering confirmed that 50Hz was removed by the 
filter. No difference in the time course of the response 
to drugs was seen with or without the filter but the basal 
noise was dramatically reduced. The resistance of the 
ganglia recorded in situ was about 60K ohms and changes in 
d.c. potential were amplified via d.c. pre-amplifiers 
(Electromed, model 3461/3460 with 10M ohms input 
impedance) and recorded on a two channel Electromed pen 
recorder (model MX216).
2.3. Application of drugs
A maximum of up to 300 uL of concentrated drug solution 
was diluted with 10 or 20 mL PSS for superfusion on to the 
ganglion. Drugs were superfused by changing the flow from 
a reservoir containing PSS to a glass vial containing 
drug/s in PSS. The flow rate was constant for each tissue 
bath and averaged around 2.5 mL per minute, ensuring the 
bathing fluid was exchanged 4 to 5 times each minute. The 
time required for the drug to reach the ganglion, i.e., 
the 'dead time' was estimated from preliminary 
experiments, by measuring the time taken for; (a) a dye to 
reach the central chamber or (b) a small air bubble to 
arrive at the chamber and (c) a ganglion to response to 
12mM potassium. All three methods were in good agreement 
with each other and the 'dead time' was estimated to be 
around 25 seconds.
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2.4. Presentation of results
In each experimental record a bar shows the point where a 
drug reached the ganglionic chamber and a downward 
deflection of the recording pen represents a 
hyperpolarsiation of a ganglion. Responses were recorded 
so that a 40mm pen deflection was equivalent to a change 
in potential difference of 500 microvolts (uV). The 
concentration of the drug in the perfusate is shown under 
the bar.
2.5. Calculations and evaluation of data
Results from different experiments are summarised as the 
mean + standard error of the mean (SEM), and the number of 
ganglia studied (N). A minimum of two experiments and 
animals were used to obtain each set of results. Data are 
presented either as response in uV or as a % change from 
control response on the same ganglion. Statistical 
analysis was performed on untransformed data (values in 
uV) using a paired or unpaired t-test (2 tailed), and 
values were considered statistically significant if P 
values of less than 0.05 were obtained. Where data was 
expressed as a % depression of muscarine, responses were 
compared for statistical significance (P < 0.05) using the 
Wilcoxon signed rank test.
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Table 2.1. Compounds used and their suppliers and 
abbreviations used throughout the text.
COMPOUND ABBREVIATION
Sigma Chemical Corporation:
2-chloroadenosine 2CA
acetylcholine chloride ACh
adenosine aminohydrolase, Type III ADA
adenosine hemisulphate AD
adenosine 5'-triphosphate disodium ATP
adenosine 3':5'-cylic monophosphate monosodium cAMP
bovine serum albumin, fraction V (product code
A-7638) BSA
8-bromo-adenosine 3 ,:5,-cylic monophosphate
monosodium BBrcAMP
N6-2*-O-dibutryladenosine 3*:5'-cylic
monophosphate monosodium dbcAMP
4-aminopyridine 4AP 
alpha-beta-methylene-adenosine-5' triphosphate a,b-MeATP
sodium
beta-gamma-methylene-adenosine-5' triphosphate b,g-MeATP 
sodium
atropine methyl nitrate N-Me-ATR
apamin Apamin
carbachol chloride CCh
cytidine 5'-triphosphate, Type III sodium salt CTP
cobaltous chloride CoCl
3,4-diaminopyridine 3,4DAP
1,1 dimethyl-4-phenyl piperazinium iodide DMPP
ethyl carbamate (urethane)
ethylene glycol-bis(b-aminoethylether)-N,N,N*,N*, EGTA 
tetra acetic acid 
eledoisin related peptide dihydrochloride ERP
furosemide FUR
gamma-aminobutyric acid GABA
hexamethonium bromide HEX
N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic
acid HEPES
5-hydroxytryptamine 5HT
indomethacin INDO
inosine I
isoprenaline ISO
l-(5-(isoquinolinylsulfonyl)-2-methylpiperazine
dihydrochloride H7
isethionate sodium
lanthanum chloride LaCl
5 *-deoxy-5 *-methy1-thioadenosine MTA
5*-N-ethyl-carboxamidoadenosine hydrate NECA
D-Ala-6-luteinising hormone releasing hormone LHRH
noradrenaline d-bitartrate NAdr
nordihydroguaiaretic acid NDGA
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pilocarpine hydrochloride PILO
pentobarbitone sodium PB
2-phenylaminoadenosine PAA
phorbol 12,13-dibutyrate PDBu
sodium carbonate NaCC^
sucrose sucrose
tetraethylammonium TEA
theophylline THEO
tetrodotoxin TTX
trifluoperazine TFP
d-tubocuarine chloride d-TC
uridine 5 1-monophosphate disodium UMP
uridine 5 1-triphosphate sodium UTP
Research Biochemical Incorporated (Semat, UK)
N6-benzyladenosine 
eyelopentyladenosine 
8-cyclopentyl-l,3-dipropylxanthine 
dipyridamole
5 *-N-ethylcarboxamidoadenosine 
muscarine hydrochloride 
8-phenyltheophylline 
8-para-sulfophenyl-theophylline
2-methyl-thioadenosine 
methoctramine hydrochloride 
oubain octahydrate 
oxotremorine-M
N6-(2-phenylisopropyl)adenosine R(-)-isomer 
N6-(2-phenylisopropyl)adenosine S(+)-isomer 
xanthine amine congener
British Drug Houses Ltd
cadmium chloride 
ethyl alcohol
nicotine hydrogen (+) tartrate 
potassium acetate
Aldrich Chemical Company Ltd
lithium chloride
May & Baker
5-hydroxytryptamine creatine sulphate
Fisons Ltd
barium chloride 
nickel chloride
BZA
CPA
DPCPX
DIP
NECA
MUSC
8-PT
8psPT
2-MeS-ATP
MTO
OU
OXO-M
R-PIA
R-PIA
XAC
CdCl 
EtOH 
NICO 
K Ac
LiCl
5-HT
BaCl
NiCl
I am indebted to SKB and in particular the 
antihypertension and chronic organic brain disease 
research groups for supplying the following:
cromakalim 
lemakalim 
denbufylline
5-carboxytryptamine 
(+) isradipine 
nitrendipin
BRL 34915 
BRL 38227 
BRL 30892 
5-CT
(+) PN 200-110 
NITR
Table 2.2. Effect of different drug vehicles and 
physiological salt solutions on the response of the rat 
SCG to adenosine
The statistical significance (paired t-test) between 
normal PSS and the new PSS is denoted by * for P<0.05.
PSS N Response to 
(lOOuM, 2 
PSS
adenosine 
minutes 
new PSS
PSS +
BSA (80mg/L)
4 -69 + 14 -45 + 10*
PSS +
ethanol (2mM)
8 -79 + 7 -69 + 9*
PSS +
sucrose (20mM)
4 -110 + 12 -79 + 4*
Ca2+ HEPES 6 -60 + 7 -50 + 6
P04/S04 free 3 -65 + 3 -53 + 3
Changing from PSS to PSS + sucrose (20mM) produced a 
transient depolarisation in two out of four ganglia (+40 + 
23uV, n=4) but no change in the response to adenosine or 
muscarine.
There was no significant difference in the depression of 
the response to lOOnM muscarine by lOOuM adenosine in PSS 
-26 + 4% and in HEPES-PSS was -19 + 3% (n=6).
Changing from PSS to P0^/S04 free PSS did not alter the 
basal d.c. potential or the response to adenosine.
Changing from PSS to HEPES-PSS produced a transient 
depolarisation (205 + 77uV, n=6) that returned to the 
original baseline within 20 minutes, with no significant 
effect on the responses to adenosine or the response to 
12mM K+ (response in PSS * 278 + 36 and Ca HEPES-PSS 308 
+ 49uV (N = 3)).
CHAPTER THREE 
EFFECTS OF PURINES AND SOME PYRIMIDINES 
ON THE RAT SCG
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Chapter Three 
INTRODUCTION
While studying the effects of catecholamines on the rat 
SCG, Brown, Caulfield & Kirby (1979) noted that exogenous 
cyclic AMP (10-lOOuM) and related compounds 
hyperpolarised. The relative potency of the compounds was 
AD > cAMP = AMP > ADP > ATP > dibutyryl cyclic AMP 
(dbcAMP). These results are consistent with the presence 
of P1-purinoceptors on the rat SCG as defined by Burnstock 
(1978). However the order of potency was based upon 
results for a single ganglion kept overnight before use 
and the maximum response to each compound was not 
obtained.
In order to determine if the rat SCG has receptors for 
adenosine and other purines a more detailed investigation 
was performed. Firstly the ability of adenosine and some 
purines to produce reproducible hyperpolarisations of the 
rat SCG was determined and quantified. Secondly the site 
of action of purines was elucidated in experiments to 
determine if adenosine indirectly activates the SCG e.g. 
via the release some mediator or if purines have an action 
on the nerve trunks. Thirdly it has been reported that 
the response of various tissues to a number of different 
transmitters is altered by the actions of adenosine (see 
review by Stone, 1989) and the ability of adenosine to 
alter the response of the rat SCG to muscarine and other 
agonists was examined.
3.1 VALIDATION OF EXPERIMENTAL METHODS AND THE EFFECTS OF 
ADENOSINE ON THE RAT SCG
The sympathetic ganglion presents various problems when 
quantitative measurements are required and to obtain
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consistent and reproducible responses the following 
factors were studied.
3.1.1 The effect of anaesthetic on the response to
drugs
No qualitative differences in the responses of the rat SCG 
(n=12) in PSS to adenosine, muscarine, potassium and 
carbachol were found between animals killed with urethane 
or those killed by spinal dislocation. This is in keeping 
with the report by Larabee (1961) that urethane 'washes 
out' of ganglia very quickly and does not alter the level 
of ganglionic ACh or choline levels (Consolo, Peri,
Prigioni, Ladinsky & Perri, 1978). Therefore ganglia were
routinely removed from rats killed with urethane.
3.1.2 Dissection of ganglia
Although particular attention was paid during the 
preparation of each ganglion, there was probably some 
variation between individual preparations. This is 
predictable both in terms of the variable anatomy of the 
ganglion, where it has been reported that the ICN has a 
variable number of postganglionic fibres from animal to 
animal (Haefely, 1972) and in terms of variation in the 
dissection and recording of the ganglion. The predominant 
cause of variability is likely to arise from missing or 
damaged nerve fibires and from the positioning of the 
ganglion across the barriers. This would alter the number 
of fibres that pass through the slot in the greased 
barrier and thus the number of ganglion cells that are 
recorded.
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3.1.3 Tissue Bath
Many of the problems encountered with the grease gap are 
similar to those of the sucrose gap, and have been 
discussed by Wallis, Lees & Kosterlitz (1975). However 
the grease gap replaces the high resistance sucrose 
chamber and the need for a constant flow rate, and has the 
advantage of reducing junction potential drift and 
solution change artifacts. With the method employed here 
only the central chamber is perfused. Perfusion of both 
central and postganglionic chambers resulted in 
qualitatively similar results but recordings with 
excessive noise and drift were obtained. The disadvantage 
of not perfusing the outer chambers, was that they were at 
room temperature (between 18 to 25°C) and not necessarily 
of the same ionic composition. The responses to potassium 
and adenosine were unaltered by increasing the potassium 
concentration of the postganglionic chamber (table 3.1). 
When appropriate the PSS in the outer chambers was changed
to the same solution as the new perfusate.
3.1.4 Measurement and consistency of responses
The grease gap method of recording the SCG is subject to 
some base line drift which was minimised by sealing the 
unperfused chambers with silicone grease. Some ganglia 
displayed a positive increase in p.d. during the first 
hour of perfusion which may have arisen due to an
increased resistance as the ganglion swells around the
grease gap to create a better seal. In initial pilot 
experiments, a downward drift in the base line occurred, 
but did not significantly alter the results, because of 
the large signal size/drift ratio. Downward drift may 
have occurred due to poor preparation of the ganglia or 
due to leakage across the barrier, and was detected by 
increased basal noise and intererence. The results from
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these ganglia were not included in the analysis of the 
results.
Responses to individual agents were defined as the 
deviation from baseline which was measured by 
extrapolating the trace preceding the response. For the 
depression of agonist responses by purines, the agonist 
response was measured from it*s start to the peak 
amplitude from the extrapolated baseline.
3,1,5 The effect of time on the response to agonists.
All drug regimes used were derived from initial 
experiments so that consistent results were obtained 
throughout an experiment (maximum of 12 hours). The 
sensitivity of isolated tissue preparations to agonists 
often changes during the course of an experiment. The 
results of experiments presented here suggest that the rat 
SCG showed a marked increase in sensitivity to muscarine 
during the first 2 to 3 hours of being placed in the 
tissue bath. Therefore all ganglia were allowed to pre­
equilibrate for at least two hours and preliminary 
responses to drugs were assessed. No ganglia exhibited 
any form of spontaneous activity.
Before studying the effects of purines on the response to 
agonists on the ganglion it was necessary to determine the 
reproducibility of the response to an agonist during the 
course of an experiment. Responses to repeated 
applications of an agonist were reproducible over many 
hours (Figs 3.1 and 3.2). In some experiments one control 
ganglion was run in parallel with test tissues to exclude 
any changes in sensitivity with time. When constructing 
concentration response curves the effect of time on the
42
response of control ganglia to agonists was examined by 
repeating the responses after a minimum of 30 minutes,
3.1.6 The effects of purines on the response to 
agonists
To determine the effect of a purine on the response to an 
agonist, two or three reproducible responses to the 
agonist were obtained and the last response used as the 
control i.e., the 'pretest response'. For the test 
response, a ganglion was perfused with a purine for 5 
minutes, and the agonist applied for one minute, a minute 
from the start of perfusion with purine. A minimum of 15 
to 20 minutes later the response to the agonist alone was 
repeated (post-test).
When studying the effect of purines on agonists each 
sequence of responses i.e., pretest/test/post-test took at 
least an hour and often only three or four concentrations 
of agonist could be evaluated in a day. Therefore some 
results are presented as a composite of responses obtained 
from randomised dose schedules. Because of the time taken 
to obtain data points and in order to reduce day to day 
variability the test responses are expressed as a % of the 
pretest responses. The pre and post test responses were 
within 20% of each other. When studying the effect of 
antagonists on the depression of muscarine responses it 
was only possible to study two concentrations of 
antagonist on the same ganglion, as each pair of 
determinations took about 3 hours.
To avoid desensitisation and inconsistent responses to 
purines a minimum of 20 minutes was allowed between 
applications. Concentration response curves (CRC) for non 
purine agonists were determined by applying single 
concentrations of drugs and washing for a minimum of
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twenty minutes unless reported differently# To construct 
concentration response curves agonists were applied at 
near or subthreshold concentrations, and then increased by 
threefold or tenfold, until the response size was maximal# 
Concentrations refer to those in contact with the 
ganglion. When changing the superfusate for a modified 
PSS, changes in d.c. potential generally reached a stable 
level within the 15 to 20 minutes and a minimum of 30 
minutes equibration time was allowed before the next 
response.
3.2 DETERMINATION OF THE SITE OF ACTION OF ADENOSINE ON 
THE SCG
There are several mechanisms by which purines may exert 
their actions including; altering the conduction of 
impuses in preganglionic and postganglionic neurones 
(Ribeiro & Sebastiao, 1984); by depressing the 
postjunctional activation of the ganglion cells to 
agonists (Gustaffson, 1981; Cox & Walker, 1987); by 
altering the release of a neurotransmitter from 
presynaptic nerve terminals (Silinsky & Ginsborg, 1983); 
by altering the interaction between neurones and other 
cells (El-Etr, Cordier, Glowinski & Premont, 1989).
The principle site of action of purines may be the 
postsynaptic soma-dendritic regions of the ganglion cells. 
However, one other site of action of purines may be on the 
preganglionic CST as an ATP-activated cation conductance 
has been found on mammalian neurones (Krishtal, Marchenko 
& Pidoplichko, 1983) and adenosine receptors have been 
located on axon terminals of excitatory neurones of 
cerebellar granule cells (Goodman, Kuhar, Hester & Snyder, 
1983) and in several white matter areas of the rat brain 
(Weber, Jones, Loshe & Palacios, 1990). In addition
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Ribeiro & Sebastiao (1987) reported adenosine enhanced and 
ATP decreased the inhibitory effect of TTX on action 
potentials recorded from frog sciatic nerves suggesting 
these nerves have functional receptors for adenosine. The 
function of these purine receptors is unknown but they may 
regulate neuronal conduction and arise from the axonal 
transport of adenosine receptors to the presynaptic 
terminal (Stone, 1981a). The presence of receptors for 
purines on axonal membranes of the rat SCG preparation may 
contribute to the change in p.d. recorded and the ability 
of purines to activate the axonal membrane of the CST of 
the rat was assessed.
Anatomical studies of the SCG have shown that the rat SCG 
comprises between 15,000 to 40,000 neurones that are 
divided into a caudal group of about 45% of the total that 
leave the ganglion via the ECN, and a rostral group 
comprising of about 35% of SCG neurones, leave the 
ganglion via the ICN (Bowers & Zigmond, 1979). The major 
input to the SCG is via the CST with a much smaller input 
via the ECN. Both the adrenergic cell bodies and 
dendrites of the SCG receive branching fibres from the 
cholinergic input of the CST. It is unknown if these 
anatomical differences are reflected in the responses 
obtained when recording the rat SCG via different 
postsynaptic nerve trunks. A few experiments were 
performed to decide if these anatomical differences are 
reflected in the ability of the ganglion to response to 
purines and muscarine.
In addition to hyperpolarising neuronal tissue adenosine 
can alter the response to a number of neurotransmitters 
and other agents (reviewed by Stone, 1989). In chapter 5 
the effect of adenosine on the response to different 
agonists is described in detail, but in summary adenosine 
was found to selectively depress the response to
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muscarinic agonists and this interaction was used to study 
the effect of purines and pyrimidines on the rat SCG,
METHODS. Modification
To examine the action of drugs on the CST, ganglia were 
dissected and the preganglionic CSTs desheathed and cut 
away from the ganglion body, 5mm distal from the body of 
the ganglion. About 20mm of CST was mounted in the tissue 
bath and maintained as for the SCG. The effect of drugs 
on the d.c. potential was measured by applying purines for 
2 minutes and muscarine (MUSC), potassium (K+ ), 5HT and 
GABA for 1 minute. In addition to recording ganglia via 
the ICN an additional five SCG were recorded between the 
ECN and the ganglion body and responses to muscarine or 
muscarine in the presence of adenosine were recorded.
RESULTS
3.2.1 Effect of adenosine on the d.c. potential of the 
SCG.
Application of 10 to lOOOuM adenosine for 2 or 5 minutes 
produced hyperpolarisations with a maximum amplitude of 
-100 to -280uV in different preparations. The mean 
hyperpolarisation produced by lOOuM adenosine on 42 
ganglia was -73 + 6uV (range -25 to 200uV). Figure 3.3 
shows hyperpolarisations produced by increasing 
concentrations of adenosine for 2 minute periods every 20 
minutes. The onset of the response was immediate, 
reaching a maximum 30 to 50 seconds after beginning 
application. Responses to adenosine at upto lOOuM were 
maintained throughout a five minute superfusion. At 300uM 
adenosine or higher, the responses peaked and stabilised 
at lower level. On washing out adenosine, there was a 
rapid return to the basal level, and apparent recovery
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within 5 minutes from the start of washing. The responses 
to adenosine appeared to be smaller when applied at less 
than 15 minute intervals, and hence more time was allowed 
between responses. Using two minute applications, 
reproducible responses were obtained every 20 to 40 
minutes throughout an experiment (maximum of 12 hours). 
Using this protocol, the hyperpolarisations to adenosine 
were dose related with an EC^q of lOuM and a maximal 
response at 300uM (Fig. 3.3).
3.2.2 Effect of tetrodotoxin (TTX) and pirenzepine 
(PIR) on the response of the SCG to adenosine.
In both PSS and OmM Ca^+/0mM Mg^+ PSS the hyperpolari­
sations to lOOuM adenosine were not significantly altered 
after pretreatment, for a minimum of 30 minutes with TTX 
(Table 3.2). In OmM Ca^+/0mM Mg^+ adenosine produced both 
a hyperpolarisation and an after depolarisation. The 
after depolarisation to adenosine in OmM Ca^+/0mM Mg^+ was 
abolished by TTX (Table 3.1). luM TTX also completely 
blocked the generation of action potentials, in two 
different ganglia (results not shown). In PSS pirenzepine 
abolished the response to lOOnM muscarine but did not 
alter the hyperpolarisation to lOOuM adenosine.
3.2.3 Effect of drugs on the CST
The results are summarised in figure 3.4 and application 
of either purines or muscarine had no significant effect 
on the resting d.c. potential of the CST. In contrast one 
minute applications of K+ , 5HT and GABA produced dose 
related depolarisations.
47
3.2.4 Effect of adenosine on the response to muscarine 
recorded via the ICN or ECN of the SCG
The response to lOOnM muscarine recorded via the ICN was 
reduced in a concentration dependent manner by increasing 
concentrations of adenosine. In the presence of lOOuM 
adenosine the response to lOOnM muscarine was reduced by 
26 + 2% (Table 3.5). The hyperpolarisation to adenosine 
measured in the first minute of application, recorded from 
the ECN were smaller than that recorded from the ICN (Fig. 
3.5a). The depolarisations to muscarine recorded from the 
ECN (334 + 37uV, n=5) were about half the size of those 
recorded from the ICN (532 + 59uV, n=9). There was no 
significant difference between the depression of muscarine 
by adenosine recorded via the ICN or the ECN (Fig. 3.5b).
DISCUSSION
The inactivity of purines and muscarine on the CST 
suggests the receptors for these drugs are either absence 
or inactive. The ability of GABA, 5HT and a non specific 
depolarising agent, potassium to depolarise the CST is 
consistent with the identification of receptors for GABA 
and 5HT on sympathetic neurones as described by Ireland 
(1987), Round & Wallis (1986) respectively.
The spontaneous generation of action potentials in the rat 
SCG could cause the release of ACh, to produce an 
endogenous cholinergic "tone", which would be abolished in 
the presence of TTX, a sodium (Na2+) voltage dependent 
channel antagonist, or in the presence of a selective Ml 
receptor antagonist, such as pirenzepine. The lack of 
effect of TTX, at a concentration found to abolish the 
generation of action potentials suggests the 
hyperpolarisation to adenosine is not the result of 
excitation of an inhibitory synaptic input from other
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neurones and adenosine does not activate voltage gated Na+ 
channels. A similar finding was reported by Henon &
McAfee (1983b) who found the depression of calcium spikes 
by adenosine on the rat SCG was not blocked in the 
presence of luM TTX. Further evidence against an action 
of adenosine on a cholinergic "tone" is provided by the 
inability of pirenzepine to alter the hyperpolarisation to 
adenosine.
It has been reported that activation of muscarinic 
receptors can hyperpolarise the ganglion via an indirect 
mechanism (discussion: chapter 1 and Ashe & Yarosh, 1984), 
but the ability of the pirenzepine to abolish the 
responses to muscarine and not adenosine, suggests the 
response to muscarine is via an action on muscarinic 
receptors of the Ml subtype.
If adenosine releases a putative hyperpolarising 
substance, then the release would most likely occur via a 
calcium dependent mechanism, as has been demonstrated for 
the release of ACh from SCG by Harvey & Macintosh (1940) 
and would be abolished in low Ca^+/high Mg^+ media. The 
enhancement of the response to adenosine in low calcium 
PSS suggests adenosine does not require a [Ca^+ ]e 
dependent process such as the release of ACh. It has been 
suggested that the hyperpolarisation to muscarinic agents 
on the rabbit SCG is partially mediated via the release of 
catecholamines from SIF interneurones of the ganglion 
(Christ & Dun, 1986), and it is possible although unlikely 
that adenosine could cause the release of catecholamines. 
Given that the release of catecholamines is calcium 
dependent the results presented do not support this 
hypothesis. Indirect evidence for a lack of involvement 
of catecholamines in the response to adenosine comes from 
the inability of phentolamine (Henon & McAfee, 1983b; 
Elliott, Marsh & Brown, 1989), and yohimbine and prazosin
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(Elliott et al., 1989) to antagonise the effects of 
adenosine on the rat SCG.
These results are consistent with the existence in the rat 
SCG of receptors for adenosine that hyperpolarise the 
ganglion via a direct action on postganglionic neurones. 
Experiments are described in chapter 4 to determine the 
ionic basis for the effects of adenosine and to determine 
if as with many tissues the actions of adenosine are 
linked to the actions of calcium.
Although two anatomically distinct populations of neurones 
have been described in the rat SCG there was no evidence 
to suggest these populations are qualitatively different 
in their response to adenosine and muscarine. As the 
responses recorded via the ECN to muscarine and adenosine 
were similar although smaller, and the literature reports 
are confined to ICN, in subsequent experiments only 
recordings via the ICN were made.
The depression of the response to muscarine is consistent 
with the idea that adenosine may modulate the 
postganglionic response of the neuroneal tissue to 
cholinergic agonists. The application of cholinergic 
agonists to the rat SCG may produce a number of effects 
including depolarising and hyperpolarisation and the 
ability of adenosine to alter these different responses is 
examined in detail in chapter 5.
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3.3 METABOLISM OF ADENOSINE BY THE SCG
It is well-documented that many tissues metabolise 
adenosine (Arch & Newsholme, 1978) and the effects of 
adenosine are mediated via adenylate cyclase (Stone,
1981a, 1989). Thus it might be expected that the rat SCG 
may metabolise adenosine and some of the actions of 
adenosine may be mimicked by cyclic nucleotides.
The inhibitory effect of adenosine on synaptic 
transmission is known to be enhanced by adenosine uptake 
inhibitors (Phillis & Wu, 1982) and it is curious that 
Alkadhi et al (1984) reported "that the uptake mechanism 
is not important in controlling the extracellular 
adenosine concentration in the superior cervical ganglion 
of the rat”. This conclusion was based on the observation 
that 2CA was equipotent with adenosine in inhibiting 
ganglionic transmission and dipyridamole at 1 and lOOuM 
failed to potentiate the inhibitory action of adenosine.
In contrast Henon & McAfee (1983a) reported that lOuM 
dipyridamole displaced the concentration response curve 
for the inhibition of the AHP by adenosine, so that the 
IC^q was about the same as that for 2CA. Alkahdi and 
colleagues do not adequately explain the reason for this 
discrepancy, and supported their argument for a lack of 
uptake by referring to the results of Henon & McAfee 
(1983a), who were unable to potentiate the accumulation of 
% - A D  from %-cAMP labelled ganglia in the presence of 
dipyridamole. It is important to note that there are many 
routes for the inactivation of adenosine (for excellent 
reviews see Arch & Newsholme (1978) and Gordon (1986)) and 
adenosine may be metabolised by enzymes such as ADA, 
adenosine kinase, and S-adenosylhomocysteinase, all of 
which maintain low levels of endogenous adenosine.
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Schubert (1988) has provided some evidence for the 
presence of a physiological concentration of adenosine, 
about luM, which had a depressive * tonus* on synaptic 
transmission. One criterion that should be met to ascribe 
a physiological role to adenosine i.e., as a 
neuromodulator is to show that a mechanism exists for the 
efficient removal and control of adenosine in the 
extracellular space and the synapse. The rapid response 
to adenosine (Fig. 3.1a) may indicate the receptors for 
adenosine are more closely linked to ion channels than 
those for the response to muscarine, which is thought to 
require the accumulation of intracellular messengers 
(Brown, 1983). Alternatively, the short-lived action of 
adenosine may result from the rapid degradation and 
elimination of adenosine from the medium, by ganglionic 
uptake and extracellular degradation to inactive 
metabolites. The ability of the rat SCT to degrade and 
take up adenosine, and the possibility of an adenosine 
* tonus* were examined.
3.3.1 Effects of ADA on the response to adenosine
ADA has been reported to reduce the inhibition of the AHP 
of the rat SCG produced by cAMP and adenosine (Henon & 
McAfee, 1983a). ADA, which catalyses the conversion of 
adenosine to inosine, reduced the hyperpolarisation of the 
rat SCG to adenosine (Fig. 3.6). These results suggest 
that inosine may be inactive on the rat SCG. This 
conclusion was confirmed by the lack of effect of inosine, 
at up to ImM on both the d.c. potential and the response 
to muscarine (Fig. 3.8, Table 3.3) and this is consistent 
with reports that inosine is a very weak activator of the 
adenosine receptors (Linden, 1989). Thus the ability of 
purines to interact with the binding sites for adenosine 
and produce a hyperpolarisation and depression of
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muscarine may require the presence of a nitrogen or an 
amine, in the 6 position of the purine ring (see Fig. 1).
Erythro-6-amino-9-(2-hydroxy-3-nonyl)purine hydrochloride 
(EHNA) is a competitive inhibitor of ADA which has been 
found to have a Ki for ADA at nanomolar concentrations 
(Agarwal, Spector & Parks, 1977) and the presence of lOuM 
ENHA would be expected to completely antagonise the 
actions of any endogenous ADA. The presence of ADA in the 
rat SCG is indirectly inferred from the ability of EHNA, 
to enhance the hyperpolarisations to low concentrations of 
adenosine (Fig. 3.7). Some support for an extracellular 
location of ADA is provided by the reports by Henderson 
(1985) that ADA is released by damaged cells. ADA has 
been suggested to have hydrophobic domains that span the 
membrane of human erythrocytes (Bielat & Tritsch, 1989).
In addition, Henon & McAfee (1983a) have reported that the 
rat SCG is able to degrade exogenous cAMP to adenosine and 
the inability of dipyridamole to potentiate the 
accumulation of % - A D  from exogenous %-cAMP.
3.3.2 Inhibition of transport of adenosine
The nucleotide uptake inhibitor, dipyridamole has been 
reported to inhibit adenosine uptake of rat brain tissues 
with an IC^q of 0.45uM (Phillis & Wu, 1982) and 1.3uM 
(Davies & Hambely, 1983) but also has very poor binding to 
rat brain membranes compared to other species. In order 
to ensure blockade of the uptake of adenosine, a high 
concentration of dipyridamole i.e., lOuM was employed 
which also allowed comparison to the results obtained by 
Henon & McAfee (1983a).
Dipyridamole did not alter the depolarisation to potassium 
suggesting this concentration of dipyridamole does not 
affect general excitability of the ganglion. The ability
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of both dipyridamole and HNBTG to shift the dose response 
curve for the inhibition of muscarine to the left (Fig. 
3.9) is consistent with the presence of an uptake 
mechanism for adenosine in ganglia and with the presence 
of external adenosine receptors. The potentiation of the 
depression of muscarinic responses by adenosine in 
dipyridamole and HNBTG was similar (cf. Figs. 3.9a, 3.9b).
The level of endogenous adenosine can alter the apparent 
potency of exogenous purines, and membranes are known to 
continuously produce adenosine (see Linden, 1989). The 
ability of dipyridamole to produce a small but significant 
(Table 3.3) reduction of the response to muscarine which 
corresponds to an equivalent reduction of muscarine by 
about luM adenosine (see chapter 5), suggests the presence 
of endogenous adenosine in the rat SCG. Caution is 
necessary in this interpretation as the depression of 
muscarine is near to the limits of detection.
Theophylline also significantly reduced the response to 
muscarine (Table 6.2). However it has been reported that 
both theophylline and dipyridamole can also affect 
intracellular calcium sequestration and phosphodiesterase 
(PDE) activity, and these effects may account for the 
reduction of muscarine responses. The equipotency of 
HNBTG and dipyridamole in enhancing the hyperpolarisation 
to adenosine, but lack of any effect of HNBTG on the 
response to muscarine does not support the idea of 
endogenous adenosine release from the rat SCG.
The non-metabolised analogue of adenosine, 2CA produced 
slowly developing and persisent hyperpolarisations of the 
rat SCG, suggesting that the rapid return of the response 
of adenosine to the basal level is due to uptake and 
metabolism of adenosine. It is reported that 2CA is a 
substrate for the adenosine uptake mechanism in dog 
erythrocytes (Jarvis, Martin & Ng, 1985) and the
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possibility that 2CA is transported by the rat SCG was 
determined. The inability of dipyridamole to alter the 
response to 2CA (Table 3.4) suggests 2CA is not a 
substrate for the adenosine uptake mechanism of the rat 
SCG. In contrast the responses to adenosine were 
significantly enhanced in the presence of dipyridamole 
(Fig. 3.8). The degree of potentiation of adenosine by 
dipyridamole is comparable to that reported by Henon & 
McAfee (1983a), on the inhibition of the AHP of the rat 
SCG by adenosine.
Marangos, Deckert & Bisserbe (1987) has suggested that 
"the uptake mechanism is probably the neurobiologically 
relevant process, since adenosine deaminase is largely 
intracellular in its distribution." The results reported 
here do not support this hypothesis as the potentiation of 
the hyperpolarisation to adenosine by EHNA was similar to 
the potentiation by dipyridamole (cf. Figs. 3.7 & 3.9).
The potentiation of the hyperpolarisation to adenosine by 
dipyridamole and EHNA on the rat SCG are similar to those 
found by Sebastiao & Ribeiro (1988). Using S-(p- 
nitrobenzyl)-6-thioinosine (NBI) and EHNA these authors 
reported the potency of adenosine on the inhibition of 
twitch responses of the isolated rat diaphragm was 
enhanced 2.6 fold in 5uM NBI and by 2.2 fold in 25uM EHNA 
(Sebastiao & Ribeiro, 1988).
Both Hopkins & Goldie (1971) and Stone (1983) have 
reported that little adenosine uptake could be detected in 
the rat heart and the rat anococcygeus muscle 
preparations, respectively and suggested the lack of 
adenosine uptake may be species dependent. Alternatively 
the lack of uptake reported by these workers could reflect 
the distribution of uptake sites, and indicate there is 
greater uptake of adenosine at postsynaptic sites.
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In summary these results are in agreement with the results 
of Henon & McAfee (1983a) and not with those of Alkadhi et 
al (1984) that the rat SCG contains an uptake mechanism 
for the removal of adenosine. At physiological 
concentrations i.e., micromolar adenosine, it is suggested 
both deamination and uptake would have equivalent roles in 
the metabolism of adenosine in the rat SCG. Both the 
selective uptake inhibitor HNBTG and the adenosine 
receptor antagonist, 8PT did not alter the d.c. potential 
or the response to muscarine and do not provide evidence 
for the presence of endogenous adenosine * tonus* in the 
isolated perfused rat SCG preparation.
3.4 RESPONSE OF THE SCG TO CYCLIC NUCLEOTIDES
The cyclic nucleotides of cyclic 3*,5*-AMP (cAMP) and 
cyclic 3*,5*-GMP (cGMP) are known to be involved in the 
actions of neurotransmitters, and in altering the 
sensitivity of neurones. cAMP is known to exert an 
excitatory action in neuronal cell bodies of rat ganglia 
(Libet et al., 1975) and Greengard (1976) has proposed 
that cyclic nucleotides play a major postsynaptic role in 
the ganglionic transmission, cAMP and cGMP being involved 
in the slow inhibitory and excitatory postsynaptic 
potentials respectively. It has been suggested that cAMP 
and cGMP operate in opposite directions (the *Yin-Yang 
hypothesis*) to exert long term control over neuronal 
excitability in sympathetic ganglia (McAfee & Greengard, 
1972). An increase in cAMP has been reported to produce a 
prolongation of the response of the rat SCG to 
methacholine (Libet et al., 1975). The ability of cAMP, 
cGMP and 8-bromo cAMP (8BrcAMP) to alter the d.c. 
potential and the response of the rat SCG to muscarine was 
investigated to discover if these compounds mimic the 
actions of adenosine.
56
Cyclic AMP produced slowly developing concentration 
related hyperpolarisations with a maximum response above 
ImM (Fig, 3,10), Both the slowness of the 
hyperpolarisation to cAMP and lower potency of cAMP 
compared to adenosine are consistent with results reported 
Brown et al, (1979) who found hyperpolarisations to cAMP 
were antagonised by theophylline, and are therefore likely 
to be due to degradation of cAMP and activation of 
adenosine receptors.
In order to activate intracellular cAMP-dependent 
processes a lipid soluble cAMP analogue, 8BrcAMP was 
tested, 8BrcAMP was chosen because it penetrates the 
plasma membranes and is deacylated to serve as a source of 
intracellular cAMP (Bletcher & Hunt, 1972), Over the same 
concentration range as cAMP, 8BrcAMP produced dose related 
depolarisations, which were not altered by the presence of 
8PT at a concentration which significantly reduced the 
hyperpolarisation to adenosine (Fig. 3.11), suggesting the 
depolarisation to 8BrcAMP may be via an increase in 
intracellular cAMP concentration and not via the 
activation of PI purinoceptors. Compared to adensoine, 
8BrcAMP was less potent at depressing the response to 
muscarine, and may indicate that the depression of 
muscarine and the hyperpolarisation to adenosine do not 
involve an increase in cAMP, although a decrease in cAMP 
cannot be excluded. Experiments to examine the role of 
cAMP in the response to adenosine are described in chapter 
5.
The low potency of cGMP (Fig. 3.11) is similar to the 
observations of Brown et al. (1979) who found ImM cGMP and 
ImM 8BrcAMP produced very small depolarisations of 2 rat 
SCG and was ineffective on another 8 ganglia. Along with 
the inability of cGMP to alter the response to muscarine 
(Table 3.4) these results indicate that the selective
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depression of muscarinic responses and the 
hyperpolarisation of the rat SCG by adenosine and adenine 
nucleotides is not shared by guanosine nucleotides.
3.5 RESPONSE OF THE RAT SCG TO PYRIMIDINES
There is now considerable evidence that ATP and adenosine 
modulate neuronal function (Stone, 1989) and more recently 
that pyrimidine nucleotides can modulate cellular 
functions via pyrimidine receptors rather than purine 
receptors (Seifert & Schult, 1989). In fact 
extracellular uridine and uracil nucleotides are 
effective activators of many cell functions including 
contraction or relaxation of blood vessels, changes in 
liver metabolism, aggregation of platelets and neutrophils 
(Seifert, Burde & Schultz, 1989). It was therefore of 
interest to examine the action of some pyrimidines on the 
rat SCG as it has been shown by Siggins et al. (1977) that 
bullfrog sympathetic neurones in explant culture showed 
pronounced depolarisations to the di- and triphosphoribose 
derivatives of several pyrimidine and purine bases. The 
effect of UTP, UMP and CTP on the d.c. potential and the 
effects of UTP on the response of the rat SCG to muscarine 
were examined.
The order of potency for depolarising the rat SCG was UTP 
> CTP >> UMP (Fig. 3.12) and is similar to the order for 
pyrimidine receptors described on most cells studies i.e., 
UTP is more effective than UDP, UMP and uridine, and TTP 
and CTP are relatively weak agonists (Seifert & Schultz, 
1989). The ability of UTP to depolarise the rat SCG 
reported here is consistent with the initial report by 
Adams and colleagues (1982a) that UTP inhibits the M- 
current of rat SCG. The ability of UTP to depolarise the 
rat SCG is also consistent with the report of Gruol,
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Siggins, Padjen & Forman (1981) who reported that 
explanted adult bullfrog ganglion cells were depolarised 
by UTP and UDP and that CTP and DCP were inactive and of 
Siggins & colleagues who found uridine nucleotides were 
the most postent of all the compounds tested* The 
possibility that UTP depolarises the rat SCG by activating 
the same mechanism as ATP has not been excluded. The 
inability of UTP to alter the response to muscarine (Table 
3*4) suggests that the depression of muscarine by 
adenosine is restricted to adenine or adenine nucleotides.
The low potency of CTP is in agreement with the reports of 
the action of cytosine and it*s phosphates on both the 
toad spinal cord (Phillis & Kirkpatrick, 1978) and their 
effects on rat cortical neurones (Phillis, Kostpoulous & 
Limachet, 1974).
A detailed characterisation of pyrimidine receptors on the 
rat SCG was outside the scope of this thesis and would 
require the use of more specific and stable analogues of 
UTP such as the phosphorothioate analogues of uracil 
nucleotides to eliminate the effects of uptake and 
metabolism of pyrimidines. Studies to produce selective 
desensitisation and antagonism of the purine and 
pyrimidine receptors would be useful to confirm the 
separate nature of these receptors. In conclusion these 
preliminary results suggest that the SCG has receptors for 
UTP that activate the ganglion but are not involved in the 
depression of the response to muscarine.
Fig. 3.1. Responses of the rat SCG to three 
consecutive applications of adenosine at lOOuM for two 
minutes every 20 minutes.
(a) Recording of a single ganglion to three 2 minute 
applications of adenosine showing reproducible 
hyperpolarisations; (b) responses of ten ganglia to 3 
applications of adenosine (lOOuM, 2 minutes) displayed 
as a histogram. The column height and vertical bars 
for this and all subsequent histograms show the mean 
response and the standard error of the mean (SEM) 
respectively. There was no significant difference 
between any of the columns (two-tailed paired t-test).
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Fig. 3.2. Response of the rat SCG to three consecutive
applications of muscarine at either 30nM, lOOnM or 
300nM.
The column height and vertical bars show the mean + SEM 
for N=4 to 19 ganglia. There was no significant 
difference (two-tailed t test) between any of the 
columns at each concentration of muscarine.
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Fig. 3.3. Response of the isolated rat SCG to
adenosine.
(a) Response of a single ganglion to increasing 
concentrations of adenosine applied for 2 minutes, 
every 20 minutes. (b) Log concentration-response curve 
for the rat SCG to 2 minute application of increasing 
concentrations of adenosine applied every 20 minutes.
In this and all subsequent graphs the symbols indicate 
the mean and the vertical lines the SEM of the results 
from four ganglia unless indicated otherwise by a 
number alongside the symbol, or where the number of 
ganglia (N) is indicated in the figure legend. When no 
SEM is indicated it lies within the area of the symbol.
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Fig. 3.4. The magnitude of the responses of the 
isolated rat cervical preganglionic sympathetic nerve 
trunk (CST) to purines and other drugs.
The response to one minute applications of 5- 
hydroxytryptamine (5HT), gamma-aminobutyric acid 
(GABA), potassium and muscarine and two minute 
applications of adenosine triphosphate (ATP), 
cyclopentyladenosine (CPA), adenosine (AD), 
phenylaminoadenosine (PAA) and cyclic adenosine-5 1 - 
monophosphate (cAMP) were measured. Each point is the 
mean, and vertical bars the SEM for n=2 to 4 CSTs. A 
significant difference (two tailed t test) from basal 
d.c. potential is indicated by a * for P < 0.05.
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Fig. 3.5. Comparison of the responses recorded from 
the internal carotid nerve and external carotid nerve 
of the isolated rat SCG.
(A) for the hyperpolarisation to increasing 
concentrations of adenosine (2 minute application a 
minimum of 20 minutes between applications) and (B) 
the % depression of the response to lOOnM muscarine 
increasing concentrations of adenosine.
ICN = internal carotic nerve; ECN = external carotid 
nerve
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Fig. 3.7. Log concentration-response curves of the 
isolated rat SCG to adenosine in the absence and 
presence of the adenosine deaminase inhibitor, erythro- 
9(2-hydroxy-3-nonyl) adenine (EHNA).
The hyperpolarisation to adenosine was determined by 
applying increasing concentrations of adenosine (1- 
300uM) for 2 minutes every 20 mins and then incubating 
the ganglia with lOuM EHNA for 30 mins and repeating 
the same sequence of adenosine applications. A 
significant difference (two tailed t test) from 
untreated ganglia in physiological salt solution (PSS) 
and PSS + EHNA is indicated by a * for P < 0.05.
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Fig. 3.8. Log concentration-response curves of the 
isolated rat SCG to inosine and to adenosine in the 
absence and presence of dipyridamole.
The effects of adenosine (AD) and inosine on the d.c. 
potential were tested by applying agonists for 2 
minutes in increasing concentrations every 20 minutes. 
After incubation of the ganglia with lOuM dipyridamole 
(DIP) for 30 minutes the sequence of adenosine 
applications was repeated on the same ganglia. 
Dipyridamole significantly (P<0.05 = *, paired t test) 
enhanced the hyperpolarisation to adenosine at 1, 100 
and 300uM.
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Fig. 3.9. % depression of the response to muscarine by
adenosine on the isolated rat SCG in presence of 
dipyridamole or S-(4-nitrobenzyl)-6-thioguanosine.
The depression of lOOnM muscarine (1 minute 
application) by adenosine at luM and lOuM was 
determined. A significant difference (two tailed t 
test) from untreated ganglia in physiological salt 
solution (PSS) and PSS + dipyridamole (DIP) or PSS + S- 
(4-Nitrobenzyl)-6-thioguanosine + (HNBTG) is indicated 
by a * for P < 0.05.
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Fig. 3.10. Log concentration response curves of the 
isolated rat SCG to two minute applications of adenosine 
(AD) or cyclic 3 1,5*-adenosine monophosphate (cAMP). Both 
AD and cAMP were applied with a minimum of 20 minutes 
between each application of agonist.
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Fig. 3.11. Comparison of the log concentration- 
response curves of the isolated rat SCG to 8 bromo- 
cyclic adenosine monophosphate, cyclic adenosine 
monophosphate and cyclic guanosine monophosphate and 
8BrcAMP in the presence of 8-phenyltheophylline.
8-Bromo-cyclic adenosine monophosphate (8BrcAMP) 
produced dose related depolarisations and at lOOOuM a 
small hyperpolarisation preceded the depolarisation to 
8BrcAMP in 2 out of 4 ganglia (-30 and -20uV). In the 
presence of lOuM 8-phenyltheophylline (8PT) the 
depolarisations to 8BrcAMP were not significantly 
changed whereas the hyperpolarisations to lOOuM 
adenosine on the same ganglia were significantly 
reduced (adenosine control = -55 + 7uV; adenosine + 8PT 
(lOuM) = -15 + 9uV, P<0.01, n=4).
All purines were applied for 2 minutes and ganglia were 
incubated in 8PT for a minimum of 40 minutes before 
repeating the response to 8BrcAMP.
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Fig. 3.12. Log concentration response curves of the 
isolated rat SCG to 2 minute application of uridine 
triphosphate, uridine monophosphate and cytosine 
triphosphate in physiological salt solution, and the 
response to uridine monophosphate in low potassium 
(2mM) and calcium (O.lmM) physiological salt solution.
In PSS a 2 minute application of uridine triphosphate 
(UTP) at 1 to lOOOuM resulted in concentration related 
depolarisations whereas lOOOuM cytosine triphosphate 
(CTP) produced small but significant depolarisations 
(34 + 2uV, n=4, P<0.001). In contrast uridine 
monophosphate (UMP) was inactive at lOOuM and produced 
small and prolonged hyperpolarisations at lOOOuM (n=7, 
P<0.05), which were about half those produced by a two 
minute application of lOOuM adenosine (-71 + 7uV, n=7). 
In low K+/Ca^+ physiological salt solution (PSS) UMP at 
lOOuM did not significantly (-23 + 9uV, n=4, NS) alter 
the d.c. potential and at lOOOuM hyperpolarised rat SCG 
by -53 + 15uV (n=4, P<0.05).
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Table 3,1. Effect of altering the concentration of 
potassium in the postganglionic chamber of the grease 
gap tissue bath, on tne response of the isolated rat" 
SCG to adenosine and potassium
There was no significant difference (two-tailed paired 
t-test) in the response of the ganglia to adenosine (2 
minutes) or potassium (1 minute) with different 
concentrations of potassium in the postganglionic 
chambers. Responses are uV (mean + SEM) for three 
ganglia.
Potassium concentration in postganglionic
chamber
6mM 12mM 66mM 6mM
Agonist Pre-test Test Test Post-test
Control Control
ADENOSINE -80 + 12 -78 + 6 -107 + 3  -65 +_ 3
lOOuM
POTASSIUM 230 + 60 242 + 32 253 + 41 263 + 45
9mM
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Table 3.2. Effect of tetrodotoxin and pirenzepine on the 
response of “isolated rat SCG to adenosine
The effect of luM tetrodotoxin (TTX) and 0.3uM pirenzepine 
(PIR) on the response of the isolated rat SCG to a two 
minute application of lOOuM adenosine in physiological 
salt solution (PSS) and calcium and magnesium free PSS was 
determined There was no significant difference between 
responses in PSS containing TTX or PIR treated ganglia and 
those in PSS (paired t test, where N = number of ganglia 
tested)•
PSS N
Response to lOOuM adenosine 
(uV, mean + sem)
Control + TTX (luM) + PIR (0.3uM)
Normal 6 -83+11 -77+10
Normal 4 -69+11 -48+11
OmM Ca^+/ 3a -163+29 -127+27
OmM Mg^+ 3b 90+38 0+0
a = hyperpolarisation to adenosine 
b = after depolarisation to adenosine
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Table 3.3. Effect of pirenzepine^ inosine, dipyridamole 
and hydroxy-nitrothiobenzylguanosine on the response of 
the isolated rat SCG to muscarine
Ganglia were incubated in pirenzepine (PIR), dipyridamole 
(DIP) and hydroxynitrobenzylguanosine (HNBTG) for a 
minimum of 20 minutes and muscarine was applied for one 
minute.
CONTROL PSS + PSS + PSS + PSS +
PSS PIR INOSINE DIP HNBTG
uV + SEM N 0.3uM lOOOuM lOuM lOuM
220 + 49 4 11 + 12*
185 + 31 3 182 + 37
227 + 23 12 199 + 16*
219 + 29 7 232 + 39
Responses are means + standard error of the mean in uV• N 
= number of ganglia tested. Statistical significance 
(paired t-test) is indicated by * for P < 0.05.
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Table 3.4, The effect of dipyridamole on the response of 
the isolated~~rat $CG to 2-chloroadenosine and potassium
The effect of a two minute application of 2- 
chloroadenosine (2CA) and a one minute application of 
potassium (K ) was determined in normal physiological salt 
solution.
AGONIST CONCENTRATION
uM
N CONTROL PSS + DIP 
(10uM)
2-CA 1 4 -53 + 10 -48 + 14a
2-CA 10 3 -57 + 15 -70 + 21?
K+ 12000 3 600 + 35 647 + 55
Responses are means + standard error of the mean in uV. N 
= number of ganglia tested. Minimum incubation time in 
DIP was (a) 40 minutes and (b) 100 minutes. Responses to 
2-CA and K in presence of DIP were not significantly 
different to values obtained in PSS (paired t test).
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Table 3.5. The effect of purines and pyrimidines on the 
response of the rat isolated SCG to muscarine
The effect of 8-bromo-cyclic-adenosine monophosphate 
(8BrcAMP), cyclic guanosine-monophosphate (cGMP), uridine 
triphosphate (UTP) on the response to a one minute 
application of lOOnM muscarine in physiological salt 
solution (PSS) was determined. The responses in the 
absence and the presence of test agonists were compared by 
a paired t test, where N = number of ganglia tested, and 
*** = P < 0.001.
COMPOUND Cone
uM
N
Response
PRETEST
to 100 
(uV) 
TEST
muscarine
POST­
TEST
% Change 
in
response
to
muscarine
Adenosine 100 61 312+20 228+16 313+21 -26+2***
8BrcAMP 100 2 273+28 230+30 223+3 -16+3
cGMP 100 3 307+12 287+13 318+6 -6+4
UTP 100 7 251+32 277+36 229+25 10+6
CHAPTER FOUR
IONIC MECHANISMS OF ACTION OF ADENOSINE 
ON THE RAT SCG
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Chapter Four IONIC MECHANISM OF ACTION OF ADENOSINE ON 
THE RAT SCG
INTRODUCTION
Many different ionic mechanisms have been proposed to 
account for the pharmacological effects of adenosine, of 
which the most commonly reported are a decrease in calcium 
conductance (gCa) and/or an increase in potassium 
conductance (gK) (Fig. 4.1).
Calcium ions have a number of important roles in neurone 
physiology including entry into presynaptic nerve 
terminals via voltage operated calcium channels during 
depolarisation to release neurotransmitters (Levitan & 
Kaczmarek, 1987), and as secondary messengers to control 
cell physiology and the entry of Ca^+ into postsynaptic 
neurones in normal and pathological states (Schubert,
1987; Dragunow & Faull, 1988).
Henon & McAfee (1983a,b) have reported that adenosine
O I
inhibited postsynaptic Ca^ dependent potentials of the 
rat SCG and thus it would be predicted that the inhibitory 
effects of adenosine on muscarinic responses and the 
adenosine-induced hyperpolarisation of the rat SCG 
reported in this study, may also be mediated via a change 
in Ca^+ dependent potentials.
Role of Ca^+ in the presynaptic actions of adenosine
• • • 2+  •Adenosine has been suggested to inhibit Ca influx
(Fredholm & Hedqvist, 1980) and/or impair the internal 
mobilisation of Ca^+ in presynaptic nerve terminals 
(Silinsky, 1986). However the results of experiments on 
the effect of adenosine on calcium fluxes and in
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particular the depression of the uptake of Ca^+ into brain 
synaptosomes are equivocal. Ribeiro and colleagues (1979) 
and Wu, Phillis & Thierry (1982) reported that adenosine 
inhibited depolarisation induced uptake of Ca^+ •
Bartrup, Wyllie & Stone (1988) found adenosine at lOuM did 
not significantly alter the uptake of 45Ca^+ , whereas 
CPA, 2CA and NECA produced a slight but significant 
reduction in flux, and attributed this effect to an action 
at A2 receptors. This latter finding requires further 
clarification as the presynaptic inhibitory actions of 
adenosine are thought to be via an action on A1 
purinoceptors (Stone, 1989).
In contrast it has been reported that adenosine does not 
affect Ca^+ uptake (Barr, Daniell & Leslie, 1985; 
Garritsen, Ijzerman & Soudijn, 1989). In a compreKensive 
study, Garritsen et al. (1989) studied the displacement of 
the selective Al purinoceptor antagonist, tritiated 8- 
cyclopentyl-1,3-dipropylxanthine ([^H]-DPCPX) binding in 
rat synaptosomes and estimated that at O.luM, R-PIA 
occupied most of the Al receptors. Both R-PIA and 5*-N- 
ethylcarboxamidoadenosine (NECA) at up to lOuM did not 
alter basal or KCl-stimulated 45Ca^+ uptake. Even after 
altering a considerable number of incubation conditions, 
including the incubation time, the addition of uptake 
inhibitors (a factor not controlled or acknowledged by 
many of the preceding reports), addition of ADA, adenosine 
and R-PIA still lacked any effect on the basal or 
stimulated 45Ca^+ uptake. The results of Garritsen et al.
(1989) provide considerable weight to the idea that 
adenosine may influence the sensitivity for calcium rather 
than the calcium concentration as proposed by Silinsky 
(Silinsky, 1986).
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Effect of adenosine on postsynaptic neuronal calcium 
currents
In 1986 Ribeiro & Sebastiao reviewed experimental evidence 
for the interactions between adenosine and calcium and 
suggested an additional adenosine receptor subtype, the A3 
receptor. The evidence in favour of an A3 purinoceptor 
was based on an extensive review of reported purine 
literature where experimental results could not easily be 
classified as Al or A2 receptor mediated. In addition 
Ribeiro & Sebastiao (1984) suggested the actions of 
purines on the frog neuromuscular junction (NMJ) (Ribeiro 
& Sebastiao, 1984) were linked to an adenosine receptor
o .
controlling Ca^ ions with a relative potency order for 
adenosine analogues unlike the Al or A2 order i.e. the A3 
receptor (see Table 1). A similar potency order on the 
mammalian heart was taken as evidence for an A3 receptor 
mediating the presynaptic inhibitory actions of adenosine.
There is some evidence that in neuronal tissue adenosine
9+causes a depression of Ca^ currents accompanied by an 
increase in membrane resistance as shown by MacDonald, 
Skerritt & Werz (1986) using voltage clamped sensory 
neurones in culture. Similar results were reported by 
Dolphin, Forda & Scott (1986), who found 2CA depressed 
barium (Ba^+ ) currents of dorsal root ganglia. In 
contrast Halliwell & Scholfield (1984) found purines were 
unable to inhibit directly evoked calcium currents, as 
defined by their blockade by cadmium (Cd^+ ) in both 
guinea-pig hippocampal and olfactory cortex neurones.
A depression of calcium spikes was reported in ganglionic 
(Henon & McAfee, 1979, 1983a) and rat CA1 hippocampal 
neurones (Proctor & Dunwiddie, 1983) and attributed to a 
direct inhibition of the Ca^+ conductance rather than an 
increase in potassium current such as calcium activated
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potassium current (lKCa). Henon & McAfee (1983a,b) 
concluded that adenosine inhibited a voltage dependent 
calcium current of the isolated rat SCG, resulting in a 
reduction of the IK^a current responsible for the AHP. In 
contrast to Henon & McAfee (1983a,b), Haas & Green (1984) 
found that adenosine potentiated the AHP and accommodation 
of rat hippocampal pyramidal cells, via an enhancement of 
an IK^a current.
In reviewing the role of calcium in the actions of 
adenosine, Stone (1989) suggested that the ability of 
adenosine to enhance or reduce the AHP "may suggest a 
difference between central and peripheral (ganglionic) 
neurones”. However, Palmer, Wood & Zafirov (1987) 
reported adenosine enhanced the AHP recorded from 
peripheral nerves of the guinea-pig myenteric plexus, and 
the reduction of the AHP of the rat SCG may be particular 
to this preparation.
Schubert (1987) has criticised many of the above results 
by suggesting that ”all of these experimental approaches
  did not allow a differentiation between pre- and
postsynaptic calcium fluxes” . This criticism appears 
unwarranted as many of the responses were recorded from 
postsynaptic neurones. Schubert has studied the calcium 
fluxes in hippocampal slices by employing ion selective 
calcium electrodes (Schubert, Heinemann & Kolb, 1986) and 
found adenosine and R-PIA induced a decrease in 
extracellular calcium levels. This decrease in calcium 
has been attributed to an influx of calcium into 
presynaptic terminals (Schubert & Kreutzbert, 1987).
Ribeiro & Sebastiao (1986) cited the results obtained by 
Henon & McAfee (1986a) in support of the presence of A3 
receptors in the rat SCG. This conclusion was based on 
the ability of adenosine, R-PIA and NECA to alter calcium
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spikes, but the order of potency given by Henon & McAfee 
(1986a) does not agree with that proposed for an A3 
receptor. Irrespective of whether the adenosine 
receptor/s involved in the reduction of the calcium spikes 
of the rat SCG (Henon & McAfee, 1983a) are classified as 
an A3 or an Al subtype, it is possible to examine if the 
effects of adenosine reported here are due to an 
interaction with Ca2+.
To determine if the response of the rat SCG to adenosine 
was dependent upon extracellular calcium ([Ca2+]e) and/or 
intracellular calcium ([Ca2+]i) the effects of adenosine 
was determined using different ionic manipulations of the 
PSS and various calcium channel antagonists.
RESULTS
Effect of changes in [Ca2+]e and [Mg2+]e on the response 
of the rat SCG to adenosine and its analogues
4.1 Effects of altering [Ca2+]e on;
(1) The hyperpolarisation to purines
The size of the response to adenosine varied according to 
the different concentrations of Ca2+ and Mg2+ in the PSS 
(Table 4.1). Increasing the Ca2+ concentration to 5mM 
depressed the adenosine-induced hyperpolarisation, moving 
the log concentration response curve to the right (Fig.
4.2). Conversely a reduction of [Ca2+]e to O.lmM 
increased the hyperpolarisations to adenosine (Fig. 4.3) 
displaced the log concentration response curve to the left 
(Fig. 4.2).
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The concentration-response curve to adenosine, PAA and 2CA 
)+in O.lmM Ca^ PSS were all potentiated to a similar extent 
(Fig. 4.4) e.g. at 30uM the ratio of the responses to PAA 
and adenosine in O.lmM Ca2+ and 2.5mM Ca2+ PSS were the 
same (2.1). Responses to adenosine in O.lmM Ca2+ (Fig.
4.4) and OmM Ca2+/EGTA PSS (Fig. 4.8) were reproducible 
during superfusion for up to eight hours.
(2) The depression of the response to muscarine by 
adenosine
The depression of the response to lOOnM muscarine by 
adenosine in PSS containing 2.5mM Ca2+ was concentration 
dependent and the log concentration response curve for the 
depression of muscarine was displaced to the left in O.lmM 
Ca2+ PSS (Fig. 4.6). In O.lmM Ca2+ the maximum 
depression of muscarine was potentiated although not 
significantly and the ED^q reduced ten fold. On two 
ganglia the depression of lOOnM muscarine by lOOuM 
adenosine was -39% and -46% in PSS and -41% and -42% in 
OmM Ca2+/EGTA PSS.
4.2 Effect of altering [Mg2+]e on the response to 
adenosine and 2CA
4.2.1 Comparison of the response to adenosine in;
4,2*1*1. The presence and absence of ImM magnesium
In the presence of normal PSS containing ImM magnesium 
both adenosine and 2CA produced concentration related
0 i
hyperpolarisations. The absence of magnesium (OmM Mg ) 
from the PSS did not significantly alter the 
hyperpolarisations to either adenosine or 2CA (Fig. 4.7).
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?+In OmM Ca PSS both the responses to adenosine and 
potassium were enhanced in the absence of Mg2+ (Fig. 4.9, 
cf a & b) and at lOOuM adenosine or higher the response 
was biphasic with an after depolarisation as shown in Fig. 
4.9a. The presence of luM TTX in OmM Ca2+ and OmM Mg2+ 
medium reduced the enhancement of the potassium 
depolarisation to values similar to the control responses 
in O.lmM Ca2+/lmM Mg2+ (313 + 70uV, n=3) and abolished the 
after-depolarisation to ImM adenosine.
In contrast to the responses to adenosine in OmM Mg2+ and 
OmM Ca2+ PSS were reduced in the absence of Mg2+ in 
Ca2+/EGTA PSS (Fig. 4.8).
4,2.1.2. The presence of ImM and lOmM magnesium
Increasing the extracellular concentration of magnesium 
from 1 to lOmM resulted in a significant reduction in the 
response to adenosine in PSS containing OmM Ca2+ (Fig.
4.9, cf b & c) or O.lmM Ca2+ but not in PSS containing 2.5 
or 5mM Ca2+ (Fig. 4.9, cf d & e; Table 4.1).
Discussion
The potentiation of the hyperpolarisation to adenosine in 
reduced Ca2+ PSS, the attentuation of the response to 
adenosine in 5mM Ca2+ PSS (Figs. 4.2 and 4.3) and the
2+enhancement of the depression of muscarine in O.lmM Ca 
PSS (Fig. 4.6) are similar to the effects reported by 
Dowdle & Maske (1980) for the inhibition of cholinergic 
transmission in the guinea-pig ileum by adenine 
nucleotides, and by Ribeiro (1982) for the depression of 
neuromuscular transmission of the rat diaphragm by 
adenosine in low calcium solutions. By themselves the 
results obtained for the rat SCG are consistent with the
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ability of adenosine to alter the influx of calcium. 
However, the ability of the ganglion to hyperpolarise 
during prolonged perfusion in OmM Ca^+ PSS with or without 
EGTA does not support this hypothesis. Likewise the 
ability of adenosine to depress the response to muscarine 
in O.lmM Ca^+ PSS (Fig. 4.6) and Ca^+ free medium are 
unlike results reported by Cox & Walker (1987), who 
reported the inhibitory action of adenosine on ACh induced 
depolarisations of parietal snail ganglion cells was 
potentiated by high [Ca^+ ]e.
The potentiation of the hyperpolarisations to 2CA and PAA 
in low [Ca^+ ]e, was similar to that obtained for adenosine 
suggesting the increase in sensitivity of the rat SCG in 
low Ca^+ media is unlikely to arise from a decrease in 
uptake or metabolism of adenosine. The low potency of 
PAA, a potent and selective PI purinoceptor agonist on A2- 
adenosine receptors suggests the hyperpolarisation to 
adenosine may be mediated by an action on Al receptors. 
Further characterisation of the adenosine receptor 
mediated hyperpolarisation of the SCG is described in 
chapter 6.
If the hyperpolarisation to adenosine is potentiated by 
depolarisation and the absence of calcium depolarises the 
ganglion this would increase the response to adenosine.
The potentiation of the hyperpolarisations to adenosine in 
reduced Ca^+ PSS is therefore consistent with this 
response being dependent on the resting membrane potential 
(RMP) and is potentiated by depolarisation of the 
ganglion.
It has been shown that a reduction in [Ca^+ ]e inhibits 
presynaptic action potential generation and postsynaptic 
terminals and nerves become hyperexcitable (Campbell,
1983). The ability of adenosine to hyperpolarise in
84
reduced or calcium free PSS suggests adenosine does not 
hyperpolarise the ganglion by inhibiting presynaptic 
neurotransmitter release.
It is recognised that divalent cations can influence the
neuronal activity by screening negative fixed charges on
the surface of the neurone. Frankenhaeuser & Hodgkin
(1957) using the squid giant axon observed that an
increase in [Ca^+ ]e produced a shift in the activation of
both Na+ and K+ currents to more positive potentials and
in low [Ca^+ ] the neuronal membrane loses much of its
selective permeability and a smaller depolarisation is
required to increase the sodium conductance to a critical
level where the cell depolarises. An increase in the
response to adenosine probably arises not because
adenosine reduces Ca^+ entry but may be due to a change in
the total divalent cation concentration which alters the
membrane surface potential. An increased excitability of
the ganglion is supported by the enhanced response to the
9+non-specific depolarising agent, potassium in low Ca^ and 
Mg2+ solutions (Fig. 4.9). Mg^+ ions have a stabilising 
action like that of Ca^+ but are less effective 
(Frankenhaeuser & Hodgkin, 1957) and some indication of 
the effect of a change in surface charge on the response 
to adenosine in low [Ca^+ ]e may be indicated by the 
ability of increased [Mg^+ ]e at lOmM to compensate for the 
potentiation of the response to adenosine in low [Ca^+ ]e 
where the responses to adenosine were similar to those in 
normal PSS (Table 4.1).
A change in excitability of the neuronal membrane alone 
may not be the only mechanism that potentiates the 
response to purines as a number of studies using isolated 
tissues have demonstrated the dependence of opioid- 
receptor mediated agonism on [Ca ]e and an increase in 
the efficacy of the agonist (Dougall & Leff, 1987). Also
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agonists that demonstrated little or no significant 
agonism under normal conditions exhibit agonism when the 
[Ca2+]e is reduced (Hayes & Sheehan, 1986) implying a 
change in efficacy. The increased responsiveness to PAA 
in O.lmM Ca2+ PSS may be evidence in favour of this 
hypothesis but as detailed analysis of the data is not 
possible and a more precise study as described by Dougall 
& Leff (1987) would be required before making any definite 
conclusions. However the similar potentiation of the 
response to adenosine and PAA suggests both actions are 
altered non-selectively in low [Ca2+]e. The effect of low 
[Ca2+]e on the antagonism of concentration response curves 
to adenosine is discussed in chapter 6.
Many of the actions of adenosine have been attributed to 
an action on cAMP levels (Londos et al., 1980). In the 
presence of IBMX to prevent degradation of cAMP, Lindl 
(1979) found the incubation of rat SCG in high calcium 
media (20mM) reduced cAMP accumulation, compared to 
controls in 2.2mM Ca2+. However the omission of Ca2+ did 
not significantly increase cAMP levels, unless the ganglia 
were also incubated with ImM EGTA. The response of the 
rat SCG to adenosine in OmM Ca2+ with or without EGTA was 
similar, suggesting the ability of low [Ca2+]e to enhance 
the response to adenosine may not arise via an increase in 
cAMP.
O I
If adenosine causes an inhibition of Ca influx of the 
rat SCG, then the two most likely currents to be affected 
would be calcium activated potassium currents (IKq 3 ) and 
the voltage sensitive Ca2+ currents. The potential charge 
resulting when adenosine is applied would then depend upon 
the relationship between the voltage sensitivity of these 
currents. Calcium channels are usually highly selective 
for calcium ions over sodium ions however if the external 
level of free Ca2+ is below micromolar values, e.g. as
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with Ca^+ free PSS, Ca^+ channels can allow the influx of 
Na+ and other ions (Lux & Carbone, 1987). The effect of 
interaction with [Mg^+ ]e are discussed in the next section 
but it is to be expected that Mg^+ would antagonise Na+ 
entry. In the event of Na+ entry this would be expected 
to depolarise the ganglion and could potentiate the 
hyperpolarisation to adenosine. The possibility that 
adenosine hyperpolarises the rat SCG by altering the
O  i i
movement of Ca and Na ions was examined further.
It has been shown that magnesium ions are required for the 
inhibitory effects of adenosine on adenylate cyclase 
(Yeung & Green, 1983). As is the case for several other 
neurotransmitters the adenosine receptor probably exists 
in multiple agonist affinity states (Marangos, Patel, 
Martino, Dilli & Boulenger, 1983; Yeung & Green, 1983; 
Lohse, Lenschow & Schnabe, 1984; Dunwiddie & Fredholm,
1984) and it is most likely that the receptors affinity 
will be subject to modulation by external divalent 
cations. Both the presynaptic depression of adenosine on 
the guinea-pig olfactory cortex (Scholfield & Steel, 1988) 
and the inhibition of hippocampal population potentials in 
vitro (Bartrup & Stone, 1988) were potentiated by 
increasing [Mg^+ ]e. Bartrup & Stone (1988) have suggested 
that "the manipulation of magnesium ion concentration may 
prove to be a simple method for eliminating the Al- 
receptor mediated actions, and for discriminating between 
A1 and A2 receptor mediated events".
The results of this study show that the response of the 
rat SCG to adenosine and 2CA were not affected by the 
absence of Mg^+ from normal PSS (Fig. 4.7).
It is known that magnesium antagonises the actions of 
calcium for evoked transmitter release (Silinsky, 1985) 
and the absence of [Mg^ "*"]e would be expected to allow an
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9 +increased influx of Ca in to the postsynaptic terminal 
and antagonise the hyperpolarisation to adenosine if it is 
mediated via an inhibition of Ca^+ influx. Thus the size 
of the adenosine induced hyperpolarisation should be 
dependent upon the [Mg^+ ]e concentration if adenosine 
modulates the site of Ca^+ entry.
2+Although low Ca PSS enhanced the response to adenosine,
increasing the Mg^+ concentration to lOmM counteracted the
effect of reduced [Ca^+ ]e and restored the response size
to that obtained in normal PSS, suggesting the increase in
the size of the hyperpolarisation to adenosine in reduced 
2+Ca media may arise from an increased neuronal 
excitability. The ability of adenosine to hyperpolarise 
in OmM Ca^+/10mM Mg^+ PSS, where presynaptic release of 
ACh is abolished suggests adenosine hyperpolarises by a 
direct action at a postsynaptic site.
In PSS containing different concentration of [Ca^+ ]e and 
ImM [Mg2+ ]e the hyperpolarisation to ImM adenosine was 
complex and consisted of an initial transient 
hyperpolarisation and a smaller late hyperpolarisation 
(Fig. 4.9). Interestingly when the [Mg^+ ]e was increased 
to lOmM the maximum response to ImM adenosine was 
sustained (Fig. 4.9 Cf b & c also d & e). The enhancement 
of the response to adenosine in OmM Ca^+/0mM Mg^+ PSS and 
K+ free PSS compared to OmM Ca^+/0mM Mg^+ PSS + 6mM K+ 
(Fig. 4.9 Cf a & f) suggests adenosine may hyperpolarise 
the rat SCG by increasing K+ efflux. If adenosine 
increases gK then one explanation for change in the peak 
response to a smaller response would be a build up of 
perineuronal K+ during the initial response which would 
then reduce the response to further application of 
adenosine. Alternatively this complex response to a high 
concentration of adenosine i.e. IOOOuM, may be due to 
desensitisation as this concentration is supramaximal (see
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Fig. 3.3b) and magnesium may prevent this desensitisation.
Given the high concentration of adenosine required to see
these effects and that there are a variety of other
possible explanations such as inhibition of metabolism
and/or uptake, or an underlying AHP, or the activation of
another receptor subtype (see chapter 6 for further
discussion of this phenomenon). The inability of high
magnesium to alter the peak response to adenosine in 2.5mM
or 5mM Ca2+ PSS could arise if there were excess free Ca2+
ions to counteract the presence of a high concentration of 
2+  •Mg ions or more likely if the effects of adenosine are 
not linked to Ca2+ entry.
In 2.5mM Ca2+ the absence of Mg2+ in the PSS did not
significantly alter the hyperpolarisations to adenosine or
2CA, whereas in O.lmM Ca2+ the removal of Mg2+
significantly enhanced the hyperpolarisation to both
adenosine and 2CA. It is well known that Ca2+ currents 
9+through Ca^ - channels can be blocked by magnesium and the 
removal of magnesium could lead to an increased 
excitability of the ganglion. Some evidence for this 
conclusion is suggested by the presence of an after­
depolarisation in response to high concentrations of 
adenosine, but this was never observed in O.lmM Ca PSS 
containing Mg2+. The possibility that the after 
depolarisation occurred due to the absence of sufficient 
Mg2+ and Ca2+ to stabilise the neuronal membranes was 
indicated by the ability of TTX to abolish the after­
depolarisation. However, it is unlikely the after­
depolarisation arose from a presynaptic release of ACh for 
the following reasons: adenosine generally inhibits ACh 
release although an action at A2 receptors has been 
reported to increase release: secondly, the release of ACh 
requires extracellular Ca2+ (Silinsky, 1985) and thirdly 
the after-depolarisation was unaffected in the presence of 
2uM atropine (n=2).
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The results of this study suggest that under physiological
concentrations of cations the requirement for magnesium is
not shared by the adenosine receptor of the rat SCG,
However the removal of Mg2+ in Ca2+ free medium markedly
reduced the response to adenosine. The removal of Mg2+
ions could conceivably allow residually bound Ca2+ to
antagonise the hyperpolarisation to adenosine but it would
be expected that residually bound Ca2+ would be
chelated by an excess of EGTA. Alternatively a reduced
response in the absence of Mg2+ could be interpreted to
reflect a requirement for Mg2+ in the actions of adenosine
(Bartrup & Stone, 1988). A more likely explanation for
the results observed here would be that the ganglion
becomes depleted of intracellular magnesium ([Mg2+]i)
during perfusion with OmM Ca2+/0mM Mg2+ PSS. Recently,
Nakayama & Tomita (1990) reported that perfusion of
guinea-pig caecum with either Mg2+ Ca2+ free solution for
up to two hours resulted in little loss of [Mg2+]i,
whereas preparations bathed in Mg2+ and Ca2+ free solution
with ImM EGTA, rapidly lost [Mg2+]i during one to two
hours incubation. Assuming the rat SCG behaves in a
2+similar manner to taenia then the incubation in Ca^ free 
PSS with Mg2+ for at least an hour before testing might be 
sufficient to deplete [Mg2+]i and explain the reduction of 
the response to adenosine.
These results show the hyperpolarisations of the rat SCG 
to adenosine and 2CA are independent of [Mg2+]e and the 
results presented in chapter 6 suggest that the adenosine 
receptors of the rat SCG are of the A1 subtype. Thus the 
proposal by Bartrup & Stone (1988) that the removal of 
Mg2+ from PSS provides a method for eliminating the A1 
actions of adenosine may only apply to certain effects 
mediated by adenosine. The reason for the lack of 
dependence of the response of the rat SCG to adenosine on 
[Mg2+]e is unclear but Schubert & Kreutzberg (1987),
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studying the effect of adenosine on calcium fluxes of rat 
hippocampus, suggested there are two types of A1 receptors 
that are Mg2+ sensitive and Mg2+ insensitive possibly 
extrasynaptic and synaptic A1 receptors (Tetzlaff,
Schubert & Kreutzberg, 1987). Perhaps the former are 
sensitive to [Mg2+]e (Bartrup & Stone, 1988) and the 
latter postsynaptic or extrasynaptic adenosine receptors 
are independent of [Mg2+]e. Likewise Fastbom & Fredholm
(1990) using autoradiography of the rat brain have 
suggested that differences in the sensitivity of Al- 
receptor-G-protein complexes to magnesium may reflect a 
heterogeneity of the G-proteins to which the Al-receptors 
are coupled.
In summary, it appears unlikely that (1) the adenosine-
induced hyperpolarisation of the rat SCG is mediated by
inhibition of Ca2+ currents, and (2) is not due to the
release of a neurotransmitter or neuromodulator but occurs
due to a direct postsynaptic action; (3) the response to
9+adenosine is not Mg^ -dependent.
4.3 Effect of calcium channel antagonists on the response 
to adenosine
The evidence for multiple types of Ca2+ channels has been 
reviewed by Tsien, Lipscombe, Madison, Bley & Fox (1988) 
and Bean (1989). Ca2+ channels, which open in response to 
membrane depolarisation admit extracellular calcium into 
the neurones and have been classified into three types on 
the basis of their gating properties and pharmacological 
sensitivities (Nowycky, Fox & Tsien, 1985). T channels 
are characterised by a transient time-course due to rapid 
inactivation (20-50 mS) and sensitivity to blockade by 
nickel ions (Ni2+). L channels slowly inactivate (>500 
mS), are selectively antagonised by dihydropyridines
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(DHPs) and are more effectively blocked by low 
concentrations of cadmium (Cd^+ ) than are T channels. T 
channels are unaffected by DHPs at concentrations below 
3uM (Bean, 1989). The other rapidly inactivated channel, 
the N channel in contrast to the T channels is sensitive 
to a snail toxin, omega-conotoxin and Cd^+ (Table 4.2).
Cultured rat SCG neurones expressed both L and N type Ca^+
channels, which are activated by strong depolarisation,
(Perney, Hirning, Leeman & Miller, 1986; Miller, 1987).
On the rat SCG the N channels are only partially
inactivated (Plummer, Logothetis & Hess, 1989) whereas the
L channels do not inactivate even during a steady
depolarisation at -20mV (Nowycky et al., 1985). These 
2+Ca^ channels are inactive at low membrane potentials but 
are activated by depolarisation in high potassium PSS 
(Vidal, Raynaud & Weber, 1989).
The response of postsynaptic muscarinic receptors of the
rat SCG can involve the modulation of N-channel gating
(Wanke, Ferroni, Malgaroli, Ambrosini, Pozzan & Meldolesi,
1987) and adenosine could depress the muscarinic
2+depolarisation by altering Ca^ influx. This observation 
is supported by the recent discovery that the inhibition
O x
of Im by muscarinic agonists was shown to be [Caz ]e 
dependent (Tokimasa & Akasu, 1990b). In addition the 
presynaptic alpha-adrenergic inhibition of 
neurotransmitter release from the rat SCG is known to be 
controlled by N-type Ca^+ channels (Hirning, Fox, 
McCleskey, Olivera, Thayer, Miller & Tsien, 1988; 
Lipscombe, Kongsamut & Tsien, 1989).
The ability of Ca^+ channel antagonists to alter the 
adenosine-induced hyperpolarisation and the depression of 
muscarine was examined using non-selective and selective
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antagonists of N, L & T channels and are summarised in 
tables 4.6 to 4.8.
4.3.1 Effects of cobalt
The antagonism of the response to adenosine in Co^+ PSS, 
is a new finding (Table 4.7) and suggests adenosine may 
hyperpolarisation the ganglion via a Ca^+ dependent 
process. The antagonism of adenosine appeard to be 
competitive as the response to adenosine in 5mM Co^+ could 
be restored by increasing the concentration of adenosine 
(Table 4.7).
The ability of Co^+ to abolish the response to adenosine 
invalidates the findings of Henon & McAfee (1983, see Fig. 
4) who reported 2CA (lOuM) did not alter the current- 
voltage curve in the presence of 5mM Co^+ , as the presence 
of Co^+ would be expected to mask the effects of 2CA.
94-Co^ at 5mM has been reported to selectively antagonise a 
Ca^+ dependent slow tail current of the rat SCG i.e. the 
Iahp (Freschi, 1983). Two other currents, a fast tail 
current (lc ) and another slow current were unaltered by 
5mM Co^+ . Unfortunately Co^+ was the only Ca^+ channel 
antagonist tested on the rat SCG by Freschi (1983) and the 
selectivity of Co^+ for other currents was not determined. 
A similar effect of Co^+ and also Mn^+ and Cd^+ to 
antagonise a fast and slow AHP of CA1 pyramidal cells of 
the rat hippocampus has been reported by Storm (1987).
Thus the hyperpolarisations to the rat SCG to adenosine
24-
may be induced via an activation of a Co sensitive gKCa. 
However this hypothesis is not supported by the inability 
of the more seletive antagonist of lK(ca) channels to 
alter the hyperpolarisation to adenosine (Table 4.4) or 
the enhancement of the hyperpolarisation to adenosine in
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Ca^+ free PSS in the presence or absence of EGTA (Table 
A.7) (see section 4,2).
However, the significant reduction of the response to
O  I
adenosine by Co was examined in further detail as the 
iR(ca) current reported to be antagonised by Co^+
(Freschi, 1983) appears to be similar to the Ca^+ current 
responsible for the shoulder on the falling phase of the 
action potential that was inhibited by adenosine (Henon & 
McAfee, 1983b).
9+If Co alters the local membrane field by screening
negative fixed charges on the surface of the neurone then
9+the addition of Co would have an effect similar to
membrane hyperpolarisation and thus could depress the
response to adenosine. Such effects are not thought to
alter the RMP and should not depend upon the species of
divalent cation. The results presented in Tables 4.1 and
4.6 do not support the above hypothesis for the depression
of the response to adenosine caused by Co^+ . For example
9+at the same concentration 5mM Mg^ was less effective than
5mM Co^+ in antagonising the response to adenosine.
Because any screening of negative fixed charges would be
9+expected to be very similar in either Co^ or other
9+divalent cations, it is concluded that Co^ does not 
depress the hyperpolarisation to adenosine by simply 
screening surface charge.
Replacing Ca^+ with Co^+ significantly reduced the 
response to both adenosine and carbachol (Fig. 4.10) 
suggesting the effects of Co^+ may not be non-selective, 
but are unlikely to be a ”general anaesthetic action” 
because Co^+ did not alter the sensitivity to potassium 
(Table 4.7).
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Further studies on the response of the ganglion to 
muscarine in Co2+ PSS, showed Co2+ could also reduce the 
response to muscarine (Table 4.7) and strongly indicate 
the actions of Co2+ were non-selective as both the 
depolarisation to muscarine (caused by a decrease in gK) 
and the hyperpolarisation to carbachol (believed to be due 
to an increase in gK) were antagonised.
4.3.2 Effects of DHPs
Ligand binding studies have demonstrated that somne DHPs
reduce adenosine ligand binding to rat brain membranes,
while having no effect on other receptors including
cholinoreceptors (Morgan, Tamborska, Patel & Marangos,
1987) although other researchers have reported that the
DHPs at above luM have non-specific interactions including
the reduction of muscarinic binding (Gerry, Rauch, Colvin,
Adler & Messine, 1987). The ability of (+) PN200 110 to
reduce the response of the rat SCG to muscarine although
not significantly may be an example of the inhibition of
9+muscarinic binding or an interaction with Ca^ currents of 
sympathetic ganglia (Tokimasa & Akasu, 1990b). Even 
though the response to muscarine was reduced in the 
presence of (+) PN200 110 the inability of (+) PN200 110 
to alter the depression of the response to muscarine by 
adenosine suggests the depression of muscarine is 
independent of DHP sensitive Ca2+ channel activity.
It is reported that some DHPs have both agonist and 
antagonist activity within the same molecule e.g. 
nitrendipine on the release of catecholamines from 
adrenomedullary cells (Castillo, Fonteriz, Ldfcez,
Rosenhelh & Garcia, 1989). The potentiation of the 
response to adenosine by (+) PN200 110 compared to 
nitrendipine (Table 4.6) may be due to a mixed
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agonist/antagonist action of nitrendipine (Hess, Lansman & 
Tsien, 1984) compared to the antagonist activity of (+) 
PN200 110 (Hof, Scholtysik, Loutzenhiser, Vuorela & 
Neumann, 1984).
Alternatively, it has been reported that some DHPs inhibit
O
the uptake of H-adenosine in to rat brain synaptosomes 
(Phillis, Swanson & Barraco, 1984; Morgan et al., 1987) 
and inhibited the binding of NBI to dog heart and brain 
membranes (Marangos, Finkel, Verma, Maturi, Patel & 
Patterson, 1984). Functional studies have revealed that 
the ability of nifedipine to enhance the inhibitory action 
of adenosine on ACh excited cortical neurones (Phillis et 
al., 1984) and the inhibitory action of adenosine on 
spontaenous and evoked field potentials of hippocampi in 
vitro (Bartrup & Stone, 1990) may arise due to the 
inhibition of the nucleoside transport system. Bartrup & 
Stone (1990) found the inhibitory effect of adenosine in 
the presence of dipyridamole was inhibited by nifedipine. 
The possibility that (+) PN200 110 inhibited the uptake of 
adenosine and potentiated the hyperpolarisation of the rat 
SCG cannot be excluded.
The effects of the DHPs reported by Bartrup & Stone (1990) 
suggested the DHP used were weak or inactive at luM, in 
contrast to the potentiation of the hyperpolarisation to 
adenosine seen in the presence of luM (+) PN200 110 (Table 
4.6). As the concentrations of DHP used by both Bartrup & 
Stone (1990) and here are several orders of magnitude 
greater than that required to saturate the high affinity 
DHP binding sites (Belleman, Schade & Towart, 1983) their 
effects are unlikely to be directly on the DHP binding 
site. The greater potency of ( + ) PN200 110 may reflect a 
greater affinity of (+) PN200 110 for neuronal tissue 
(Weiland & Oswald, 1985), or that (+) PN200 110 is more
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potent than nifedipine on the inhibition of adenosine 
uptake.
Irrespective of the mode of action of the DHPs the 
inability of either compound to reduce the adenosine- 
induced hyperpolarisation of the rat SCG and the similar 
depression of the response to muscarine in the presence of 
(+) PN200 110 suggests that the actions of adenosine are 
not mediated by a change in calcium influx through voltage 
sensitive L-type channels. In addition it is reported 
that DHPs antagonise CaM mediated events such as the 
activation of CaM dependent cAMP PDE (Minocherhomjee &
Roufogalis, 1984, cited by Phillis et al., 1984) and the 
inability of (+) PN200 110 to antagonise the adenosine 
mediated hyperpolarisation of the rat SCG supports the 
idea that this response is independent of CaM (see Section
4.4).
4.3.3 Effects of nickel
Nickel ions block T-type Ca2+ currents approximately ten
9+times more potently than other Ca^ currents and even m  
the presence of high [Ca2+]e, 10 to lOOuM Ni2+ selectively
antagonises low threshold T-type Ca channels and at
9+ 9+higher concentrations Ni^ antagonises most Ca^ currents,
e.g. the Ca2+ currents of the dorsal root ganglion (DRG)
were abolished by 5mM Ni2+ (Carbone, Swandulla & Lux,
1988). The small reduction of the hyperpolarisation to
adenosine of the rat SCG in PSS containing Ni2+(Table 4.6) and the
lack of any evidence for the presence to T-type channels
in this ganglion (Wanke et al., 1987; Hirining et al.,
1988) is consistent with the suggestion that T-type Ca2+
currents are not involved in the response of the rat SCG
to adenosine.
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4.3,4 Effects of cadmium
As well as inhibition of Ca^+ currents Cd^+ has also been
found to inhibit the binding of [^H]CHA to Al receptors in
the rat brain membranes with an IC^q of 70uM (Marangos et
al., 1983, 1987). The inability of Cd^+ to alter the
response to adenosine suggests Cd^+ does not alter the
affinity of adenosine for the adenosine receptor of the
rat SCG. In addition these results confirm the response
to adenosine was independent of an endogenous "ACh tone"
9+as the antagonism of presynaptic N-type Ca^ channels by 
micromolar concentrations of Cd^+ would be expected to 
inhibit the release of ACh and reduce the response to 
adenosine.
2+Cadmium is a potent antagonist of both L- and N-type Ca^ 
chanels with an IC^q of about lOuM on DRG neurones and is 
about ten fold weaker on T-type channels (Miller, 1987).
At higher concentrations Cd^+ is not that selective on the 
rat SCG and at 200uM antagonises both the Ia^p and also a 
Cl” current (Selyanko, 1984) and at 500uM Cd^ abolished 
an inward calcium current (Galvan & Adams, 1982). The 
antagonism of an inward Cl” current would be predicted to 
decrease the RMP and enhance the response to adenosine, as 
it would start from a greater RMP. If the 
hyperpolarisation was due to the activation of the inward 
chloride current, it should have been reduced by 500uM 
Cd^+ instead the response was larger (Table 4.6) suggesting the
hyperpolarisation of the rat SCG is independent of an
_ # 9+
increase in gCl" or decrease in gCa
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4•4 The effect of Ca2+ channel antagonists on the 
response to muscarine
The ability of muscarine to depolarise and adenosine to
depress the response to muscarine in Ca2+ free PSS is
consistent with both responses occurring via a Ca2+
independent mechanism. The ability of Co2+, La^+ , Ni2+
2+and Ba to reduce the response to muscarine suggests a 
part of the response to muscarine could be Ca2+ dependent. 
Even so the inability of these calcium channel antagonists 
to alter the depression of muscarinic responses by 
adenosine suggests this effect of adenosine is independent 
of Ca2+ influx. As well as inhibition of Ca2+ channels 
divalent cations can cause a depolarisation shift in the 
steady state activation curve for Im (Mayer & Sugiyama,
1988). A reduction in the amplitude of Im by these metal 
ions would be expected to reduce the depolarisation to 
muscarine and is consistent with the reductions reported 
in Table 4.8. Adams, Brown & Constanti (1982a) reported 
that not only Ic and Ik but also Im of the rat SCG was 
inhibited by divalent cations with the following potency:
Ba2+ >= Ni2+ > Co2+ > Mn2+ > Cd2+
It is interesting that Ba2+ caused a potentiation of the 
depression by adenosine of muscarinic responses. This may 
have occurred due to one or other of the many actions of 
Ba2+ including passing readily through Ca2+ channels into 
neurones (Hagiwara & Byerly, 1981) or the antagonism of 
various outward K+ currents including Ca2+ dependent K+ 
currents (Connor, 1979; Segal, 1982) and Im (Constanti et 
al., 1981b). The results of other experiments reported
2 I
here suggest many of these actions of Ba on the 
hyperpolarisation to adenosine can be disregarded, and the 
slight increase in the depression of the muscarinic 
response by adenosine in the presence of some metal ions
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reported here may be a consequence of the inhibition of 
Im. The depolarisation of the ganglion by Ba2+ was 
probably due to the inhibition of Im (see Constanti et 
al., 1981b) and the ability of Ba2+ to enhance the 
response to adenosine suggests adenosine may activate 
closed M channels. This hypothesis was tested and is 
described in section 5.3.
4.4.1 Relative potency of Ca2+ channel antagonists on 
the response of the rat SCG to adenosine
An extensive study of the blocking effect of a number of 
polyvalent cations was performed on the Ca2+ component of 
the action potential of the barnacle muscle by Hagiwara & 
Takahashi (1967) and similar orders of potency have been 
confirmed for other tissues (Blaustein & Goldman, 1968; 
Hagiwara & Byerly, 1981; Nachshen, 1984; Lansman et al., 
1986). The order of Ca2+ channel antagonism was:
La3+ > Co2+ > Mn2+ > Ca2+ > Mg2+
Although Cd2+ was not tested on barnacle muscle it has
been found to be a potent Ca2+ channel antagonist on
2+neurones, particularly on presynaptic Ca channels of the 
rat SCG (Hirning et al., 1988; IC5q for N and L-type 
channels of about 2uM) where it was the most potent 
compound to inhibit Ca2+-spikes of the rat SCG (Elliott et 
al., 1989), the order of the potency being:
Cation Cd2+ > La3+ > Ni2+ > Co2+ > Mn2+ > Mg2+
IC50 uM 3 10 55 510 1070 15000
The observed reduction in the response to adenosine by 
divalent cations on the rat SCG, was somewhat different to 
that found for the blockade of the Ca2+ currents described
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above. Greater concentrations of divalent cations were
required to produce antagonism of the hyperpolarisation to
adenosine than used to block the Ca2+ spikes of the rat
SCG (Elliott et al., 1989) or other tissues. For example,
500uM Cd2+ virtually eliminates Ca2+ current in nodose
ganglia (Ikeda, Schofield & Weight, 1986), whereas 500uM 
2+Cd did not significantly alter the hyperpolarisation of
the rat SCG to adenosine. La^+ is thought to block all
Ca2+ movements and the inability of La^+ and also Cd2+ and 
9+Ni^ to alter the hyperpolarisation of the rat SCG to
adenosine or of La^+ to reduce the effectiveness of
adenosine in depressing the response to muscarine is
inconsistent with the effects of adenosine being mediated
9+by a reduction in Ca* influx.
9+At the concentrations used to antagonise Ca* channels the
inorganic cations used in this study are believed to have
a number of other effects on the membrane including
changing surface charge potential, inactivating a range of
ionic conductances (Galvan & Sedlmeir, 1983), and altering
the binding of specific ligands to adenosine (Marangos et
al., 1987) and muscarinic receptors (Birdsall, Burgen,
Hulme & Wells, 1979). Although changes in the RMP of the
ganglion could bias the conclusions obtained from the
experiments reported here, overall these results with
different metal cations indicate both the
hyperpolarisation and the depression of muscarine
9 +
responses by adenosine remained unaltered by Ca channel 
antagonists, with the exception of Co2+, which produced 
non-specific reductions in the sensitivity of the rat SCG.
Marangos & colleagues (1983) have reported that the 
binding of adenosine to Al-receptors is reduced by some 
Ca2+ channel antagonists whereas other researchers have 
reported the binding of ligands to adenosine receptors 
including cyclohexyladenosine (CHA) to cerebral membranes
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is enhanced by magnesium and calcium ions (Goodman,
Cooper, Gavish & Snyder, 1981; Yeung & Green, 1983; Yeung,
Fossom, Gill & Cooper, 1985). Likewise Co2+, Ni2+ and 
3+La are reported to enhance binding. However in the 
present studies the functional response to adenosine was 
decreased in high Ca2+ PSS (Table 4.7), unaltered by the 
absence of Mg2+ (Table 4.1) and not significantly altered 
by many Ca2+ channel antagonists (Table 4.6), suggesting 
the results of these binding studies may have little 
functional significance.
4.5 Effect of A23187 and trifluoperazine on the 
response to adenosine
The studies in the previous section have shown that the 
effect of adenosine on the rat SCG are independent of 
[Ca2+]e and to complement these studies some experiments 
were done to examine the possibility that adenosine 
produces its effects via an action on [Ca2+]i.
The ionophore A23187 has been shown to raise the [Ca2+]i
by causing a large uptake of extracellular calcium
(Campbell, 1987) and would be expected to antagonise the
effects of adenosine on the rat SCG if they are mediated
through a decrease in Ca2+ entry. The results of Dowdle &
Maske (1980) support such a hypothesis, as they found that
A23187 at O.luM antagonised the inhibitory effect of
adenosine on the response of the guinea-pig ileum. The
fact that A23187 did not significantly alter the basal
d.c. potential (Table 4.3) is consistent with the idea
that A23187 is a neutral charge carrier without a direct
effect on membrane potential (Campbell, 1987). It has
9+been reported that as well as facilitating Ca transport, 
A23187 may also stimulate the release of [Ca2+]i and/or 
alter intracellular pH (Campbell, 1987). It is unknown if
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these effects occurred in the experiments described here 
but with these caveats the lack of effect of A23187 (Table
4.3) suggests adenosine does not hyperpolarise the rat SCG 
by inhibiting calcium entry and the presumed increase in
O j _
[Ca ]i by A23187 did not alter the hyperpolarisation to 
adenosine.
The maintenance of [Ca^+ ]i is controlled by a number of 
proteins including CaM and there is considerable evidence 
that CaM mediates many Ca^+ dependent processes and can 
regulate both pre- and postsynaptic events (Roufogalis, 
1980). As CaM can regulate the metabolism of cAMP and is 
itself regulated by cAMP an increase in [Ca^+ ]i due to 
influx or intracellular release of Ca^+ could initiate the 
activation of CaM dependent PDE*s to decrease cAMP and act 
as the transduction signal for the actions of adenosine. 
The inability of TFP to alter the response to adenosine 
(Table 4.3) suggests that CaM may not be involved in the 
hyperpolarisation of the rat SCG to adenosine and is 
consistent with the lack of effect of A23187 on the 
response to adenosine.
The evidence for the mechanism of action of adenosine
2+  •occurring via an interaction with Ca^ m  some tissues,
e.g. atrial and blood vessel muscle is not conclusive.
2+For example it is known that adenosine inhibits both Ca 
uptake and the Ca^+ mediated action potential plateau in 
atrial muscle (Schrader, Rubio & Berne, 1975) but effects 
on other conductances including sodium and potassium have 
not been conclusively excluded. More recently, Cerbal, 
Klockner & Isenberg (1988) reported that adenosine and ACh 
blocked about one third of the L-channels and not T- 
channels of patch clamped myocytes recorded with blocked 
K+ channels and suggested adenosine and ACh may reduce the 
number of functional L-type Ca^+ channels. However, more 
important was the observations made using myocytes with
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unblocked K+ channels, where physiological concentrations 
of adenosine reduced the calcium current (lca) by 30% but 
enhanced the potassium current (Ir ) by 300% suggesting the 
"K-agonistic" properties of adenosine are responsible for 
the hyperpolarisation, shortening of the action potential 
and negative inotropy reported.
Preceding evidence is strongly against the actions of
adenosine on the rat SCG arising from an interaction with 
2+Ca^ currents and an examination of figure 4.1 suggests 
that the ionic mechanism responsible for the actions of 
adenosine is most likely generated a change in membrane 
permeability to either Na+ , K+ and/or Cl” ions. Each of 
these possibilities was examined.
4.6 Effects of low [Cl"]e and furosemide on the response 
to adenosine
Chloride is the most abundant anion in PSS and another way 
adenosine may hyperpolarise the ganglion would be to 
increase the permeability of ganglionic neurones to Cl” 
ions (Fig. 4.1). Adenosine has been reported to enhance 
labelled Cl~efflux of many tissues including Aplysia 
neurones (Chenoy-Marchais, 1982), rabbit colon (Gras & 
Turheim, 1984) and canine tracheal epithelium (Pratt, 
Clancy & Welsh, 1986). A similar Cl” current to that 
described by Chenoy-Marchais (1982) has been found in the 
rat SCG and was inhibited by 200uM Cd^+ (Selyanko, 1984). 
The results presented in table 4.6 show that Cd^+ at 500uM 
did not significantly alter the response to adenosine 
suggesting adenosine does not enhance Cl" efflux.
Another aspect of the role of Cl" in the response to 
adenosine is the ability of muscarine to inhibit not only 
the outward K+ current (Im), but also the reduction of a
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steady state voltage-independent inward current, termed Ix 
(Brown & Selyanko, 1985a), Ix is believed to be carried 
by Cl ions and the depression of muscarine by adenosine 
could occur due to activation of Ix.
Depolarisation of the rat SCG by GABA increases Cl" 
conductance (Adams & Brown, 1975) and K+ efflux (Ballanyi 
& Grafe, 1985) and upon repolarisation produces an AHP due 
to redistribution of Cl" by the co-transport of Cl" into 
the neurones in exchange for Na+ or K+ i.e. the Na+/K+/Cl" 
co-transporter (Ballanyi & Grafe, 1985). Furosemide a 
Na+/Cl" or K+/C1” co-transport inhibitor is known to 
antagonise the reuptake of Cl" and K+ in a variety of 
tissues including the rat SCG (Ballanyi, Grafe, Reddy & 
ten Bruggencate, 1984; Ballanyi & Grafe, 1985).
If a change in gCl is responsible for the production of 
the hyperpolarisation of the SCG to adenosine, the 
amplitude of this hyperpolarisation would be affected by 
replacing the [Cl"]e with other anions, which would not be 
permeable through the neuronal membrane, such as 
isethionate ions. Low [Cl"]e will reverse the Cl" 
gradient so that there will be an efflux or considerable 
reduction in the influx of Cl" and should decrease a 
putative muscarinic gCl, i.e. Ix. The ability of low 
[Cl"]e to abolish the AHP to GABA(Table 4.2)is indicative that the 
Na+/K+/Cl" co-transport mechanism was antagonised and the 
inability of low [Cl”]e to alter the response to adenosine 
(Table 4.2) suggests adenosine is unlikely to alter Ix or the 
Na+/K+/Cl" co-transporter.
Likewise the inability of low [Cl"]e to enhance the 
response to muscarine suggests that Cl efflux contributes 
very little to the response to muscarine at the 
concentration used and most of the response to muscarine 
probably occurred via some other mechanisms: an inhibition
i
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of Im. Therefore it is unlikely that the interaction of 
adenosine and muscarine occurs at the level of Ix.
4.6.1 Effect of furosemide on the hyperpolarisation to 
adenosine
In lOuM furosemide the AHP to GABA (lOuM) was abolished 
whereas a comparable hyperpolarisation to adenosine was 
reduced to a lesser extent (Table 4.14). Increasing the 
concentration of furosemide to lOOuM abolished the AHP 
produced by a ten fold higher concentration of GABA 
(lOOuM) but did not produce a significantly greater 
reduction in the response to adenosine. The ability of 
furosemide to partially inhibit the hyperpolarisation to 
adenosine may be indicative of an interaction of adenosine 
with the Na+/K+/Cl" co-transporter or alternatively a 
requirement of the active transport of Cl" in to neurones. 
Further evidence against adenosine altering the Na+/K+/Cl“ 
co-transport is provided by the fact that the response to 
adenosine was unaltered during the activation of the 
Na+/K+/Cl“ co-transporter by GABA (Fig. 4.12b). However, 
the lack of a significant effect of low [Cl“]e on the 
adenosine hyperpolarisation or the activation of the 
Na+/K+/Cl" co-transporter by GABA on the response to 
adenosine suggests the hyperpolarising effect of adenosine 
is not coupled to Cl" currents.
The Ki reported for the Na+/K+/Cl" co-transport for 
furosemide is probably around 5uM (Aronson, 1984) and at 
concentrations above lOOuM furosemide has been reported to 
affect the Na+ pump and other exchange processes. As the 
specificity of furosemide on the response to adenosine was 
not assessed in this study and this possibility cannot be 
ruled out. A 10 to 20 minute application of furosemide at 
500uM caused a longlasting depletion of Cl and complete
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blockade of K+ and Cl" uptake in the rat SCG (Ballanyi et 
al., 1984). As a reduction of [Cl“]i may inhibit 
regulatory G-protein activity (Higashijima, Ferguson & 
Sternweis, 1987) and the hyperpolarisation of the rat SCG 
may be linked to G-proteins (Newberry & Gilbert, 1989b) 
this may be the cause of the inhibition of the response to 
adenosine. Alternatively as furosemide strongly delays or 
completely inhibits the reuptake of K+ , the build up of 
[K+ ]e due to inhibition of the Na+/K+/Cl" co-transporter 
would be expected to decrease the response to adenosine if 
it is produced by an increase in gK.
4.7 Effect of inactivation of the electrogenic Na+ pump 
on the response to adenosine
There are certain similarities in the actions of 
catecholamines and purines on the rat SCG as both agents 
inhibited Ca^+ currents (McAfee & Yarowsky, 1979; Henon & 
McAfee, 1983a) and hyperpolarise postganglionic SCG 
neurones (Brown et al., 1979). Catecholamines and purines 
may promote depressant effects on neuronal activity and 
catecholamines can enhance the rate of ATP hydrolysis by 
activating Na+/K+ ATPases (Phillis & Wu, 1981). Thus the 
activation of the sodium/potassium ATPase transporter 
(here after referred to as the electrogenic Na+ pump) 
would lead to the exchange of [Na+ ]i for [K+ ]e and a 
hyperpolarisation of the SCG.
The ability of adenosine to activate the electrogenic Na+ 
pump may account for the potentiating effects of adenosine 
in Ba^+-PSS, as Ba^+ antagonises many K+ currents but does 
not antagonise the electrogenic Na+ pump (Padjen & Smith, 
1983). In fact Ba^+ enhanced the potential changes 
resulting from electrogenic Na+ pumping by increasing 
membrane resistance (Rm), and potentiated the AHP produced
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by the application of ACh to bullfrog ganglia (Smith & 
Dombro, 1985).
The possibility that adenosine hyperpolarises the rat SCG 
by activating the electrogenic Na+ pump was investigated 
in a series of experiments which in addition provided 
information about other ionic mechanisms that may be 
involved in the response of the ganglion to adenosine.
The role of electrogenic Na+ pumping in sympathetic 
ganglia can be studied by examining the AHP which follows 
the application of high concentrations of ACh (Brown et 
al., 1972; Smith, 1984). Na+ enters during nicotinic 
depolarisation and the accumulated Na+ load is extruded 
electrogenically during the AHP. The stimulation of Na+ 
extrusion by K+ results from the activation of Na+/K+ 
ATPase, and this activation is inhibited by cardiac 
glycosides e.g., ouabain. The depressant effects of 
adenosine on the cerebral cortex (Sastry & Phillis, 1977) 
and amphibian ganglia (Koketsu & Nakamura, 1976) were 
selectively depressed by the cardiac glycoside, ouabain. 
Thus the ability of the rat SCG to hyperpolarise in oubain 
was assessed.
In other experiments both the ability of adenosine to 
activate the electrogenic Na+ pump and/or increase a gK 
was assessed by determining the effect of K+ free PSS (0K+ 
PSS) on the response to adenosine, a condition where the 
electrogenic Na+ pump is believed to be inactive. Another 
method used to inactivate the electrogenic Na+ pump was to 
replace extracellular Na+ by Li+ . These experiments also 
provided information about the effect of Na+ free PSS on 
the response to adenosine. The substitution of [Na+ ]e by 
Li+ in many tissues including bullfrog ganglia (over short 
incubation periods, Koketsu & Yamamoto, 1974) allows the 
maintenance of membrane excitation, but in mammalian
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ganglia Li+ does not substitute for Na+ at the internal 
site of the sodium pump and thus inhbits the electrogenic 
Na+ pump (Pappano & Voile, 1966a, 1967).
4.7.1 Effect of ouabain on the response to adenosine
The hyperpolarisation to adenosine persisted in the 
presence of 1 and lOuM ouabain, and was enhanced in lOuM oubain 
(Table 4.10), suggesting adenosine does not activate
electrogenic Na+ pumping. Both the depolarisation and the 
AHP response to DMPP were unaltered in PSS containing lOuM oubain 
(Table 4^13), although inhibition of the electrogenic Na+ pump 
would have been expected to potentiate depolarisation and 
attenuate the AHP to DMPP.
The ability of ouabain to produce a slowly developing 
depolarisation of the ganglion suggests ouabain altered 
the RMP, and the low concentration of DMPP employed may 
have produced such a small change in [Na^+ ]i that it was 
restored by a partially inactivated Na+/K+ ATPase pump.
It was reported by Brown et al. (1972) that the EC^q for 
the inhibition of the AHP to DMPP by ouabain was about 
50uM. It would be predicted that K+ free media would 
inactivate the electrogenic Na+ pump, however Smith (1984) 
reported that a brief AHP to ACh remained in K+ free 
Ringer’s and suggested this was due to the efflux of 
[K+ ]i. Therefore in PSS and ouabain or K+ free PSS an 
accumulation of [K+ ]e during the experiment (Galvan, ten 
Bruggencate & Senekowitsch, 1979) could serve to maintain 
Na+ pumping. Jones (1989) reported that the electrogenic 
Na+ pump may be responsible for maintaining the ionic 
gradients to Na+ and K+ and the RMP of sympathetic 
neurones (Jones, 1989). Ouabain increases the resting 
efflux of K+ (Galvan et al., 1979) and the potentiation of
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the hyperpolarisation to adenosine in ouabain is 
consistent with an increase in gK.
4.7.2 Effect of Rubidium (Rb+ ) on the response to
adenosine
The substitution of Rb+ for K+ in PSS enhanced the 
hyperpolarisation to adenosine. Since Rb+ moves into 
cells almost as quickly as K+ and the permeability of 
nerve membranes to Rb+ is much less than its permeability 
to K+ the enhanced response to adenosine in Rb+ PSS is 
consistent with greater Rm in Rb+ .
4.7.3 Effect of lithium on the response to adenosine
The response to adenosine in PSS containing lOmM Li+ was 
unaltered after incubation for almost 2 hours (Table
4.10). The difference between the response in Li-HEPES 
and lOmM Li PSS may have arisen due to the low 
permeability of mammalian SCG to Li+ (Papanno & Voile,
1966a,b; 1967).
Normally Na+ ions carry the inward current to depolarise 
ganglion cells, but when Na+ ions are not available for 
this purpose other ions including Ca^+ make a major 
contribution as carriers of inward current. Calcium ions 
are only capable of supporing the depolarisation to ACh
for a short time in medium completely lacking Na+ ions
(Pappano & Voile, 1966b). The inhibition of the AHP to DMPP 
(Table 4.13) is consistent with Li-HEPES inhibiting the Na+ pump 
as reported by Brown et al. (1972). The ability of 
adenosine to hyperpolarise in Li-HEPES suggests adenosine 
does not hyperpolarise the rat SCG by activating the Na+ 
pump. Indirect evidence to support this idea comes from
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the reduction or abolition of the AHP to carbachol in Ca^+ 
free PSS (Brown et al., 1972), and the ability of 
adenosine to hyperpolarise in K+ free PSS, a condition 
where the activity of the electrogenic Na+ pump would be 
inhibited.
Lithium has been found to discriminate between muscarinic 
receptors and abolished the response produced by 
stimulation of Ml receptors in the rat hippocampus 
(Muller, Brunner & Misgeld, 1989). Thus the abolition of 
the response to muscarine in Li-HEPES (Figs. 4.13 & 4.14) 
may be due to the blockade of phosphoinositol turnover 
(PIT), which is coupled to Ml receptors (Fisher, 1986; 
Batty & Nahorski, 1987) and/or Li+ may inhibit the 
coupling of muscarinic receptors to G-proteins (Avissar, 
Schreiber, Danon & Belmaker, 1988).
In contrast the response to adenosine in Li-HEPES was 
initially enhanced during a two hour incubation in Li- 
HEPES returning to the pre Li treatment level (Fig.
4.13b,c & Fig. 4.14). Short term treatment of tissues 
with Li+ enhances responses linked to inositol breakdown 
(Drummond & Raeburn, 1984) possibly by antagonising the 
metabolic cascade of inositol phosphates (IP) after the 
activation of protein kinase C (PKC) at the monophos­
phatase level (Allison & Blisner, 1976). Although Li- 
HEPES did not completely inhibit the response to 
adenosine, the response after more than two hours 
incubation was shorter than the previous control responses 
suggesting Li+ inhibits part of the response to adenosine. 
The effects of Li+ may be due to an effect on PIT or on 
the coupling of adenosine receptors to PTX sensitive G- 
proteins (Avissar et al., 1988).
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4.8 The role of potassium channels in the response to 
adenosine
There is good evidence that adenosine enhances a variety 
of potassium currents in various cell types including 
Xenopus oocytes (Lotan, Dascal, Cohen & Lass, 1982), heart 
muscle (Hartzell, 1979; Belardinelli & Isenberg, 1986; 
Kurachi, Nakajima & Sugimoto, 1986), parasympathetic 
ganglia (Akasu et al., 1984), hippocampal pyramidal 
neurones (Segal, 1982; Haas & Greene, 1984; Greene & Haas, 
1985; Schubert & Lee, 1986; Trussell & Jackson, 1987,
1989) and striatal and cortical neurones (Trussell & 
Jackson, 1987, 1989).
Diversity of potassium channels in neuronal tissues
Many agents that hyperpolarise neurones have been found to 
increase gK (North, 1989) through a great diversity of 
potassium channels. At least eleven different types of K+ 
channel have been described, based on their voltage gating 
and sensitivity to calcium (see: Cook, 1990; Castle et 
al., 1989). Many types of K+ channel have been found to 
exist within the same cell and up to six different K+ 
currents have been identified in the rat SCG (Freschi, 
1983; Galvan & Sedlmeir, 1983) including a delayed outward 
rectifier (lj(); a transient outward current (I^)> three Ca 
activated currents (Iq , Iahp^ an(* M-current (Im). The 
presence of these K+ channels in SCG neurones allows the 
maintenance of the RMP and the termination of excitation 
by repolarisation or hyperpolarisation of the neuronal 
membrane (Belluzzi, Sacchi & Wanke, 1985a,b).
To discover if adenosine hyperpolarised the rat SCG by 
increasing gK experiments were done using drugs known to 
alter potassium channel activity.
112
4.8.1 Effects of altered [K+ ]e on the response to 
adenosine
The response to adenosine in OmM Ca2+/10mM Mg2+ PSS was 
comparable to that in normal PSS, and the reduction of 
[K+ ]e from 6mM to 2mM in OmM Ca2+/10mM Mg2+ PSS 
significantly enhanced the response to lOOuM adenosine 
(Table 4.11).
The potentiation of the response to adenosine in 2mM K+
PSS in a solution that has been shown by others to block 
synaptic transmission (OmM Ca2+/10mM Mg2+ PSS) (Table
4.11) is consistent with adenosine increasing gK via a 
direct postganglionic response. The leftward shift in the 
concentration response curve to adenosine in 0K+ PSS and 
antagonism of the response to adenosine in 12mM K+ PSS 
(Fig. 4.15) is consistent with adenosine increasing gK as 
reduction of [K+ ]e would inhibit the Na+ pump and increase 
the concentration gradient for K+ efflux. If the 
adenosine induced hyperpolarisation is generated by an 
increase in gK, the driving force for the outward movement 
of K+ will depend on the difference between the RMP (Em) 
and the potassium equilibrium potential (Ek) i.e. Em-Ek. 
Intracellular microelectrode recordings suggest Em varies 
from about -40 to -60mV (McAfee & Yarowsky, 1979; Galvan & 
Sedlmeir, 1983) and Ek is about -80 mV (Constanti & Brown, 
1981) (the low value of Em could be explained by a high 
Na+ permeability) and the antagonism of electrogenic Na+ 
pumping would tend to move Ek and ENa towards zero mV.
The absence of [K+ ]e will augment [Na+ ]i due to the 
inhibition of the electrogenic Na+ pump, and this will 
stimulate Na+/Ca2+ exchange which may elevate [Ca2+]i.
Thus if the effects of low K+ or ouabain arise from an 
increase in [Ca2+]i this would be more indirect evidence 
that an increase in [Ca2+]i is not inhibitory for the 
response to adenosine. It is unlikely that reduction in
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the response to adenosine in 12mM K+ PSS is due to an 
increase in [Ca^+ ]e as Galvan and co-workers (1979), using 
ion sensitive electrodes, found the extracellular calcium 
activity was unaltered by doubling the [K+ ]e to 12mM.
Although an increased response to adenosine in the 
presence of low or K+ free PSS indicates adenosine 
increases gK+ these results may also indicate a decrease 
in gNa may contribute to the effects of adenosine. If 
adenosine reduced Na+ entry this may also cause a 
reduction in passive outward Cl~ movement, and both 
effects would tend to hyperpolarise ganglion cells. These 
possibilities can be best studied using conventional 
microelectrode techniques or ion sensitive electrodes. 
However, a change in gNa+ is unlikely as Henon & McAfee 
(1983a) reported adenosine does not inhibit the rate of 
rise or amplitude of the Na+ AP spike and TTX did not 
antagonise the response to adenosine (Henon & McAfee, 
1983a) (Table 4.9) and Na+ free PSS i.e. Li-HEPES did not 
alter the peak response to adenosine.
4.8.2 Effect of K+ channel activators cromakalim (BRL 
34915) and diazoxide on the d.c. potential
Several compounds have been identified that increase the 
permeability of smooth muscle cells to K+ , to 
hyperpolarise them. Two of these compounds, cromakalim 
and diazoxide are thought to owe their effects to 
activation of ATP-sensitive K+ channels (^k (ATP)^ an<^  are 
potent vasodilators but more recently cromakalim has been 
reported to have anticonvulsant activity (Alzheimer & ten 
Bruggencate, 1988), to enhance a voltage dependent K+ 
current in the rat hippocampus (Politi, Suzuki &
Rogawaski, 1989) and antagonised a behavioural response to 
pilocarpine (Tricklebank, Flockhart & Freedman, 1988).
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K(a t p ) channels have also been detected in neonatal 
cerebral cortex cultures (Ashford, Struges, Trout, Gardner 
& Hales, 1988). The presence of K^XP) channels in 
neuronal tissues may not be restricted to the CNS and 
could mediate the response of adenosine on the rat SCG.
The ability of cromakalim and diazoxide to alter the d.c. 
potential and the response of the rat SCG to muscarine and 
pilocarpine was investigated. As the biological activity 
of cromakalim resides primarily in the (-) enantiomer i.e. 
lemakalim (BRL 38227) (Buckingham, Clapham, Coldwell, 
Hamilton & Howlett, 1986; Hof, Ouast, Cook & Blarer, 1988) 
the effect of cromakalim and lemakalim were studied in 
some experiments.
The inability of diazoxide and lemakalim to alter the d.c. 
level of the ganglion (Tables 4.15 and 4.16) suggests 
K(a t p ) channels are absent or inactive on the rat SCG.
This conclusion was further strengthened by the 
observation that both lemakalim and diazoxide did not 
significantly alter the depolarisation to muscarine 
(Tables 4.15 and 4.16) suggesting K^xp) channels are not 
involved in the response to muscarine or its interaction 
with adenosine.
Cromakalim has been reported to antagonise the induction 
of purposeless mouth movements of mice treated with 
pilocarpine with no effect on muscarinic binding or 
phospholipid hydrolysis (Tricklebank et al., 1988). The 
inability of lemakalim to alter the response to both 
muscarine and pilocarpine suggests the behavioural 
interactions of cromakalim and pilocarpine are indirect.
It is possible that the SCG has few ATP-sensitive K+ 
channels as reported for cultured neuronal cells (Ashford 
et al., 1988) and/or neuronal ATP-sensitive K+ channels
115
are located presynaptically (Hall & MaClagan, 1988; for 
discussion see Ben-Ari, 1990). The inactivity of ATP 
sensitive K+ channel activators on the SCG makes it 
unlikely that the actions of adenosine or muscarine are 
mediated via these channels.
4.8.3 Effect of calcium activated potassium channel 
antagonists on the response to adenosine
Under physiological conditions the electrochemical 
gradient for passive diffusion of K+ is outward (see Fig.
4.1), and it is predicted that the opening of calcium 
activated K+ channels (K(ca))by adenosine would allow the 
efflux of K+ to hyperpolarise the cell. Thus one 
mechanism of action of adenosine could be to potentiate a 
Ca^+ activated K+ current (iK(Ca)) as rePorted f°r the 
effect of adenosine on the rat hippocampus by Haas & 
Greene (1984) and on the myenteric neurones of the guinea- 
pig by Palmer et al. (1987).
K(ca) channels have been identified in a number of 
neurones: including guinea-pig enteric plexus neurones 
(North & Tokimasa, 1987; Akasu & Tokimasa, 1989), rabbit 
parasympathetic neurones (Nishimura, Tokimasa & Akasu, 
1988), bullfrog sympathetic neurones (Constanti, Adams & 
Brown, 1981a; Adams, Constanti, Brown & Clark, 1982b; 
Tokimasa, 1984) and rat SCG in culture (Smart, 1987; 
Gurney, Tsien & Lester, 1987) and may contribute to the 
RMP. In sympathetic neurones an increase in channel
conductance can prolong the spike AHP (McAfee & Yarowsky, 
1979; Brown et al., 1982; Belluzzi & Sacchi, 1989) to 
regulate repetitive firing (Kuba, Morita & Nohmi, 1983) or 
accelerate spike repolarisation (Brown, Constanti & Adams, 
1983; Belluzzi & Sacchi, 1989) allowing the neurone to
116
pass high frequency discharge during muscarinic 
excitation.
Before discussing the channels described for the rat
SCG it is useful to summarise the properties of 
channels, ^(Ca) channels are selective for K+ and are 
activated by micromolar concentrations of [Ca^+ ]i and 
classified on the differences in conductance and 
sensitivity to calcium and pharmacological antagonists 
(for reviews see Blatz & Magleby, 1987; Castle et al., 
1989; Latorre, Oberhauser, Labarca & Alvarez, 1989).
There are three main classes namely: big (BK), 
intermediate (IK) and small (SK) conductance channels 
(Castle et al., 1989) (Table 4.2). SK channel currents 
(lahp) are selectively antagonised by apamin, an 
octadecapeptide found in bee venom (reviewed by Baidan & 
Zholos, 1989), whereas BK channel currents are antagonised 
by tetraethylammonium (TEA) (Cook & Quast, 1990; Castle et 
al., 1989).
Apamin was reported as ineffective in bullfrog sympathetic 
ganglion cells by Brown et al (1983), but further study by 
Pennefather, Lancaster, Adams & Nicoll (1985) showed there 
were two distinct components of AHP, of which the slow 
component was apamin sensitive. A slow K^Qa  ^ current 
similar to that described in bullfrog ganglia has been 
found in adult rat SCG dissociated in culture (Marrion, 
Smart, Marsh & Brown, 1989) and Kawai & Wantanabe (1986) 
reported 50nM apamin significantly reduced a slow AHP of 
the rat SCG (Iahp)« Apamin was highly selective for SK 
and after 20 minutes incubation the IC^q of apamin for the 
inhibition of synaptically activated AHP was 15nM (Kawai & 
Wantanabe, 1986). The K(Ca) channels that are insensitive 
to apamin are antagonised by TEA (Smart, 1987; Marrion et 
al., 1989). Ic current of the rat SCG is activated by 
both a rise in [Ca^+ ]i and depolarisation and is
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insensitive to muscarine (lOuM), apamin (100-300nM) and 4- 
aminopyridine (4AP, at l-3mM) (Smart, 1987). In contrast 
Iahp -^s antagonised by muscarine or substance P in frog 
(Tokimasa, 1984; Pennefather et al., 1985; Akasu & 
Tokimasa, 1989) and rat ganglia (Brown, 1988).
The AHP of the rat SCG consists of two components, a 
primary voltage dependent gK which contributes 
substantially to the peak amplitude of the AHP and a Ca^+ 
dependent gK (gK(ca)) (McAfee & Yarowsky, 1979). The 
magnitude of the AHP is proportional to the amount of Ca^+ 
entry during the spike (McAfee & Yarowsky, 1979) and was 
antagonised in the presence of adenosine (Henon & McAfee, 
1983a) suggesting adenosine decreases, not increases an 
*K(Ca)# identified by Henon & McAfee (1983a) was
characterised as being both TTX and TEA (up to lOmM) 
resistant but sensitive to blockade by Co2+ and manganese 
(Mn2+) (McAfee & Yarowsky, 1979) suggesting it may be due 
to activation of SK channels. Thus it was of interest to 
examine the actions of adenosine on the rat SCG when 
either or both Iahp and Ic are inhibited to see if 
antagonism of these channels altered the adenosine-induced 
hyperpolarisation of the ganglion. In some experiments 
the response to adenosine in apamin PSS was measured in
the presence of bovine serum albumin (BSA) to prevent the
peptide sticking to the glassware. However BSA in PSS 
significantly reduced the response to adenosine (Table
2.2), perhaps due to some adenosine binding to BSA, and 
control responses to adenosine were measured in the 
presence of BSA and compared to apamin and BSA, PSS.
Irrespective of the presence or absence of BSA, the
inability of apamin to alter the response to adenosine at 
up to five times the concentration reported to block Ic of 
the rat SCG (Kawai & Wantanabe, 1985) suggests adenosine 
does not activate Ic. The inability of dTc to alter the
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response to adenosine is also consistent with a lack of 
effect of adenosine on Ic.
It is expected that both Ic and Ia^p would be reduced or
abolished in low [Ca^+ ]e and the augmentation of the
adenosine-induced hyperpolarisation in low [Ca^+ ]e and the 
inability of apamin and dTc to alter the response to 
adenosine both in normal PSS (Table 4.4) and in OmM
Ca^+/10mM Mg2+ + ImM 4AP PSS in the absence (adenosine,
lOOuM - -50, -HOuV) or presence of dTc lOOuM (-60, - 
H O u M V  respectively) indicates adenosine does not 
hyperpolarise the rat SCG by an increase in gK(ca)*
4.8.4 Effect of tetraethylammonium (TEA), 4-
aminopyridine (4AP) and 3,4-diaminopyridine 
(3,4-DAP) on the response to adenosine
The development of various K+ channel antagonists as 
pharmacological tools with high selectivity for different 
K+ channels (see Cook, 1988; Castle et al., 1989) has 
allowed the differentiation of individual K+ currents 
which are selectively antagonised by TEA and 4AP, and 
these drugs have been used to discover if the actions of 
adenosine on neurones are via K+ channels (Perkins &
Stone, 1980; Schubert & Lee, 1986). TEA antagonises K+ 
currents and some calcium activated currents, with a low 
potency against IA , Ic and Iahp> although higher 
concentrations of TEA antagonise the majority of K+ 
channels including 1^, IA , inward rectifiers (Ir )> ^k (ATP) 
and Im (Cook, 1990; Castle et al., 1989; Cook & Quast,
1990). Likewise 4AP can also function as a non-selective 
K+ channel antagonist, but IA is particularly sensitive to 
antagonism by aminopyridines including 4AP and 3,4- 
diaminopyridine (3,4DAP). The ability of TEA and 4AP to 
alter the response to adenosine was investigated to
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discover if the hyperpolarisation to adenosine occurs due 
to the activation of a K+ channel.
The ability of 2mM TEA to reduce the response to adenosine 
(Table 4.9) is indicative that adenosine may hyperpolarise 
the rat SCG by activating an increase in gK.
A likely site of action of adenosine might be to activate 
delayed rectifier K+ current, Ik as Galvan & Sedlmeir 
(1983) and Belluzzi et al. (1985b) studying the rat SCG 
found 1 to 3mM TEA abolished Ik. There are at present no 
more selective antagonists of 1^ (Anikoztejn & Ben-Ari, 
1991; Cook, 1990) and other currents such as Im and Ic 
could also be antagonised by TEA. Although TEA is known 
to antagonise SK channels with an IC^q of 3 to lOmM (Cook 
& Quast, 1990), BK channels of the rat SCG (Smart, 1987) 
and bullfrog ganglia at ImM (Adams et al., 1982), it is 
unlikely these channels are involved in the response to 
adenosine (see section 4.4).
The inability of TEA at lOmM to antagonise the 
hyperpolarisation to adenosine is perplexing as TEA might 
be expected to be more effective at lOmM. However, TEA at 
lOmM antagonises most classes of K+ channels (Cook &
Quast, 1990) including those found to present in the rat 
SCG neurones, including Ik and Ic (Constanti et al.,
1981b; Adams et al., 1982) and Im (Adams et al., 1982).
The depolarisations to 2mM and lOmM TEA, ImM 4AP (Table
4.9) and 8mM K+ (Table 4.10) in PSS were about equal but 
only 2mM TEA depressed the response to adenosine, 
suggesting the level of depolarisation of the ganglion is 
unlikely to account for difference between the effects of 
these K+ channel antagonists on the response to adenosine. 
The potentiation of the response to potassium in lOmM TEA 
indicated that there was a general increase in
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excitability of the ganglion, possibly via the release of 
ACh or a direct postsynaptic action. An increased 
blockade of Im by lOmM TEA could potentiate the 
hyperpolarisation to adenosine if the hyperpolarisation is 
mediated by an increase in gK e.g. Im, and reduce the 
overall antagonism of the response to adenosine. However, 
the lack of antagonism of the response to adenosine by 
lOmM TEA in PSS containing either atropine or TTX (Table
4.9) does not support this hypothesis.
TEA at lOmM may unmask an effect of adenosine on another 
conductance as described for the actions of TEA on the 
response of the guinea-pig atria to carbachol and 
adenosine (De Biasi, Froldi, Ragazzi, Pandolfo, Caparrotta 
& Fassina, 1989). In addition to antagonising K+ channels 
TEA is known to produce a variety of pharmacological 
actions including mimicking the actions of ACh on 
nicotinic receptors. The activation of nicotinic 
receptors by TEA was not determined but nicotinic 
depolarisation did not alter the response to adenosine 
(see Chapter 5) thus the ability of TEA to activate 
nicotinic receptors would not be expected to alter the 
response to adenosine.
The ability of 4AP to enhance the response to adenosine 
may arise from an inhibition of operative 1^ channels.
4AP may block these outward K+ currents due to neuronal 
depolarisation and allow the activation by adenosine of an 
outward 4AP resistant current. In addition to blocking K+ 
channels from the exterior K+ channel antagonists may have 
had both internal and external sites of action as these 
agents could enter through cut nerve endings, e.g. ECN to 
depolarise the ganglion. 4AP may cause the release of 
ACh, although these seem unlikely as in PSS containing 
TTX, 4AP still potentiated the responses to adenosine 
(Table 4.9).
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It was suggested that adenosine hyperpolarised the rat 
neocortex (Perkins & Stone, 1980) and hippocampus (Okada & 
Ozawa, 1980; Schubert & Lee, 1986) by enhancing IA as the 
response to adenosine was antagonised by 4AP. The 
inability of 4AP to antagonise the hyperpolarisation of 
the rat SCG to adenosine indicates that adenosine is 
unlikely to be working via a change in IA . The ability of 
4AP to increase the hyperpolarisation to adenosine in 
contrast to the actions of TEA is intriguing and may have 
arisen due to the ability of TEA to produce a 
hyperpolarising shift of the K+ channel activation curve 
and 4AP to shift the activation in the opposite direction 
(Ruff, 1986).
The results suggest that adenosine activates an increase 
in gK such as 1^ and 1^ to hyperpolarise the rat SCG.
GENERAL DISCUSSION
The results presented in this chapter indicate adenosine 
directly hyperpolarises the rat SCG. The most likely 
mechanism of action of adenosine is via an increase in gK 
and not via a change in gCa as reported for some actions 
of adenosine on the rat SCG (Henon & McAfee, 1983a,b). 
There was no evidence to support the hypothesis that 
adenosine causes a decrease in gNa, an increase in gCl", 
or activates an electrogenic pump for Na+ or Cl“ ions.
Both the potentiation and the attenuation of the response 
to adenosine in low and high K+ containing PSS 
respectively, suggest adenosine hyperpolarises the rat SCG 
via an increase in gK. Further analysis of this 
hypothesis was complicated by the ability of K+ channel 
antagonists to depolarise ganglia and therefore indirectly 
alter the response to adenosine. Thus the response to
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adenosine in the presence of a K+ channel antagonist may 
have been due to a primary or secondary consequence of 
drug effect on membrane potential change. However, the 
ability of TEA and not 4AP to antagonise the response to 
adenosine indicates a potential role of an 1^ like channel 
in the actions of adenosine. The inability of other K+ 
channel antagonists to alter the response to adenosine 
suggests the hyperpolarisation of the ganglion was not due 
to an increase in I^, Ik (a TP) or *K(Ca)> although changes 
in other gK's e.g. a K+ leak current of the type described 
by Jones (1989) in amphibian ganglia, has not been 
excluded.
Similarly the depression of the response to muscarine by 
adenosine was not due to a change in gCa, but is 
consistent with an increase in gK by adenosine to 
antagonise the inhibition of Im by muscarine.
One approach to examining the hypothesis that adenosine 
increases gK would be to use intracellular recording 
techniques such as those described by Belluzz and 
colleagues (1985a,b) to determine both the voltage 
sensitivity and the reversal potential of the response to 
adenosine. Further information could be derived from 
single channel studies of patch clamped dissociated SCG 
neurones (Gurney et al., 1987) to discover the channel 
properties and if the response to adenosine and carbachol 
occurs via the same K+ channels (Belardinelli & Isenberg, 
1983; Andrade, Malenka & Nichol, 1986) and/or if common 
intracellular messengers and G-proteins are involved in 
the transduction of the hyperpolarisation to adenosine.
Fig. 4.1. A schematic diagram summarising the various 
ionic concentrations (numbers under chemical symbols 
refer to mM concentration: estimates of intracellular 
ions concentration taken from Galvan et al., 1984) of 
the major anions and cations and the conductances that 
may be altered by adenosine in the postganglionic 
neurone of the rat SCG. The following ionic mechanisms 
have been implicated in the effects of adenosine on the 
rat SCG; (l) an increase in the entry of calcium ions 
(Ca^+) e.g. Ribeiro, Sa'-Almeida & Namorado, 1979; (2) 
an increase in the efflux of potassium ions (K+ ) e.g.
Segal, 1982; Trussel & Jackson, 1987, 1989; (3) an
+ ) + +increase in the efflux of K via Ca activated K
channels e.g. Proctor & Dunwiddie, 1987; (4) a decrease 
in the entry of sodium ions (Na+ ) e.g. Imai & Takeda, 
1967; (5) activation of the electrogenic Na+/K+ 
exchange mechanism (Smith, 1986) and/or (6) an increase 
in chloride influx via Cl“ channels or Cl“ exchange 
mechanism (Palmer & Wood, 1987).
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Fig. 4.2. Log concentration-response curve of the rat SCG 
to two minute applications of adenosine in normal 
physiological salt solution (PSS) containing 2.5mM Ca^+ , 
5mM Ca^+ (high calcium PSS) or O.lmM Ca^+ (low calcium 
PSS).
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Fig. 4.3. Response of the rat SCG to increasing
concentrations of adenosine at 10, 100 and 300uM, applied
for 2 minutes, every 20 minutes in physiological salt
solution (PSS) containing (a) 2.5mM Ca^+/lmM Mg2+ and (b)
O.lmM Ca^+/lmM Mg2+.
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Fig. 4.4. Effect of low calcium physiological salt
solution on the response of the rat isolated SCG to
adenosine and phenylamino-adenosine
Comparison of log concentration-response curves to 
adenosine (AD) and phenylaminoadenosine (PAA) in 
physiological salt solution containing 2.5mM calcium 
(2.5mM Ca^+) or low calcium (O.lmM Ca^+). The 
responses to adenosine in O.lmM Ca containing PSS 
(1st DRC) were significantly (* = P < 0.05) enhanced 
10 and lOOuM and reproducible when compared to 
responses obtained 2 hours later (2nd DRC).
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Fig. 4.5. Effect of low calcium physiological salt
solution on the response of the rat isolated SCG to 2-
chloroadenosine
Comparison of the log concentration-response curves to 
a 2 minute application of 2-chloroadenosine (2CA) in 
physiological salt solution (PSS) containing 2.5mM 
calcium (2.5mM Ca^+) or PSS containing low calcium PSS 
(O.lmM Ca^+). Low calcium significantly (* = P < 0.05) 
enhanced the hyperpolarisation to 2CA at 0.3uM and 
lOuM.
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Fig. 4.6. % depression of the response to muscarine by
adenosine on the rat SCG in the presence of 2.5mM 
calcium or O.lmM calcium.
The % depression of muscarine for a given concentration 
of adenosine was compared using an unpaired t-test (as 
the responses in different concentrations of calcium 
(Ca^+) and different adenosine concentrations were 
randomised and recorded from different ganglia), and 
expressed as statistically significant from responses 
in 2.5mM Ca^+ by * for P < 0.05 and *** for P < 0.01.
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Fig. 4.7. Effect of magnesium free solution on the
response of rat isolated SCG to 2-chloroadenosine and
adenos ine
Log concentration-response curves to two minute 
applications of 2 chloroadenosine (2CA) and adenosine 
(AD) in physiological salt solution in the absence (OmM 
Mg2 + ) and presence of ImM magnesium (ImM Mg2+). There 
was no significant difference (paired t-test) between 
the responses to 2CA or AD in the absence or presence 
of Mg^+ .
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Fig. 4.8. Effect of magnesium free solution on the 
response of rat isolated SCG to adenosine
Log concentration-response curves to two minute 
applications of adenosine (AD) in calcium (Ca^+ ) free 
physiological salt solution (PSS) in the presence or 
absence of ImM magnesium (OmM Ca^+/lmM Mg^+ and OmM 
Ca^+/0mM Mg^+ respectively). Also log concentration- 
response curves to adenosine in OmM Ca^+ PSS and 
ethylene-glycolamino-ethylether-tetra-acetic acid 
(EGTA) in the presence or absence of ImM magnesium (OmM 
Ca^+/lmM Mg^+ + EGTA (2mM) and OmM Ca^+/0mM Mg^+ + EGTA 
(2mM) respectively.
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Fig. 4.9. Response of an isolated rat SCG to potassium 
and adenosine in different concentrations of calcium 
and magnesium.
The first two columns refer to the concentration of 
calcium (Ca^+) and magnesium (Mg^+) in the 
physiological salt solution (PSS) and the next two 
columns an example of a trace obtained from a single 
ganglion; response to 12mM potassium (K+ ) applied for 1 
minute about 25 minutes prior to the application of 
adenosine (AD), ImM, 2 minutes) in each example. The 
results in the last two columns refer to the mean + 
standard error of the mean for the response to 
potassium and adenosine respectively and the number of 
ganglia tested is indicated by a figure in the box.
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Fig. 4.10. Effect of cobalt on the response of the rat
isolated SCG to carbachol and adenosine
Log concentration-response curves of four rat SCG to a 
two minute application of adenosine (AD) and one minute 
application of carbachol (CARB) in the presence of 
0.5mM calcium (Ca^+) or 0.5mM cobalt (Co2+). In a 
P04/S04 free physiological salt solution (PSS) 
containing 0.3uM pirenzepine (PIR) and 2mM K+ replacing 
0.5mM Ca^+ with 0.5mM Co2+ reduced the
hyperpolarisation to both adenosine (AD) and carbachol
(CARB). A significant difference (two tailed t test)
between 0.5mM Ca^+ PSS and 0.5mM Co2+ is indicated by a
* for P < 0.05 and ** for P < 0.01. Second
concentration response curves to both AD and CARB
2+repeated 30 minutes after washing out Ca for 30 
minutes were not significantly different to the first 
curves.
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Fig. 4.11. Log concentration response curve of the rat
SCG to gamma-amino butyric acid
One minute applications of gamma-aminobutyric acid 
(GABA) were applied every twenty minutes. GABA 
produced both a depolarisation followed by an after 
hyperpolarisation (AHP). Each point is the mean, and 
vertical bars the standard error of the mean for four 
ganglia. A significant difference (two tailed paired 
t-test) from basal d.c. potential is indicated by a * 
for P < 0.01.
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Fig ./|..l2 . Response of a single ganglion to gamma-amino 
butyric acid, adenosine in the absence and presence of 
furosemide
(A) Responses of an isolated rat SCG in normal 
physiological salt solution (PSS) produced by one 
minute applications of lOuM and 300uM of gamma- 
aminobutyric acid (GABA) at twenty minute intervals and
(B) responses to lOOuM adenosine (AD) and GABA lOuM and 
the response to lOOuM AD applied during the after 
hyperpolarisation (AHP) of the response to lOuM GABA, 
followed by incubation in furosemide (FURO, lOuM, for 1 
hour) and the response to lOuM GABA and lOOuM AD. In 
all traces GABA and AD were applied for one and two 
minutes respectively. Scale for (a) 2.5mV and (b) 
0.5mV, note in (b) the depolarisation to GABA is 
truncated.
The AHP to lOuM GABA was submaximal (cf: The AHP to 
lOuM and 300uM GABA, P<0.01, n=4, paired t-test), 
suggesting incomplete activation of the Na+/K+/Cl” 
cotransporter and this concentration of GABA was chosen 
to gauge the interaction between the GABA-induced AHP 
and the hyperpolarisation to adenosine. AtlOuM GABA 
the AHP was maximal 3.5 minutes and the response to 
adenosine was timed to occur 3.5 minutes after the 
application of GABA, i.e. during the peak of the AHP to 
GABA. On four ganglia the response to adenosine in the 
presence of the AHP to GABA (-60 + 7uV) was not 
significantly different from the response before (-68 + 
13uV) or after GABA (-71 + 12uV). On three ganglia the 
response to adenosine in both lOuM and on three ganglia 
lOOuM furosemide was significantly reduced (see Table 
4.14) and showed a partial recovery when lOOuM 
furosemide was washed out for 20 minutes (-50 + lOuV).
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Fig. 4.13. Effect of lithium on the response of 
isolated rat SCG to adenosine, muscarine and 
dimethylphenylpiperazinium
(a) The response of an isolated rat SCG in normal 
physiological salt solution (PSS) to lOOnM muscarine 
(M) and lOOuM adenosine (AD) applied for 1 and 2 
minutes respectively; and (b) after 30 minutes 
incubation in sodium-HEPES PSS (Na+-HEPES), the 
response to lOOnM muscarine in the absence (M) and
presence of lOOuM adenosine (5 minutes application, AD
and M), and lOOuM adenosine for 2 minutes; (c) the
response to lOOuM adenosine applied for 2 minutes after
incubation in lithium-HEPES PSS (Li+-HEPES) for 40 (i), 
108 (ii) and 144 (iii) minutes, followed by the 
response to a one minute application of muscarine at 
lOOnM (M) and muscarine at luM and dimethylpheny1 
piperazinum (DMPP) at lOuM.
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Fig. 4.14. Response of four rat SCG to muscarine and
adenosine in the absence and presence of lithium
(a) The depolarisation to lOOnM muscarine (1 min 
applications) was not significantly altered by changing 
from normal physiological salt solution (PSS) to Na+ 
containing HEPES-PSS to lithium containing HEPES-PSS 
(Li+-HEPES) significantly (P<0.001 = ***) reduced the 
response to muscarine.
(b) The hyperpolarisation to a two minute application 
of adenosine (lOOuM) were reduced in the presence of 
Na+ HEPES-PSS. Changing from Na+-HEPES to Li+-HEPES 
produced a transient increase in the response to 
adenosine with time for the first hour of incubation in 
Li+-HEPES.
Statistical significance was determined using paired t- 
tests - and are indicated by a * for P<0.05, ** for 
P<0.01 and *** f0r P<0.001.
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Fig. 4.15. Response of the rat SCG to adenosine in
potassium free and high potassium containing 
physiological salt solution
A histogram of the response of isolated rat SCG to 
adenosine (10, 100 and 300uM, 2 minute applications 
every 40 minutes) in nominally K+ free (OmM K+), normal 
(6mM K+) and high (l2mM K+) potassium medium. Bars 
represent the mean values, the SEM for at least six 
ganglia. Test for statistical significance by paired 
t-test of responses in OmM K+ or 12mM K+ relative to 
6mM K+ control, and is indicated by * for P < 0.05 and 
** for P < 0.01.
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Chapter 5 : INTERACTION OF ADENOSINE WITH DIFFERENT
AGONISTS
In part, the results of the preceeding chapters have 
relied on the ability of adenosine to depress the response 
to muscarine. In this chapter the selectivity of 
adenosine for other agonists and the possible 
intracellular messengers involved in the interaction with 
adenosine are discussed. There is evidence that ACh 
(Birks & Macintosh, 1961), catecholamines (Brown &
Caulfield, 1979), 5HT (Wallis, Williams & Wali, 1978),
GABA (Wolff, Joo, Kasa, Storm-Mathiesen, Toldi & Balcar,
1986; Eugene, 1987), and vasointestinal polypeptide (VIP)
(Voile & Patterson, 1982; Durroux, Barberis & Jard, 1987) 
have either a neuromodulatory or neurotransmitter function 
in the rat SCG and employ different ionic and biochemical 
mechanisms to mediate their effects. Thus an interaction 
or lack of interaction between these agonists and 
adenosine has provided useful clues for the identification
of the mechanism of action of adenosine on the rat SCG. A
range of agonist responses were examined in the presence 
of adenosine and the response to adenosine in the presence
of some of these agonists was assessed.
5.1 Concentration response curves to different agonists.
The response to increasing concentrations of ACh, 
muscarine, 2-methyl-5-hydroxytryptamine (2Me5HT), 
vasoactive intestinal polypeptide (VIP) and oxotremorine-M 
(OXO-M) are summarised in figure 5.1. Each agonist 
produced concentration related depolarisations and DMPP,
GABA and ACh also produced AHPs (Figs 5.2; 4.16). High 
concentrations of ACh were required to evoke a response of 
the ganglion, with muscarine being over 1,000 fold more 
potent than ACh on the same ganglia. The low potency of 
ACh on the rat SCG most probably was due to the presence
ADDENDUM CHAPTER 5- Please see insert in back pocket of thesis.
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of a significant amount of acetylcholinesterase (AChE).
The presence of AChE which predominates the presynaptic 
terminal is responsible for the destruction of liberated 
ACh (Koelle & Koelle, 1959) and the spontaneous release of 
ACh in the rat SCG can only be detected in the presence of 
an AChE inhibitor (Briggs, McAfee & McCaman, 1988). To 
avoid using high concentrations of ACh and selectively 
activate muscarinic receptors, AChE resistant analogues of 
ACh including muscarine, carbachol and methyIfurmethide 
were used. The response to muscarine was comparable to 
that obtained in other laboratories and was abolished by 
N-methyl-atropine and pirenzepine (Table 5.1) suggesting 
the response to muscarine is due to the activation of Ml 
muscarinic receptors (Brown et al., 1980; Newberry & 
Priestley, 1987).
5.1.1 Effect of adenosine on the response to different 
agonists
The ability of adenosine to alter the response to 
submaximal responses of different agonists producing about 
equivalent sized responses was examined and the results 
are summarised in tables 5.2 and 5.3.
5.1.1.1 Effect of adenosine on the response to potassium
Increasing the total [K+ ]e to 8 or 12mM would be expected 
to cause a non-specific depolarisation of the ganglion.
The inability of adenosine to alter the response to K+ 
(Fig. 5.2a, Table 5.3) suggests the adenosine-induced 
hyperpolarisation does not necessarily alter the response 
of the ganglion to depolarising agonists.
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5.1.1.2 Effect of adenosine on the response to GABA
The depolarisation of rat SCG to GABA and the ability to 
record a fast non-cholinergic depolarising postsynaptic 
potential from the rat SCG (Eugene, 1987) which is 
antagonised by bicuculline is good evidence for the 
existence of functional postsynaptic receptors for GABA in 
the rat SCG* Postsynaptic depolarisations of the rat SCG 
by GABA are accompanied by a small efflux of K+ and a 
larger change in Cl” efflux due to opending of Cl” 
channels to decrease intracellular Cl” activity (Ballanyi 
et al*, 1984; Ballanyi & Grafe, 1985; Adams & Brown,
1975). During and after the GABA depolarisation a 
Na+/K+/Cl” cotransporter is activated to restore and 
maintain the [Cl“]i (see Chapter 4). The AHP to GABA was 
not significantly altered in the presence of adenosine.
The slight but significant potentiation of low 
concentrations of GABA by adenosine would be consistent 
with an increase in efflux of Cl” and/or K+ ions. As the 
response to adenosine was unaltered by the low chloride 
PSS (see Chapter 4), a condition which would favour the 
efflux of Cl” , an increase response to GABA in the 
presence of adenosine may have occurred if adenosine 
increased the GABA mediated K+ efflux. Overall the 
effects of adenosine on the response to GABA were moderate 
(Fig. 5.2b) and it appears unlikely that adenosine would 
significantly alter GABA-ergic transmission of the rat SCG 
in vivo.
5.1.1.3 Effect of adenosine on the response to 
nicotinic agonists
Adenosine can inhibit sympathetic neuroeffector 
transmission and it has been reported that adenosine at 
physiological concentrations potentiates pressor responses
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to nicotinic agonists in vivo apparently by enhancing the 
effects of nicotine on sympathetic ganglia (von Borstel, 
Renshaw, Wurtman, 1984; Von Borstel, Evoniuk & Wurtman, 
1984; 1986), The order of potency for the potentiation of 
the response to nicotine by adenosine suggests an action 
via an A2 receptor as the order of potency was:- N- 
cyclopropylcarboxamidoadenosine (CPCA) > 2CA > R-PIA > S- 
PIA with an R/S ratio of about 10. In partial agreement 
with von Borstel & colleagues, Henon & McAfee (1983b) 
found 2CA reduced single EPSP but facilitated ganglionic 
transmission during repetitive stimulation. The reduction 
in the single EPSP amplitude occurred without a change in 
the sensitivity of postganglionic neurones to bath applied 
carbachol (0.5uM), suggesting a presynaptic site of action 
for adenosine. The mechanism of these effects was not 
discussed but an inhibition of the Ca2+ activated K+ 
current by adenosine (Henon & McAfee, 1983a) could 
increase repetitive firing to facilitate repetitive 
synaptic transmission and presynaptic inhibition of ACh 
release by adenosine (Briggs et al., 1988) would reduce 
the effect of a single CAP. Therefore the effects of 
adenosine reported in vivo experiments may have occurred 
due to an indirect action and not as a direct consequence 
of nicotinic stimulation.
The results presented in tables 5.2 and 5.3 and Fig. 5.2c, 
show adenosine did not alter the depolarisation to DMPP, a 
selective nicotinic agonist. Also the “fast" nicotinic 
depolarisation produced by carbachol at 10 and 30uM was 
unaltered by lOOuM adenosine (Table 5.4). These findings 
are consistent with the lack of effect of adenosine on the 
sensitivity of the nicotinic receptor reported by Akasu 
and colleagues (Akasu et al., 1981; 1983a; 1985) using 
bullfrog sympathetic ganglia.
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In vivo nicotine and adenosine may interact at several 
loci to modify autonomic activity and the effect of 
adenosine on ganglia and/or the end organs was not 
differentiated by von Borstel and colleagues (1986). The 
inability of adenosine to alter the response of the rat 
SCG to nicotinic depolarisations suggests the actions of 
adenosine in vivo are unlikely to have occurred at the end 
organs. Alternatively it may be argued that the use of a 
nonphysiological concentration of adenosine may have 
inhibited the potentiation of nicotinic responses of the 
ganglion. There is some evidence in favour of this 
hypothesis as adenosine at plasma concentrations of 3 to 
4uM potentiated the response to nicotine but at higher 
concentrations of adenosine the potentiation was 
diminished. Even if the concentration of adenosine chosen 
was too high to record potentiation of DMPP it is clear 
from the results (Tables 5.2 and 5.3) that the major 
action of adenosine is to depress the response to 
muscarinic agonists. In addition the results presented in 
the next chapter suggest the adenosine receptors of the 
rat SCG are not of the A2 subtype as selective A2 agonists 
were weak or inactive on the SCG. If the potentiation of 
nicotinic responses in vivo is mediated via A2 receptors 
as judged from the data of von Borstel & colleagues (1986) 
then it is difficult to understand how adenosine can 
potentiate the nicotinic responses of the SCG. One 
mechanism that may have been recorded as an increase in 
the response to nicotine is an increase in the presynaptic 
release of ACh. However this seems unlikely as it has 
been reported by Briggs et al. (1988) that adenosine 
reduced ACh release from rat SCG in vitro.
Consistent with the inability of ouabain and Li-HEPES PSS 
to antagonise the response to adenosine (see chapter 4) 
adenosine did not alter the AHP produced by DMPP, 
suggesting adenosine does not hyperpolarise the rat SCG by
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activating the electrogenic Na+ pump. The inability of 
adenosine to alter the depolarisation to nicotinic 
agonists is also consistent with a lack of effect of 
adenosine on the response in low Na+ or low Ca^+ PSS as 
carbachol is known to increase the influx of Na+ and Ca^+ 
ions during nicotinic depolarisation.
5.1.1.4 .Effect of adenosine on the response to 5HT
It is well documented that 5HT exerts excitatory actions 
on sympathetic ganglia and depolarisation of the 
ganglionic cell membrane by 5HT is reported to facilitate 
synaptic transmission (Eccles & Libet, 1961). The fast 
depolarisation of the rat SCG to 5HT is believed to be 
mediated by 5HT3 receptors (Fortune, Ireland & Tyers, 
1985), and the AHP is mediated via the activation of the 
electrogenic Na+ pump (Wallis & Woodward, 1975). In 
addition to these responses, 5HT also hyperpolarises the 
rat SCG due to an action mediated by 5HT^ receptors 
(Ireland, 1987; Ireland & Jordan, 1987; Gilbert & 
Newberry, 1987) and accumulates 5HT via an avid uptake 
system (Ireland, Staughan & Tyers, 1987). The ability of 
adenosine to alter the response to 5HT may thus be 
complicated by these factors. Using a submaximal 
concentration of 5HT only a depolarisation was observed 
(Fig. 5.2d), which was significantly enhanced by lOOuM 
adenosine. The reason for this potentiation is unknown, 
but is unlikely to have been due to a potentiation of the 
5HT3 mediated depolarisation as the depolarisation of the 
selective 5HT3 agonist, 2Me5HT was unaltered by the 
presence of lOOuM adenosine (Cf. Fig. 5.2 d & e, Table 
5.3). Results presented in chapter 4 and in this section 
it suggests that adenosine has no effect on responses 
mediated via activation of the electrogenic Na+ pump and
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it is therefore most unlikely that adenosine enhanced the 
response to 5HT by interacting with the Na+ pump.
5.1.1.5 Effect of adenosine on the response to 
isoprenaline (ISO)
Among the agents known to increase the cAMP content of the 
rat SCG, isoprenaline is one of the most potent (Cramer, 
Johnson, Hanbauer, Silberstein & Kopin, 1973; Quenzer,
Yahn, Alkadhi & Voile, 1979; Quenzer, Patterson & Voile,
1980; Briggs et al., 1988) and at luM the application of 
isoprenaline for 4 minutes to the rat SCG increased the 
cAMP content by ten fold (Quenzer et al., 1980).
Adenosine at lOuM produced a small but significant 
reduction in the response to lOOnM isoprenaline and at 
lOOuM adenosine produced a similar reduction of the response to 
isoprenaline which was not significant. Given that 
isoprenaline would be expected to produce a significant 
increase in the cAMP content of the SCG it is difficult to 
understand why the response to isoprenaline was not 
dramatically reduced by adenosine (Fig. 5.2e), if 
adenosine activates Al-adenosine receptors to reduce 
cyclic AMP levels.
5.1.1.6 Effect of adenosine on the response to 
muscarinic agonists
From the results presented in tables 5.2 & 5.3 and Fig. 
5.2g,h,i, it can be seen that adenosine selectively 
depressed the response of the rat SCG to muscarinic 
agonists. The response to lOOnM muscarine was reduced by 
10 and lOOuM adenosine in a concentration-dependent manner 
(Figs. 5.3 and 5.6).
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The ability of adenosine to depress the response to 
muscarinic agonists was dependent both on the agonist and 
the level of depolarisation. Both the depression of the 
response to lOOnM muscarine by lOOuM adenosine (Fig. 5.4a) 
and the depression of increasing concentrations of 
muscarine by adenosine (Fig. 5.4b) was biphasic and 
maximal at about lOOnM muscarine and lOOuM adenosine 
declining at higher concentrations of muscarine or 
adenosine.
The ability of adenosine to reduce the response to 
submicromolar concentrations of muscarine is postulated to 
arise from an action of adenosine on a specific component 
of the response to muscarine. Some reports indicate the 
effects of muscarine are concentration-dependent with the 
induction of different ionic conductances at different 
concentrations of muscarine. Whatever the explanation for 
the depression of muscarinic agonists by adenosine, it was 
clearly complex and not directly related to the degree of 
depolarisation as the response to non-muscarinic agonists 
was similar but these responses were either unaltered or 
enhanced in the presence of adenosine (Fig. 5.2, Tables
5.2 and 5.3).
The depression of muscarinic responses by adenosine was 
agonist dependent and similar depolarisations did not 
necessarily produce the same depression of the agonist 
response (Fig. 5.2a-i; Tables 5.3 and 5.4). In addition 
to muscarine, adenosine depressed the response to 
carbachol and MeF (Fig. 5.2h-i; Table 5.2) to similar 
extent at lOuM adenosine, although the depression of 
carbachol was not significant. At lOOuM adenosine, the 
depression of muscarine was about twice that produced by 
adenosine on carbachol and MeF (Table 5.3). The 
depression of carbachol by adenosine was variable and at 
some concentrations of carbachol, adenosine was weak or
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ineffective (Table 5,4). Given muscarinic agonists not 
only depolarise the rat SCG but also hyperpolarise the 
ganglion via M2 muscarinic receptors the low potency of 
J ‘ to carbachol may arise from the
hyperpolarisation and the Ml depolarisation. Enhancement 
of the M2-mediated hyperpolarisation would increase the 
depolarisation to antagonise the depression of the 
response to carbachol by adenosine.
It is possible that the inability of MeF to generate a 
hyperpolarisation to combat increased antagonism of the 
depression of the depolarisation to MeF would reduce the 
effectiveness of adenosine. Whereas an increase in the M2 
mediated hyperpolarisation to increasing concentrations of 
carbachol and muscarine may potentiate the depression by 
adenosine.
5•2 Effect of adenosine on the muscarinic 
hyperpolarisation of the SCG
As there are no M2 receptor selective agonists the ability 
of adenosine to alter the M2 receptor mediated response to 
muscarinic agonists was assessed in two sets of 
experiments. In the first series the depression of the 
response to muscarinic agonists was measured in the 
presence of an M2 muscarinic receptor antagonist, 
methoctramine (MTO)• In a second series of experiments 
the ability of adenosine to alter the hyperpolarisation to 
carbachol in low calcium PSS containing pirenzepine, an Ml 
receptor antagonist was determined.
ability of adenosine.alter both the M2 mediated
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5.2,1 Effect of adenosine on the response to
muscarinic agonists in the presence of MTO
It is reported that MTO selectively antagonises the 
muscarinic hyperpolarisation of the rat SCG in vitro by 
Field & Newberry (1988). Using the same concentration 
(0.3uM) of MTO reported by Field & Newberry (1989) to 
selectively reduce the hyperpolarising response to 
muscarine it was found that the response to MeF was 
significantly reduced (Table 5.5). This result was
unexpected as MeF is reported to be a highly selective Ml
receptor agonist on the rat SCG and does not hyperpolarise 
the rat SCG (Newberry & Connolly, 1989; see below). Thus
these results suggest that MTO antagonises the
hyperpolarisation to muscarine but may also produce a 
small but significant depression of the depolarisation to 
muscarinic agonists i.e. the Ml-mediated response. An 
examination of a more detailed account of the actions of 
MTO on the response of the rat SCG to muscarine (see Fig.
1 in Field & Newberry, 1989) suggests a reduction of the 
depolarisation to muscarine by MTO at 0.3uM. The 
depression of both Ml and M2 mediated responses in MTO may 
complicate the interpretation of the results presented 
here in that the depression of muscarinic agonists by 
adenosine was found to be dependent on the degree of 
depolarisation by these agonists (Table 5.4). However the 
inability of MTO to alter the response to adenosine is 
consistent with the inactivity of pirenzepine on the 
response to adenosine suggesting that the 
hyperpolarisation to adenosine is independent of any 
presynaptic release of ACh. The inability of MTO to 
antagonise the depression of muscarinic responses by 
adenosine indicates the adenosine-mediated depression was 
not due to an increase in the M2-receptor mediated 
hyperpolarisation.
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5.2.2 Effect of adenosine on the carbachol-induced
hyperpolarisation of the SCG
The similar potency of the depression of different 
muscarinic agonists by adenosine in MTO suggests the 
presence of an M2-mediated hyperpolarisation may 
antagonise the actions of adenosine. The ability of 
adenosine to alter the M2-receptor mediated response to 
carbachol was investigated. If the presence of an M2- 
mediated hyperpolarisation is responsible for the low 
potency of adenosine on the response to carbachol then it 
would be expected that carbachol would be the most potent 
muscarinic agonist to hyperpolarise the ganglion. The 
results presented in Fig. 5.8 show that the relative 
potency order for muscarinic agonists to hyperpolarise the 
SCG was:-
Agonist: Carbachol > OXO-M > muscarine >> methylfurmethide 
estimated
EC50 (nM) > = 210 > 300 > 800 >> 10000
Carbachol at up to luM produced concentration dependent 
hyperpolarisations (Fig. 5.9a) and at lOuM the 
hyperpolarisation was followed by a fast nicotinic 
depolarisation. Although the fast depolarisation was 
antagonised by dihydrobetaerthroydine (DHBE), a selective 
nicotinic antagonist, the carbachol hyperpolarisation was 
also reduced. The poor selectivity of nicotinic 
antagonists versus the nicotinic and muscarinic responses 
of the rat SCG to electrical stimulation has been reported 
by Newberry & Connolly (1989) and a nicotinic antagonist 
was not used to avoid any adverse effects on the responses 
to carbachol and adenosine.
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The inability of adenosine to alter submaximal of near 
maximal hyperpolarisations to carbachol (Table 5.6) is 
illustrated in Fig. 5.9b, where adenosine reduced the 
depolarisation and not the hyperpolarisation to 3uM 
carbachol (n=2) (Fig. 5.9c). The inability of adenosine 
to reduce the M2-mediated hyperpolarisation indicates that 
the depression of muscarinic responses is due to the 
selective reduction of the Ml-mediated muscarinic 
depolarisation.
Further evidence in favour of this hypothesis is provided 
by the ability of both pilocarpine, an effective Ml 
agonist on the rat SCG (Caulfield & Stubley, 1982) and N- 
methyl-N-(l-methyl-4-pyrrolidino-2-butynyl)acetamide (BM- 
5) an oxotremorine analogue with presynaptic antagonist 
and postsynaptic agonist properties (Casomenti, Cosi & 
Pepeu, 1986) to enhance the hyperpolarisation to adenosine 
(Table 5.8). These results indicate that the potentiation 
of adenosine occurs via an interaction with postsynaptic 
Ml receptors.
If adenosine and carbachol act upon the same intracellular 
mechanism then once fully activated by carbachol no 
greater effect would be obtained. The inability of luM 
carbachol and adenosine (lOuM) to attain the same response 
size as the sum of the individual responses suggests both 
agonists may hyperpolarise the rat SCG via a common 
mechanism. Recently it has been reported that many 
inhibitory neurotransmitters activate an inwardly 
rectifying K+ channel by a mechanism that involves a 
pertusis toxin sensitive G-protein (Trussell & Jackson, 
1989; Newberry & Gilbert, 1989). Given that muscarinic 
hyperpolarisation of amphibian ganglia increases gK 
(Gallgher, Shinnick-Gallagher, Cole, Griffith & Williams, 
1980) and that adenosine mediates the sIPSP of cat 
parasympathetic ganglia (Akasu et al., 1984), both the
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adenosine and carbachol-induced hyperpolarisation of the 
rat SCG may be mediated by a common mechanism i.e., 
increased gK (Chapter 4).
5.3 Competitive depression of the response to muscarine 
by adenosine
Adenosine at lOuM and 100 uM produced parallel shifts in 
the concentration response curve to muscarine (Fig. 5.6) 
suggesting adenosine is a competitive antagonist of 
muscarine. It seems unlikely that adenosine is a 
functional antagonist of the depolarisation to muscarine 
as adenosine would have been expected antagonise the 
response to other agonists to the same extent and this was 
not the case (Table 5.1). However it may be argued that 
some form of functional antagonism of muscarine occurred 
as there was a good correlation between the change in uV 
between the response to muscarine in the presence and 
absence of adenosine and the size of the hyperpolarisation 
to adenosine, as recorded during the first minute of 
application (Fig. 5.4a).
If the depression of the response to muscarine by 
adenosine is simply due to functional antagonism then it 
would be expected that any other compound that 
hyperpolarise the ganglion would also reduce the response 
to muscarine. It has been reported that the effect of the 
GABAg agonist baclofen (BAC) and adenosine are similar in 
a number of tissues, e.g. both compounds decrease synaptic 
excitability of isolated hippocampal cells (Newberry & 
Nicoll, 1985) and hyperpolarised the rat SCG (unpublished 
observations: Newberry & Gibert, 1989). In order to 
examine the possibility that the two effects of adenosine 
to hyperpolarise the ganglion and depress the response to 
muscarinic agonists are directly interelated, the effects
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of adenosine were compared to the activity of (-)baclofen 
using the same paradigm described for adenosine. As can 
be seen from figure 5.5 (-)baclofen produced 
hyperpolarisations comparable to adenosine but was less 
potent on the depression of the response to muscarine, 
producing a maximal reduction of muscarine of 11 + 3% 
((-)baclofen lOuM, P<0.05, n=7) about a third of that 
achieved by adenosine. These results suggest the 
hyperpolarisation by adenosine and the depression of the 
response of the rat SCG to muscarine by adenosine may be
concomitant but hyperpolarisation of the ganglion may not
be the cause of the depression of muscarinic responses.
Further support for this view point is provided by the 
data shown in Fig. 5.4b which illustrates the 
hyperpolarisation to lOOuM adenosine was consistent but 
the depression of the response to muscarine was dependent 
upon the concentration of muscarine.
5.4 Effect of depolarisation with various agonists on the 
response of the SCG to adenosine
5.4.1 Effect of potassium on the adenosine-induced 
hyperpolarisation
The RMP (Em) of the rat SCG has been measured by several
research groups and is around -50 to -70mV being
predominantly determined by the K+ transmembrane gradient 
(Blackman, Ginsborg & Ray, 1963; Kosterlitz et al., 1968). 
When [K+ ]e is raised, the K+ concentration gradient is 
decreased, and the neurones will be depolarised (the 
reduction of the RMP can be estimated from substituting 
values for [K+ ]i and [K+ ]e in to the Nernst equation) to 
generate an increased "driving force (Em-Ek)" for 
potassium. The response to adenosine during the
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depolarisation to K+ was unaltered suggesting 
depolarisation per se does not enhance the 
hyperpolarisation to adenosine.
5.4.2 Effect of isoprenaline on the adenosine-induced 
hyperpolarisation
Adenosine has been reported to have no effect on a gCa of
the SA-node of the rabbit heart unless these cells were
first activated by isoprenaline (Belardinelli, Giles &
West, 1988). If a similar phenomenon exists in rat SCG
neurones then it is possible that the lack of effects of
calcium antagonists on the response to adenosine and its
interaction with muscarine reported in Chapter 4 may not
have been studied under conditions which would produce an 
2+influx of Ca^ into postganglionic neurones. However the 
inability of the isoprenaline to alter the response of 
ganglia to adenosine (Table 5.7) does not support this 
hypothesis.
Depolarisation of the rat SCG by isoprenaline increases 
ganglionic cAMP (Quenzer et al., 1980; Petit, Barberis & 
Jard, 1988) and if adenosine receptor activation modulates 
cAMP as has been reported for arginine vasopression of the 
rat SCG (Petit et al., 1988) then it is surprising that 
isoprenaline did not alter the response to adenosine.
These results are consistent with the lack of effect or 
small reduction of the response to isoprenaline by 
adenosine and indicate the effects of adenosine may not be 
mediated via a change in cAMP.
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5.4.3 Effect of VIP on the adenosine-induced 
hyperpolarisation
At O.luM VIP is reported to increase the cAMP content of 
the rat SCG by about four fold (Voile & Patterson, 1982; 
but see Audigier, Barberis & Jard, 1986) and at higher 
concentrations (> luM) potentiate the response to 
muscarinic stimulation by carbachol (Kawatani, Rutigliano 
& De Groat, 1985). In the present study O.luM VIP did not 
alter the response to adenosine or muscarine (Table 5.1) 
suggesting an increase in cAMP may not facilitate these 
responses•
5.4.4 Effect of Ba2+ on the adenosine-induced 
hyperpolarisation
There are several possible mechanisms that may be 
responsible for the potentiation by Ba2+ of the response 
to adenosine. Firstly Ba2+ might cause the release of ACh 
from presynaptic terminals, as it does in cholinergic 
motor neurones. However the preceeding results suggests 
that the actions of adenosine are due to a direct action 
on postganglionic neurones. Furthermore, the rapid 
response of sympathetic ganglia to Ba2+ recorded by both 
Takeshige & Voile (1964) and Tashiro & Nishi (1972) was 
antagonised by dTC to leave a slow depolarisation which 
was not antagonised by atropine (Adams et al., 1982a), 
suggesting the effects of Ba2+ are directly on the 
postganglionic neurones. The second possibility is that 
Ba2+ penetrates in to ganglion cells via Ca2+ channels 
(Tashiro & Nishi, 1972) and this would be expected to 
decrease neuronal RMP and depolarise the ganglion and 
could potentiate the response to adenosine. It is likely 
that the ability of Ba2+ to decrease the permeability of 
the ganglion cell membrane to K+ , i.e. K channel
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antagonism inhibits Im as PSS containing Ba2+ has been
reported to substantially reduce the M-current (Constanti
et al., 1981a; Tsuyi & Kuba, 1988). Fourth, Ba2+ might
activate protein kinase C (PKC) in the ganglion as
suggested for the C-kinase purified from heart (Wise,
Raynor & Kuo, 1982). If PKC is involved in the mechanism
of the slow muscarinic excitation (see section 5 .4 ) an
increase in the activated PKC by Ba^+ would result in the
potentiation of the adenosine hyperpolarisation. Finally, 
2+4mM Ba has been shown to block Im of amphibian ganglia 
(Tsuji & Kuba, 1988) and enhance an outward current (Ip)* 
If Ip is present in the rat SCG an enhancement of Ip would 
be predicted to augment the response to adenosine.
2+The application of Ba for long periods can lead to
unexplained changes in rat SCG neurones (Adams et al.,
1982a). Adams & colleagues reported that brief
2+applications of 4mM Ba^ produced effects fully compatible 
with inhibition of Im, comprising of a membrane 
depolarisation accompanied by an increased input 
resistance and increased excitability. However, prolonged
application of Ba^+ resulted in irreversible depression of
2+ 24-large outward currents, due to entry of Ba^ through Ca^
calcium channels and a progressive intracellular
accumulation of Ba^+ (Hagiwara & Byerly, 1981). It is
2+possible that prolonged treatment of the rat SCG with Ba^ 
antagonised an outward current activated by adenosine, and 
may account for the loss of the potentiation of the 
hyperpolarisation to adenosine.
Even though the potentiation of the hyperpolarisation to 
adenosine by Ba^+ disappeared within 30 minutes incubation 
in Ba^+-PSS, Ba^+ still potentiated the depression of the 
response to muscarine by adenosine, suggesting the actions 
of Ba^+ on the rat SCG are linked to the interactions of 
adenosine and muscarine. As reported for many divalent
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cations, the actions of Ba^+ may not be specifically on Im 
and other potassium currents such as Ij(Ca (Connor, 1979), 
and Ik may be inhibited as well (Constanti et al., 1981b). 
The potentiation of Im and experiments in the next section 
examine this possibility.
5.4.5 Effect of nicotinic depolarisation on the 
adenosine-induced hyperpolarisation
In contrast to the results of Smith & Zidichouski (1985) 
where the effect of noradrenaline was enhanced during a 
nicotinic depolarisation, the response to adenosine in the 
presence of nicotine was unaltered (Fig 5.7). Smith & 
Zidichouski concluded that the response to noradrenaline 
was mediated by an increase in gK in a manner similar to 
that suggested for the reported effects of adenosine 
during the application of muscarinic agonists.
5.4.6 Effect of muscarinic agonists on the adenosine- 
induced hyperpolarisation
The hyperpolarisation to adenosine was augmented in the 
presence of muscarine or pilocarpine but not during 
depolarisations to potassium, isoprenaline, forskolin or 
nicotine (Tables 5.7 and 5.8). These results suggest that 
the potentiation of the response to adenosine is unlikely 
to have occurred simply due to a voltage shift to enhance 
the driving force on the adenosine mediated ionic 
conductance. The potentiation of the response to 
adenosine may occur through various mechanisms which could 
be common to both of these agonists or via an independent 
mechanism.
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A similar potentiation of the hyperpolarisation to NA when 
applied during a muscarinic depolarisation of the rat SCG 
has been reported by Brown & Caulfield (1979). Based on 
an investigation of the ionic conductances of single cells 
Brown & Caulfield suggested that muscarine and NA produced 
their effects via separate voltage-sensitive components, 
i.e. via an action of muscarine on Im and NA on I^Ca or 
gNa (Brown & Caulfield, 1981). In contrast it has been 
reported by Selyanko, Smith & Zidichouski (1990) that 
muscarine and adrenaline can have opposite effects on M- 
channels recorded from amphibian sympathetic ganglia.
5• 5 Effect of compounds reported to suppress the r e ­
current on the response of the SCG to adenosine
Complex and concentration-dependent effects of muscarine 
on sympathetic ganglia have been reported by many research 
groups and involve a variety of ionic conductances 
including Im, 1^, Ip and other currents (Brown & Selyanko, 
1985a,b; Brown et al., 1989; Mochida & Kobayashi, 1986a,b; 
Tokimasa, 1984; Tokimasa & Akasu, 1990a; Tsuji & Kuba,
1988). However, on the rat SCG the predominant effect of 
muscarine is to increase neuronal excitability to produce 
a 'slow1 depolarisation mediated by a decrease in gK 
(Weight & Voltava, 1970; Kuba & Koketsu, 1974, 1976, 1978; 
Brown & Adams, 1980) as a consequence of inhibiting the 
outwardly rectifying K+ current, Im (Brown & Constanti, 
1980).
The results discussed in Chapter 4 suggest the effects of 
adenosine could be due to an increase in gK and given the 
reported decrease in gK by muscarine, it would be 
predicted that adenosine and muscarine would strongly 
interact so that the adenosine induced hyperpolarisation 
would be enhanced during a muscarinic depolarsation and
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the muscarinic depolarsation would be depressed in the 
presence of adenosine. The results of experiments 
presented in this chapter and chapter 4 support this 
hypothesis.
Many chemically diverse compounds suppress Im and Brown 
(1988) suggested the mechanism for the transduction of 
receptor activation and the closure of M-channels in the 
rat SCG is indirect. Subsequently, it was reported that 
the inhibition of Im requires the activation of a G- 
protein as the addition of non-hydrolysable GTP analgoues, 
GTP-beta-S or Gpp(NH)p to dialysed rat SCG neurones either 
inhibited Im or potentiated and prolonged the inhibition 
produced by muscarine, LHRH or substance P (Brown, Marrion 
& Smart, 1989). Conversely addition of GDP-beta-S into 
amphibian or rat sympathetic neurones reduced the 
inhibition of Im by muscarine (Pfaffinger, Leibowitz, 
Bosma, Aimers & Hille, 1988b; Brown et al., 1989).
There are a number of compounds including muscarine (Brown 
& Adams, 1980; Constanti & Brown, 1981) that inhibit Im 
including LHRH (Adams & Brown, 1980; Jones, 1987), ATP but 
not adenosine (Akasu, Hirai & Koketsu, 1983a,b) and 
adrenaline (Akasu, 1989)), substance P (Adams, Brown & 
Jones, 1983) on bullfrog ganglia and LHRH and UTP (Adams 
et al., 1982a) on the rat SCG. The effect of some of 
these compounds reported to inhibit Im on the response of 
the rat SCG to adenosine is summarised in table 5.8. 
Unfortunately most of these agonists produced small 
depolarisations (UTP and LHRH) and the concentrations 
employed may not have been sufficient to inactivate 
sufficient M-current to alter the response to adenosine. 
ERP produced a similar depolarisation and potentiation of 
the adenosine hyperpolarisation (although not significant) 
and may indicate inhibition of Im potentiates the 
hyperpolarisation to adenosine.
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5.6 The role of secondary messengers in the response of
the SCG to adenosine and muscarine
Two most frequently proposed biochemical transduction 
systems used to explain the actions of adenosine are the 
adenylate cyclase (AC)/cAMP system, and the PI/PKC system.
5.6.1 The adenylate cyclase/cAMP system
One of the first indications that the actions of adenosine 
were related to modifications of adenylate cyclase 
activity was described by Sattin & Rail (1970) who showed 
adenosine increases cAMP accumulation in the guinea-pig 
cerebral cortex. Further evidence was provided by Van 
Calker et al. (1979) who demonstrated that adenosine and 
its analogues can stimulate or inhibit cAMP accumulation 
in cultured brain cells and proposed that two different 
receptors are involved in the increase in cAMP (A2) and 
decrease (Al) in cAMP. However, since these early studies 
it has become apparent this classification of PI 
purinoceptors may be too restricted and not all adenosine 
receptors are coupled to a change in cAMP concentration.
Greengard (1976) proposed that cyclic nucleotides have a 
major role in postsynaptic transmission of sympathetic 
ganglia, and that cAMP and cGMP exert long term control of 
neuronal excitability (McAfee & Greengard, 1972). Both 
the response to muscarinic agonists and the response to 
adenosine in some tissues is mediated via a change in the 
level of cyclic nucleotides (Stone, 1981, 1989) and a 
change in the cyclic nucleotides content of the rat SCG 
may be responsible for the interaction of muscarinic 
agents with adenosine.
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It has been proposed that muscarinic depolarisation of the 
SCG is mediated through an increase in cGMP (Weight, 
Petzold & Greengard, 1974; Kobayashi, 1982; Kebabian, 
Steiner & Greengard, 1975), This idea was strengthened by 
the observation that cGMP mimicked the excitatory effects 
of ACh on pyramidal neurones (Stone & Taylor, 1977). 
Complex effects of cGMP and derivatives have been 
reported, and on rabbit SCG, McAfee & Greengard (1972) 
found dibutyryl-cyclic-guanosine 3 1:5*-monophosphate 
(DbcGMP) produced a small transient hyperpolarisation 
followed by a larger depolarisation. Dun and colleagues 
confirmed that DbcGMP depolarised postganglionic neurones 
but also produced a long acting and variable AHP (Dun, 
Kaibara & Karczmar, 1978). It has, however, also been 
reported that cGMP and its derivatives had no consistent 
effect on the RMP when iontophoresed or microinjected in 
to rabbit SCG neurones (Buiss, Weight & Smith, 1978).
In support of the hypothesis that muscarinic agonists 
depolarise the rat SCG by increasing cGMP both Voile, 
Quenzer, Patterson, Alkadhi & Henderson (1981) and Briggs, 
Whiting, Ariano & McAfee (1982) reported muscarinic 
agonists increased cGMP two fold. Carbachol has also been 
found to increase cGMP levels of rabbit SCG by two fold 
(McAfee -in Voile et al., 1981), and by six to eight fold 
in guinea-pig SCG (Wamsley, West, Black & Williams, 1979) 
and in both cases the increase in cGMP was antagonised by 
atropine. An increase in cGMP in response to muscarinic 
agents has also been reported using bovine SCG (Kebabian 
et al., 1975) and rabbit SCG (Takahashi, Mochida & 
Kobayashi, 1988). The ability to immunohistologically 
localise cyclic nucleotides and the increase in cGMP by 
carbachol to the postganglionic neurones of the rat SCG 
(Ariano, Briggs & McAfee, 1982) strengthens the hypothesis 
that the muscarinic depolarisation is mediated by cGMP.
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However other biochemical and electrophysiological studies 
do not support this association. Brown et al. (1980) 
reported that muscarine at 1 or lOOuM applied for 2 to 5 
minutes did not alter resting levels of cGMP of the rat 
SCG. Also an increase in cGMP by eight fold by sodium 
azide was shown by Voile and colleagues not to alter the 
resting d.c. potential or the response to bethanechol 
(Voile et al., 1981). It has also been noted that when 
DbcGMP is reported to depolarise rabbit or rat SCG, the 
depolarisation was accompanied by an increase in membrane 
conductance (gM) (Dun et al., 1977, 1978; Gallagher & 
Shinnick-Gallagher, 1978) and in contrast there is either 
no change or a decrease in gM during the response to the 
sEPSP (Kuba & Koketsu, 1978), an observation incompatible 
with the hypothesis that cGMP-mediated the sEPSP. However 
Hashiguchi, Ushiyama, Kobayashi & Libet (1978) also found 
an increase in gM, but when the membrane of the rabbit SCG 
was voltage clamped there was no change in gM and it was 
concluded these effects are compatible with the mediation 
of the sEPSP by cGMP. Thus cyclic GMP appears to mediate 
at least one of the components in the mechanism underlying 
the sEPSP of the rabbit SCG (Kobayashi, 1982) and more 
recent studies by Kobayashi and colleagues suggest that 
muscarine and cGMP and its derivatives phosphorylate the 
same endogenous protein, and that cGMP appears to be 
involved in a part of the sEPSP (Takahashi et al., 1988).
The results of this study suggest cGMP depolarises the rat 
SCG, although the responses to cGMP were smaller than 
those to muscarine (Fig. 3.10), but are in agreement with 
Gallagher & Shinnick-Gallagher (1978) who found exogenous 
DbcGMP (250uM) depolarised the rat SCG, and in partial 
agreement with Brown & colleagues who found cGMP and 
8BrcGMP at ImM depolarised two out of ten rat SCG and was 
ineffective on the other eight (Brown et al., 1980). Thus 
an increase in cGMP may mediate some part of the response
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of the rat SCG to muscarine but not the majority of the 
response.
For many cell types stimulation of muscarinic receptors 
has two consequences: an increase in PIT and a change in 
intracellular cGMP or cAMP, e.g. the hydrolysis of PIT due 
to the stimulation of Ml receptors in a transfected cell 
line stimulates adenylate cyclase to increase cAMP 
(Felder, Kanterman & Axelrod, 1989) and muscarine 
increases cAMP in NE-115 cells (Tsunoo & Narahashi, 1987).
Alternatively muscarinic stimulation can cause a reduction 
of the cAMP content of tissues, e.g. in 1321N1 human 
astrocytoma cells muscarinic stimulation reduces cAMP via 
the activation of a Ca^+/CaM sensitive PDE (Meeker & 
Harden, 1982). Muscarinic agonists are reported to 
increase the cAMP content of the rabbit SCG (Kalix,
McAfee, Shorderet & Greengard, 1974) and cAMP has been 
reported to mediate a dopamine induced long term 
enhancement (LTE) of the muscarinic response of rabbit SCG 
(Libet et al., 1975).
The intracellular injection of cAMP into postganglionic 
cells caused a sustained potentiation of the sEPSP of 
rabbit SCG (Kobayashi, Hashiguchi & Ushiyama, 1978) and 
thus would be expected to counteract the depression of 
muscarine by adenosine, if LTE occurs in the rat SCG. The 
evidence for the change in cAMP upon muscarinic 
stimulation in the rat SCG is conflicting. Briggs & 
colleagues found an increase in cAMP (Briggs et al., 1982) 
where as Voile and co-workers (Voile et al., 1981) found 
no such change in intracellular cAMP. Likewise the 
application of extracellular or intracellular cAMP and its 
derivatives has been found to depolarise (Akasu & Koketsu, 
1977; Hsu & Mclsaac, 1978; Brown & Dunn, 1983; Gallagher & 
Shinnick-Gallagher, 1977), hyperpolarise (McAfee &
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Greengard, 1972; Machova & Kristofova, 1973; Brown et al., 
1979; Brown & Dunn, 1983) or have no effect on SCG (Dun et 
al., 1977; Dun & Karczmar, 1977; Gallagher & Shinnick- 
Gallagher, 1977; Busis et al., 1978).
The results of experiments described in this thesis show 
that compounds known to increase cAMP such as 8BrcAMP, 
isoprenaline, forskolin and theophylline depolarised the 
rat SCG. In addition a depolarisation by forskolin of 
similar magnitude to that produced by muscarine enhanced 
the hyperpolarisation to adenosine (Table 5.7), suggesting 
an increase in cAMP enhances the response to adenosine and 
its effects may result from a decrease in cAMP. Thus the 
depression of muscarinic responses by adenosine may be due 
to the antagonism by adenosine of an increase in cAMP 
generated during muscarinic stimulation.
Some evidence for the dual regulation of Im by agents that 
increase cAMP to stimulate Im and for muscarinic 
stimulation to decrease Im has been described for both 
smooth muscle cells of the toad (Sims, Singer & Walsh,
1988) and adrenaline has been found to increase Im in 
sympathetic ganglia of the frog (Selyanko et al., 1990) 
although the application of extra- or intracellular cAMP 
has been reported not to alter Im of sympathetic ganglia 
(Adams et al., 1982a; Brown & Adams, 1987; Brown et al.,
1989). However other effects of cAMP have not been 
excluded, including the antagonism of the muscarinic 
depolarisation via the activation of a conductance 
distinct from Im and similar to that recently described H- 
current of bull-frog sympathetic neurones (Tokimasa & 
Akasu, 1990a).
In an analogous manner to that found in rat or guinea-pig 
brain the action of adenosine on the rat SCG may occur due 
to a change in cAMP levels via an effect on adenylate
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cyclase activity (Dunwiddie & Fredholm, 1984; Yeager, 
Nelson & Storm, 1986; Donaldson, Brown & Hill, 1988) or 
PDE activity (Smellie, Davis, Daly & Wells, 1979; De 
Mazancourt & Giudicelli, 1984).
The response of the rat SCG to muscarine may be a 
composite of an increase in cAMP and/or cGMP in order to 
discover if these cyclic nucleotides are involved in the 
response of the rat SCG to adenosine or the depression of 
muscarinic responses the following experiments were 
performed. Firstly the response to adenosine was assessed 
in the presence of selective inhibitors of the breakdown 
of cAMP and cGMP, i.e. the cAMP PDE inhibitors 4-(3,4- 
dibutoxybenayl)-2-imidazolidinone (Ro 20-1724) and 
denbufylline (BRL 30892), and a cGMP PDE inhibitor, M&B 
222,948. Secondly the depression of muscarinic responses 
by CPA was tested in the presence of an adenylate cyclase 
inhibitor SQ 22,536 or Ro 20-1724. The proposed sites of 
action of these compounds is shown in Fig. 5.11.
5.6 .1.1 Effect of adenylate cyclase inhibition on the 
response to adenosine
One model for sympathetic neurones are PC12 cells which 
respond to adenosine by the activation of purinoceptors 
and an increase in cAMP due to the activation of adenylate 
cyclase (Guroff, Dickens, End & Constantin, 1981). If the 
PC12 cell line is representative of the rat SCG, which 
hyperpolarises to Al receptor agonists (Chapter 6) then 
the inhibition of adenylate cyclase would be predicted to 
reduce both the response to muscarine and its depression 
by CPA.
SQ 22,536 is a potent inhibitor of adenylate cyclase 
(Harris, Asaad, Phillips, Goldenberg & Antonaccio, 1979)
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and at lOOuM blocked the increase in cAMP generated by the 
application of isoprenaline to the rat SCG (Brown & Dunn,
1983). However the same concentration of SQ 22,536 did 
not alter the depression or the response to muscarine 
(Table 5.10) indicating the depression of muscarinic 
agonists by adenosine is unlikely to be due to an 
interaction with adenylate cyclase. Likewise the 
inability of SQ 22,536 to alter the depolarisation to 
muscarine, suggests the increase in cAMP reported upon 
muscarinic stimulation does not arise from an indirect 
stimulation of adenylate cyclase via an increase in 
[Ca^+ ]i due to the stimulated hydrolysis of inositol 
lipids. SQ 22,536 is reported to be a "P-site" selective 
adenosine agonist (Fredholm & Lingren, 1984) (Chapter 1, 
table 1) and as such the inability of SQ 22,536 to alter 
the d.c. potential of the rat SCG indicates the 
hyperpolarisation of the ganglion is unlikely to occur via 
a decrease in cAMP content.
5.6.1.2 Effect of PDE inhibitors on the response to
adenosine and depression of muscarinic responses
The effects of PDE inhibitors on the response of the rat 
SCG may be complicated by the presence of multiple forms 
of cyclic nucleotide PDE.
Four major isozymes have been described: one with Ca^+/CaM 
stimulated activity (PDE I), one having activity with a 
preference for cGMP (PDE II) and two preferring cAMP, with 
different Michaelis constants (Km) for cAMP and 
sensitivity to cGMP (PDE III and PDE IV) (Thompson & 
Appleman, 1971; Weishaar, 1987; Beavo, 1988; Beavo & 
Reifsnyder, 1990).
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Histological studies have indicated a postsynaptic 
localisation of cAMP PDE in central cerebral cortex 
(Florendo, Barnet & Greengard, 1971) and the rat SCG 
(Vente, Garssen, Tilders, Steinbusch & Schipper, 1987) and 
a cGMP PDE in rabbit SCG (Quenzer, Yahn, Alkadi & Voile,
1979). Furthermore two forms of cAMP PDE have been 
characterised from crude enzymes isolated from the guinea- 
pig SCG by Capuzzo, Biondi, Borasio, Ferretti & Fabbri 
(1986), one with a high affinity for cAMP (Km luM) which 
was weakly inhibited by the non-selective PDE inhibitor,
IBMX (Ki 90uM) and may be similar to the isozyme, PDE IV 
extracted from the mammalian brain. The second PDE had a 
low affinity for cAMP (Km HOuM) and was stimulated by 
Ca^+ and CaM, an effect completely antagonised by TFP at 
60uM.
The inactivity of TFP on the adenosine-induced
hyperpolarisation of the rat SCG (Table 4.3) suggests the
actions of the isozyme of the PDE I type, if present in 
rat SCG neurones is unlikely to be involved in the 
response to adenosine.
Oleshansky (1980) reported that adenosine inhibits cGMP 
stimulation of cAMP hydrolysis, i.e. PDE II activity, with 
an IC50 of 80uM in the rat striatum to raise the level of 
neuronal cAMP. However, the inability of the PDE I and II 
isozyme inhibitor, M&B 22,948 (Souness, Brazdil, Diocee & 
Jordan, 1989) to alter the response of the rat SCG to adenosine 
(Table 5.9) suggests adenosine does not stimulate a 
similar PDE and the depression of muscarine by adenosine 
is not mediated by a decrease in cGMP.
The Ca^+/CaM-independent low Km cAMP PDE isozyme, (PDE IV)
is selectively inhibited by denbufylline (Nicholson,
Jackman & Wilke, 1989) and Ro 20-1724 (Sheppard & Wigan,
1970; Sheppard, Wigan & Tsien, 1972) and is thought to
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regulate the cAMP concentration in both the rat cerebrum 
and guinea-pig hippocampus (Stanley, Brown & Hill, 1989; 
Challiss & Nicholson, 1990). Denbufylline, an analogue of 
theophylline is a potent inhibitor of PDE IV and almost 
abolished the in vitro PDE activity of of rat cerebral 
cortex at lOuM (Nicholson & Wilkie, 1987), and Ro 20-1724 
at 180uM increased both the basal and carbachol stimulated 
increase in cAMP levels of the rabbit SCG (Kalix et al., 
1974). It would be expected that the incubation of the 
rat SCG with either Ro 20-1724 or denbufylline would 
augment the response to adenosine if it is due to a 
decrease in cAMP.
Ro 20-1724, denbufylline and SQ 22,536 were either 
ineffective or reduced (denbufylline at lOOuM) the 
depolarisation of the rat SCG to muscarine (Table 5.^ ). 
These results suggest the muscarinic response does not 
occur via an increase in cAMP as it would be predicted 
that the PDE inhibitors would potentiate inhibition of 
adenylate cyclase and reduce the response to muscarine. 
Likewise, the inability of Ro 20-1724, denbufylline (up to 
lOuM) to significantly alter the depression of the 
response to muscarine by adenosine or CPA suggests an 
action of adenosine on PDE IV activity is unlikely.
The inability of denbufylline or Ro 20-1724 to potentiate 
the response to adenosine suggests the hyperpolarisation 
of the rat SCG by adenosine is independent of cAMP. At 
luM and lOuM denbufylline caused a small (P<0.05 at lOuM) 
reduction of the hyperpolarisation to adenosine with an 
estimated ED5q (36uM) for the antagonism of the 
hyperpolarisation of the rat SCG which was similar to the 
Ki (20uM) reported for the inhibition of the Al 
radiolabelled ligand binding of [3H] cyclohexyl adenosine 
(CHA) by denbufylline (Nicholson & Jackman, 1988). Thus 
the antagonism by denbufylline of the hyperpolarisation of
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the rat SCG to adenosine may be due to receptor 
antagonism.
In contrast to the methylxanthine PDE inhibitors Ro 20- 
1724 has been used extensively in experiments where there 
is a need for a PDE inhibitor which is structurally 
unrelated and thus will not interfere with the binding of 
adenosine and related ligands. However, it has been 
reported that at lOOuM Ro 20-1724 inhibited the binding of 
[%]-PIA to rat brain membranes by 20% (Schwabe & Trost,
1980) and it is possible that Ro 20-1724 at 200uM strongly 
antagonised the binding of adenosine to the rat SCG. Both 
Ro 20-1724 and purinoceptor antagonists caused an 
apparently non-parallel antagonism of the concentration- 
response curve to adenosine (Cf Figs. 5.10 and 6.20) and 
Ro 20-1724 may also act as an adenosine receptor 
antagonist.
Furthermore, there is circumstantial biochemical evidence 
to suggest that adenosine does not affect the response of 
agonists that stimulate cAMP formation in SCG. Roch & 
Kalix (1975) studying blocks of bovine SCG found the cAMP 
content was not altered by incubation in lOOuM adenosine 
for 9 minutes in either untreated, or SCG treated with 
theophylline or Ro 20-1724. Adenosine was reported not to 
alter the increase in cAMP induced by high potassium 
medium, the latter effect of high [K+ ]e was attributed to 
the release of catecholamines, which presumably activated 
beta-adrenoceptors to stimulate cAMP formation. Similarly 
Kalix and colleagues reported that in rabbit SCG adenosine 
had no effect on cAMP levels at rest or during cholinergic 
stimulation (Kalix et al., 1974). Unfortunately both of 
these reports lack sufficient experimental details in that 
the concentrations of agonists and antagonists, and 
conditions employed are unknown but support the results
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presented, in that the effects of adenosine on the rat SCG 
are cAMP-independent.
The ability of forskolin to enhance the response to 
adenosine may be mediated through some other effect rather 
than a direct stimulation of adenylate cyclase (Laurenza, 
Sutkowski & Seaman, 1989) such as an increase in open 
channel activity as suggested by Akagi & Kudo (1985) for 
the rat SCG.
5.6.2 Interaction of adenosine with PIT in the rat SCG
As the effects of adenosine and muscarine on the rat SCG 
appear independent of cyclic nucleotide metabolism, then 
the interaction between adenosine and muscarine may occur 
via some other secondary messenger. Recent molecular 
characterisation of muscarinic receptors has revealed at 
least five subtypes of receptor (outlined in chapter 1) 
which may be selectively coupled with different effector 
systems, but not exclusively (Fukuda, Higashida, Kubo, 
Maeda, Akiba, Bujo, Mishina, & Numa, 1988). Muscarinic 
receptors coupled to phospholipase C (PLC) have been 
demonstrated in many neuronal tissues (Fisher & Agranoff,
1987) and based on the sensitivity to pirenzepine it was 
suggested that Ml receptors are coupled to PLC activation 
while pirenzepine insensitive M2 receptors are linked to 
adenylate cyclase inhibition (Gill & Wolfe, 1985).
One consequence of the stimulation of cholinergic 
receptors by muscarine is the hydrolysis by PLC of 
phosphatidylinositol 4,5-bisphosphate (PIP2) to yield two 
second messengers, inositol 1,4,5-triphosphate (IP3) and 
1,2-diacylglycerol (DAG) (Berridge, 1987; Fisher & 
Agranoff, 1987; Fig. 5.9). It has been reported that 
adenosine may interact with PIT in a variety of cell types
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including rat striatum (Petcoff & Cooper, 1987), mouse 
cerebral cortex (Kendall & Hill, 1988), cultured GH3 
pituitary tumour cells (Delahunty, Cronin & Linden, 1988), 
frog NMJ (Sebastiao, 1989), and frog sympathetic ganglia 
(Rubio, Bencherif & Berne, 1988) and rat aorta (Long & 
Stone, 1987), and thus represents a potential target for 
the selective interactions of adenosine and muscarine on 
the rat SCG,
IP3 stimulat es the release of intracellular Ca^+ while 
DAG can activate a family of Ca^+ and phospholipid 
dependent protein kinases, referred to as protein kinase C 
(PKC) (Berridge, 1987; Nishizuka, 1989; Huang, 1989), 
which may in turn phosphorylate specific proteins. Ca^+ 
mobilisation may activate phospholipase A2(PLA2) and 
trigger the release of arachidonic acid (AA) and the 
formation of cyclo-oxygenase or lipoxygenase products to 
cause hyperpolarisation (Higashida & Brown, 1986; Kim & 
Clapham, 1989; Kim, Lewis, Graziadei, Neer, Bar-Sagi & 
Clapham, 1989; Kurachi, Ito, Sugimoto, Shimizu, Miki & Ui, 
1989a,b; Fig. 5.15). Likewise the PI response of various 
tissues has been linked to a hyperpolarisation produced by 
activation of Ii(ca> e.g. in the hippocampus and NG108-15 
cells. Higashida & Brown (1986) have shown that 
stimulation of NG108-15 cells with bradykinin has two 
sequential effects on gM:- the first is a 
hyperpolarisation attributed to the activation of an Ij(ca 
and was mimicked by the application of IP3 or increased 
[Ca^+ ]i and the second, a subsequent depolarisation 
resulting from inhibition of a voltage dependent K+ 
current (Im), which was inhibited by DAG activators.
In hippocampal neurones (Fig. 5.12), Dutar & Nicoll (1988) 
concluded IP3 is responsible for Im suppression as agonists 
that activate PLC suppress Im. Whereas phorbol ester 
activation of PKC has no effect (Malenka, Madison, Andrade
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& Nicholl, 1986) and the intracellular injection of IP3
results in the loss of Im via Ca^+ independent process,
suggesting a direct effect of IP3 or an IP3 metabolite on
Im. In contrast the underlying biochemical mechanisms
responsible for the inhibition of Im and hence the
depolarisation of the rat SCG are not fully understood.
It is known that muscarinic stimulation of the rat SCG
increases the incorporation of 32Pi into phospholipids and
the accumulation of IP3 (Hokin, 1965; Lapetina, Brown &
Michell, 1975; Horwitz, Tsymbalov & Perlman, 1984; Bone &
Michell, 1985). Muscarine at lOOuM caused a 6 to 15 fold
increase in PI labelling which was not mimicked by ImM
8BrcGMP, 8BrcAMP or dopamine (Horwitz et al., 1984). Low
[Ca^+ ]e increased the basal levels of PI and did not alter
the accumulation of PI by muscarine and PIT hydrolysis was
independent of [Ca^+ ]e. In contrast, Tokimasa & Akasu
(1990) have reported that Im of amphibian ganglia is
subject to regulation by the [Ca^+ ]e and up to 90% of Im
9+was antagonised by the application of Ca^ antagonists.
In contrast Brown & colleagues found Im of the rat SCG is 
independent of both [Ca^+ ]e and [Ca^+ ]i (Adams et al., 
1982a; Brown et al., 1989), although the possibility that 
Im requires a minimum level of [Ca^+ ]i for its activation 
has not been discounted.
In the absence of receptor-induced PIP2 hydrolysis the 
tumour promoting phorbol esters, such as phorbol 12,13- 
dibutyrate (PDBu) can substitute for DAG to activate PKC 
(Berridge, 1987) and the addition of PDBu or unsaturated 
DAGs partially suppressed the M-current (Pfaffinger, 
Leibowitz, Subers, Nathanson, Aimers & Hille, 1988a; Brown 
et al., 1989). Im was not altered by the intracellular 
injection or extracellular application of agents that 
increase cAMP, e.g. db-cAMP, 8BrcAMP, theophylline or 
forskolin (Adams et al., 1982a; Moore, Madamba, Joels & 
Siggins, 1988) suggesting Im is independent of cAMP.
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Neither forskolin nor cAMP increased Im or reversed a 
partial blockade of Im by muscarine in frog ganglion cells 
(Adams et al,, 1982; Brown & Adams, 1987; Moore et al,,
1988), However, perhaps more importantly the suppression 
of Im was not enhanced by raising either [Ca^+ ]i to >
200nM or the level of IP3 to lOOnM (Pfaffinger, Leibowitz, 
Bosma, Aimers & Hille, 1988b), Additional studies by 
Brown & colleagues using Li+ at a concentration (2mM) that 
would be expected to inhibit PIT, did not alter Im (Brown 
et al., 1989), All these results strongly indicate that 
the inhibition of Im and hence the depolarisation of the 
rat SCG occurs via an IP3-independent mechanism.
Alternatively DAG has been proposed as the mediator of the 
muscarinic depolarisation of the rat SCG based on two 
observations, namely (1) muscarinic agonists stimulate PIT 
and the production of DAG (Bone, Fretten, Palmer, Kirk & 
Michell, 1984; Patterson & Voile, 1984; Horwitz et al.,
1984) and (2) PDBu mimics the depolarisation of muscarine 
by partially suppressing Im and a leak current of rat SCG 
neurones (Brown et al., 1989),
In contrast Bosma & Hille (1989) found the PKC inhibitors 
H7 and staurosporine had no effect on LHRH suppression of 
Im but blocked the response to phorbol esters. A similar 
effect of PKC inhibitors on the response of the rat SCG 
was very recently reported by Grove & colleagues who found 
PDBu mimicked the muscarinic depolarisation of the rat 
SCG. Staurosporine abolished the response to PDBu but 
only slightly reduced the response to muscarine, probably 
via a non-specific action (Grove, Caulfield & Evans,
1990).
Furthermore, studies by Hille and his colleagues have 
produced evidence that agonist-induced suppression of Im 
in frog sympathetic neurones is independent of the PLC
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second messenger cascade as phorbol esters caused only 
partial suppression of Im and the addition of LHRH 
following phorbol ester application suppressed the 
remaining current, suggesting LHRH can inhibit Im in PKC- 
independent manner (Pfaffinger et al., 1988a). Thus there 
may be a PLC independent and dependent mechanism of action 
of muscarine on the rat SCG.
5.6 .2.1 Effect of phorbol esters and the PKC inhibitor 
H7 on the response to adenosine
When applied to the rat SCG (Fig 5.14c) PDBu produced a 
slowly developing depolarisation, which probably reflects 
the time needed for this compound to cross the cell 
membrane and act upon PKC. The slow recovery to PDBu 
would be expected to be dependent on its degradation 
and/or diffusion from the ganglion. The comparable 
depolarisation and potentiation of the hyperpolarisation 
to adenosine by PDBu and muscarine is indicative of a 
common site of action for adenosine, at or beyond the 
activation of PKC. The inability of the PKC-inhibitor H7 
to alter the response to PDBu is in contrast to the 
reported action of another PKC inhibitor, staurosporine to 
inhibit the depolarisation of the rat SCG to PDBu (Grove 
et al., 1990). It has been reported PKC inhibitors are 
not completely specific in that all of them are reported 
to inhibit other PKs, e.g. H7 also inhibits cAMP dependent 
PK at 3uM and cAMP dependent PK at 6uM (Hidaka, Inagaki,
Kawamoto & Sasaki, 1984), and polymixin B inhibits both 
PKC and Ca^+/CaM dependent PK but not the cyclic
nucleotide dependent PKs. The inactivity of H7 on the response to 
adenosine (Tables 5.10 & 5.11)further supports the hypothesis that 
cAMP is not involved in the response to adenosine as H7 
would be expected to inhibit PKA.
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One possibility is that the concentration of H7 (50uM) 
employed was insufficient to block PKC. Some evidence for 
the need for a higher concentration to inhibit PKC was 
suggested by Linden & Routtenberg (1989) who in reviewing 
the literature on long term potentiation (LTP) reported 
Malinow, Madison & Tsien (1988) found the LTP of the 
hippocampus was inhibited by 300uM H7, whereas another 
group of investigators found no inhibition of hippocampal 
LTP at lOOuM H7 . In contrast a concentration of 50uM H7 
may be sufficient to inhibit PKC as the depression of Ca^+ 
dependent components of the CAP of isolated cultured 
rabbit SCG neurones by ACh, an effect mimicked by phorbol 
esters was abolished by a minimum of 10 minutes incubation 
in 50uM H7 (Mochida & Kobayashi, 1988).
Similarly, Sebastiao (1989) reported 60uM H7 inhibited the 
evoked endplate potential (e.p.p.) of frog sartorius 
muscle, but did not modify the excitatory action of lOOnM 
phorbol diacetate (PDAc) on e.p.p. amplitude, whereas 
polymixin B antagonised the excitatory effect of PDAc.
The apparent ineffectiveness of H7 was attributed to the 
ability of polymixin B to inhibit the binding of PKC in an 
indirect manner, i.e. to inhibit the binding of 
phospholipid to PKC.
PKC inhibitors can also act at two different sites, i.e.
2+the regulatory domain of PKC, which binds Ca ,
phospholipid and DAG or phorbol ester to unmask the second
active site, the catalytic domain. Sphingosine and
7+polymixin B compete with phosphatidylserine, Ca* and DAG 
at the regulatory site, whereas H7 competes with ATP at 
the catalytic phosphotransferase site. Thus these 
differences in the sites of action between H7 and 
spingosine may account for the depression of the response 
of the rat SCG to PDBu by sphingosine but not by H7.
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The results presented here suggest that the interaction of 
adenosine with muscarine and PDBu is at a site distinct to 
the ATP binding site of PKC. Adenosine may alter the 
activation by PKC at the regulatory site although this 
seems unlikely as TFP has been shown to antagonise the 
binding of Ca^+ to the regulatory domain of PKC (Huang,
1989) but not the hyperpolarisation of the rat SCG by 
adenosine.
It is possible that a neurotransmitter such as ACh whose 
principle biochemical effect is to increase PIT can also 
increase cAMP formation via an indirect action (Fredholm, 
Longren, Lindstrom & Norstedt, 1987; Karbon, Shenolikar & 
Enna, 1986).
Tumour-promoting phorbol esters have been reported to 
augment drug and neurotransmitter-induced second messenger 
production, e.g. cAMP, by an unknown mechanism in a 
variety of tissues including brain (for references see 
Karbon et al., 1986). However, it is unlikely that the 
enhanced response of the rat SCG to adenosine in the 
presence of PDBu is due to an increase in cAMP as reported 
for the effects of 2CA on rat brain slices (Karbon et al.,
1986) as the alteration of cyclic nucleotide metabolism in 
PSS did not enhance the response to adenosine.
Whatever the mechanism of interaction between muscarine 
and adenosine the ability of muscarine and PDBu to enhance 
the response to adenosine during the persistent 
depolarisation to muscarine, suggests the effector 
mechanism is not transient, and is unlikely to be a 
depletable secondary messenger. In addition the ability 
of PDBu to augment the response to adenosine suggests that 
adenosine modifies a second messenger response beyond the 
level of muscarinic receptor.
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The ability of muscarine to potentiate subthreshold 
responses, i.e. at c luM adenosine (Fig. 5.13c) is 
indicative that the effect of adenosine on the rat SCG 
would be greater in vivo during normal and patho­
physiological situations. The difference in the response 
shape at millimolar concentrations (Fig. 5.13c, cf lOOuM 
and lOOOuM adenosine) is discussed further in Chapter 6 . 
Possible explanations for such an effect include; 
desensitisation to adenosine, an interaction at two 
different receptors or the efflux of K+ in to the 
extracellular space.
Muscarinic agonists differ considerably in their ability 
to enhance PIT in brain (Fisher & Agranoff, 1987; Baumgold 
& White, 1989) an effect which depends on agonist 
structure since ACh and carbachol activate PIT to a much 
greater extent than pilocarpine (Fisher, Klinger,
Agranoff, 1983; Brown & Brown, 1984). The ability of 
different muscarinic agonists to produce different degrees 
of PIT in the rat SCG is indicated by the results of 
Horwitz et al. (1984) who found muscarine was more 
effective than bethanechol at stimulating phospholipid 
metabolism. Using rat cerebral cortex Freedman, Harley & 
Iversen (1988) suggested that methylfurmethide is not 
considered to be a "full” agonist at stimulating the PI 
system.
The different susceptibility of muscarinic agonists to 
adenosine reported here (Table 5.4) may be associated with 
the coupling of these agonists to the muscarinic receptor 
and their respective responses via secondary messengers. 
The most potent effects of adenosine were found on MeF 
which is reported to be poorly coupled to PIT and the 
smallest depression by adenosine was of carbachol an 
agonist that may be strongly coupled to PIT.
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The coupling of muscarinic receptors to two different 
biochemical pathways could also explain the biphasic 
nature of the depression of muscarinic responses, i.e. 
with increasing concentrations of muscarine a second 
biochemical mechanism is activated and antagonises the 
depression of the response of the muscarinic agonist by 
adenosine.
5.7 The role of prostaglandins and leukotriens on the 
response of the SCG to adenosine
It is possible that the G-protein that couples muscarinic 
receptors to PLC second messenger cascade may also couple 
in an independent manner, to the suppression of Im, 
perhaps via a direct mechanism. Alternatively the 
suppression of Im in the rat SCG could occur via DAG which 
is hydrolysed by DAG-lipase to form monoacylglycerol (MAG) 
and AA (Irvine, 1982). In support of this idea is the 
ability of A9L cells to release AA upon stimulation of Ml 
receptors (Irwin, 1982) and the activation of muscarinic 
receptors of some cell lines (De George, Morell, McCarthy 
& La Petina, 1986). Recently the products of AA 
metabolism, i.e. prostaglandins (PG) and leukotrienes (LT) 
(Fig. 5.15) have been found to modulate K+ channels 
(Higashida & Brown, 1986; Kim & Clapham, 1989; Kim et al., 
1989; Kurachi et al., 1989a,b).
A second pathway for the synthesis of AA is via the 
hydrolysis of phospholipids by PLA2 to release 
lysophospholipid and free fatty acid, usually AA, which 
can directly activate or inhibit PKC (Huang, 1989). In 
addition AA in neurons can be metabolised by lipoxygenase, 
cyclooxygenase or epoxygenase enzymes to form LTs, 
hydroxyeicosatetraenoic acids (HETEs), PGs, thromboxanes
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(TXs) and epoxides respectively (Axelrod, Burch & Jelsema,
Most electrophysiological effects of adenosine so far 
identified appear to result from its ability to alter cAMP 
or PIT metabolism and arachidonate pathway products do not 
appear to be a major second messenger system for adenosine. 
>and ATP arose from the ability of ATP rather its 
metabolically stable, phosphate-modified analogues to 
stimulate the synthesis and release of PG*s (Brown & 
Burnstock, 1981b; Needleman, Minkes & Douglas, 1974). 
Recently this dogma has been challenged by two reports of 
the activation of PG synthesis by adenosine in guinea-pig 
atria (Caparrota, Fassina, Froldi & Poja, 1987) and the 
rabbit heart (Karwatowska-Prokocsuk, Ciabattoni &
Wennmalm, 1988).
Both intact and homogenated rat SCG have the ability to 
synthesise PGs. Ganglia spontaneously released PGE and 
indomethacin at 55uM inhibited the synthesis of PGE in 
intact ganglia, with an IC5Q for rat SCG homogenates of 
lluM (Webb, Saelens & Halushaka, 1978). Homogenates of 
rat SCG were also reported to produce PGE2 and 6-keto- 
^^lalpha (Gonzales, Goldyne, Taiwo & Levine, 1989) and 
the ability of adenosine to activate the LT and PG 
pathways of the rat SCG was tested.
At 50uM indomethacin produced a small non-significant 
rightward shift in the concentration-response curve for 
the hyperpolarisation of the rat SCG to adenosine (Fig. 
5.16). The concentration of indomethacin chosen is likely 
to be supramaximal for the inhibition of PG synthesis and 
was reported to inhibit the formation of PGs in the rat 
SCG (Webb et al., 1978), suggesting PGs are not involved 
in the response of the ganglion to adenosine. If PLA2 
activation is necessary for the hyperpolarisation to
Ik) FVK-r 0M6 KeaSdA) &€CGPTdfi.S PtR. A O e N i Z i t i E
1988) (Fig. 5.15).
< < r
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adenosine then the effect of a PLA2 inhibitor such as 
nordihydroguaiaretic acid (NDGA) should be to decrease the 
response to adenosine. In combination with indomethacin 
to inhibit PG synthesis, NDGA produced a significant 
antagonism of the hyperpolarisation of the rat SCG to 
adenosine, suggesting either the activation of PLA2 and/or 
the lipoxygenase pathway may mediate a significant part of. 
the response to adenosine.
The results reported here appear to be similar to those 
effects on the opening of S-channels of Aplysia sensory 
neurones. The opening of these K+ channels was imitated 
by exogenous AA and blocked by inhibitors of phospholipase 
and lipoxygenase, but not by indomethacin (Piomelli, 
Volterra, Dale, Siegelbaum, Kandel, Schwartz & Belardetti,
1987).
Other similar actions of AA metabolites, i.e. the 
lipoxygenase products have been found to be intracellular 
modulators of G-protein-gated muscarinic K+ channels of 
guinea-pig atrial cells (Kurachi et al., 1989a,b) and 
neonatal rat atrial cells (Kim & Clapham, 1989; Kim et 
al., 1989).
Given the broad spectrum of actions of PGs and LTs the 
results reported here must be considered as preliminary 
findings and suitable controls will need to be included 
before any specific claims can be made for the role of AA 
in the actions of adenosine on the rat SCG. However, a 
recent report has suggested that the Al receptors of rat 
striatal glial cells may be coupled to the PLA2“PG 
synthesis pathway (Caciacli, Ciccarelli, Di Iorio, 
Tacconelli & Ballerni, 1989) and a similar coupling of 
adenosine receptors to the PLA2 secondary messenger system 
may occur in rat SCG neurones.
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It is proposed that adenosine may increase the production 
of arachidonic acid and the production of lipoxygenase 
products which can then activate K+ channels to 
hyperpolarise the rat SCG. To determine whether the 5- 
lipoxygenase pathway is involved in the response to 
adenosine in the presence of a specific inhibitor of LT 
synthesis such as nafazatrom could be tested. Muscarinic 
depolarisation would thus augment the response to 
adenosine due to an increased activity of PLC that would 
increase the concentration of DAG and AA. An increase in 
free AA may be sufficient to inhibit the activation of PKC 
and cause a subsequent depression of the muscarinic 
response.
Discussion
An interaction of purines with postsynaptic responses to 
ACh and cholinergic agents has been reported by several 
research groups although both the receptors and the 
mechanisms of action are unknown or poorly characterised 
(Table 5.12).
It has been shown that 5 *-isobutylthio-adenosine (SIBA) 
and its analogues at lOOuM antagonised ACh-induced 
contractions of the guinea-pig ileum (Pankaskie, Kachur, 
Itoh, Gordon & Chiang, 1985). It is reported that SIBA 
and related agonists can alter the binding of muscarine to 
muscarinic receptors (Smejkal, Ibrahim, Pankaskie &
Chiang, 1989). It seems unlikely that adenosine directly 
inhibited the binding of muscarine to muscarinic receptors 
as methroctramine and pirenzepine did not alter the 
response of the ganglion to adenosine. In addition the Ki 
for the inhibition of specific binding of JH-pirenzepme 
to the rat cerebral cortex was 160uM (Smejkal et al.,
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1989), a value 10 fold greater than the IC^q for the 
depression of muscarinic responses on the rat SCG.
Opposite effects to those described here have been 
reported by Worley & colleagues (Worley, Baraban,
McCarren, Snyder & Alger, 1987; Worley, Heller, Snyder & 
Baraban, 1988). Both phorbol esters and cholinomimetics 
were shown to prevent the inhibitory effects of adenosine 
on orthodromically-induced synaptic potentials and the 
adenosine-induced hyperpolarisation of CAl-pyramidal cells 
(Worley et al., 1987; 1988). Carbachol was substantially 
more effective than oxotremorine in blocking the adenosine 
elicited outward current (Worley et al., 1987), whereas on 
the rat SCG carbachol was the most resistant to the 
depressant by effects of adenosine. It is interesting to 
speculate that the stimulatory and inhibitory activity of 
phorbol esters and cholinomimetics arises from a 
difference in the role of PKC in the ganglion and 
hippocampus (Fig. 5.12).
In agreement with the results reported here Brooks & Stone 
(1988) found that adenosine reduced the activity of 
cholinomimetics at concentrations that did not alter the 
actions of excitatory amino acids on the hippocampus. The 
mechanism of action was not studied but both the potency 
and relative order of potency of the purines tested i.e. 
R&S-PIA, NECA and adenosine was similar to that reported 
for these agonists on the rat SCG (r^ ■ 0.95) suggesting a 
similar mechanism may be responsible for both actions of 
adenosine. Both of these studies appear to be different 
from the reports by Worley & colleagues as the actions of 
adenosine on the rat SCG and hippocampus (Brooks & Stone,
1988) were postsynaptic and the concentration of adenosine 
achieved at the cell surface by Worley & colleagues is 
predicted to be much higher than that used in this study 
and that used by Brooks & Stone (1988).
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The effects reported here and by Brooks & Stone (1988) are 
in sharp contrast to other studies where purines enhanced 
the nicotinic or muscarinic sensitivity of other 
preparations (Table 5,12)* These results are in partial 
agreement with studies on the central neurones of Helix 
(Cox & Walker, 1987) where low concentrations potentiated 
and higher concentrations depressed the ACh response. The 
adenosine receptor responsible for the depressant activity 
of adenosine on Helix neurones may be of the A3-receptor 
subtype given the inactivity of NECA and the Ca^+ 
dependent nature of the depression.
A bell-shaped depression of the response of the rat SCG to 
muscarine by increasing concentrations of purines was 
observed in both normal and low Ca^+ PSS. The application 
of adenosine at increasing time intervals did not alter 
the size or shape of the response, suggesting receptor 
desensitization may not account for the shape of the 
concentration-response curves. A second possibility is 
that higher concentrations of purines activate a second 
receptor or another process that antagonises the effects 
of lower concentrations of adenosine. The possibility of 
a second adenosine receptor is addressed in the next 
chapter.
Thus there are many potential interactions between purines 
and responses to cholinomimetics which may provide the 
capacity for the modulation of both central and peripheral 
neurones•
In summary the results presented in this chapter suggest 
that adenosine selectively depressed the response of the 
rat SCG to muscarinic agonists via a reduction of the Ml- 
mediated depolarisation and that these actions were 
competitive and readily reversible.
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Furthermore, the results presented point to adenosine 
sensitive and adenosine insensitive components in the 
response to muscarine and may reflect the multiple actions 
of muscarine reported (Mochida & Kobayashi, 1986a,b).
Many agonsits that are reported to increase intracellular 
cAMP depolarised the rat SCG but did not alter the 
response to adenosine suggesting an increase in cAMP is 
not the mechanism responsible for the potentiation of the 
hyperpolarisation to adenosine in the presence of 
muscarinic agents. The potential for an interaction of 
adenosine at a number of intracellular sites has been 
reviewed and it is suggested that adenosine may alter the 
activity of these sites to counteract the inhibition of Im 
by muscarine.
Fig. 5.1. Log concentration response curves for 2 
methy1-5-hydroxytryptamine, acetylcholine, muscarine, 
vasoactive intestinal polypeptide and oxotremorine-M on 
rat isolated SCG
Concentration-response curves for the depolarising 
responses induced by 2-methy1-5-hydroxytryptamine (2Me- 
5HT), acetylcholine (ACh), muscarine, vasoactive 
intestinal polypeptide (VIP) and oxotremorine-M (OXO-M) 
were constructed with one minute applications and a 
minimum of 15 minutes between applications. The 
responses to agonists were reproducible. Each data 
point represents the mean of 4 to 12 ganglia with 
vertical or downward bars for S.E.M.
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Fig. 5.2. Effect of adenosine on the response of 
isolated SCG of the rat to cholinomimetics and other 
depolarising agents.
The effect of adenosine (AD) on the response to one 
minute applications (solid bars) of (a) potassium (K+ ), 
(b) gamma-aminobutyric acid (GABA), ( c ) dimethyl- 
piperadinium (DMPP), (d) 5-hydroxytryptamine (5HT), (e) 
2-methy1-5-hydroxytryptamine (2Me-5HT), (f) 
isoprenaline (ISO), (g) muscarine (Muse), (h) carbachol 
(Carb) and (i) methyIfurmethide (MeF) is shown.
For each trace (I) pretest response before adenosine 
(CONTROL), (II) response to agonist during a five 
minute application of lOOuM adenosine and (III) 
response to agonist after washing out adenosine.
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Fig. 5.3. Depression of the responses of a single rat
superior cervical ganglion to muscarine produced by 
increasing concentrations of adenosine
Responses to muscarine (lOOnM, 1 minute applications at 
a minimum of 20 minute intervals) before adenosine 
(CONTROL), during a five minute application of 
adenosine (ADENOSINE) and after washing out of 
adenosine for a minimum of 20 minutes (WASH) were 
recorded sequentially. The values in the right hand 
column refer to the % reduction (mean + SEM) of the 
response to muscarine at the respective concentrations 
of adenosine used. The value in brackets refers to the 
number of ganglia tested.
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CONTROL ADENOSINE WASH % REDUCTION 
CONTROL
8 ±1(7)
13 ± 2(9)
■ ■ ■
10pM
21 ±2(9)
■■ ■
30mM
27 ±3(10)
100m M
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0-5m V300 pM
5min
Fig. 5.4. Depression of the response of the rat SCG to
(A) increasing concentrations of adenosine and (B) 
effect of lOOuM adenosine on different concentrations 
of muscarine by lOOuM adenosine.
Statistical significant depressions of the response to 
muscarine were determined using a paired t-test on the 
responses in uV and is indicated by * for P < 0.05, ** 
for P < 0.01 and *** for P < 0.001.
The depression of the muscarinic response was fully 
reversible at all concentrations of adenosine (up to 
ImM), upon washing out adenosine, and allowing up to an 
hour for recovery.
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Fig. 5.5. Effect of (-) baclofen on the response of 
the rat SCG to muscarine
The response to muscarine (lOOnM, 1 min application) 
was assessed in the absence and presence of increasing 
concentrations of (-) baclofen. Statistical signficant 
depressions of the response to muscarine were 
determined using a paired t-test on the responses in uV 
and is indicated by a * for P < 0.05.
Fig. 5.6. Effect of adenosine on the concentration-
response curve to muscarine
Log concentration response curve of the rat SCG 
muscarine in the presence of (A) lOuM adenosine 
(muscarine + AD lOuM) and (B) lOOuM adenosine 
(muscarine + AD lOOuM). Statistical significant 
depressions of the response to muscarine were 
determined using a paired t-test on the response 
and is indicated by a * for P < 0.05, ** for P < 
and *** for P < 0.001. A minimum of six ganglia 
used at each concentration of muscarine.
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Fig. 5.7. Response of a single rat SCG to adenosine in
the absence and presence of increasing concentrations 
of nicotine.
(A) The response to a one minute application of luM 
carbachol (CARB), (B&C) The response to two minute 
applications of nicotine (N) at O.luM, luM and (D) 
application of lOuM nicotine for 1 minute and the 
response to adenosine (AD, lOOuM, 2 minutes) during 
nicotinic depolarisations and after washout of 
nicotine. NOTE: In (D) the maximum response to lOuM 
nicotine was trunkcated by the chart recorder.
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Fig. 5.9. Response of a single SCG to increasing 
concentrations of carbachol and the effect of adenosine 
on the response to carbachol
The ganglion was recorded in physiological salt 
solution containing low calcium (O.lmM) and pirenzepine 
(300nM). (A) Effect of increasing concentrations of
carbachol, (B) response to adenosine (AD) (2 minutes), 
control response to luM carbachol (C), followed by 
response to luM carbachol during the hyperpolarisation 
to adenosine and the response to luM carbachol recorded
20 minutes after the removal of adenosine, (C) response
to 3uM carbachol and response to 3uM carbachol during a
hyperpolarisation to adenosine. Note: Reduction of the
amplitude of the depolarisation produced after the 
initial hyperpolarisation to carbachol.
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F i g . 5.13. Response of a single rat SCG to muscarine,
adenosine and increasing concentrations of adenosine 
during the continuous application of muscarine
(A) a one minute application of lOOnM muscarine
(B) a two minute application of lOOuM adenosine 
followed by the continuous application of lOOnM 
muscarine and of lOOuM adenosine (5 minutes) and (C) 
continuous trace of the same ganglion as in a & b, and 
the response to increasing concentrations of adenosine 
(l-1000uM) during continuous the application of 
muscarine. Note: The response to adenosine (lOOuM) 
during the application of muscarine (c) is over twice 
that obtained in the absence of muscarine (b).
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Fig. 5.14. Response of an isolated rat SCG to 
adenosine in the absence and presence of muscarine, 
pilocarpine or phorbol dibutyrate.
The response to lOOuM adenosine (AD, 2 minutes) is 
shown before the depolarising response to (A) muscarine 
(muse), (B) pilocarpine (lOuM, 1 minute) and (C) 
phorbol dibutyrate (PDBu, 200nM) and during the 
depolarisations to these agonists. NB: Phorbol
dibutyrate (PDBu) produced a concentration-dependent 
sustained depolarisation of the SCG. The arrow denotes 
displacement of chart recorder pen to allow continuous 
recording of response. Responses to 20 and 200nM began 
1 to 2 minutes after application and developed slowly 
over at least 15 minutes and took over 2 hours to 
washout. At 20nM PDBu produced a comparable peak 
depolarisation to that produced by lOOnM muscarine (1 
min application) and a similar potentiation of the 
hyperpolarisation to lOOuM adenosine (AD) (Tables 5.7 & 
5.8).
■ 
Q-
AD AD
Muse
loonM AD
0 * 5 m
m  V
1 -0 (b )
1 0 m m
AD AD
PDBu 
too nM
AD
Fig. 5.15. Pathways for the generation and metabolism
of arachidonic. acid (adapted from Cook, 1990).
The activation of a receptor (R) can activate G 
proteins (G) to release arachidonic acid directly from 
phospholipids through the action of phospholipase A 2 
(PLA2 ) or from the prior action of phospholipase C 
(PLC), followed by the action of diglyceride lipase. 
Alternatively the diglyceride may be phosphorylated to 
phosphatidic acid by the action of diglyceride kinase, 
and arachidonate may be released through the action of 
PLA2 . Arachidonic acid may then be metabolised by 5 or 
12-lipoxygenase to produce 5 or 12-
hydroperoxyeicosatetranoic acids (5-HPETE, 12-HPETE 
respectively), by cyclooxygenase to prostaglandins 
(PGs) and thromboxanes (TXs) or by epoxygenase to 
epoxides. The arrows, broken lines indicate inhibition 
of synthesis of PGs and TXs by indomethacin and 
inhibition of 5 and 12-lipoxygenase products by 
nordihydroguaiaretic acid (NDGA).
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Fig. 5.16. Effect of indomethacin and
nordihydroguaiaretic on the log concentration-response 
curve of the rat SCG to adenosine.
The response to adenosine (AD, 2 minutes applciation) 
was recorded in the absence and presence of lOuM 
indomethacin (INDO) and then lOuM INDO + 50uM 
nordihydroguairaretic acid (NDGA). The statistical 
significance was determined by paired t-tests with 
respect to control responses and is
for INDO vs. INDO + NDGA.
A stock solution of indomethacin was freshly prepared 
for each experiment and used within 4 hours. This 
stock solution contained indomethacin, lOmg and 
anhydrous sodium carbonate 5mg dissolved into 10ml 
distilled water and diluted to achieve a final 
concentration of lOuM INDO in PSS.
controls vs. INDO and
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CHAPTER SIX
CHARACTERISATION OF THE PURINOCEPTORS OF THE RAT SCG
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CHARACTERISATION OF THE PURINOCEPTORS OF THE RAT SCG
The classification of purine receptors, for the PI 
receptor has been mainly based on the relative order of 
potency of adenosine and its analogues, and for the P2 
receptor on the order of potency of ATP analogues (Chapter 
One, table 1). By themselves these results are not 
conclusive evidence for the existence of two separate 
receptors and need to be substantiated by the study of the 
effects of selective antagonists on these responses,
6•1 Characterisation of the purinoceptors of the rat SCG
To discover if the rat SCG contains P2-purinoceptors, the 
effects of ATP were compared to slowly degradable 
analogues of ATP, namely alpha, beta-methylene ATP 
MeATP) and beta, gamma-methylene ATP and a relatively 
selective P2 purinoceptor agonist, 2 methylthio-ATP (2MeS- 
ATP). In addition the effect of 8PT on the responses to 
ATP and , Jf-MeATP were examined.
6.1.1 The effect of ATP on the d.c. potential of the 
rat SCG
ATP produced small and often insignificant changes in the
d.c. potential unless the responses to ATP were recorded 
from ganglia bathed in low K+/Ca^+ PSS (Fig. 6.1). In low 
K+/Ca^+ PSS, ATP produced concentration-dependent 
hyperpolarisations, however the response to other agonists 
including adenosine and carbachol were also enhanced.
It has been proposed that some of the effects of ATP are 
mediated by adenosine due to the enzymatic (5*-nucleo- 
tidase) hydrolysis of the nucleotide (Bruns, 1980b; 
Zimmermann, Grondal & Keller, 1985) e.g. in the central 
nervous system many effects of nucleotides are antagonised
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by methylxanthine analogues and there is little evidence 
for the presence of P2-purinoceptors in the hippocampus 
(Stone & Cusack, 1989). The lower potency of ATP compared 
to adenosine on the rat SCG may be indicative of the 
degradation of ATP to adenosine or may reflect other 
factors such as differences in the efficacy of numbers of 
receptors on the ganglion.
6.1.2 Effect of 8-phenyltheophylline on the response 
to ATP and beta,gamma-MeATP
The ability of 8PT to antagonise the hyperpolarisation of 
the ganglion by ATP (Figs. 6.1 and 6.2; table 6.1) and 
convert the response into a depolarisation suggests ATP 
may hyperpolarise and depolarise the rat SCG via PI- and 
P2-purinoceptors respectively. The former action would be 
predicted to occur if ATP was metabolised to adenosine and 
subsequently activates adenosine-receptors. The opposing 
nature of the PI- and P2-purinoceptor mediated responses 
to ATP (Fig. 6.1) may thus account for the relatively 
lower potency of ATP compared to adenosine (Fig. 6.3).
The ability of ATP to depolarise sympathetic ganglia has 
also been observed by two different research groups led by 
Siggins and by Akasu (Siggins, Gruol, Padjen & Forman, 
1977; Akasu, Hirai & Koketsu, 1981). In contrast Brown 
and colleagues reported ATP hyperpolarised the rat SCG by 
upto 150uV in a PSS very similar to normal PSS used in 
this study (see Figures 5a & b, Brown et al., 1979). It 
is possible that the larger hyperpolarisations reported by 
Brown & colleagues occurred because of the storage of 
ganglia at 4°C overnight, resulting in a loss of 
sensitivity to the P2-purinoceptor mediated 
depolarisation. A similar phenomenon was reported by 
Brown & Caulfield (1979) for the absence of the
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depolarisation to isoprenaline by rat SCG stored overnight 
at 4°C.
In low K+/Ca^+ PSS, the P2x-purinoceptor agonist^ ,^-MeATP 
produced concentration related hyperpolarisations.
Because of the likelihood of degradation of^jlJ-MeATP to 
adenosine (Cusack, Hourani & Welford, 1988), the effect of 
8PT on the response to p ,)f-MeATP was examined. 8PT 
produced a parallel rightward shift in the concentration- 
response curve over the limited concentrations of^3,}{- 
MeATP tested (Fig. 6.4). Adenosine and ^,^-MeATP probably 
activate the same receptor, i.e. a Pl-purinoceptor as the 
response to £ ,)J-MeATP was clearly antagonised by 8PT. The 
greater CR produced by H  -MeATP in the presence of 8PT 
may simply have arisen from the lower concentration of 
adenosine generated from the degradation of £ ,X“MeATP. 
Alternatively, other mechanisms may be responsible for the 
larger CR, including; (1) the response top ,Jf-MeATP was 
composed of an 8PT sensitive hyperpolarisation and an 8PT 
insensitive depolarisation to^ ,Y"MeATP, and the presence 
of 8PT would then enhance the relative potency of 8PT, 
and/or (2) JJ,)|-MeATP may activate an ATP sensitive Pl- 
purinoceptor (Collis & Pettinger, 1982) or a P3- 
purinoceptor (Westfall, Shinozuka & Bjur, 1990). Further 
investigation of the effects of ^ ,^-MeATP would 
necessitate the use of a greater range of concentrations 
of antagonist to obtain an accurate pA£ value (by the 
method of Arunlakshana & Schild, 1959).
6.1.3 Effect of 2-methylthio-adenosine-5*-triphosphate 
on d.c. potential and response to muscarine
The introduction of 2-substituents on to methylene 
phosphonates enhances their potency on P2-purinoceptors 
(Cusack, Welford & Hourani, 1988) and the effect of a
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relatively selective P2y purinoceptor agonist, 2 methylene 
thio ATP (2MeS-ATP) (Burnstock, Cusack, Hills, Mackenzie & 
Meghj, 1983) on the rat SCG was examined.
Although metabolised by some tissues 2MeS-ATP is a potent 
P2y purinoceptor agonist at nanomolar to low micromolar 
concentrations and the small depolarisations in response 
to lOOuM 2MeS-ATP (Fig. 6.3, c.f. Figures 6.3 & 6.6, 
response of 2MeS-ATP and 0(, ^ -MeATP) suggest there are few 
if any P2y purinoceptors on the rat SCG. The inability of 
lOOuM 2MeS-ATP to alter the response to muscarine (Table 
6.1) supports this view.
Thus the actions of ATP and £ MeATP are most likely to 
occur either due to an action on P2x-purinoceptors or via 
their metabolism to adenosine. Of the nucleotides tested, 
it would be expected thato^,^-MeATP is the most resistant 
to enzymatic hydrolysis to adenosine and does not activate 
Pl-purinoceptors. Support for this hypothesis is provided 
by the lack of antagonism of the response toO(,p-MeATP in 
the presence of 8PT (Fig. 6.6). Given the low potency of 
2MeS-ATP and insensitivity of o£,p-MeATP-mediated 
depolarisations to 8PT, it is suggested that the effect of 
ATP on the ganglion is due to a mixutre of a P2x-mediated 
depolarisation and a Pl-mediated hyperpolarisation.
Further evidence to support this conclusion was obtained 
using suramin P2x-purinoceptor antagonist.
6.1.4 Effect of suramin on the response of the 
ganglion to adenosine, ATP, ^  ,^-MeATP and
MeATP
The classification of P2-purinoceptors is limited by the 
lack of selective competitive antagonists. The 
trypanocide suramin has recently been suggested to be a
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specific antagonist of the P2x-purinoceptor in the mouse 
vas deferens (Dunn & Blakely, 1988) and antagonises the 
effects ofOCj^-MeATP and NANC transmission of the rat vas 
deferens (Mallard, Marshall & Spriggs, 1989). In contrast 
Den Hertog, Nelemans & Van den Akker (1989) reported 
suramin antagonised the relaxation of taenia caeci, an 
effect believed to be mediated by P2y-purinoceptors. Leff 
and colleagues reported that suramin is a slowly 
equilibrating but competitive P2x-receptor antagonist on 
the purinoceptor of the rabbit ear artery (Wood, O'Connor, 
Fear & Leff, 1990). Recently the first report of the 
effects of suramin on non-muscle cells was presented by 
Nakazawa, Fujimori, Takanaka & Inoue (1990) who found 
suramin reversibly and selectively antagonised an ATP- 
receptor operated membrane current of PC12 
phaeochromocytoma cells.
The results of incubation with suramin on the response of 
the rat SCG to ATP and its analogues are shown in figure 
6.7. The ability of suramin to selectively antagonise the 
depolarisation of the rat SCG tood,p-MeATP suggests the 
depolarisation occurs via an activation of P2x- 
purinoceptors. Suramin enhanced the hyperpolarisations to 
ATP and ^  ,Jf-MeATP, indicating the response to ATP and j) ,^ {- 
MeATP comprised of a hyperpolarisation and depolarisation 
the latter of which functionally antagonised the former 
response (see also Fig. 6.1). A tenfold increase in the 
concentration of oC,j}-MeATP to l,000uM in the presence of 
suramin produced a greater response than at lOOuM, 
suggesting the antagonism by suramin was competitive. The 
reason for the enhancement of the hyperpolarisation to 
adenosine in the presence of suramin is unknown but may 
result from an inhibition of the metabolism of adenosine 
as suramin has been reported to inhibit the extracellular 
metabolism of ATP (Hourani & Chown, 1989), or via the
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modulation of the adenosine-receptor G-protein complex 
(Huang, Dehaven, Cheung, Diehl, Dixon & Strader, 1989).
6.1.5 Effect of purine nucleotides on the response to 
muscarine
A postsynaptic interaction between muscarinic receptors 
and purine nucleotides has been reported by Bertrand, 
Chapal, Loubatiers-Mariana (1986) where ATP and ADP were 
synergistic with ACh in increasing the release of insulin 
from the isolated perfused rat pancreas. Unlike Bertrand 
et al. (1986) none of the ATP analogues tested on the rat 
SCG increased the response to muscarine, instead anagloues 
of ATP were inactive or depressed muscarinic responses 
(Table 6.1). The similar potency of ATP and adenosine in 
depressing the response of the rat SCG to muscarine (Fig.
6.5) suggest ATP may activate the same mechanism as 
adenosine to depress the response to muscarine. The 
depression of muscarinic responses may occur via the 
stimulation of P2 purinoceptors by ATP or the degradation 
of ATP to adenosine and activation of PI purinoceptors.
In contrast to the similar potency of adenosine and ATP to 
depress muscarinic responses, the hyperpolarisation to ATP 
(Table 6.1) was considerably less and is consistent with 
the small hyperpolarisations recorded during a two minute 
application of ATP in PSS (Fig. 6.1). Thus the degree of 
hyperpolarisation by an agonist may not directly correlate 
with the extent of depression of the response to 
muscarine. This conclusion is strengthened by the ability 
o f p *  -MeATP to produce significant hyperpolarisations at 
concentrations that did not depress the response to 
muscarine. Both the hyperpolarisation to ATP and the 
depression of muscarinic responses by ATP were reduced in 
the presence of 8PT (Table 6.2) indicating both actions of 
ATP were mediated via Pl-purinoceptors. Consistent with
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this finding is the inability of both the stable ATP 
isos ter OC, jJ-MeATP and 2-MeS-ATP to alter the responses to 
muscarine (Table 6,1) suggesting P2x and P2y purinoceptors 
are not involved in the modulation of muscarine. The 
ability of oC,|}-MeATP to depolarise but not depress the 
muscarinic responses of the rat SCG may arise from the 
depression of Im as Akasu & colleagues have reported that 
ATP strongly depressed Im of frog sympathetic ganglia 
(Akasu & Koketsu, 1982; Akasu, Hirai & Koketsu, 1983a,b; 
Morita, Katayama, Koketsu & Akasu, 1984), although effects 
on gNa or a non-selective effect on cationic channels 
could also occur.
6.1.6 Effect of ATP and B  ^ -MeATP on the responses to
Akasu & colleagues in addition to showing the slow 
depolarisation of bullfrog sympathetic spinal ganglion 
cells in response to ATP was via an inactivation of gK, it 
was discovered that ATP augmented the responses to GABA 
(Morita et al., 1984). The effect of GABA on the rat SCG 
is complex and the depolarising action of GABA occurs 
with an accumulation of [K+ ]0 and an increase in gCl“ and 
an outward movement of Cl“ (Ballanyi & Grafe, 1985). The 
ability of^,tf-MeATP to potentiate the response of the rat 
SCG to GABA (Table 6.1) may arise from a potentiation of 
the chloride efflux as reported by Ferrero & Frischknecht 
(1983) or may be due to a change in the GABA-receptor ion 
channel complex as described for bullfrog ganglia by 
Morita et al (1984).
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6.1,7 Summary of effects of ATP and its analogues on 
the rat SCG
Ideally a study of the P2 purinoceptors of the rat SCG 
should be performed using stable nucleotides that are not 
hydrolysed to adenosine, such as those synthesised and 
tested by Cusack on both peripheral (Cusack & Hourani,
1984) and central neurones (Stone & Cusack, 1989).
However, these analogues were unavailable and the effects 
of ATP were compared to the slowly degradable analogues of 
ATP, o6,^-MeATP and p,)(-MeATP (Moody & Burnstock, 1982).
The results of this study were complicated by the 
hyperpolarisation of the ganglion by ATP and its analogue 
via Pl-purinoceptors, but the potency of producing a 
depolarisation indicates a predominance of P2x- 
purinoceptors rather than P2y-purinoceptors on the rat 
SCG.
6.2 The Classification of the Adenosine Receptors of the 
Rat SCG
The 5* and N6 substituted analogues of adenosine were used 
to classify adenosine receptors in to Al and A2 subtypes 
by Van Calker et al. (1979) and Londos et al. (1980).
More recently the relative potency of N6-substituted 
adenosine analogues as agonists was examined in a variety 
of tissues (Daly, Padgett, Thompson, Kosachi, Bugni & 
Olsson, 1986; Ukena, Olsson & Daly, 1987) and it was 
proposed on the basis of these binding studies that out of 
145 analogues, 31 compounds might be useful in classifying 
the adenosine receptor, and a further subset of 7 
analogues, namely 5'-N-ethylcarboxamideadenosine (NECA) 
and it's N6-cyclohexyl derivative, cyclohexyladenosine 
(CHA), R or S-N^-phenylisopropyladenosine (R-PIA and S- 
PIA), 2CA and phenylaminoadenosine (PAA) might be
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particularly valuable for use in functional studies. This 
study has employed these compounds and some other agonists 
and antagonists that are reported to show selectivity for 
Al- and A2-adenosine receptor subtypes. Both the order of 
potency of agonists to hyperpolarise and depress the 
response of the rat SCG to muscarine was used to determine 
the Pl-purinoceptor subtype of the ganglion.
6.2.1 The potency of adenosine and its analogues on 
the d.c. potential of the SCG
Adenosine and its analogues hyperpolarised the ganglion in 
a concentration-dependent manner. The response to 
analogues of adenosine developed more slowly than the 
response to adenosine and were maximal within two minutes. 
The adenosine receptor responsible for the 
hyperpolarisation of the rat SCG appears to be an Al- 
adenosine receptor. This conclusion is based on the 
following observations.
The order of potency to hyperpolarise the ganglion was 
firstly the selective Al agonist cyclopentyladenosine 
(CPA) (Bruns et al., 1986) which was 5 fold more potent 
than 2CA, an agonist with equal affinity for Al and A2 
receptors: about 80 fold more potent than adenosine and 
140 times more potent than PAA, a selective A2 agonist 
(Fig. 6.8, Table 6.3). In PSS the maximal response to PAA 
was considerably less than that for other agonists and 
lOOuM the hyperpolarisation to PAA was not altered by 
increasing the application time to 5 minutes. The low 
potency of both PAA and PD 117,413 (N^-(9-fluorenyl- 
methyl)adenosine) a potent A2-adenosine receptor agonist 
(Trivedi, Bristol, Bruno, Haleen, & Steffen, 1988) 
indicates functionally active A2-adenosine receptors do 
not alter the d.c. level of the rat SCG.
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The potency of adenosine is likely to have been 
underestimated because of tissue uptake and metabolism.
If 2CA and adenosine have similar affinities as has been 
predicted by Bruns et al. (1986), who suggested 2CA is a 
good substitute for adenosine under conditions where 
breakdown of adenosine is a problem; then a purely 
additive effect of inhibition of uptake and metabolism by 
ADA may not account for the higher potency of 2CA verses 
adenosine. However, uptake and deamination may not be the 
only mechanisms for the inactivation of adenosine and/or 
their combined effects may be supra-additive.
Purines may have multiple actions on some preparations and 
there are several examples of biphasic responses to ATP 
e.g. the contractile response of the vas deferens (Fedan 
et al., 1982a,b, 1986), smooth muscle cells in culture 
(Molleman et al., 1989) and a curious feature of the log 
concentration-response curves to adenosine analogues 
shared a reduced response at higher agonist concentrations 
(e.g. Figs. 6.5, 6.8 and 6.11) and are similar to the 
findings of Henon & McAfee, 1983a; see Figs. 2 and 7). It 
is possible that high concentrations of adenosine may 
disturb the balance between endogenous purine metabolites 
(Stone, 1981). However the inhibition of uptake (Chapter 
3; Henon & McAfee, 1983a, Fig. 7) or deamination (Chapter 
3) did not dramatically alter the maximal effects of 
adenosine suggesting the reduced response to adenosine is 
not due to the increased metabolism of adenosine. One 
possibility suggested by Henon & McAfee (1983a) was that 
more than one adenosine receptor subtype is present on the 
ganglion. Thus an opposing inhibitory response may occur 
at high concentrations of adenosine and its analogues to 
activate A2-adenosine receptors and this could account for 
the "bell-shaped" agonists concentration-response curves 
obtained (Figs. 6.8 and 6.10). Such an effect, i.e. 
functional antagonism has been reported for the effects of
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submicromolar concentrations of CHA to inhibit renin 
secretion and higher (micromolar) concentrations of CHA 
stimulate secretion (Churchill, Jacobson & Churchill,
1987), However, the low potency of PAA and inability of 
lOOuM, PD 117,413 to depress the response to muscarine 
does not support this hypothesis.
NECA is about equipotent on Al and A2 receptors (table
6.5) and if the depression of muscarine is mediated by 
both Al and A2 receptors, it would be expected that the 
maximal depression of muscarine would be greater for 
compounds that are equipotent on A2 and Al receptors. It 
seems unlikely that A2 receptors increase the response to 
muscarine as the two selective A2 agonists, PAA and PD 
117,413, depressed or did not significantly alter the 
response to muscarine (Fig. 6.10).
It is unlikely that the adenosine receptors of the rat SCG 
were desensitised by high concentrations of adenosine 
(>100uM) as they were not altered by increasing the 
interval between applications (20 to 60 minutes) or the 
application time from 2 to 5 minutes for adenosine. An 
alternative explanation that would explain the bell-shaped 
concentration response curves for the hyperpolarisation of 
the ganglion and depression of the response to muscarine 
by purines, would be if these purines activate a single 
receptor subtype, but stimulate different affinity states 
of the receptor at various concentrations of agonist.
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Multiple affinity states of a single receptor subtype and 
different receptor coupling for these states have been 
described for both the muscarinic receptor (Birdsall & 
Burgen, 1979) and adenosine receptors (Lohse et al., 1984; 
Marangos et al., 1983, 1984, 1987; Patel et al., 1982; 
Nakata & Fuijisawa, 1983; Dunwiddie & Fredholm, 1984), and 
these receptors may be present on the rat SCG preparation.
6.2.2 The effect of 5 1-deoxy-51-methylthioadenosine on 
the d.c. potential of the SCG
5*-Deoxy-5*-methylthio adenosine (MTA) is an agonist of Al 
receptors of the rat cerebellum and a competitive 
antagonist of A2 receptor mediated stimulation of 
fibroblasts (Bruns, 1980) and neuroblastoma adenylate 
cyclase (Munshi, Clanachan & Baer, 1988). MTA was a weak 
agonist on Al receptors and an A2 adenosine receptor 
antagonist on the isolated rabbit jejunum (Munshi et al., 
1988). On the rat SCG in normal PSS or low K+/Ca^+ PSS, 
MTA was less potent than adenosine and produced a 
shallower concentration-response curve (Fig. 6.9). The 
weak agonist effect of MTA could result from the 
metabolism of the nucleotide due to the action of MTA 
phosphorylase to form adenine which would be expected to 
be inactive on the adenosine receptors of the rat SCG.
The metabolism of MTA via uptake to deamination is 
unlikely as MTA did not bind to uptake sites in the 
cerebellum and is resistant to ADA (Munshi et al., 1988). 
Alternatively, Bruns (1980) has reported that 
modifications to the 5'-position of nucleotides had 
drastic effects on both the affinity and efficacy of 
binding to adenosine receptors. The low potency and low 
efficacy of MTA on the rat SCG may thus result from 
metabolism and/or via low affinity of MTA for the 
adenosine receptor. The substituion of the oxygen at the 
5*-position with sulphur may reduce the affinity of MTA
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for the adenosine receptor of the rat SCG as has been 
reported for the loss of substrate specificity for ADA, 
adenosine kinase, S-adenonyl-homocysteine hydrolase, where 
MTA does not substitute for adenosine as a substrate 
(Carrera, Willis, Chilcote, Kubota & Carson, 1988; 
personal communication J. Duley).
The order of potency for hyperpolarising the rat SCG;
CPA > 2CA > AD > PAA > PD 117,413
is consistent with the classification of the adenosine 
receptors responsible for the hyperpolarisation of the 
ganglion as a Pl-purinoceptor of the Al-adenosine receptor 
subtype.
6.2.3 The potency of adenosine and its analogues to 
depress the response of the SCG to muscarine
The response to muscarine was reduced in a concentration- 
dependent manner by adenosine and all adenosine analogues 
tested except for PD 117,413 which was inactive at upto 
lOOuM (Fig. 6.10; see also Figures 6.11 & 6.12). The 
evidence for a depression of muscarine responses by 
adenosine receptors of the Al-subtype is based upon the 
following observations.
In binding studies it has been found that N^-Benzyl- 
adenosine (BZA) shows little selectivity for Al or A2 
receptors and has similar physio-chemical properties to 
CPA (Bruns et al., 1986; Bridges et al., 1988). Therefore 
in functional studies it would be predicted that in tissue 
containing predominantly Al recpetors, CPA would be 
considerably more potent than BZA and about equipotent for 
a preparation containing predominantly A2-adenosine
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receptors. An examination of figure 6.10 and table 6.4 
shows that both CPA and BZA produced equivalent and large 
depressions of muscarine and a CR of 0.002, indicating CPA 
was 500 fold more potent than BZA, and the adenosine 
receptor induced depression of muscarine is mediated via 
an action on the Al receptor subtype.
Al and A2 receptors have been reported to differ in their 
stereoselectivity with respect to the isomers of PIA, with 
the A1 receptor having a 40 to 100 fold preference for the 
R over the S diastereo-isomer and the A2 receptor 
exhibiting only a 5 fold preference for the R-isomer 
(Smellie, Daly, Dunwiddie & Hoffer, 1979; Bruns, 1980; 
Bruns, Daly & Snyder, 1980). For the rat SCG, the S- 
isomer of PIA was less potent with a R/S potency ratio of 
about 5 (Fig. 6.11), suggesting the presence of A2 
receptors. However a R/S potency ratio of 11 has been 
reported for Al receptors by Trost & Schwabe (1981), and 
an R/S ratio of 15 was reported for the A2a high affinity 
receptor, and is intermediate between the classically 
accepted ratios for Al and A2 sites. Likewise for rat 
liver preparations the rank order was clearly Al but the 
R/S ratio was only 1.7 (Schutz, Tuisl & Kraupp, 1982). 
Stone (1989) has shown "the R/S ratio spans a very wide 
and arguably quite meaningless range". As more tissues 
have been studied and concluded to contain Al or A2 
receptors; the range of the R/S ratios reported has become 
broader and although the ratio is still used by some 
researchers (Paton, 1988), others have concluded that this 
ratio is probably not a reliable criterion for the sub­
classification of adenosine receptors (see Bruns et al., 
1986; Stone, 1989).
In an A2 adenosine receptor binding study Bruns and 
colleagues (Bruns et al., 1986) found PAA possesses about 
10,000 fold selectivity for the high affinity A2 receptor
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(A2a) over the low affinity A2 receptor (A2b). The low 
potency of PAA (Figs. 6.8 and 6.10) is indicative of the 
absence or low efficacy of A2 receptors on the rat SCG. 
Likewise it seems unlikely that A2 receptors increase the 
response to muscarine as the two selective A2 agonists,
PAA and PD 117,413, depressed or did not significantly 
alter the response to muscarine (Fig. 6.10).
Three agonists, 2CA, NECA and BZA, which are reported to 
bind to Al and A2a receptors with approximately equal 
affinity (Table 6.5) were less efficacious or had a 
similar efficacy for depressing the response to muscarine 
(Figs. 6.10 & 6.12), compared to CPA suggesting the 
depression of muscarinic responses is not mediated by A2 
receptors, as it would be expected that the maximal 
depression of muscarine would be greater for agonists that 
are equi-active on both Al and A2-adenosine receptors.
The hyperpolarisation produced by adenosine analogues was 
slow to develop and may arise from their highly lipophilic 
nature, resulting in slow equilibration with_ neuronal tissue 
(Dunwiddie & Fredholm, 1984). It has been reported that 
PIA is a more lipid-soluble compound than NECA, and this 
may account for its greater potency on many isolated 
tissues and its reduced potency in vivo (Fastbom, Post & 
Fredholm, 1990). It is evident from table 6.4 that the 
potency of NECA was intermediate between that of R-PIA and 
S-PIA, and as stereoisomers have the same physiochemical 
properties a difference in lipid solubility is unlikely to 
account for the reported potency order. If differences in 
lipid solubility are responsible for the differneces in 
the maximal depression of muscarine, then they should be a 
good correlation between logarithm partition coefficient 
(log P) and the maximal depression of muscarine. Both 
NECA, R- and S-PIA were of a similar efficacy on the rat 
SCG suggesting these compounds function in a similar
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manner and the greater potency of R-PIA relative to NECA 
is indicative of the presence of Al receptors on the rat 
SCG.
Lipophilicity has been found to be an essential factor 
governing potency of all kinds of CNS agents. Often the 
correlations obtained for potency versus log P show a 
parabolic nature with an optimum lipophilicity near 2 +
0.3 and this is the ideal log lipophilic character in a 
neutral molecule for passive penetration into the CNS 
(Gupta, 1989). The hydrophobicity of a compound is 
related not only to in vivo penetration and distribution 
but also to the interaction with receptor sites, which 
will increase the binding of adenosine derivatives to its 
receptor. CPA and benzyladenosine (BZA) were the most 
efficacious at depressing the response of the ganglia to 
muscarine and have a similar log P value of about 1.6. It 
is postulated that the adenosine receptor of the SCG may 
be optimally activated by compounds with a log P value of 
about 1.6. However, many other factors, such as the 
ability to form hydrogen bonds, charge distribution and 
polarisability may affect the binding of ligands to the 
adenosine receptor.
From the results presented in table 6.4 and figures 6.10, 
6.11 and 6.12, the rank order of potency for the 
depression of muscarinic responses by adenosine and its 
analogues was:-
CPA > R-PIA = 2CA > NECA > S-PIA > BZA > AD > PAA > PD 117,413
The relative order of potency for the depression of 
muscarinic responses by adenosine and adenosine analogues 
is similar to the potency series for the hyperpolarisation 
of the ganglion, suggesting the same receptor subtype is 
responsible for both effects.
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The potency for the depression of muscarinic responses by 
purines was about 10 fold higher than that reported for 
the inhibition of Ii((Ca) of the rat SCG (Henon & McAfee, 
1983a) suggesting these events may be mediated by two 
different mechanisms or adenosine receptors.
Both the relative order of potency for the 
hyperpolarisation and the depression of the response to 
muscarine are indicative of the involvement of an Al- 
adenosine receptor. Likewise the absolute potencies of 
adenosine agonists is consistent with those published for 
the Al-adenosine receptor in other systems (Daly, 1982; 
Burnstock & Buckley, 1985; Williams, 1989),
6,3 Correlation of the depression of muscarinic responses 
and the inhibition of binding of adenosine to rat 
brain membranes
Using the extensive and elegant binding data presented by 
Bruns and colleagues for the inhibition of the binding of 
[%]-CHA to rat brain and [%]-NECA to rat striatal 
membranes (Bruns et al., 1986) various studies have found 
good correlations between the binding of agonists and the 
effects studied, e.g. Fig. 6.13 shows the correlation 
obtained from a scatter diagram of the IC^q for the 
depression of the response of the rat SCG to muscarine by 
adenosine analogues and the inhibition of the binding of 
these analogues to rat brain membranes (Bruns et al.,
1986). There was a good correlation for the effects of 
adenosine and its analogues on the rat SCG and the binding 
to Al-receptors (Fig. 6.13) but a poor correlation of the 
former values and the inhibition of binding to A2- 
receptors supporting the hypothesis that the adenosine 
receptors of the rat SCG are of the Al-subtype.
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6•4 Effect of purinoceptor antagonists on the effects of
adenosine
To examine the actions of adenosine in more detail and 
establish a pA£ for the adenosine receptor antagonist and 
the effects of selective Al and A2 antagonists were 
studied.
6.4.1 The effect of pentobarbitone on the response to 
adenosine
It has been proposed that barbiturates might be adenosine 
receptor antagonists based on the ability of barbiturates 
to displace [3H]-PIA and 1 ,3-diethyl-8-[3H]-phenylxanthine 
([3H]-DPX) binding of rat brain synaptosomal membranes 
(Lohse, Lenschow & Schwabe, 1984). Further work by Lohse 
and colleagues supported this view and pentobarbitone 
inhibited in a competitive manner [3H]-PIA binding to 
solubilised Al-adenosine receptors with a Ki of around 
90uM (Lohse, Klotz, Jakobs & Schwabe, 1985; Lohse, Boser, 
Klotz & Schwabe, 1987) without any agonist activity.
The ability of pentobarbitone to enhance the response of 
the rat SCG to GABA (Little, 1987) was confirmed (Table 
6.6, Fig. 6.14a) although the response to adenosine in 
50uM or lOOuM pentobarbitone was unaltered (Table 6.6,
Fig. 6.14a,b) suggesting the adenosine receptor of the rat 
SCG may not be subject to modulation by barbiturates. 
Recently Stone (1988) examined the actions of three anti­
convulsants on the response of rat hippocampal slices to 
adenosine; carbamazepine (>20uM) reduced the inhibitory 
response to adenosine, whereas chlormethiazole and 
pentobarbitone were without effect.
The reason for the difference between the functional 
studies reported here and by Stone (1988), and the binding
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studies of Lohse and colleagues (1984, 1985, 1987) is 
unknown. However, it has been reported that another 
barbiturate phenobarbitone did not alter the binding of 
PIA and CHA to brain membranes (Skerritt, Davies & 
Johnston, 1982; Weir, Padgett, Daly & Anderson, 1984). 
Further studies of the effects of phenobarbitone and 
pentobarbitone will be required to see if, as suggested by 
Stone (1988) the results obtained by Lohse and colleagues 
(1984, 1985, 1987) are unique to their experimental 
preparation or reflect a difference between the two 
barbiturates studied.
6.4.2 Effect of methylxanthines on the response to 
muscarine, adenosine and the depression of 
muscarinic responses by purines
To examine if the responses to adenosine are due to an 
action on external Pl-purinoceptors, the effects of 
adenosine on the d.c. potential, response to muscarine and 
the depression of muscarinic responses by adenosine and 
ATP were examined in the absence and presence of purine 
receptor antagonists, i.e. theophylline (THEO) and 8- 
phenyltheophylline (8PT), and the results summarised in 
table 6.2.
Both theophylline and 8PT have been used to show the 
effects of purines are mediated by an action on Pl- 
purinoceptors and the ability of theophylline or 8PT to 
antagonise both the hyperpolarisation to adenosine and the 
depression of muscarine by adenosine supports this view. 
Likewise the reportedly non membrane permeable analogue of 
theophylline 8-parasulphotheophylline (8psPT) also reduced 
the hyperpolarisation and the depression of muscarine by 
adenosine (Table 6.2), strengthening the view that these
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effects of adenosine are mediated via an external Pl- 
purinoceptor.
It is tempting to postulate that theophylline depolarises 
and reduces the response to muscarine (Table 6.2) via an 
action unrelated to purinoceptor antagonism, e.g. 
inhibition of Im; Hille & colleagues reported that high 
concentrations of caffeine depolarised frog sympathetic 
neurones by suppressing Im via an action on G proteins 
(Pfaffinger, Leibowitz, Subers, Nathanson, Aimers & Hille,
1988). However other sites of action including an 
increase in [Ca^+ ]i and/or PDE inhibition may also occur. 
Interestingly the reduction of muscarinic responses may 
not be restricted to theophylline as Fredholm & Duner- 
Engstrom (1989) found propentofylline reduced the activity 
of muscarinic autoreceptors by an unknown mechanism and 
these results may represent a general effect of 
methylxanthines on muscarinic responses.
In contrast the more selective purinoceptor antagonist 
8PT, which may have some PDE inhibitory activity at lOuM 
did not alter the d.c. potential or the response to 
muscarine suggesting the depolarisation to theophylline is 
unlikely to be due to an antagonism of purinoceptors.
These results also indicate that there was no detectable 
endogenous release of adenosine from the rat SCG.
6.4.2.1 Effect of 8PT on the hyperpolarisations of the 
rat SCG to adenosine
The ability of 8PT to produce parallel and rightwards 
shift the concentration response curve to adenosine and 
for adenosine to produce a similar maximal response in the 
presence of 8PT (Fig. 6.15) suggests 8PT competitively 
antagonised the adenosine mediated hyperpolarisation of 
the rat SCG. Substituting the concentration ratios (CR)
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obtained at the EC^q values for adenosine in the absence 
and presence of 8PT into the Schild equation (Arunlakshana 
& Schild, 1959, equation (1)),
pA2 = log (CR-1) - log [8PT]
where [8PT] is the molar concentration of 8PT, pAo is the 
negative logarithm of the concentration of antagonist 
which shifts the agonist concentration-response curve two 
fold to the right.
From the CR derived from the data presented in figure 6.16 
the calculated mean pA2 value were 6.44 + 0.09 (n=3) and 
5.68 + 0.12 (n=7) for 8PT and luM and lOuM respectively.
Other researchers have studied the antagonistic potency of 
8PT in isolated tissue preparations and pA2 values of 
between 6.1 to 6.6 have been reported. Collis and 
colleagues reported pA2 values of 6.39 to 6.6 for the 
purinoceptors of the guinea-pig atrium and aorta (Collis & 
Pettinger, 1982). Stone (1985) reported pA2 values for 
8PT against adenosine and ,Jf-MeATP of 6.08 and 6.36 
respectively (not significantly different from each other) 
for the rat vas deferens. Likewise pA2 values of 6.46 and
6.5 were reported for 8PT as an antagonist of the 
purinoceptors of cat cerebral arteries and guinea-pig 
trachea (Edvinson & Fredholm, 1983; Farmer, Canning & 
Wilkins, 1988 respectively). The mean pA2 for antagonism 
of the hyperpolarisation of the ganglion by adenosine by 
8PT was in broad agreement with the values obtained by 
other researchers cited above. The ability of the 
ganglion to transport adenosine (Chapter 3; Henon &
McAfee, 1983a) may have decreased the apparent potency of 
8PT, i.e. at lOuM 8PT (Clanachan & Muller, 1980). 
Confirmation of the presence of Pl-purinoceptor would be 
best established by the use of a non-metabolised analogue
250
of adenosine. The present results however, are consistent 
with the presence of Pl-purinoceptors on the rat SCG.
6.4.2.2 Effect of 8PT on the depression of the response 
to muscarine by adenosine and CPA
In order to determine if the receptors responsible for the 
depression of the response to muscarine are the same as 
those receptors responsible for the hyperpolarisation of 
the ganglion the effect of 8PT on these responses were 
examined. The time necessary for these experiments made 
it impractical to construct detailed concentration- 
response curves before and after the antagonist. 
Consequently, CR's were determined at the level of 20% 
depression of the response to muscarine, i.e. 
approximately the IC^q level. The pA£ value for 8PT was 
calculated using the equation described (section 6.4.2.1) 
assuming the antagonist was competitive. 8PT antagonised 
the depression of muscarinic responses by adenosine (Fig. 
6.16, Table 6.2), CPA (Fig. 6.17) and 2CA (Table 6.2).
The pA2 values for 8PT*s antagonism of the depression of 
the response to muscarine by CPA were estimated to be 6.45 
and 6.75 at luM and lOuM respectively. These results are 
consistent with an action of adenosine, 2CA and CPA on Pl- 
purinoceptors to depress the response to muscarine.
The ineffectiveness of adenosine-receptor antagonists on 
the response to muscarine alone suggests that endogenous 
adenosine does not contribute to the response to 
muscarine.
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6,4.3 The effect of 3,7-dimethy1-1-propargylxanthine
(DMPX) on the depression of muscarine by CPA and 
the response of the rat SCG to adenosine, CPA 
and PAA
It is not possible to define the adenosine subtype by 
using 8PT as although 8PT is a competitive PI purinoceptor 
antagonist, it does not show any selectivity for Al and A2 
adenosine receptor subtypes (Collis, Palmer & Saville,
1985). In order to discover if the adenosine receptors 
responsible for the effects of adenosine and its analogues 
are of the A2-adenosine receptor subtype the effects of 
DMPX, an analogue of caffenine, were studied. DMPX has 
both good in vitro (Daly, Padgett & Shamim, 1986; Ukena, 
Shamim, Padgett & Daly, 1986) and in vivo (Seale, Abla, 
Shamim, Carney & Daly, 1988) selectivity for A2-adenosine 
receptors, compared to Al-adenosine receptors, was 
investigated on the response of the rat SCG to adenosine, 
CPA and PAA, and the depression of the response to 
muscarine by CPA.
Daly & colleagues (Daly et al., 1986) reported the Ki for 
the inhibition of CHA binding to the Al-adenosine receptor 
of the rat cerebral cortex was 6uM. DMPX at a 
concentration of upto 50uM had no effect on the response 
of the rat SCG to adenosine and its analogues (Table 
6.7a,b; Fig. 6.18) or the depression of muscarinic 
responses by CPA (Table 6.7a) and on the basis of these 
results it suggested that A2-adenosine receptors are not 
involved in these responses.
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6.4.4 Effect of 8-cyclopentyl-lt3-dipropylxanthine 
(DPCPX) on the depression of muscarinic 
responses by CPA and the response to adenosine 
and its analogues
DPCPX competitively antagonised both the inhibition of 
adenylate cyclase activity via Al-adenosine receptors and 
the stimulation via A2-adenosine receptors (Lohse, Klotz, 
Lindenborn-Fotinos, Reddington, Schwabe & Olsson, 1987). 
The Ki-values of this antagonism were 0.45nM at the Al- 
receptor of fat cells, and 330nM at the A2 receptor of 
human platelets, giving a more than 700-fold Al 
selectivity. A similar Al-selectivity was determined in 
radioligand binding studies (Lohse et al., 1987; Bruns, 
Fergus, Badger, Bristol, Santay, Hartman, Hays & Huang,
1987) and 150 fold Al selectivity was reported by 
Martinson, Johnson & Wells (1986). DPCPX has been used as 
a pharmacological tool to demonstrated the effects of 
adenosine receptor agonists are mediated by Al-adenosine 
receptors in a number of studies including the negative 
chronotropic activity of R-PIA on the heart (Haleen, 
Steffen & Hamilton, 1987) and the detection of Al- 
receptors in tissues with very low receptor density (Lohse 
et al., 1987).
6.4.4.1 The effect of DPCPX on the response to adenosine
and its analogues
The actions of CPA, NECA, adenosine and PAA were reduced 
in the presence of InM DPCPX (Fig. 6.19). The ability of 
DPCPX to antagonise the hyperpolarisation to PAA and 
convert it into a small depolarisation suggests the 
response to PAA may be combination of an Al-adenosine 
receptor receptor mediated hyperpolarisation and an A2- 
adenosine receptor mediated depolarisation. The pA2
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values for CPA and adenosine in DPCPX (InM) were 
calculated to be 9.95 and 9.61 respectively suggesting CPA 
and AD hyperpolarise the ganglion via or action on Al- 
adenosine receptors.
6.4.4.2 The effect of DPCPX on the depression of the 
response to muscarine by CPA
CPA produced concentration dependent depression of the 
response to muscarine and increasing concentrations of 
DPCPX produced a progressive inhibition of this depression 
(Fig. 6.20). To avoid high concentrations of agonist 
which could potentially have an effect on other types of 
adenosine receptor the effect of low concentrations of 
DPCPX were studied. DPCPX at O.lnM did not significantly 
alter the depression of muscarinic responses by CPA (Fig. 
6.20a). In both 0.5 and InM DPCPX the maximal depression 
of the response muscarine by CPA was reduced indicating a 
non-competitive antagonism of the effects of CPA by DPCPX 
and that CPA inhibits muscarinic responses via an action 
on Al-adenosine receptors (Fig. 6.20b,c).
6.4.4.3 The effect of DPCPX on the concentration 
response curves to adenosine and CPA
A more detailed study of the concentration-dependent 
hyperpolarisations to adenosine, showed adenosine produced 
reproducible concentration dependent hyperpolarisations 
(Fig. 6.18a). However in the presence of increasing 
concentrations of DPCPX, the concentration-response curves 
to adenosine were displaced to the right in a non-parallel 
manner (Fig. 6.21b,c,d). Figure 6.22 illustrates a 
typical experiment showing the depression of the 
hyperpolarisation to increasing concentrations of
254
adenosine by 0.6 and 0.9nM DPCPX. High concentrations of 
adenosine produced an initial rapid hyperpolarisation 
followed by a smaller more sustained hyperpolarisation,
e.g. 300 or l,000uM adenosine in Figure 6.22. Both the 
initial rapid and the more sustained hyperpolarisations 
were equally reduced in the presence of DPCPX. The non­
competitive nature of the antagonism by DPCPX was not 
restricted to the antagonism of adenosine, as figure 6.23 
illustrates the effect of DPCPX on the hyperpolarisations 
to CPA were also non-parallel. When the responses to CPA 
in DPCPX were normalised and expressed as a % of the 
maximal response to each control curve, apparent PA2*- 
values of 9.37, 9.56 and 9.70 were obtained for 0.3, 0.5 
and 0.9nM DPCPX respectively. The mean pA2 value of 9.54 
+ 0 . 1  indicates an apparent affinity of 0.3nM for the 
adenosine receptor of the rat SCG, a value consistent with 
the involvement of Al-adenosine receptors (Kd < 0.5nM 
Bruns et al., 1987; Lohse et al., 1987; Kiotz, Lohse, 
Schawbe, Cristalli, Vittori & Grifantini, 1989). Likewise 
a Ki of 0.45nM was reported for DPCPX for the Al-receptor 
of the rat hippocampus (Sebastiao, Stone & Ribeiro, 1990).
One factor that may have influenced the concentration- 
response curve to adenosine and its antagonism is the 
[Ca^+ ]e. It has been shown that a reduction in [Ca^+ ]e 
can alter the affinity of receptors for their agonist 
(Dougall & Leff, 1987) and hence may affect the affinity 
of the adenosine receptor of the rat SCG to adenosine. In 
2.5mM Ca^+ PSS, DPCPX produced a ’non-competitive* 
antagonism of the hyperpolarisations to adenosine (Fig. 
6.20a) suggesting low calcium does not alter the affinity 
of DPCPX for the adenosine receptor (cf 6.21a,b).
It is unlikely that the non-competitive actions of DPCPX 
recorded on the rat SCG are due to the inhibition of 
cyclic nucleotide phosphodiesterase as DPCPX at up to
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690nM had very little effect on PDE activity producing 
about 2% inhibition at 69 and 690nM (Martinson et al.,
1986).
The non-competitive action of DPCPX on the depression of 
muscarine responses by CPA may be due to the nature of the 
"bell-shaped" concentration response curves. Over a 
narrow range of concentrations of DPCPX the antagonism may 
appear competitive. Higher concentrations of DPCPX may then 
reduce the maximal inhibition achieved by CPA and DPCPX 
would thus appear to be a non-competitive antagonist.
This phenonomenon would also explain the non­
competitive antagonism of the hyperpolarisations to 
adenosine or CPA.
Often the low potency of purines on isolated tissues 
compared to the potency on purified rat brain receptor 
membrane preparations is lower and attributed to the 
'poor' access to the receptor in the isolated tissue. The 
potency of adenosine agonists and antagonists on the rat 
SCG was closely correlated with the reported binding 
affinities (Tables 6.5 and 6.8) suggesting adequate access 
to the adenosine receptors of the ganglion. However it 
has also been reported that nicotine is concentrated 
within SCG neurones (Brown, Halliwell & Scholfield, 1971) 
and likewise it is possible that DPCPX was concentrated 
within SCG neurones. A log P value for DPCPX of 3.6 
(Bruns et al., 1987) may predispose this compound towards 
sequestration into hydrophobic sites (not present in the 
studies of receptor binding) and could lead to an over 
estimation of the apparent potency and apparent non­
competitive antagonism.
Recently the antagonistic profiles of a number of 
substituted xanthines as functional antagonists of the 
responses mediated by adenosine receptors have been
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described (Ribeiro & Sebastiao, 1989; Sebastiao, Stone & 
Ribeiro, 1990). 1,3-dipropyl-8-(4-((2-aminoethyl)amino)- 
carbonylmethyloxyphenyl) xanthine, i.e. XAC, has been 
reported to be more potent on the A2-adenosine receptors 
of human platelets and the A3-adenosine receptors of the 
frog NMJ (Ribeiro & Sebastaio, 1989) than DPCPX, whereas 
DPCPX is more potent than XAC on the Al-adenosine 
receptors of rat brain membranes, fat cells (Ribeiro & 
Sabastiao, 1989) and the rat NMJ and hippocampus 
(Sebastaio et al., 1990). XAC was around ten fold less 
potent than DPCPX (cf Figs 6.21 c & d) indicating the adenosine 
receptors of the rat SCG are Al-adenosine receptors. Interesting XAC 
also produced a "non-parallel" competition of the 
concentration-response curve to adenosine (Fig. 6.21d).
There is evidence to suggest that Al and A2-adenosine 
receptors may be differently affected by temperature 
(Broadley, Broome & Paton, 1985) however the pA2 for XAC 
on the rat hippocampal Al-adenosine receptor was not 
significantly altered by temperature between 22-30°C 
(Sebastiao et al., 1990) suggesting the reduced 
temperature used in these studies, i.e. 25°C may not be a 
critical factor influencing the antagonism of the 
hyperpolarisation to CPA and adenosine by DPCPX or XAC.
There are many mechanisms which may account for the 
biphasic response to adenosine including an action on two 
separate receptors, e.g. Al and another adenosine receptor 
(NB: but not the A2 adenosine receptor - see section 
I 6.4.3). The existence of multiple coupling states which
differ in their affinity for agonists has been described 
for the Al-adenosine receptor (Goodman et al., 1981; Yeung 
& Green, 1983; Lohse et al., 1984; Green, 1984; Bruns et 
al., 1987). CPA preferentially binds to a high affinity 
agonist-preferring coupling state of the Al receptor 
whereas DPCPX labels both coupling states (Bruns et al.,
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1987), Even within the same tissue Marangos & colleagues 
have demonstrated two binding sites for CHA which had 
affinities of 0.4 and 4nM respectively (Marangos et al., 
1984a,b). Thus the ability of DPCPX and XAC to antagonise 
the hyperpolarisations to adenosine and CPA in an 
apparently competitive manner at low concentrations of 
antagonist and in a "non-competitive" manner at higher 
concentrations of antagonist could reflect the existence 
of multiple affinity states of the adenosine receptor.
Another possibility that may explain the effects of DPCPX 
may be that reported by Gurden, Brialla & Kennedy (1987) 
who have questioned the Al-selectivity of DPCPX. DPCPX 
antagonised the effect of adenosine on the guinea-pig 
aorta, a tissue reported to contain A2-adenosine receptors 
(Collis & Brown, 1983) with a similar pA2 value to that of 
the guinea-pig left atria, which contains Al-adenosine 
receptors (Collis, 1983) and had pA£ values of 6.72 and 
7.25 respectively. These pA2 values are closer to the 
range of Kds reported for the A2-adenosine receptors in 
binding assays (Kd, 330-340nM) by Bruns et al., 1987;
Lohse et al., 1987). The pA2 value obtained on the rat 
right atria, an Al-adenosine receptor was significantly 
different from the values obtained for the guinea-pig 
aorta and left atria being 8.74 and is closer to that 
reported for other tissues. This report has yet to be 
confirmed in a more extensive study by these authors or 
repeated by other researchers.
It is interesting that other substituted xanthines 
including (1,3-dipropy1-8-(2-amino-4-chlorophenyl)xanthine 
(PACPX), a potent Al selective adenosine receptor 
antagonist (Bruns et al., 1983; Daly et al., 1985; Schwabe 
et al., 1985) and the triazoloquinazoline, CGS 15943 a 
selective A2-adenosine receptor antagonist (Williams, 
Francis, Ghai, Braunwalder, Psychoyos, Stone & Cash,
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1987a) have both been found to behave competitively in one 
Al or A2 system but non-competitively in other systems 
(Burnstock & Hoyle, 1985; Williams, Ferkany, Jarvis,
Stills & Braunwalder, 1987b). CGS 15943A was a non­
competitive inhibitor of rat brain A2-adenosine receptors 
and a competitive antagonist in peripheral tissues (Ghai, 
Francis, Williams, Zimmerman, Goodman, Hopkins, Cote & 
Dotson, 1987 in Williams et al., 1987a; Farmer, Canning & 
Wilkins, 1988). A similar paradox has been noted for 
PAPCX, which is non-competitive in the Al-adenosine 
receptor driven guinea-pig left atrial model and 
competitive at Al-receptors in brain tissues (Burnstock & 
Hoyle, 1985). It is thus possible that the non­
competitive nature of DPCPX on the response of the rat SCG 
to adenosine and CPA versus the competitive antagonism of 
Al-adenosine receptors of the rat brain, is an example of 
a similar phenomenon.
In conclusion, DPCPX was demonstrated to be a very potent 
antagonist of both the hyperpolarisation to adenosine,
CPA, BZA and the depression of the response to muscarine 
by CPA and BZA. The potency of DPCPX and XAC as 
antagonists of the hyperpolarisation to CPA are comparable 
with their potencies as antagonists on the Al-adenosine 
receptor and not A2 -adenosine receptors. Thus both
the agonist and antagonist profiles for the adenosine 
receptor of the rat SCG are consistent with the presence 
of Al-adenosine receptors in this preparation.
Fig. 6.1. Effect of 8-phenyltheophylline on the
concentration response curve to adenosine-5 1 - 
triphospha te
In normal physiological salt solution (PSS) adenosine- 
51 - triphosphate (ATP) produced small and statistically 
insignificant hyperpolarisations. The response to 
lOOOuM ATP was small and inconsistent on different 
ganglia: two ganglia depolarised by 30 and 50uV, two 
more ganglia hyperpolarised by -10 and -25uV.
Four different ganglia were examined in low potassium 
and low calcium PSS (low K+/Ca^+ PSS), ATP produced 
dose related hyperpolarisations. The response to lOOuM 
ATP was significantly (62 + 870 the response to 
adenosine, n=4, P<0.05) smaller than the 
hyperpolarisation to lOOuM adenosine (-215 + 56uV).
Upon repeating the concentration response curve to ATP 
in the presence of 8-phenyltheophylline (8PT), ATP 
produced concentration dependent depolarisations and 
at 300uM and lOOOuM ATP, a hyperpolarisation appeared 
superimposed on the depolarisation (see Fig. 6.2).
(n=4 for both groups).
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Fig. 6 .2 . Response of a single rat SCG to increasing
concentrations of adenosine-51 - triphosphate in the 
absence and presence of 8-pheny1 theophylline
(A) Response to a two minute application of 1, 10,
100, lOOOuM and repeated response to lOOOuM adenosine­
s' - triphosphate (ATP) in physiological salt solution 
containing 2mM potassium and O.lmM calcium (low K /Caz 
PSS).
(B) Response to two minute applications of 1, 10, 100 
and 1000 ATP repeated in low K+/Ca^+ PSS in the 
presence of lOuM 8-phenyltheophylline (8PT).
In low K+/Ca^+ PSS the response to 300 and lOOOuM ATP 
was complex, consisting of an initial hyper­
polarisation, a transient depolarisation and an after­
depolarisation. There was no sign of desensitisation 
to ATP at up to lOOOuM (Fig. 6.2) and the responses to 
lOOOuM ATP were reproducible with 2 minute applications 
every 30 mins (1st application -113 + 30uV, and 30 
minutes later -129 + 23uV, n=4) (Trace A).
2 59
AT
P+
 
8-
PT
Fig. 6.3. Log concentration-response curves for the 
effect of adenosine, adenosine-5 1 - triphosphate, 
beta,gamma-adenosine-51 - triphosphate and 2-methy1thio- 
adenosine-51 - triphosphate on the isolated rat SCG
Adenosine, adenosine-5*-triphosphate (ATP), beta,gamma 
methylene-adenosine-5*-triphosphate (b,g-MeATP) and 2- 
methy1thio-adenosine-51 - triphosphate (2MeS-ATP) were 
applied in increasing concentrations for 2 minutes, at 
>20 minutes to ganglia perfused with normal 
physiological salt solution.
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Fig. 6.4. Log concentration-response curves for 
adenosine and beta,gamma-methylene-adenosine-5'- 
triphosphate in the absence and presence of 8- 
phenyltheophylline
In low potassium and low calcium physiological salt 
solution (low K+/Ca^+ PSS) both adenosine and 
beta,gamma-methylene-adenosine-51-triphosphate (b,g- 
MeATP) (2 minute applications, minimum of 20 minute 
intervals) produced concentration related 
hyperpolarisations with a maximum response at about one 
millimolar. In the presence of 8-phenyltheophylline 
(8PT) the res ponses to adenosine and b,g-MeATP were 
antagonised and the concentration-response curves 
displaced rightwards.
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Fig. 6.5. Effect of adenosine, beta,gamma-methylene- 
adenosine-5 triphosphate and adenosine-triphosphate on 
the response of rat isolated SCG to muscarine
Adenosine (AD), beta,gamma-methylene-adenosine-51 - 
triphosphate (b,g-MeATP) and adenosine-51 -triphosphate 
(ATP) reduced the response to lOOuM muscarine (1 
minute). However b,g-MeATP only significantly reduced 
the response to muscarine at 30uM (* = P<0.05).
Minimum number of ganglia used, N = 6 for all 
compounds.
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Fig. 6.6. Effect of a l p h a ,beta-methylene ATP on the
d.c. potential of rat isolated SCG
In physiological salt solution (PSS) a two minute 
application of alpha,beta-methylene ATP (a,b-MeATP) 
resulted in a slow depolarisation of ganglia, compared 
to adenosine (2 minutes, lOOuM) which hyperpolarised (- 
70 + 22uV, n=4). The responses to a,b-MeATP were 
enhanced in 2mM K+/0.1mM Ca^+ (low K+/Ca^+ PSS) 
compared to normal PSS, but were not significantly 
altered by the presence of 8-phenyltheophylline (8PT), 
whereas the response to adenosine (-263 + 41uV, n=3) 
was significantly reduced to -50 + 6uV (P<0.05, n=3).
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Fig. 6.7. Effect of suramin on the response of the 
isolated rat SCG to adenosine, adenosine-51- 
triphosphate, a,b-Methylene-ATP and b ,g-Methylene-ATP
In low K+/low Ca^+ physiological salt solution (PSS) 
adenosine (AD), adenosine-51-triphosphate (ATP) and 
b ,g-Methylene-ATP (b,g-MeATP) hyperpolarised and a,b- 
Methylene-ATP (a,b-MeATP) depolarised four ganglia.
The effect of suramin on the response of the ganglion 
to agonists was compared in the presence and absence of 
suramin (300uM) using a paired t-test and the 
significance is indicated by a * for P<0.05.
Note: When the same concentrations of agonists were 
applied in the presence of suramin the 
hyperpolarisations to adenosine and ATP, and the 
depolarisations to a,b-MeATP were significantly 
increased or decreased respectively.
264
co cc o
CL CO 00
2;
D
CO >  <— D
0
Q.
<U
Q.
>>
1
Fig. 6.8. Effect of adenosine and some adenosine
analogues on the d.c. potential of the rat isolated SCG
Hyperpolarisation to two minute applications (minimum 
of 20 minutes between applications) of cyclopentyl 
adenosine (CPA), 2-chloroadenosine (2CA), adenosine, 
phenylamidoadenosine (PAA) and N6-(9H-fluorenylmethy1)- 
adenosine (PD 117,413). Each point represents the mean 
from 6 (2CA) or 3 (other purines) ganglia.
PD 117,413 at up to lOOuM did not significantly alter 
the basal d.c. potential of ganglia tested.
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Fig. 6.9. Comparison of response of rat isolated SCG
to adenosine and 51-methylthioadenosine
The response to both adenosine and 5f- 
methy1thioadenosine (MTA) was tested by applying 2 
minute applications at a minimum of 20 minute 
intervals.
The response to MTA was maximal at lOOuM (i.e. no 
significant difference between responses at 100, 300 or 
lOOOuM, paired t-test, P>0.05, N=4).
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Fig. 6.10. Effect of adenosine and some adenosine
analogues on the response of the rat SCG to muscarine
% Depression of the response to lOOnM muscarine (l 
minute application) by cyclopenyladenosine (CPA), 
benzyladenosine (BZA), phenylaminoadenosine (PAA) and 
N6-(9H-fluoroenylmethyl)adenosine (PD 117,413). There 
was no significant alteration (paired t-test) of the 
response to muscarine in the presence of up to lOOuM PD 
117,413. The ratio of the EC^q 1s for CPA and BZA was 
about 500.
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Fig. 6.11. Effect of cyclopentyladenosine and R and s-
isomers of phenylisopropyladenosine on the response of 
the rat SCG to muscarine
Cyclopentyladenosine (CPA) and R- and S-phenyliso- 
propyladenosine (R-PIA, S-PIA) produced significant and 
concentration-dependent depression of the response to 
lOOnM muscarine (1 minute).
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Fig. 6.12. Effect of 2-chloroadenosine, 51-N- 
ethylcarboxyamidoadenosine and adenosine on the 
response of the rat isolated SCG to muscarine
2-Chloroadenosine (2CA), 5 *-N-ethylcarboxyamido­
adenosine (NECA) were more potent than adenosine (AD) 
at depressing the response of the ganglion to lOOnM 
muscarine (1 minute application).
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Fig. 6.13. Scatter diagram comparing the affinities of 
adenosine analogues for the adenosine receptor at the 
rat SCG (expressed on the abscissae as the IC^q values 
shown in Table 6.5) and for (A) the binding of [^H]- 
cyclohexyladenosine to A-^-adenosine receptors in whole 
rat brain membranes minus brainstem and cerebellum 
(Bruns et al., 1986) and (B) the A 2 ~adenosine receptors 
of rat striatal membranes, determined from the binding 
of [^H]-5*-N-ethylcarboxamidoadenosine in the presence 
of 50nM CPA to rat striatal brain membranes (Bruns et 
al., 1986).
The regression line is indicated by the continuous 
line. The coefficient of determination (r^) for the 
IC5 0  values on the rat SCG and (A) the A^-adenosine 
receptor binding was 0.82 (P<0.005) and for (B) the A 2 -
n
adenosine receptor binding, r = 0.05.
For key to the abbreviations used see Table 2.1 and 
ABBREVIATIONS.
270
log Al K 1 (
-6-
BZ
-7-
ADS-PIA
2CA
-8-
NEC
-9 R-PIA
CPA
-7 -'6
log IC50 ( M) depression of muscarine on rat SCG
B
- 6 .0-
-7.0-
log A2 Ki ( M)
- 8 .0-
_ S-PIA 
r =0-05
CPA BZA•
• •
R-PIA
% AD
2CA
•
NECA
- ---------1----------1---- ----- h----
-5
log IC50 ( U) depression of muscarine on rat SCG
Fig. 6.14. Effect of pentobarbitone on the response to
gamma-aminobutyric acid and adenosine
(A) Response of a single ganglion to gamma-aminobutyric 
acid (GABA, 1 minute application) and adenosine (lOOuM, 
2 minutes) in the absence and presence of 
pentobarbitone (PB, lOOuM). The depolarising response 
to GABA (10uM) was significantly increased from 160 + 
70uV to 398 + 132uV (n=4, P<0.05) in the presence of 
PB. In contrast, both the AHP to lOuM GABA (control = 
50 + 24uV, +PB = -89 + 45, P>0.05, n=4) and the 
response of adenosine (lOOuM, 2 minutes) was not 
significantly altered in the presence of PB (control = 
230 + 40uV and AD in the presence in PB = 220 + 49uV, 
n=4) after a minimum of 20 minutes incubation.
(B) Effect of PB on the concentration-response curve of 
adenosine in physiological salt solution (PSS) 
containing 2mM potassium/0.ImM calcium. There was no 
significant effect of PB (paired t-test) on the 
response to adenosine at all concentrations of 
adenosine tested.
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Fig. 6.15. Effect of 8-phenyltheophylline on the log
concentration-response curve to adenosine
In physiological salt solution containing 2mM K+/0.1mM 
? +Ca , the concentration-response curves to adenosine 
(AD) were reproducible (cf: 1st and 2nd CRC). In the 
presence of 8-phenyltheophylline (8PT) the 
concentration-response curve to adenosine was displaced 
to the right. N=4 ganglia.
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Fig. 6.16. Effect of 8-phenyltheophylline on the
depression of the response to muscarine by adenosine
The effect of adenosine (lOOuM) on 
lOOnM muscarine in (A) absence and 
phenyltheophylline (lOuM). NB: In 
the hyperpolarisation to adenosine 
the response to muscarine.
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Fig. 6.17. Effect of 8-phenyltheophylline on the 
depression by cyclopentyladenosine of the response of 
the rat SCG to muscarine
The response to lOOnM muscarine (1 minute) was reduced 
in a concentration-dependent manner by cyclopentyl­
adenosine (CPA). 8-phenyltheophylline (8PT) at luM (A) 
and lOuM (B) produced a rightward displacement of the 
concentration-response curve. N=3 to 8 ganglia.
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Fig. 6.18. Effect of dimethylpropargylxanthine on the
concentration response curve of the rat SCG to 
adenosine
A) Concentration-response curve to adenosine (1st CRC), 
repeated after 30 minute interval (2nd CRC).
B) Responses to adenosine (AD) in the absence and 
presence of 50uM dimethylpropargylxanthine (AD + DMPX). 
N = 3 ganglia. NB: there was no statistically 
significant difference (paired t-test) between 
responses in the absence or presence of DMPX.
Physiological salt solution = 2mM K+/0.1mM Ca^+ .
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Fig. 6.19. Effect of S-cyclopentyl-l.3-dipropylxanthine on the
response of the rat SCG to adenosine, cyclopentyl­
adenosine, 5 1-N-ethylcarboxylamido-adenosine and 
phenylamidoadenosine
The effect of 50uM 8-cyclopentyl-l,3-dipropylxanthine (DPCPX) on 
the response to adenosine (AD), cyclopenty1-adenosine 
(CPA), 5 1-ethylcarboxyamidoadenosine (NECA) and 
phenylamidoadenosine (PAA).
(1) Responses of a single ganglion in 2mM K+/0.1mM 
Ca^+ physiological salt solution in the absence (A) and 
presence of 50uM DMPX (B).
(2) Histogram showing responses of four ganglia in the 
absence and presence of DMPX.
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Fig. 6.20. Depression of the response of the rat SCG
to muscarine by CPA in the presence of 1,3-dipropy1-8- 
cyclopentylxanthine
Ganglia were incubated in the presence of different 
concentrations of 1,3-dipropy1-8-cyclopentylxanthine 
(DPCPX) for a minimum of 40 minutes before determining 
the depression of the response to lOOnM muscarine by 
increasing concentrations of cyclopentyladenosine 
(CPA).
(A) The depression of the response to muscarine by 10 
and lOOnM CPA was determined (1st CRC) and repejated 
after a minimum of 80 minutes (2nd CRC) (N=4). On 
other ganglia (N=7) the effect of O.lnM DPCPX on the 
depression of the response to muscarine by CPA was 
determined. The effect of O.lnM DPCPX was not 
discernible within the variability of the control 
responses.
In further experiments the effect of 0.5nM (B; N=4), 
InM and lOnM (C; N=3 to 11 and N=5 respectively) DPCPX 
on the depression of the response to muscarine by CPA 
were examined.
N=number of ganglia studied.
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Fig. 6.21. Effect of 1,3-dipropy1-8-cyclopenty1- 
xanthine and xanthine amine congener on the 
hyperpolarisation of the rat SCG to adenosine
In physiological salt solution (PSS) containing 2mM 
potassium and O.lmM calcium (2mM K+/0.1mM Ca^+ PSS)
1,3-dipropy1-8-cyclopentylxanthine (DPCPX) (Fig. 6.20A-
C) and xanthine amine congener (XAC) (Fig. 6.20D) 
antagonised the response to adenosine (AD).
The hyperpolarisations to AD were smaller in 2mM 
K+/2.5mM Ca^+ PSS (Fig. 6.20A) compared to 2mM K+/0.1mM 
Ca^+ PSS (Fig. 6.20B), but the effect of DPCPX was 
similar.
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Fig. 6.22. Response of a single ganglion to adenosine
in the absence and presence of 1,3-dipropy1-8- 
cyclopentylxanthine
A) Control responses to 2 minute applications of 
increasing concentrations of adenosine and (B) in the 
presence of 1,3-dipropy1-8-cyclopentylxanthine (DPCPX) 
at 0.6nM and (C) 0.9nM DPCPX.
NB: The response to cyclopentyladenosine (CPA) at luM 
(2 minutes application) in 0.9nM DPCPX is shown for 
comparison to the responses to adenosine.
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Fig. 6.23. Effect of 1,3-dipropyl-8-cyclo- 
pentylxanthine on the hyperpolarisation of the rat SCG 
to cyclopentyladenosine
Log concentration response curves to
cyclopentyladenosine (CPA) in the absence and presence 
of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) at (A) 
0.6nM, (B) 0.3nM and 0.9nM DPCPX.
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Table 6.2. Effect of methylxanthines on the d.c. 
potential response to muscarine^ adenosine, adenosine­
s'  - triphosphate , 2-chloroadenosine and the depression 
of the response to muscarine
The effect of theophylline and 8-phenyl theophylline 
(8PT) on the basal d.c. potential, response to a one 
minute application of muscarine, 2 minute applications 
of adenosine, 2-chloroadenosine (2CA) or adenosine-5 1 - 
triphosphate (ATP) and the depression of the response 
to a one minute application of muscarine by adenosine, 
2CA or ATP was determined as described in chapter 2. A 
minimum of 30 minutes incubation in theophylline or 8PT 
and 20 minutes between responses to agonists was used. 
Responses are means + SEM, where N = number of ganglia 
tested. Statistical significance was determined using 
a paired t-test comparing the response in physiological 
salt solution (PS) to PSS-containing theophylline, 8PT 
or 8-parasulpho-phenyltheophylline (8psPT) and is 
indicated by a * for P<0.05.
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Table 6.7. The effect of 3,7-dimethy1-1- 
propargylxanthine on the depression of the response of 
the rat SCG to muscarine by cyclopentyladenosine and 
the response to adenosine, cyclopentyladenosine and 
phenylaminoadenos ine
(A) % Depression of response to lOOnM muscarine by 
lOOnM cyclopentyl adenosine (CPA) in normal 
physiological salt solution (PSS) and PSS containing 
3,7-dimethy1-1-propargylxanthine (DMPX). The ability 
of CPA to depress the response to muscarine in PSS was 
repeated in PSS (on three ganglia) or PSS + DMPX (on 
five ganglia) after a minimum of 60 minutes between 
applications of CPA i.e. 1st and 2nd control responses 
or 1st control and 2nd response in DMPX respectively (N 
= number of ganglia tested).
(B) Response of rat SCG to two minute applications of 
adenosine, CPA and phenylaminoadenosine (PAA) in the 
absence (control) or presence of DMPX. There was no 
statistically significant difference between responses 
(uV + SEM) obtained in the absence or presence of DMPX 
(paired t-test on three ganglia). The values in 
brackets refer to the responses obtained from the "time 
control" ganglion.
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CHAPTER SEVEN 
GENERAL DISCUSSION
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CHAPTER SEVEN: GENERAL DISCUSSION
The main aims of this thesis were to characterise the 
adenosine-induced hyperpolarisation that can be recorded 
extracellularly from the rat isolated SCG; to study the 
ionic mechanisms responsible for these effects; to examine 
any interaction between adenosine and various 
neurotransmitters and to identify the receptors involved 
in the actions of adenosine.
The results presented in chapter 3 show that adenosine and 
its analogues hyperpolarised the SCG in a concentration- 
dependent manner and that a system for the uptake and 
deamination of adenosine exists. This uptake system may 
reflect a requirement for the uptake of purines that are 
not synthesised by the ganglion and/or represents an 
efficient method for the removal of circulating adenosine. 
The effects of adenosine are attributable to a direct 
action on the ganglion as purines were weak or inactive on 
isolated nerves (CST) and unaltered in conditions known to 
inhibit neurotransmitter release.
O I
It has been reported that adenosine altered Ca^ -dependent 
potentials of the rat SCG (Henon & McAfee, 1983a,b),
2+however no evidence was found to support a role of Ca 
channels in the actions of adenosine reported in this 
thesis. The response to adenosine was resistant to 
antagonism of Na+ , Ca^+ and Cl" conductances, but was 
sensitive to changes in extracellular K+ concentration 
indicating the response to adenosine is likely to be due 
to an increase in gK (chapter 4). The pharmacological 
profile of the adenosine-induced hyperpolarisation was 
distinct from those gK described for the effects of 
adenosine on other neurones. The response to adenosine 
was not antagonised byt the following pharmacological 
agents: 4AP which antagonises IA and ID , high
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concentrations of TEA, which antagonises Ir , Iq and Im;
apamin and dTc which antagonise Ia^p and Iq respectively.
Adenosine-induced hyperpolarisations were enhanced in the 
?+presence of Ba^ , high concentrations of TEA and in the 
presence of muscarinic agonists, suggesting the effects of 
adenosine are mediated via an interaction with Im. In 
support of this hypothesis the data presented in chapter 5 
show that adenosine selectively depressed the response to 
muscarine but not the response to other agonists which 
mediate their effects via ionic conductances distinct from 
Im.
The depression of muscarinic responses by adenosine was 
not replicated by the pyrimidine UTP or alpha,beta-MeATP, 
both of which depolarised the ganglion, suggesting the SCG 
contains receptors for these compounds and the depression 
of muscarinic responses is selective for adenine or 
adenine nucleotides.
It is unlikely that the depression of muscarinic responses 
occurred as a result of a functional antagonism by 
adenosine as agonists that produced equivalent sized 
hyperpolarisations compared to adenosine e.g. (-) 
baclofen, beta,gamma-MeATP, R- and S-PIA were not 
equipotent at depressing the response to muscarine. Also 
ATP was weak or ineffective at hyperpolarisating the 
ganglion but produced equivalent reductions of the 
response to muscarine compared to adenosine. It would be 
desirable to confirm that the depression of muscarinic 
responses in individual ganglionic neurones was independet 
of the degree of hyperpolarisation of these neurones. 
Intracellular recording techniques were only available for 
a short period during the course of the experimental work 
for this thesis and when intracellular recordings were 
made by a similar method to that of Henon & McAfee 
(1983a). The actions of adenosine were inconsistent as
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reported by Henon & McAfee (1983a). A similar 
complication was reported by Smith & Zidichouski (1985) 
who found adrenaline produced small and inconsistent 
responses when recorded intracellularly from bullfrog 
paravertebral ganglia. It was therefore not feasible to 
confirm the grease gap results using this technique. A 
more suitable technique such as whole cell patch clamping 
may provide both conformation and additional information 
about the results reported here.
The level at which the interaction between adenosine and 
muscarine occurs is somewhat speculative. One general 
mechanism that may apply to these studies is the 
interaction of adenosine and muscarinic receptors with a 
common population of K+ channels via GTP-binding proteins 
(Trussel & Jackson, 1989; Kurachi, Na Kajima & Sugimoto, 
1986) (Fig. 7). In contrast to the proposed action of 
adenosine on the hippocampus (Trussel & Jackson, 1989), 
the effect of adenosine on sympathetic ganglia may be due 
to the activation of an outward K+ . The mechanism of 
interaction proposed is shown in figure 7, where the 
activation of Ml-receptors by ACh or muscarine leads to 
the closure of M-channels and depolarisation of the 
ganglion. The activation of Al-adenosine receptors could 
then open these channels to antagonise the effects of 
muscarine. It seems unlikely that a direct effect via a 
common pool of G-protein subtypes occurs as the effects of 
muscarine and adenosine are PTX insensitive and sensitive 
respectively. Perhaps more likely is a modification of 
the intracellular secondary messenger pathways.
To date the biochemical mechanism of muscarine on the rat 
SCG and the hippocampus are poorly understood (Duttar & 
Nicholl, 1988; Brown, 1989; Marrion et al., 1990) although 
there is good evidence to suggest a lack of involvement of 
cyclic nucleotides. Likewise there are several lines of
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evidence to suggest the effects of adenosine on the rat 
SCG are not mediated by cyclic nucleotide levels, 
including the inability of adenosine to reduce the 
response to agonists known to increase the cAMP content of 
the ganglion (chapter 5). Muscarinic agonists have been 
shown to activate PIT and in interaction with this 
intracellular system and the ability of a phorbol ester to 
enhance the response to adenosine supports a role of PKC 
in the actions of adenosine.
It is possible that either branch of the inositol 
phospholipid signal transduction pathway may be involved 
in the modulation of the muscarinic depolarisation via DAG 
production and subsequent activation of PKC or via an IP3 
metabolite and/or an action on PLA2 . There was some 
evidence to suggest arachidonic acid production was 
involved in the response to adenosine although it remains 
to be determined whether the depressant effects of 
adenosine are due to the stimulation of arachidonic acid 
formation or via another mechanism.
The effects of adenosine and its derivatives were 
inhibited by adenosine receptor antagonists including,
8 PT, DPCPX and XAC (chapter 6 ) and the response to 
adenosine was enhanced by dipyridamole (chapter 3) 
suggesting an action via external adenosine receptors.
The similar potency order for the depression of muscarinic 
responses and the hyperpolarisation to adenosine and its 
analogues indicates that a common population of adenosine 
receptors was involved in both these responses.
The high potency and apparent pA2 values for DPCPX and XAC 
as antagonists of the effects of adenosine strongly 
suggest the presence of Al-adenosine receptors on the rat 
SCG. The apparent non-competitive antagonism of the 
effects of adenosine may arise from the biphasic nature of
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the concentration-response curves. Some support for theis 
hypothesis is provided by the inability of DMPX, a 
selective A2-receptor antagonist to alter the 
concentration response curve to adenosine. Alternatively 
the adenosine receptors of the rat SCG may be different to 
those reported for the CNS, i.e. an Al-adenosine receptor 
subtype. Wiklund, Wiklund & Gustafsson (1989) have 
reported that the Al-adenosine receptors of the autonomic 
nervous system may be different from CNS neurone 
receptors. Preliminary findings suggested CV 1674 (2-(4- 
methoxyphenyladenosine) is an agonist at CNS but not 
autonomic nerve adenosine receptors and the latter
receptors have a lower affinity for some antagonists. As
CV 1674 was unavailable the possibility of Ala receptors 
on the rat SCG cannot be discounted. However, the high 
potency of DPCPX and the high correlation between CNS Al- 
receptor binding and the inhibition of muscarinicic 
responses suggests the A1 receptors are similar, if not
identical to those of the CNS.
General implications and physiological role of adenosine 
on the rat SCG
In both human (Valli, Zuccia, Seghezzi, Bonifati & Botta, 
1985), rabbit (Voile, 1969; Brimble & Wallis, 1974) and 
rat superior cervical ganglia (Brown, 1983) a significant 
proportion of the response to stimulation of the ganglion 
is mediated via muscarinic transmission, which regulates 
neuronal discharge patterns over prolonged periods by 
closing M-channels. The opening of K+ channels by 
adenosine would provide a suitable mechanism for 
hyperpolarising the cell by a small amount to decrease the 
rate of spike discharge. Thus the main effect of 
adenosine might be a modification of the discharge- 
frequency characteristics, which would be predicted to be 
particularly significant under conditions where Im is
suppressed by muscarinic agonists or peptides. Factors 
such as the frequency of stimulation of the ganglion may 
influence the effect of adenosine on the sensitivity of 
the postsynaptic nerves (Cacigli et al., 1985; Henon & 
McAfee, 1985) and in vivo the effects of adenosine would 
be dependent upon a complex interaction at both pre- and 
postsynaptic receptors. Circulating or neuronally 
released adenosine may serve to inhibit excessive 
activation of muscarinic receptors.
Conclusions
Adenosine is now wide regarded as a modulator of neuronal 
activity in a variety of tissues and the rat isolated SCG 
has provided a useful and reasonable model for the study 
of the actions of adenosine on the peripheral nervous 
system. There was a significant and selective interaction 
of adenosine with postsynaptic muscarinic depolarisations 
which may represent a general phenomenon occuring in a 
variety of tissues including the CNS, where muscarinic 
transmission rather than nicotinic transmission 
predominates excitation of CNS neurones by ACh. However, 
further experimentation will be required before the 
physiological implications of this process become clear.
Fig. 7. Schematic diagram of the purinergic and 
muscarinic activation of a K+ channel in the rat SCG 
neuronal membrane. Acetylcholine (ACh) activates a 
muscarinic receptors (Ml-R) to stimulate the formation 
of diacylglycerol (DAG) via a G-protein (G) and 
phospholipase C(PLC) to activate protein kinase-C (PKC) 
which closes the K+ channel. Adenosine (AD) activates 
an adenosine 1-receptor subtype (Al-R) to open the K+ 
channel via a pertussis toxin sensitive mechanism. The 
activation of a G-protein may stimulate phospholipase 
A 2 (PLA2 ) to produce arachidonic acid (AA) with the 
subsequent formation of leukotrienes (LT) which may 
open the K+ channel.
This scheme does not represent any quantitative 
relationships between the various components shown and 
their exact location within the cell membrane. Solid 
lines represent pathways known to be involved in the 
response to ACh and adenosine, whereas the dotted lines 
represent putative mechanisms.
(+) = activation; (^) = inhibition
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Chapter 5 : INTERACTION OF ADENOSINE WITH DIFFERENT AGONISTS. 
INTRODUCTION.
The results of the preceding chapters have provided some evidence 
for the ability of adenosine to depress the response of the rat 
SCG to muscarine. In this chapter the selectivity of adenosine 
for muscarinic agonists and the potential intracellular 
messengers involved in these responses are examined.
Over the last decade it has been reported that adenosine can 
modulate the activity of numerous tissues including the 
sensitivity of smooth muscle to noradrenaline (NA) and neuronal 
tissue to ACh (Table 5.12) (Akasu et al., 1983a; Stone, 1989). 
A large number of substances have been reported to have a 
neuromodulatory or neurotransmitter function in the rat SCG, 
including :-ACh (Birks & Macintosh, 1961), catecholamines (Brown 
& Caulfield, 1979), 5HT (Wallis, Williams & Wali, 1978), GABA 
(Wolff, Joo, Kasa, Storm-Mathiesen, Toldi & Blacar, 1986; Eugene, 
1987), and vasoactive-intestinal polypeptide (VIP)(Voile & 
Patterson, 1982; Dorroux, Barberis & Jard, 1987). The ability of 
these agents to activate different ionic and biochemical 
mechanisms has therefore been used here to aid the identification 
of the mechanism of action of adenosine on the rat SCG.
The results described in chapters 3 & 4 suggest that adenosine 
depressed the response to muscarine but the relationship been the 
degree of depolarisation and the depression by adenosine, or the 
selectivity of adenosine for the muscarinic depolarisation versus 
muscarinic hyperpolarisation was not examined (see Chapter 1 for 
discussion of Ml mediated depolarisation & M2 mediated 
hyperpolarisation, also Brown et al., 1980; Newberry et al, 
1987). To examine the first question the effects of a GABA0 
agonist, (-) baclofen (BAC) were compared to the effects of 
adenosine. The rationale for these experiments is provided by the 
reports that baclofen produces similar effects to adenosine in
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a number of tissues, e.g. both compounds decrease synaptic 
excitability of isolated hippocampal cells (Newberry & Nicholl,
1985) and baclofen hyperpolarises the rat SCG (see Results, Figs
5.4 & 5.5). More recently this latter finding was confirmed by 
Newberry & Gilbert, 1989).
To address the question of whether adenosine modulates both the 
Ml and M2 mediated responses of muscarinic agonists, further 
experiments were performed to study the ability of adenosine to 
depress the depolarisation or hyperpolarisation produced by 
muscarinic agonists (Results 5.3, 5.5. & 5.6 ). As there are no
M2 receptor selective agonists the ability of adenosine to alter 
the M2 receptor mediated response to muscarinic agonists was 
assessed in two sets of experiments. In the first series the 
depression of the response to muscarinic agonists was measured 
in the presence of a an M2 muscarinic receptor antagonist, 
methoctramine (MTO). In a second series of experiments the 
ability of adenosine to alter the hyperpolarisation to carbachol 
in low Ca2+ PSS containing an Ml receptor antagonist, pirenzepine 
(PIR), was determined.
It is of interest that the hyperpolarisation to adenosine was 
attributed to an increase in gK (Chapter 4), whereas the 
muscarinic depolarisation of the rat SCG is reported to occur via 
a decrease in gK (see introduction Chapter 1; Brown & Constanti, 
1980; Fig 5.12). Given these findings it would be predicted that 
adenosine would depress the response to muscarine as described 
in Chapters 3 & 4, and in addition the adenosine-induced
hyperpolarisation of the ganglion would be enhanced during a 
muscarinic depolarisation. To test the latter hypothesis the 
response of the rat SCG to adenosine in the presence of 
muscarinic and non-muscarinic agonists was determined (see 
Results 5.7).
An interaction of purines with postsynaptic responses to ACh and 
cholinergic agents has been reported by several research groups 
although both the receptors and the mechanism of action are
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unknown or poorly characterised (Table 5.12). To determine if the 
interaction of adenosine and muscarine occurs due to an effect 
on Im, the interaction of adenosine on compounds reported to 
inhibit Im, including muscarine (Brown & Adams, 1980; Constanti 
& Brown, 1981), LHRH (Adams & Brown, 1980; Adams et al., 1982a; 
Jones, 1987), a substance P analogue, ERP (Adams, Brown & Jones, 
1983) and UTP (Adams et al., 1982a) was determined.
An increasing number of intracellular messenger, including cyclic 
nucleotides, PIT and arachidonic acid (AA) are believed to 
mediate the effects of adenosine. The two most frequently 
proposed transduction systems that may explain the actions of 
adenosine are the adenylate cyclase (AC)/cAMP system and the 
PI/PKC system. In 1976, Greengard proposed that cyclic 
nucleotides have a major role in postsynaptic transmission of 
sympathetic ganglia, and that cAMP and cGMP exert long term 
control of neuronal excitability (McAfee & Greengard, 1972). Thus 
in an analogous manner to that found in rat or guinea-pig brain 
the action of adenosine on the rat SCG may occur due to a change 
in cyclic nucleotides. It is possible that adenosine and/or 
muscarine alter ganglionic cAMP levels via an effect on adenylate 
cyclase (Dunwiddie & Fredholm, 1984; Yeager, Nelson & Storm, 
1986; Donaldson, Brown & Hill, 1988) and/or a change in PDE 
activity (Smellie, Davis, Daly & Wells, 1979; De Manzancourt & 
Giudicelli, 1984) and each of these hypotheses was examined 
(Results 5.9). The possibility that the actions of adenosine are 
mediated via an interaction with PIT, PKC and AA was also 
examined (Results 5.8 & 5.10).
METHODS.
Ganglia were isolated and recorded as described in chapter 2 
(methods) and perfused with PSS. CRCs to agonists were 
constructed with one minute applications and a minimum of 15 
minutes between applications. Once the responses to agonists were 
reproducible the ability of adenosine to alter the response to 
an agonist was assessed by measuring the peak response to the
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agonist applied before (pre-test), during (test) and after (post­
test) incubation with adenosine or (-) baclofen, and the change 
in the agonist response was expressed as a percentage of the 
control response.
The ability of adenosine to alter the hyperpolarisation to 
carbachol was determined as for the effect of adenosine on the 
response to muscarinic agonists except that hyperpolarisations 
to carbachol were obtained by perfusing ganglia in PSS 
containing 0.1 mM Ca2+ and 0.3 uM pirenzepine (PIR).
The effect of MTO on the responses to muscarinic agonists, 
adenosine and the depression of muscarinic agonists by adenosine 
was determined in PSS as described above. Ganglia were incubated 
in 0.3 uM MTO for a minimum of an hour before reassessing both 
the response to muscarinic agonists and their interaction with 
adenosine.
The role of cyclic nucleotide metabolism in the response of the 
rat SCG to adenosine was assessed using selective inhibitors of 
the breakdown of cAMP and cGMP i.e. the cAMP PDE inhibitors 
(PDEI), 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 
20-1724) and denbufylline (BRL 30892), and a cGMP PDEI, M&B 
22,948. The sites of action of these agents are shown in Fig 
5.11. In addition the depression of muscarinic responses by CPA 
was tested in the presence of an adenylate cyclase inhibitor SQ 
22,536 or Ro 20-1724.
The effect of indomethacin (INDO) and nordihydroguaiaretic acid 
(NDGA) were assessed by first constructing CRCs to 2 minute 
applications of adenosine every 20 minutes in the absence and 
presence of indomethacin (50 uM), followed by a CRC to adenosine 
in the presence of freshly prepared indomethacin (50 uM) and NDGA 
(10 uM) in PSS.
RESULTS.
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5.1 Concentration response curves to a g o n i s t s .
The response to increasing concentrations of ACh, muscarine, 2- 
methyl-5-hydroxytryptamine (2Me5HT), VIP and oxotremorine-M (0X0- 
M) are summarised in figure 5.1.
High concentrations of ACh were required to evoke a response of
the ganglion, with muscarine being over 1,000 fold more potent
than ACh on the same ganglia. To avoid using high concentrations 
of ACh and selectively activate muscarinic receptors, AChE 
resistant analogues of ACh including
muscarine (Fig 5.1), carbachol (CARB) (Fig 5.2h) and
methylfurmethide (MeF) (Fig 5.2i) were used.
The depolarisation to 100 nM muscarine was abolished by
incubation with either N-Methylatropine or pirenzepine (Table
5.1), whereas the response to adenosine was unaltered by
pirenzepine (Table 5.1).
5 .2 Effect of adenosine on the response to non-muscarinic
agonists.
The ability of adenosine to alter the response to submaximal 
responses of different agonists producing about equivalent sized 
responses is summarised in tables 5.2 and 5.3.
Potassium produced concentration dependent depolarisations which 
at 8 and 12 mM were not significantly altered by the presence 
of 100 uM adenosine (Fig 5.2a, Table 5.3).
GABA produced concentration dependent depolarisations followed 
by AHPs which were easily observed at 100 uM (see Figs 4.11 &
4.12). Adenosine at 10 uM did not alter the response of up to 10 
uM GABA (Table 5.2). In the presence of 100 uM adenosine the AHP 
in response to 100 uM GABA was not significantly altered whereas 
depolarisations to 1 and 10 uM GABA were significantly enhanced 
(Table 5.3).
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DMPP produced concentration related depolarisations and AHPs (Fig 
5.2c) both of which were unaltered by the presence of 30 uM or 
100 uM adenosine (Fig 5.2, Tables 5.2 & 5.3). Likewise the
'fast' nicotinic depolarisation produced by carbachol at 10 and 
30 uM was unaltered by the presence of 100 uM adenosine (Table
5.4) .
The depolarisation to 10 uM 5HT was unaltered in the presence of 
10 uM adenosine and significantly enhanced by 100 uM adenosine 
(Tables 5.2 & 5.3). 2Me5HT produced concentration-dependent
depolarisations (Fig 5.1) which were broader than responses to 
5HT (Fig 5.2 cf d & e). The response to 30 uM 2Me5HT was similar 
in shape and size to that produced by 100 nM muscarine (Fig 5.2 
cf e & g) but in contrast to muscarine the response to 2Me5HT 
was unaltered by 100 uM adenosine (Fig 5.2 cf e & g, Table 5.3).
Isoprenaline (ISO) at 100 nM produced a response similar to the 
response observed for 100 nM muscarine (Fig 5.2 f & g and Tables
5.3 & 5.4). The response to 100 nM isoprenaline was significantly 
reduced by 10 uM adenosine (Table 5.2) but not by 100 uM 
adenosine (Table 5.3).
5.3 Effect of adenosine on the response to muscarinic
agonists.
The results presented in tables 5.2 & 5.3 and Fig 5.2 g-i, show 
adenosine depressed the responses to muscarinic agonists. The 
response to 100 nM muscarine was significantly reduced by 10 and 
100 uM adenosine in a concentration dependent manner (Figs 5.3,
5.4 & 5.6, Tables 5.2 & 5.3). Both the depression of the response 
to 100 nM muscarine by 100 uM adenosine (Fig. 5.4a) and the 
depression of increasing concentrations of muscarine by adenosine 
(Fig. 5.4b) were biphasic and maximal at about 100 nM muscarine 
and 100 uM adenosine declining at higher concentrations of 
muscarine or adenosine.
The ability of adenosine to depress the response to muscarinic
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agonists was dependent both on the agonist and the level of 
depolarisation (Tables 5.2 & 5.3; Fig 5.2 g-i). At 10 uM
adenosine there was no selectivity for carbachol, muscarine or 
MeF but at 100 uM adenosine the depression of the response to 
muscarine was about twice as great as that for adenosine on 
carbachol or MeF (Table 5.4). Adenosine at 100 uM did not 
significantly alter the response to carbachol and in contrast to 
muscarine and MeF the depression of the agonist response showed 
considerably greater variability.
5.4 The effect of (-) baclofen on the response to 
muscarine.
(-)BAC produced concentration dependent hyperpolarisations and 
at 10 and 30 uM significantly reduced the response to 100 nM 
muscarine (Fig 5.5). The response to muscarine was reduced by 10 
uM (-)BAC by 11 ± 3 % (response to muscarine = 366 ± 69 uV, 
response to muscarine in (-)BAC 10 uM = 331 ± 65 uV, P < 0.05, 
n=7) .
5.5 Effect of adenosine on the hyperpolarisation to 
carbachol.
Muscarinic agonists in the presence of PIR in low Ca2+ PSS 
produced concentration related hyperpolarisations (Figs 5.8,
5.9). Carbachol in low Ca2+ PSS containing PIR produced 
concentration dependent hyperpolarisations (Fig 5.9) and at 10 
uM produced a hyperpolarisation followed by a fast
depolarisation and a slower depolarisation. Both the 
hyperpolarisation and the slow depolarisation were abolished in 
2 uM atropine (N=2), and the rapid depolarisation was reduced by 
dihydrobetaerythroidine (DHBE). In addition to reducing the fast 
component of the carbachol response, DHBE also reduced the 
hyperpolarisation to carbachol. Thus to avoid the use of DHBE the 
effect of adenosine on the response to carbachol was assessed in 
low Ca2+ PSS containing pirenzepine (Table 5.6). The ability of 
adenosine to selectively reduce the depolarising response but not
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the hyperpolarisation to carbachol is illustrated in Fig 5.9c.
5.6 Effect of adenosine on the response to muscarinic 
agonists in the presence of MTO.
The response to MeF and muscarine were significantly reduced, 
in the presence of 0.3 uM MTO and the responses to carbachol and 
adenosine were not significantly altered (Table 5.5). MTO 
produced a significant increase in the depression of responses 
to carbachol in MTO (Table 5.5).
5.7 Effect of depolarisation with different agonists on 
the response to adenosine.
5.7.1 Effect of depolarisation with potassium on the 
response to adenosine.
The continuous application of 2 mM potassium produced a sustained 
depolarisation which did not significantly alter the response to 
100 uM adenosine (Table 5.7).
5.7.2 Effect of depolarisation with nicotine on the 
response to adenosine.
Nicotine produced concentration dependent depolarisations of the 
ganglia (Fig 5.7 & Table 5.7). The response to adenosine when 
applied during the depolarisation to 100 nM nicotine was 
significantly depressed compared to controls (Fig 5.7 & Table
5.7) but was not significantly altered during the depolarisation 
to 1 or 10 uM nicotine (Table 5.7).
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5.7.3. Effect of adenosine on the response to agonists
reported to inhibit the M-current.
5. 7. 3.1 Barium (Ba2+)
The depolarisation to 1 mM barium was of a similar magnitude to 
that produced by 100 nM muscarine, and was significantly reduced 
in the presence of 100 uM adenosine (Table 5.3). The application 
of Ba2+ at 3 mM for 1 minute to depolarise the ganglion 
significantly enhanced the subseguent response to 100 uM 
adenosine during the depolarisation to Ba2+, whereas the 
continuous application of 2.5 mM Ba2+ did not alter the response 
to adenosine (Table 5.8).
5. 7. 3.2 Muscarinic agonists.
Pilocarpine (Fig 5.14), BM5 (Table 5.8), muscarine (Figs 5.13 & 
5.14) significantly enhanced the hyperpolarisation to adenosine 
(Table 5.8). The continuous application of 100 nM muscarine 
produced a persistent depolarisation and an enhancement of the 
hyperpolarisation to adenosine (Figs 5.13 & 5.14; Table 5.8).
5. 7. 3. 3 LHRH, UTP and ERP.
LHRH and UTP produced small but significant depolarisations of 
the ganglia but did not significantly alter the response to 100 
uM adenosine (Table 5.8). ERP depolarised ganglia and 
significantly enhanced the response to adenosine (Table 5.8 ).
5.8 Effect of an activator and inhibitor of PKC.
5.8.1 Response to adenosine during depolarisation by PDBu.
PDBu produced concentration dependent sustained depolarisation 
of ganglia, with responses to 20 nM and 200 nM beginning within 
1 to 2 minutes of application. Responses developed slowly over 
15 to 20 minutes and took 1 to 2 hours to washout. At 200 nM
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PDBu, depolarised ganglia to a similar degree to 100 nM muscarine
(Table 5.7, Fig 5.14) and the response to adenosine was
potentiated when applied during the response to PDBu (Fig 5.14, 
Table 5.8).
5.8.2 The effect of H7 on the response to adenosine,
carbachol, muscarine, PDBu and the depression of the
response to muscarine by adenosine.
In low Ca2+ and PIR containing PSS, 100 uM adenosine and 300 nM 
carbachol produced similar sized hyperpolarisations which were 
unaffected by incubation in PSS containing 50 uM H7 (Table 5.10).
Incubation of ganglia in PSS containing H7 did not alter the 
response to muscarine, PDBu, adenosine or the depression of the 
response to muscarine by adenosine (Table 5.11).
5.9 Effect of inhibitors of cGMP and cAMP
phosphodiesterases and adenylate cyclase on the 
response to purines, muscarine and depression of the 
muscarinic response.
Denbufylline at 1 uM did not significantly alter the response to 
adenosine, muscarine or the depression of the response to 
muscarine by adenosine (Table 5.9). Denbufylline at 10 uM did not 
alter either the response to muscarine (100 nM) or it's 
depression by adenosine, and significantly reduced the 
hyperpolarisation to adenosine (Table 5.9). At 100 uM 
denbufylline significantly reduced the responses to adenosine and 
muscarine and reduced the depression of the response to muscarine 
by adenosine (Table 5.9).
Ro 20-1724, denbufylline and SQ 22,536 were either ineffective 
or reduced (denbufylline at 100 uM) the depolarisation of the rat 
SCG to muscarine (Table 5.9). Ro 20-1724 significantly reduced 
the response to adenosine (Fig 5.10; Table 5.9) and reduced the
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response to CPA but not the response to muscarine or the
depression of the response to muscarine by adenosine (Table 5.9). 
Ro 20-1724 caused an apparently non-parallel antagonism of the 
CRC to adenosine (cf Figs. 5.10 and 6.20).
SQ 22,536 did not significantly alter the response to muscarine 
or the depression of the response to muscarine by CPA (Table
5.9) .
5.10 Effect of agents that alter AA metabolism.
At 50 uM indomethacin produced a small rightward shift in the CRC
for the hyperpolarisation to adenosine (Fig 5.16). In the
presence of indomethacin (50 uM) and NDGA (10 uM) responses to 
adenosine were displaced further to the right and significantly 
reduced at 10 and 100 uM adenosine (Fig 5.16).
DISCUSSION.
Effect of adenosine on the response to depolarising agonists.
The depression of muscarinic responses by adenosine was agonist 
dependent and similar depolarisations by different agonists were 
not depressed to a comparable extent by adenosine (Fig. 5.2a-i; 
Tables 5.3 and 5.4). The ability of adenosine to modulate the 
response to some agonists but not others allows inferences to be 
made as to how adenosine may function during ganglionic
transmission.
Interaction with GABA.
One means by which adenosine might interfere with transmission 
is to modify GABA activity. Both the presence of GABA and the 
ability of GABA to depolarise ganglia (see Bowery & Brown, 1974; 
Figs 4.11 & 4.12) together with the existence of a fast non- 
cholinergic postsynaptic potentials which resemble the effects 
of GABA (Eugene, 1987) is evidence in favour of functional GABA-
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ergic transmission in the rat SCG. However the function of GABA 
receptors on SCG cells remains unclear and it has been reported 
that GABA had only slight effects on ganglionic transmission 
(Adams & Brown, 19 75).
The results presented here suggest a small but significant 
potentiation of low concentrations of GABA by adenosine (Tables
5.2 & 5.3), an effect that would be consistent with an increase 
in efflux of Cl" and /or K+ (see Chapter 4.6, also Ballanyi et 
al., 1984; Ballanyi & Grafe, 1985; Adams & Brown, 1975). The 
results presented in chapter 4.6 showed that the response to 
adenosine was unaltered in low Cl" PSS, a condition which would 
be expected to enhance efflux of Cl", indicating the potentiation 
of the response to GABA by adenosine is more likely to have 
arisen from increased K+ efflux. This hypothesis is consistent 
with the potentiation of the response to adenosine in low K+ PSS 
(see Chapter 4.8.1).
Interaction with 5HT.
A second potential site of interaction of adenosine in vivo is 
with tryptaminergic transmission. 5HT exerts excitatory actions 
on sympathetic ganglia and depolarisation by 5HT is reported to 
facilitate synaptic transmission (Eccles & Libet, 1961). The fast 
depolarisation of the rat SCG to 5HT is believed to be mediated 
by 5HT3 receptors (Fourtune, Ireland & Tyres, 1985), and the AHP 
is mediated via the activation of the electrogenic Na+ pump 
(Wallis & Woodward, 1975). In addition to these responses, 5HT 
also hyperpolarises the rat SCG due to an action mediated by 5HT-, 
receptors (Ireland, 1987; Ireland & Jordan, 1987; Gilbert & 
Newberry, 1987) and accumulates 5HT via an avid uptake system 
(Ireland, Staughan & Tyers, 1987). The ability of adenosine to 
alter the response to 5HT may thus be complicated by these 
factors. Using a submaximal concentration of 5HT only a 
depolarisation was observed (Fig 5.2d), which was significantly 
enhanced by 100 uM adenosine. The reason for this potentiation 
is unknown, but is unlikely to have been due to a potentiation
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of the 5HT3 mediated depolarisation as the response to a 
selective 5HT3 agonist, 2Me5HT was unaltered by the presence of 
100 uM adenosine (cf Figs 5.2 d & e, Table 5.3). Results 
presented in chapters 4 and 5 suggest adenosine has no effect on 
responses mediated via activation of the electrogenic Na+ pump 
and it is most unlikely that adenosine enhanced the response to 
5HT by interacting with the electrogenic Na+ pump.
Interaction with acetylcholine.
Interaction with nicotinic receptors.
A third method by which adenosine could alter sympathetic 
ganglionic transmission in vivo is to modulate the response to 
cholinergic receptor activation (see Table 5.12) and in 
particular the response to nicotinic receptor stimulation (Akasu 
et al, 1981; 1983a,1985) and hence the pressor responses to
nicotinic agonists (see von Borstel, Evoniuk and Wurtman, 1984; 
1986).
It was not possible to directly determine the effect of adenosine 
on the response of the SCG to ACh due to it's low potency (Fig
5.1) and non-selectivity at higher concentrations that 
depolarised ganglia. The low potency of ACh most probably arose 
from the presence of acetylcholinesterase (AChE) within the 
ganglion and is responsible for the destruction of both liberated 
(Koelle & Koelle, 1959) and spontaneously released ACh in the rat 
SCG (Briggs, McAfee & McCaman, 1988).
Adenosine did not alter depolarisations to a selective nicotinic 
agonist, DMPP (Tables 5.2 & 5.3 and Fig 5.2c) or the 'fast' 
nicotinic depolarisation produced by carbachol (Table 5.4) . These 
findings are consistent with the lack of effect of adenosine on 
the sensitivity of the nicotinic receptor reported by Akasu et 
al (1981; 1983a; 1985) using bullfrog sympathetic ganglia.
The results presented here are in contrast to those obtained by
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von Borstel et al., (1984,1986) who reported that adenosine 
potentiated the pressor response to nicotinic agonists invivo. 
The order of potency for the potentiation of the response to 
nicotine was N-cyclopropylcarboxamidoadenosine (CPCA) > 2CA > R- 
PIA > S-PIA with an R/S ratio of about 10 (von Borstel et al.,
1986) suggesting an action via A2 receptors. In partial 
agreement with von Borstel et al., (1984,1986), Henon & McAfee 
(1983b) found 2CA reduced single EPSP but facilitated ganglionic 
transmission during repetitive stimulation (see Henon & McAfee, 
1983b). The reduction in the single EPSP amplitude occurred 
without a change in the sensitivity of postganglionic neurones 
to bath applied carbachol (0.5 uM) , suggesting a presynaptic site 
of action for adenosine. The mechanism of these effects was not 
discussed but it is reasonable to suggest that the inhibition of 
a Ca2+ activated K+ current by adenosine (see Henon & McAfee, 
1983a) could increase repetitive firing to facilitate synaptic 
transmission while presynaptic inhibition of ACh release by 
adenosine (Briggs et al., 1988) would reduce the effect of a 
single CAP.
Thus nicotine and adenosine may interact at several loci to 
modify autonomic activity and the effect of adenosine on ganglia 
and the nature of the effects reported by von Borstel et al., 
(1984, 1986) requires further study. The inability of adenosine 
to alter the response of the rat SCG to nicotinic depolarisations 
(see Tables 5.2 to 5.4) suggests the actions of adenosine, 
reported by von Borstel et al, are more likely to have occurred 
at the end organs. Alternatively it may be argued that the use 
of nonphysiological concentrations of adenosine in this study may 
have inhibited the potentiation of nicotinic responses of the 
ganglion. There is some evidence in favour of this hypothesis as 
adenosine at plasma concentrations of 3 to 4 uM potentiated the 
response to nicotine but at higher concentrations of adenosine 
the potentiation was diminished (von Borstel et al., 1984). Even 
if the concentration of adenosine chosen was too high to record 
potentiation of DMPP it is clear from the results (Tables 5.2 &
5.3) that the major action of adenosine is to depress the
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response to muscarinic agonists.
In agreement with the results of Akasu et al., ( 1981, 1983a,
1985) adenosine did not alter the response to nicotinic agonists 
nor did nicotinic depolarisation potentiate the response to 
adenosine (Fig 5.7, Table 5.7).
Furthermore the results presented in chapter 6 indicate the 
adenosine receptors of the rat SCG are not of the A2 subtype as 
selective A2 agonists were weak or inactive on the SCG. If the 
potentiation of nicotinic responses in vivo is mediated via A2 
receptors as judged from the data of von Borstel et al., (1986) 
then it is difficult to understand how adenosine can potentiate 
the nicotinic responses of the SCG.
Consistent with the inability of ouabain (Table 4.10) and Li- 
HEPES PSS (Figs 4.13 & 4.14 & Table 4.13) to antagonise the 
response to adenosine the AHP produced by DMPP was unaltered by 
up to 100 uM adenosine (Tables 5.3 & 5.4), suggesting adenosine 
does not hyperpolarise the rat SCG by activating the electrogenic 
Na+ pump. The inability of adenosine to alter the depolarisation 
to nicotinic agonists is also consistent with a lack of effect 
of low Na+ PSS on the response to adenosine as carbachol is known 
to increase the influx of Na+ ions during nicotinic 
depolarisation.
Interaction with muscarinic receptors.
ACh, in addition to activating nicotinic receptors, also 
activates muscarinic receptors and represents another potential 
modulatory site for adenosine (see Table 5.12 for reported 
interactions). An examination of the data presented in this 
thesis shows that by far the greatest interaction between 
adenosine and depolarising agonists is the depression of the 
response to muscarine by adenosine (Fig 5.3). Adenosine at 10 uM 
and 100 uM produced parallel shifts in the CRC to muscarine (Fig 
5.6) suggesting adenosine is a competitive antagonist of
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muscarine. The correlation between the change in response to 
muscarine in the presence of adenosine and the size of the 
hyperpolarisation to adenosine (Fig 5.4a) may be interpreted to 
suggest adenosine is a functional antagonist of the 
depolarisation to muscarine. However adenosine would have been 
expected to antagonise the response to a variety of other 
agonists to a similar extent and this was not the case (see 
Tables 5.2 & 5.3). Likewise the smaller depression of muscarinic 
responses but similar degree of hyperpolarisation of ganglia by 
(-)baclofen (cf Figs 5.4a & 5.5) suggests the depression of 
muscarinic responses was not due to functional antagonism. The 
results with (-) baclofen support the view that there is a 
specific and selective interaction of muscarine and adenosine.
Further evidence for a selective interaction between adenosine 
and muscarinic responses is provided by the lack of effect of 
adenosine on the depolarisation to potassium (Fig 5.2a, Table
5.3) and isoprenaline (Fig 5.2f, Tables 5.3 & 5.4) and the
ability of muscarinic agonists to enhance the hyperpolarisation 
to adenosine (Results 5.7.3.2 & Table 5.8).
It has been shown that 5'-isobutylthio-adenosine (SIBA) and its 
analogues at 100 uM antagonised ACh-induced contractions of the 
guinea-pig ileum (Pankaskie, Kachur, Itoh, Gordon & Chiang, 
1985). It is reported that SIBA and related agonists can alter 
the binding of muscarine to muscarinic receptors (Smejkal, 
Ibrahim, Pankaskie & Chiang, 1989). It seems unlikely that 
adenosine directly inhibited the binding of muscarine to 
muscarinic receptors as MTO and pirenzepine did not alter the 
response of the ganglion to adenosine (Tables 5.1 & 5.5). In 
addition the Ki for the inhibition of specific binding of 
3H-pirenzepine to the rat cerebral cortex by SIBA was 160 uM 
(Smejkal et al., 1989 ), a value 16 fold greater than the IC50 for 
the depression of muscarinic responses on the rat SCG.
Opposite effects to those described here have been reported by 
Worley & Colleagues (Worley, Baraban, McCarren, Snyder & Alger,
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1987; Worley, Heller, Snyder & Baraban, 1988). Both phorbol 
esters and cholinomimetics were shown to prevent the inhibitory 
effects of adenosine on orthodromically-induced synaptic 
potentials and the adenosine-induced hyperpolarisation of 
CA1-pyramidal cells (Worley et al., 1987; 1988). Carbachol was 
substantially more effective than oxotremorine in blocking the 
adenosine elicited outward current (Worley et al., 1987), whereas 
on the rat SCG carbachol was the most resistant to the depressant 
effects of adenosine. It is interesting to speculate that the 
stimulatory and inhibitory activity of phorbol esters and 
cholinomimetics arises from a difference in the role of PKC in 
the ganglion and hippocampus (Fig. 5.12).
In agreement with the results reported here Brooks & Stone (1988) 
found that adenosine reduced the activity of cholinomimetics at 
concentrations that did not alter the actions of excitatory amino 
acids on the hippocampus. The mechanism of action was not 
studied but both the potency and relative order of potency of the 
purines tested i.e. R & S-PIA, NECA and adenosine was similar to 
that reported for these agonists on the rat SCG (r2 = 0.95) 
suggesting a similar mechanism may be responsible for both 
actions of adenosine. Both of these studies appear to be 
different from the reports by Worley et al., (1987, 1988) as the 
actions of adenosine reported here on the rat SCG and on the 
hippocampus (Brooks & Stone, 1988) were postsynaptic and the 
concentration of adenosine achieved at the cell surface by Worley 
et al., ( 1987, 1988) may be considerably higher than that
reported here or in the study by Brooks & Stone (1988).
The effects reported here and by Brooks & Stone ( 1988) are in 
sharp contrast to other studies where purines enhanced the 
nicotinic or muscarinic sensitivity of other preparations (Table
5.12). These results are in partial agreement with studies on 
the central neurones of Helix (Cox & Walker, 1987) where low 
concentrations potentiated and higher concentrations depressed 
the ACh response. The adenosine receptor responsible for the 
depressant activity of adenosine on Helix neurones may be of the
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A3 purinoceptor subtype given the inactivity of NECA and the Ca2+ 
dependent nature of the depression.
The bell-shaped depression of the response of the rat SCG to 
muscarine by increasing concentrations of purines was observed 
in both normal and low Ca2+ PSS. The application of adenosine at 
increasing time intervals did not alter the size or shape of the 
response, suggesting receptor desensitization may not account for 
the shape of the CRC. A second possibility is that higher 
concentrations of purines activate a second receptor or another 
process that antagonises the effects of lower concentrations of 
adenosine. The latter explanations may also account for the 
inability of adenosine to abolish the response to muscarine. 
However other factors such as differences in the coupling or 
number of receptors for adenosine and muscarine may also account 
for these phenomena e.g., if there were an appreciable number of 
spare receptors for muscarinic agonists (Brown et al., 1980) but 
few if any spare adenosine receptors, as may be indicated by the 
non-parallel CRC to adenosine in the presence of a competitive 
Al antagonist (see Chapter 6).
In addition to muscarine, adenosine depressed the response to 
carbachol and MeF (Figs 5.2 h-i; Table 5.2) with the response to 
muscarine being the most susceptible. It is well documented that 
muscarine can both depolarise and hyperpolarise the ganglion and 
the effects of adenosine may result from effects on the Ml 
depolarisation and/or the M2 mediated hyperpolarisation.
Using the same concentration of MTO reported by Field & Newberry 
(1988) to reduce selectively the hyperpolarising response to 
muscarine, the response to MeF was significantly reduced (Table
5.5). This result was unexpected as MeF is reported to be a 
highly selective Ml receptor agonist on the rat SCG and does not 
hyperpolarise the rat SCG (see Results and Newberry & Connolly, 
1989). The results obtained here suggest that MTO antagonises the 
hyperpolarisation to muscarine but may also produce a small but 
significant depression of the depolarisation to muscarinic
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agonists. In a more recent report published after the completion 
of this research, the effects of MTO as illustrated by Fig 1 in 
Field & Newberry (1989) indicate a reduction of the 
depolarisation to muscarine by MTO. Thus the depression of both 
Ml and M2 mediated responses by MTO may complicate the 
interpretation of the results presented here in that the 
depression of muscarinic agonists by adenosine was found to be 
dependent on the degree of depolarisation by these agonists 
(Table 5.4). Even so the inability of MTO to alter the response 
to adenosine is consistent with the inactivity of pirenzepine on 
the response to adenosine (Table 5.1) suggesting that the 
hyperpolarisation to adenosine is independent of presynaptic 
release of ACh.
To examine if adenosine alters the M2 mediated hyperpolarisation 
of the ganglion the effect of adenosine on the hyperpolarisation 
to carbachol was studied. Carbachol was the most potent 
muscarinic agonist to hyperpolarise the ganglion, whereas MeF did 
not hyperpolarise the SCG. The potency order for muscarinic 
agonists to hyperpolarise was:-
Carbachol > OXO-M > muscarine >> MeF 
ca EC50 (nM) >= 210 > 300 > 800 >> 10000
The response to carbachol was complex and at up to 1 uM produced 
concentration dependent hyperpolarisations (Fig. 5.9a, whereas 
at 10 uM the hyperpolarisation was followed by a 'fast' 
depolarisation. Although the 'fast' depolarisation was 
antagonised by a nicotinic antagonist, DHBE, the initial 
hyperpolarisation to carbachol was also reduced. The poor 
selectivity of nicotinic antagonists versus the nicotinic and 
muscarinic responses of the rat SCG to electrical stimulation has 
been reported by Newberry & Connolly (1989) and a nicotinic 
antagonist was not used to avoid any adverse effects on the 
responses to carbachol and adenosine.
The inability of adenosine to alter submaximal or near maximal
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hyperpolarisations to carbachol (Table 5.6, Fig 5.9b) indicates 
that the depression of muscarinic responses is due to the 
selective reduction of Ml-mediated depolarisation (see also Fig 
5.9c).
Consistent with this conclusion is the ability of both 
pilocarpine, an effective Ml agonist on the rat SCG (Caulfield 
& Stubley, 1982) and N-methyl-N-(1-methyl-4- pyrrolidino-2- 
butynyl)acetamide (BM-5) an oxotremorine analogue with 
presynaptic antagonist and postsynaptic agonist properties 
(Casomenti, Cosi & Pepeu, 1986) to enhance the hyperpolarisation 
to adenosine (Table 5.8). These results indicate that the 
potentiation of adenosine occurs via an interaction with 
postsynaptic Ml receptors.
If adenosine and carbachol activate the same intracellular 
mechanism then when fully activated by carbachol no greater 
effect by adenosine would be obtained. The inability of a 
combination of 1 uM carbachol and 10 uM adenosine to attain the 
same response size as the sum of the individual responses (Table
5.6) therefore suggests both agonists may hyperpolarise the rat 
SCG via a common mechanism. Recently it has been reported that 
many inhibitory neurotransmitters activate an inwardly rectifying 
K+ channel by a mechanism that involves a pertussis toxin 
sensitive G-protein (Trussell & Jackson, 1989; Newberry & 
Gilbert, 1989). Given that muscarinic hyperpolarisation of 
amphibian ganglia increases gK (Gallagher, Shinnick-Gallagher, 
Cole, Griffith & Williams, 1980) and that adenosine mediates the 
sIPSP of cat parasympathetic ganglia (Akasu et al., 1984), both 
the adenosine and carbachol-induced hyperpolarisation of the rat 
SCG may be mediated by a common mechanism i.e., increased gK 
(Chapter 4).
Thus the differential potency of adenosine on the response to 
muscarinic agonists (Table 5.4) appears to arise from some other 
effect than a difference in ability to modulate the M2-mediated 
hyperpolarisation of the ganglion. A difference in biochemical
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coupling of the muscarinic receptor and/or in the coupling of 
intracellular messengers (see discussion below) would also 
explain the ability of adenosine to reduce the response to 
submicromolar and not higher concentrations of muscarine (Fig 
5 . 4a) .
Effect of ganglionic depolarisation on the response to adenosine.
Complex and concentration-dependent effects of muscarine on 
sympathetic ganglia have been reported by many research groups 
and involve a variety of ionic conductances including Im, Ix, ID 
and other currents (Brown & Selyanko, 1985a,b; Brown et al., 
1989; Mochida & Kobayashi, 1986a,b; Tokimasa, 1984; Tokimasa & 
Akasu, 1990a; Tsuji & Kuba, 1988). It is unlikely that adenosine 
interacts with muscarine induced Ix as the response to adenosine 
was independent of [Cl']e (Chapter 4) and for rat SCG neurones 
the predominant effect of muscarine is to increase neuronal 
excitability to produce a 'slow' depolarisation mediated by a 
decrease in gK (Weight & Voltava, 1970; Kuba & Koketsu, 1974, 
1976, 1978; Brown & Adams, 1980). This decreases in gK occurs as 
a consequence of the activation of Ml receptors (Brown et al., 
1989) and the inhibition of the outwardly rectifying K+ current, 
Im (Brown & Constanti, 1980). In contrast the effects of 
adenosine in some preparations have been found to be via an 
increase in gK (reviewed in Stone 1981, 1989) and this hypothesis 
is strongly favoured from the results presented here and in 
Chapter 4. Thus it was predicted and confirmed experimentally 
that adenosine and muscarine would strongly interact so that the 
adenosine induced hyperpolarisation would be enhanced during a 
muscarinic depolarisation (Fig 5.13 & 5.14 & Table 5.7). The 
difference in the shape of the response to adenosine at 
millimolar concentrations (Fig. 5.13c) may arise because of 
desensitisation to adenosine, an interaction at two different 
receptors or the efflux of K+ in to the extracelluar space (see 
Chapter 6 for further discussion).
The RMP (Em) of the rat SCG has been measured by several research
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groups to be between -50 to -70 mV and is predominantly 
determined by the K+ transmembrane gradient (Blackman, Ginsborg 
& Ray, 1963; Kosterlitz et al., 1968). When [K+]e is raised, the 
K+ concentration gradient is decreased, and ganglionic neurones 
will be depolarised (the reduction of the RMP can be estimated 
by substituting values for [K+]i and [K+]e in to the Nernst 
equation) to generate an increased "driving force (Em -Ek)" for 
potassium. The response to adenosine during the depolarisation 
to K+ was unaltered suggesting depolarisation per se does not 
enhance the hyperpolarisation to adenosine. Depolarisation with 
isoprenaline (Table 5.8) or nicotine (Fig 5.7 & Table 5.8) did 
not enhance the response to adenosine, supporting this view.
It is interesting to note that a similar potentiation of the 
hyperpolarisation to NA when applied during a muscarinic 
depolarisation of the rat SCG was observed by Brown & Caulfield 
(1979). Based on an investigation of the ionic conductances of 
single cells Brown & Caulfield suggested that muscarine and NA 
produced their effects via separate voltage-sensitive components 
by an action of muscarine on Im and NA on IKCa or gNa (Brown & 
Caulfield, 1981). In contrast it has been reported by Selyanko, 
Smith & Zidichouski (1990) that muscarine and adrenaline can have 
opposite effects on M-channels recorded from amphibian 
sympathetic ganglia. The results presented in chapter 4 suggest 
the response of the SCG to adenosine is not via IKCa channels or 
a change in gNa and it is therefore unlikely that the effects of 
adenosine occur via an interaction with these conductances.
A number of compounds apart from muscarine (Brown & Adams, 1980; 
Constanti & Brown, 1981) inhibit Im including LHRH (Adams & 
Brown, 1980; Jones, 1987), barium (Constanti et a l ., 1981a),
substance P (Adams, Brown & Jones, 1983) on bullfrog ganglia and 
LHRH and UTP (Adams et al., 1982a) on the rat SCG. The effect of 
some of these compounds reported to inhibit Im on the response 
of the rat SCG to adenosine is summarised in table 5.8. The 
potentiation of the response to adenosine in the presence of most 
of these agonists that are reported to inhibit Im (Table 5.8)
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supports the hypothesis that adenosine interacts with Im.
Both UTP and LHRH produced small depolarisations which did not 
significantly alter the response to adenosine (Table 5.8). It is 
possible that the concentrations employed may not have been 
adequate to inactivate sufficient M-current to alter the response 
to adenosine. This conclusion would be in agreement with the 
results obtained by Jones (1987) where amphibian ganglia required 
high concentrations of muscarine and low concentrations of LHRH 
to inhibit Im, whereas the converse situation would be expected 
in mammalian ganglia, where ACh is the predominant transmitter 
to mediate inhibition of Im. In addition one uncontrolled factor 
in the experiments described here (Table 5.8) was the metabolism 
of LHRH and UTP to inactive or less active metabolites.
In contrast both the substance P analogue, ERP and Ba2+ 
depolarised the ganglion and significantly potentiated 
hyperpolarisations to adenosine (Table 5.8) supporting the 
hypothesis that adenosine may interact with Im.
There are several possible mechanisms that may be responsible for 
the potentiation of the response to adenosine by Ba2+. Firstly 
Ba2+ might cause the release of ACh from presynaptic terminals, 
as it does in cholinergic motor neurones. The rapid response of 
sympathetic ganglia to Ba2+ recorded by both Takeshige & Voile 
(1964) and Tashiro & Nishi ( 1972) Was antagonised by dTC to leave 
a slow depolarisation which was not antagonised by atropine 
(Adams et al., 1982a), suggesting a direct effect of Ba2+ on 
postganglionic neurones.
A second possibility is that Ba2+ penetrates in to ganglion cells 
via Ca2+ channels (Tashiro & Nishi, 1972) and decreases neuronal 
RMP to depolarise the ganglion and potentiate the response to 
adenosine. Although the indirect effect of Ba2+ to depolarise the 
ganglion via Ca2+ entry was not examined, the results presented 
in Chapter 4 do not support the hypothesis that adenosine 
interacts with Ca2+ entry and is an unlikely explanation for the
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depression of the response to Ba2+ by adenosine (Table 5.3). In 
addition the degree of depolarisation induced by Ba2+ (see Table
5.3) would be unlikely to activate voltage operated Ca2+ 
channels.
However the application of Ba2+ for long periods can lead to 
unexplained changes in rat SCG neurones (Adams et al., 1982a). 
Adams et al., (1982a) reported that brief applications of 4 mM 
Ba2+ produced effects fully compatible with inhibition of Im, 
comprising a membrane depolarisation accompanied by an increased 
input resistance and increased excitability. Prolonged 
application of Ba2+ resulted in irreversible depression of large 
outward currents (Adams et al, 1982a), probably due to entry of 
Ba2+ through calcium channels and a progressive intracellular 
accumulation of Ba2+ (Hagiwara & Byerly, 1981). It is possible 
that prolonged treatment of the rat SCG with Ba2+ antagonised an 
outward current activated by adenosine, and may account for the 
loss of the potentiation of the hyperpolarisation to adenosine 
(Table 5.8).
Even though the potentiation of the hyperpolarisation to 
adenosine by Ba2+ disappeared within 30 minutes incubation (Table
5.8), Ba2+ potentiated the depression of the response to 
muscarine by adenosine (Table 4.8), suggesting the actions of 
Ba2+ on the rat SCG are linked to the interactions of adenosine 
and muscarine. As reported for many divalent cations, the actions 
of Ba2+ may alter other membrane currents, such as IKCa (Connor, 
1979 ), and Ik (Constanti et al., 1981b) may be inhibited or 
potentiated e.g., (ID) (Tsuji & Kuba, 1988) and interact with 
adenosine. The most likely explanation of the ability of 
adenosine to reduce the response to Ba2+ (Table 5.3), is due to 
an interaction with the decrease in permeability of the ganglion 
cell membrane to K+ induced by Ba2+ due to inhibition of Im 
(Constanti et al., 1981a; Tsuyi & Kuba, 1988).
Another and not mutually exclusive hypothesis is that Ba2+ 
activates protein kinase C (PKC) in the ganglion as suggested for
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the C-kinase purified from heart (Wise, Raynor & Kuo, 1982). 
Given that PKC is involved in the mechanism of the slow
muscarinic excitation (see Brown, 1988 & discussion on PKC below) 
an increase in the activated PKC by Ba2+ would result in the
potentiation of the adenosine hyperpolarisation.
The role of secondary messengers in the response of the rat SCG 
to adenosine and muscarine.
The effect of altered cyclic nucleotide metabolism.
One of the first indications that the actions of adenosine were 
related to modifications of adenylate cyclase activity was
described by Sattin & Rail (1970) who showed adenosine increases 
cAMP accumulation in the guinea-pig cerebral cortex. Further 
evidence was provided by Van Calker et al., (1979) who 
demonstrated that adenosine and its analogues can stimulate or 
inhibit cAMP accumulation in cultured brain cells and proposed 
that two different receptors are involved in the increase in cAMP 
(A2) and decrease (Al) in cAMP. However, since these early 
studies it has become apparent this classification of PI
purinoceptors may be too restricted and not all adenosine 
receptors are coupled to a change in cAMP concentration.
Greengard (1976) suggested cyclic nucleotides have a major role 
in postsynaptic transmission of sympathetic ganglia, and that 
cAMP and cGMP exert long term control of neuronal excitability 
(McAfee & Greengard, 1972). It was suggested that muscarinic 
depolarisation of the SCG is mediated through an increase in cGMP 
(Weight, Petzold & Greengard, 1974; Kobayashi, 1982; Kebabian, 
Steiner & Greengard, 1975). This idea was strengthened by the 
observation that cGMP mimicked the excitatory effects of ACh on 
pyramidal neurones (Stone & Taylor, 1977). Complex effects of 
cGMP and derivatives have been reported, and on rabbit SCG, 
McAfee & Greengard (1972) found dibutyryl-cyclic-guanosine 
3 5 ' -monophosphate (DbcGMP) produced a small transient
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hyperpolarisation followed by a larger depolarisation. Dun et 
al., (1978) confirmed that DbcGMP depolarised postganglionic 
neurones but also produced a long acting and variable A H P . It 
has, however, also been reported that cGMP and its derivatives 
had no consistent effect on the RMP when iontophoresed or 
microinjected in to rabbit SCG neurones (Buiss, Weight & Smith,
1978) .
In support of the hypothesis that muscarinic agonists depolarise 
the rat SCG by increasing cGMP both Voile, Quenzer, Patterson, 
Alkadhi & Henderson (1981) and Briggs, Whiting, Ariano & McAfee 
(1982) reported muscarinic agonists increased cGMP two fold. 
Carbachol has also been found to increase cGMP levels of rabbit 
SCG by two fold (McAfee -in Voile et al., 1981), and by six to 
eight fold in guinea-pig SCG (Wamsley, West, Black & Williams,
1979) and in both cases the increase in cGMP was antagonised by 
atropine. An increase in cGMP in response to muscarinic agents 
has also been reported using bovine SCG (Kebabian et al., 1975) 
and rabbit SCG (Takahashi, Mochida & Kobayashi, 1988). The 
ability to localise immunohistologically, cyclic nucleotides and 
the increase in cGMP by carbachol to the postganglionic neurones 
of the rat SCG (Ariano, Briggs & McAfee, 1982) strengthens the 
hypothesis that the muscarinic depolarisation is mediated by 
cGMP.
However other biochemical and electrophysiological studies have 
not confirmed this association. Brown et al. (1980) reported that 
muscarine at 1 or 100 uM applied for 2 to 5 minutes did not alter 
resting levels of cGMP of the rat SCG. Also an increase in cGMP 
by eight fold by sodium azide was reported by Voile et al., 
(1981) not to alter the resting d.c. potential or the response 
to bethanechol. It has also been noted that the depolarisation 
of rabbit or rat SCG by DbcGMP, is accompanied by an increase in 
membrane conductance (gM) (Dun et al., 1977, 1978; Gallagher & 
Shinnick-Gallagher, 1978) whereas there was no change or a
decrease in gM during the response to the sEPSP (Kuba & Koketsu, 
1978). Theses observations are incompatible with the hypothesis
180
that the sEPSP is mediated by cGMP. However Hashiguchi, 
Ushiyama, Kobayashi & Libet (1978) also found an increase in gM, 
but when the membrane of the rabbit SCG was voltage clamped there 
was no change in gM and it was concluded these effects are 
compatible with the mediation of the sEPSP by cGMP. Thus cyclic 
GMP appears to mediate at least one of the components in the 
mechanism underlying the sEPSP of the rabbit SCG (Kobayashi, 
1982 ) and more recent studies by Takahashi et al . , ( 1988) suggest 
that muscarine and cGMP and its derivatives phosphorylate the 
same endogenous protein, and that cGMP appears to be involved in 
mediating a part of the sEPSP.
The results of this study show cGMP depolarises the rat SCG, 
although the responses to cGMP were smaller than those to 
muscarine (Fig. 3.11), but are in agreement with Gallagher & 
Shinnick-Gallagher (1978) who found exogenous DbcGMP (250 uM) 
depolarised the rat SCG, and in partial agreement with Brown et 
al., (1980) who found cGMP and 8BrcGMP at 1 mM depolarised two 
out of ten rat SCG and was ineffective on the other eight. Thus 
an increase in cGMP may mediate some part of the response of the 
rat SCG to muscarine but not the majority of the response.
The intracellular injection of cAMP into postganglionic cells 
caused a sustained potentiation of the sEPSP of rabbit SCG 
(Kobayashi, Hashiguchi & Ushiyama, 1978). If long term 
enhancement (LTE) occurs in rat SCG neurones then an increase in 
cAMP levels would be predicted to counteract the depression of 
muscarine by adenosine. However the evidence for a change in 
cAMP upon muscarinic stimulation in the rat SCG is conflicting. 
Briggs et al ., (1982) found an increase in cAMP whereas Voile
et al., (1981) found no such change in intracellular cAMP. 
Likewise the application of extracelluar or intracellular cAMP 
and its derivatives has been found to depolarise (Akasu & 
Koketsu, 1977; Hsu & Mclsaac, 1978; Brown & Dunn, 1983; Gallagher 
& Shinnick-Gallagher, 1977), hyperpolarise (McAfee & Greengard, 
1972; Machova & Kristofova, 1973; Brown et al., 1979; Brown & 
Dunn, 1983) or have no effect on SCG (Dun et al., 1977; Dun &
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Karczmar, 1977; Gallagher & Shinnick-Gallagher, 1977; Busis et 
al., 1978).
For many cell types stimulation of muscarinic receptors has two 
consequences: an increase in PIT and a change in intracellular 
cGMP or cAMP, e.g. the hydrolysis of PIT due to the stimulation 
of Ml receptors in a transfected cell line stimulates adenylate 
cyclase to increase cAMP (Felder, Kanterman & Axelrod, 1989) and 
muscarine increases cAMP in NE-115 cells (Tsunoo & Narahashi, 
1987 ) . Alternatively muscarinic stimulation can cause a reduction 
of the cAMP content of tissues, e.g. in 1321N1 human astrocytoma 
cells muscarinic stimulation reduces cAMP via the activation of 
a Ca2+/CaM sensitive PDE (Meeker & Harden, 1982). Muscarinic 
agonists are reported to increase the cAMP content of the rabbit 
SCG (Kalix, McAfee, Shorderet & Greengard, 1974) and an increase 
in cAMP has been reported to mediate a dopamine induced LTE of 
the muscarinic response of rabbit SCG (Libet et al., 1975). In 
addition muscarine might increase cAMP formation via an indirect 
action, via a rise in [Ca2+]i due to the stimulated hydrolysis of 
phosphoinositol lipids (PI) (Fredholm, Longren, Lindstrom & 
Norstedt, 1987; Karbon, Shenolikar & Enna, 1986). This mechanism 
is unlikely to be responsible for the response of the SCG to 
muscarine given that SQ 22,536 did not alter the depolarisation 
to muscarine (Table 5.9).
In an analogous manner to that found in rat or guinea-pig brain 
the action of adenosine on the rat SCG may occur due to a change 
in cAMP levels via an effect on adenylate cyclase activity 
(Dunwiddie & Fredholm, 1984; Yeager, Nelson & Storm, 1986; 
Donaldson, Brown & Hill, 1988) or PDE activity (Smellie, Davis, 
Daly & Wells, 1979; De Mazancourt & Giudicelli, 1984). To 
discover if a change in cyclic nucleotide metabolism is involved 
in the response of the rat SCG to adenosine or the depression of 
muscarinic responses, the response to adenosine was assessed in 
the presence of selective inhibitors of the synthesis of cAMP and 
breakdown of cAMP or cGMP. The proposed sites of action of these 
compounds are shown in Fig. 5.11.
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One model for sympathetic neurones are PC12 cells which respond 
to adenosine by the activation of adenylate cyclase to increase 
intracellular cAMP (Guroff, Dickens, End & Constantin, 1981). If 
the PC12 cell line is representative of the rat SCG, which 
hyperpolarises to Al receptor agonists (Chapter 6) then the 
inhibition of adenylate cyclase would be predicted to depress the 
response to muscarine and potentiate its depression by CPA. SQ
22.536 a potent inhibitor of adenylate cyclase (Harris, Asaad, 
Phillips, Goldenberg & Antonaccio, 1979) at 100 uM blocked the 
increase in cAMP generated by the application of isoprenaline to 
the rat SCG (Brown & Dunn, 1983). The same concentration of SQ
22.536 did not alter the depression of the response to muscarine 
or the response to muscarine itself (Table 5.9) indicating these 
responses are not due to an interaction with adenylate cyclase. 
The inability of SQ 22,536 a "P-site" (see Chapter 1, Table 1) 
selective adenosine agonist (Fredholm & Lingren, 1984) to alter 
the d.c. potential of the ganglion argues against a decrease in 
cAMP mediating the adenosine-induced hyperpolarisation of the rat 
SCG.
Alternatively adenosine may alter cAMP levels of the ganglion by 
altering PDE activity (Fig 5.11). The effects of PDEI on the 
response of the rat SCG may be complicated by the presence of 
multiple forms of cyclic nucleotide PDE. Four major isozymes have 
been described: one with Ca2+/CaM stimulated activity (PDE I), 
one having activity with a preference for cGMP (PDE II) and two 
preferring cAMP, with different Michaelis constants (Km) for cAMP 
and sensitivity to cGMP (PDE III and PDE IV) (Thompson & 
Appleman, 1971; Weishaar, 19 87; Beavo, 1988; Beavo & Reifsnyder, 
1990 ) .
Histological studies have indicated a postsynaptic localisation 
of cAMP PDE in central cerebral cortex (Florendo, Barnet & 
Greengard, 1971) and the rat SCG (Vente, Garssen, Tilders, 
Steinbusch & Schipper, 1987 ) and a cGMP PDE in rabbit SCG 
(Quenzer, Yahn, Alkadi & Voile, 1979). Furthermore two forms of 
cAMP PDE have been characterised from crude enzymes isolated from
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the guinea-pig SCG by Capuzzo, Biondi, Borasio, Ferretti & Fabbri 
( 1986 ), one with a high affinity for cAMP (Km 1 uM) which was 
weakly inhibited by the non-selective PDE inhibitor, IBMX (Ki 90 
uM) and may be similar to the isozyme, PDE IV extracted from the 
mammalian brain. The second PDE had a low affinity for cAMP (Km 
110 uM) and was stimulated by Ca2+ and CaM, an effect completely 
antagonised by TFP at 60 uM. The inactivity of TFP on the
adenosine-induced hyperpolarisation of the rat SCG (Table 4.3) 
suggests the effects of the PDE I type isozyme if present in rat 
SCG neurones is unlikely to be involved in the response to 
adenosine.
Oleshansky (1980) reported that adenosine inhibits cGMP
stimulation of cAMP hydrolysis, i.e. PDE II activity, with an 
IC50 of 80 uM in the rat striatum to raise the level of neuronal 
cAMP. However, the inability of the PDE I and II isozyme 
inhibitor, M&B 22,948 (Souness, Brazdil, Diocee & Jordan, 1989) 
to alter the response of the rat SCG to adenosine (Table 5.9) 
indicates adenosine does not stimulate a similar PDE and the 
depression of muscarine by adenosine is unlikely to be mediated 
by a decrease in cGMP.
The Ca2+/CaM-independent low Km cAMP PDE isozyme, (PDE IV) is 
selectively inhibited by a theophylline analogue, denbufylline 
(Nicholson, Jackman & Wilke, 1989) and Ro 20-1724 (Sheppard & 
Wigan, 1971; Sheppard, Wigan & Tsien, 1972) and is thought to 
regulate the cAMP concentration in both the rat cerebrum and 
guinea-pig hippocampus (Stanley, Brown & Hill, 1989; Challiss & 
Nicholson, 1990). It would be expected that the incubation of the 
rat SCG with Ro 20-1724 or denbufylline would depress the 
response to adenosine if it is due to a decrease in cAMP.
Ro 20-1724, denbufylline and SQ 22,536 were either ineffective
or reduced the depolarisation and depression by adenosine of the 
muscarinic response (Table 5.10). The ability of denbufylline and 
Ro 20-1724 to antagonise the effects of adenosine may indicate 
the effects of adenosine are mediated by a reduction in cAMP.
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The concentration of denbufylline required to reduce the 
hyperpolarisation to adenosine by 50% was estimated to be 36 uM 
and is similar to the Ki (20 uM) reported for the inhibition of 
Al radiolabelled ligand binding of [3H] cyclohexyladenosine (CHA) 
by denbufylline (Nicholson & Jackman, 1988). Thus the antagonism 
of the effects of adenosine (Table 5.9) reported here may have 
occurred due to direct receptor antagonism. Given that 
denbufylline almost completely abolished the PDE (Type IV) 
activity of the rat cerebral cortex at 10 uM (Nicholson & Wilkie, 
1987 ) it is possible that the reduction of the response to 
muscarine (Table 5.9) may be due to a nonspecific action.
It has been shown that at 180 uM Ro 20-1724 increased both the 
basal and carbachol stimulated increase in cAMP levels of the 
rabbit SCG (Kalix et al., 1974) and it would be expected to have 
a similar effect on the rat SCG. The reduction of the 
hyperpolarisation to adenosine but not the depression of the 
response to muscarine (Table 5.9) indicates the former but not 
the latter effects of adenosine may be mediated by cAMP.
Ro 20-1724 was chosen as a PDEI as it has been used extensively 
in experiments where there is a need for a PDEI which is 
structurally unrelated to the methylxanthines and therefore 
should not interfere with the binding of adenosine and related 
ligands. However, it has been reported that at 100 uM Ro 20-1724 
inhibited the binding of [3H]-PIA to rat brain membranes by 20% 
(Schwabe & Trost, 1980) and it is possible at 200 uM Ro 20-1724 
strongly antagonised the binding of adenosine to the rat SCG. 
Thus both the antagonism by denbufylline and Ro 20-1724 of the 
effects of adenosine on the rat SCG may be due to receptor 
antagonism. In support of this hypothesis, Ro 20-1724 (Fig 5.10) 
and an Al adenosine receptor antagonist (Fig 6.23) caused a 
similar antagonism of the CRC to adenosine.
There is some circumstantial biochemical evidence to suggest that 
adenosine does not affect the response of agonists that stimulate 
cAMP formation in SCG. Roch & Kalix (1975) studying blocks of
185
bovine SCG found the cAMP content was not altered by incubation 
in 100 uM adenosine for 9 minutes in either untreated, or SCG 
treated with theophylline or Ro 20-1724. Adenosine did not alter 
the increase in cAMP induced by high potassium medium, the latter 
effect of high [K+]e being attributed to the release of 
catecholamines, which presumably activated beta-adrenoceptors to 
stimulate cAMP formation. Similarly Kalix et a l . , ( 1974)
reported that in rabbit SCG adenosine had no effect on cAMP 
levels at rest or during cholinergic stimulation. Unfortunately 
both of these reports lack sufficient experimental details in 
that the concentrations of agonists and antagonists, and 
conditions employed are unknown, but the results do support those 
presented here, in that the effects of adenosine on the rat SCG 
are cAMP-independent.
Among the agents known to increase the cAMP content of the rat 
SCG, isoprenaline is one of the most potent (Cramer et a l . , 1973; 
Quenzer et al., 1979; Quenzer, Patterson & Voile, 1980; Briggs 
et al, 1988; Petit, Barberis & Jard, 1988), e.g., at 1 uM the 
application of isoprenaline for 4 minutes to the rat SCG 
increased the cAMP content ten fold (Quenzer et al., 1980). If 
adenosine receptor activation modulates cAMP as reported for the 
actions of arginine vasopressin on the rat SCG (Petit et a l . ,
1988) it is surprising that isoprenaline did not alter the 
response to adenosine (Table 5.7).
It has been reported that adenosine had no effect on a Ca2+ 
dependent potential in sino atrial node of the rabbit heart 
unless these cells were first activated by isoprenaline 
(Belardinelli, Giles & West, 1988). The inability of isoprenaline 
to alter the response to adenosine reported here (Table 5.7) 
suggests adenosine does not interact with a current similar to 
that described by Belardinelli et al., (1988). This result 
supports the results obtained in Chapter 4 where it was shown 
that adenosine does not interact with Ca2+ dependent potentials.
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Likewise VIP, which at 0.1 uM is reported to increase the cAMP 
content of the rat SCG by about four fold (Voile & Patterson, 
1982; but see Audigier, Barberis & Jard, 1986) and at higher 
concentrations (> 1 uM) potentiated the response to muscarinic 
receptor stimulation by carbachol (Kawatani, Rutigliano & De 
Groat, 1985), did not alter the response to adenosine or 
muscarine (Tables 5.1 & 5.7). These results are consistent with 
the small reduction or inactivity of adenosine on the 
depolarising response to isoprenaline (Tables 5.2 & 5.3, Fig 5.2 
f) and indicate the effects of adenosine may not be mediated via 
a change in cAMP. The potentiation of the response to adenosine 
by forskolin may be mediated through some other effect rather 
than stimulation of adenylate cyclase (Laurenza, Sutkowski & 
Seaman, 1989), such as an increase in open channel activity as 
reported by Akagi & Kudo (1985) for rat SCG neurones.
The dual regulation of Im by agents that increase cAMP to 
stimulate Im and for muscarinic stimulation to decrease Im has 
been described for smooth muscle cells of the toad (Sims, Singer 
& Walsh, 1988) and for adrenaline to increase Im in frog ganglia 
(Selyanko et al., 1990). In contrast Im was not altered by the 
intracellular injection or extracelluar application of agents 
that increase cAMP, e.g. DbcAMP, 8BrcAMP, theophylline or 
forskolin (Adams et al., 1982a; Moore, Madamba, Joels & Siggins,
1988) suggesting Im is independent of cAMP. Neither forskolin 
nor cAMP increased Im or reversed a partial blockade of Im by 
muscarine in frog ganglion cells (Adams et al., 1982a; Brown & 
Adams, 1987; Moore et al., 1988; Brown et al., 1989). The results 
presented here support the hypothesis that adenosine interacts 
with Im but not with cAMP and are in agreement with the findings 
above.
Role of inositol triphosphate and PKC on the response of the rat 
SCG to adenosine.
As the effects of adenosine and muscarine on the ganglion appear 
independent of cyclic nucleotide metabolism, then the interaction
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between adenosine and muscarine may occur via some other 
secondary messenger. Recent molecular characterisation of 
muscarinic receptors has revealed at least five subtypes of 
receptor (described in chapter 1) which are often selectively but 
not exclusively coupled with different effector systems, (Fukuda, 
Higashida, Kubo, Maeda, Akiba, Bujo, Mishina, & Numa, 1988). 
Muscarinic receptors coupled to phospholipase C (PLC) have been 
demonstrated in many neuronal tissues (Fisher & Agranoff, 1987) 
and based on the sensitivity to pirenzepine it was suggested that 
Ml receptors are coupled to PLC activation while pirenzepine 
insensitive M2 receptors are linked to adenylate cyclase 
inhibition (Gill & Wolfe, 1985).
One consequence of the stimulation of cholinergic receptors by 
muscarine is the hydrolysis by PLC of phosphatidylinositol
4.5-bisphosphate (PIP2) to yield two second messengers, inositol
1.4.5-triphosphate (IP3) and 1,2-diacylglycerol (DAG) (Berridge, 
1987; Fisher & Agranoff, 198 7; Fig 5.12). It has been reported 
that adenosine may interact with PIT in a variety of cell types 
including rat striatum (Petcoff & Cooper, 1987), mouse cerebral 
cortex (Kendall & Hill, 1988), cultured GH3 pituitary tumour 
cells (Delahunty, Cronin & Linden, 1988), frog NMJ (Sebastiao,
1989), frog sympathetic ganglia (Rubio, Bencherif & Berne, 1988) 
and rat aorta (Long & Stone, 1987 ), and thus represents a 
potential target for the selective interactions of adenosine and 
muscarine on the ganglion.
IP3 stimulates the release of intracellular Ca2+ while DAG can 
activate a family of Ca2+ and phospholipid dependent protein 
kinases i.e. PKC (Berridge, 1987; Nishizuka, 1989; Huang, 1989), 
which may in turn phosphorylate specific proteins. Ca2+ 
mobilisation may activate phospholipase A2 (PLA2) and trigger the 
release of arachidonic acid (AA) and the formation of 
cyclo-oxygenase or lipoxygenase products to cause 
hyperpolarisation (Higashida & Brown, 1986; Kim & Clapham, 1989; 
Kim, Lewis, Graziadei, Neer, Bar-Sagi & Clapham, 1989; Kurachi, 
Ito, Sugimoto, Shimizu, Miki & Ui, 1989a,b; Fig. 5.15). Likewise
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the PI response of various tissues has been linked to a 
hyperpolarisation produced by activation of lKCa, e.g. in the 
hippocampus and NG108-15 cells. Higashida & Brown (1986) have 
shown that stimulation of NG108-15 cells with bradykinin has two 
sequential effects on gM:- the first is a hyperpolarisation 
attributed to the activation of an IKCa and was mimicked by the 
application of IP3 or increased [Ca2+]i and the second, a 
subsequent depolarisation resulting from inhibition of Im, which 
was inhibited by DAG activators.
In hippocampal neurones (Fig. 5.12), Dutar & Nicoll (1988) 
concluded IP3 is responsible for Im suppression as agonists that 
activate PLC suppress Im. Phorbol ester activation of PKC had no 
effect on Im and the intracellular injection of IP3 resulted in 
the loss of Im via a Ca2+ independent process (Malenka, Madison, 
Andrade & Nicholl, 1986), suggesting a direct effect of IP3 or 
an IP3 metabolite on Im. In contrast the underlying biochemical 
mechanisms responsible for the inhibition of Im and hence the 
muscarinic depolarisation of the rat SCG are not fully 
understood. It is known that muscarinic stimulation of the rat 
SCG increases the incorporation of 32Pi into phospholipids and 
the accumulation of IP3 (Hokin, 1965; Lapetina, Brown & Michell, 
1975; Horwitz, Tsymbalov & Perlman, 1984; Bone & Michell, 1985). 
Muscarine at 100 uM caused a 6 to 15 fold increase in PI 
labelling which was not mimicked by 8BrcGMP, 8BrcAMP or dopamine 
(Horwitz et al., 1984). Low [Ca2+]e increased the basal levels of 
PI and did not alter the accumulation of PI by muscarine and PIT 
hydrolysis was independent of [Ca2+]e. In contrast, Tokimasa & 
Akasu ( 1990) have reported that Im of amphibian ganglia is 
subject to regulation by [Ca2+]e and up to 90% of Im was 
antagonised by the application of Ca2+ antagonists. Brown et al.,
( 1989 ) found Im of the rat SCG is independent of both [Ca2+]e and 
[Ca2+]i (see also Adams et al., 1982a), although the possibility 
that Im requires a minimum level of [Ca2+]i for its activation has 
not been discounted.
Using amphibian ganglia the suppression of Im was not enhanced
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by raising either [Ca2+]i to > 200 nM or the level of IP3 to 100 
nM (Pfaffinger, Leibowitz, Bosma, Aimers & Hille, 1988b). 
Additional studies by Brown et al., (1989) using Li+ at a 
concentration (2 mM) that would be expected to inhibit PIT, did 
not alter Im. Lithium at 10 mM did not alter the response of the 
rat SCG to adenosine or muscarine (Tables 4.8 & 4.10) suggesting 
PIT is not involved in these responses.
Muscarinic agonists differ considerably in their ability to 
enhance PIT in brain (Fisher & Agranoff, 1987; Baumgold & White,
1989) an effect which depends on agonist structure since ACh and 
carbachol activate PIT to a much greater extent than pilocarpine 
(Fisher, Klinger, Agranoff, 1983; Brown & Brown, 1984). The 
ability of different muscarinic agonists to produce different 
degrees of PIT in the rat SCG is indicated by the results of 
Horwitz et al. (1984) who found muscarine was more effective than 
bethanechol at stimulating phospholipid metabolism. The different 
susceptibility of muscarinic agonists to adenosine reported here 
(Table 5.4) may be associated with the differential coupling of 
these agonists to the muscarinic receptor and their respective 
responses via secondary messengers. The most potent effects of 
adenosine were found on MeF which is reported to be poorly 
coupled to PIT in the rat cerebral cortex (Freedman, Harley &
Iversen, 1988) and the smallest depression by adenosine was of
carbachol, an agonist that may be strongly coupled to PIT
(Freedman et al, 1988). Both of these results indicate that the 
interaction of muscarine and adenosine may occur via an 
IP3-independent mechanism.
The coupling of muscarinic receptors to two different biochemical 
pathways could also explain the biphasic nature of the depression 
of muscarinic responses, i.e. with increasing concentrations of 
muscarine a second biochemical mechanism is activated and 
antagonises the depression of the response of the muscarinic 
agonist by adenosine.
DAG has been proposed as the mediator of the muscarinic
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depolarisation of the rat SCG based on two observations. Firstly 
muscarinic agonists stimulate the production of DAG (Bone, 
Fretten, Palmer, Kirk & Michell, 1984; Patterson & Voile, 1984; 
Horwitz et al., 1984). Secondly in the absence of receptor 
induced PIP2 hydrolysis the tumour promoting phorbol esters, such 
as phorbol 12,13-dibutyrate (PDBu) can substitute for DAG to 
activate PKC (Berridge, 1987 ) and the addition of PDBu or 
unsaturated DAGs partially suppressed Im (Pfaffinger, Leibowitz, 
Subers, Nathanson, Aimers & Hille, 1988a; Brown et al., 1989). 
Likewise PDBu mimics the depolarisation of muscarine by partially 
suppressing Im and a leak current of rat SCG neurones (Brown et 
al., 1989).
In contrast Bosma & Hille (1989) using amphibian ganglia found 
the PKC inhibitors H7 and staurosporine had no effect on LHRH 
suppression of Im but blocked the response to phorbol esters. 
A similar effect of PKC inhibitors on the response of the rat SCG 
was very recently reported by Grove, Caulfield & Evans (1990) 
who found PDBu mimicked the muscarinic depolarisation of the rat 
SCG and staurosporine abolished the response to PDBu but only 
slightly reduced the response to muscarine, probably via a 
non-specific action.
Furthermore, studies by Pfaffinger et al., (1988a) have produced 
evidence that agonist-induced suppression of Im in frog
sympathetic neurones is independent of the PLC second messenger 
cascade as phorbol esters caused only partial suppression of Im 
and the addition of LHRH following phorbol ester application 
suppressed the remaining current, suggesting LHRH can inhibit Im 
in PKC-independent manner (Pfaffinger et al., 1988a). Thus there 
may be both a PLC independent and dependent mechanism of action 
of muscarine on the rat SCG.
When applied to the rat SCG (Fig 5.14c) PDBu produced a slowly
developing depolarisation, which probably reflects the time
needed for this compound to cross the cell membrane and activate 
PKC. The slow recovery to PDBu would be expected to be dependent
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on its degradation and/or diffusion from the ganglion. The 
comparable depolarisation and potentiation of the 
hyperpolarisation to adenosine by PDBu and muscarine (Table 5.7, 
Fig 5.14) is indicative of a common site of action for adenosine, 
at or beyond the activation of PKC. The inability of the 
PKC-inhibitor H7 to alter the response to PDBu is in contrast to 
the reported action of another PKC inhibitor, staurosporine to 
inhibit the depolarisation of the rat SCG to PDBu (Grove et al.,
1990) .
These findings can be explained in variety of ways. One 
possibility is that the concentration of H7 employed was 
insufficient to antagonise PKC. Some evidence for the need for 
a higher concentration to inhibit PKC was suggested by Linden & 
Routtenberg (1989) who in reviewing the literature on long term 
potentiation (LTP) reported Malinow, Madison & Tsien (1988) found 
the LTP of the hippocampus was inhibited by 300 uM H7, whereas 
another group of investigators found no inhibition of hippocampal 
LTP at 100 uM H7. In contrast the concentration of H7 used on 
the rat SCG may have been sufficient to inhibit PKC as the 
depression of Ca2+ dependent components of the CAP of cultured 
rabbit SCG neurones produced by phorbol esters was abolished by 
a minimum of 10 minutes incubation in 50 uM H7 (Mochida & 
Kobayashi, 1988). Similarly, Sebastiao (1989) reported 60 uM H7 
inhibited the evoked endplate potential (e.p.p.) of frog 
sartorius muscle, but did not modify the excitatory action of 100 
nM phorbol diacetate (PDAc) on e.p.p. amplitude, whereas 
polymixin B antagonised the excitatory effect of PDAc. The 
apparent ineffectiveness of H7 was attributed to the ability of 
polymixin B to inhibit the binding of PKC in an indirect manner, 
i.e. to inhibit the binding of phospholipid to PKC.
The conclusions of Sebastiao (1989) are in agreement with current 
knowledge as to how inhibitors of PKC may inhibit two different 
sites, i.e. the regulatory domain of PKC, which binds Ca2+, 
phospholipid and DAG or phorbol ester to unmask the second active 
site, the catalytic domain. Sphingosine and polymixin B compete
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with phosphatidyl serine, Ca2+ and DAG at the regulatory site, 
whereas H7 competes with ATP at the catalytic phosphotransferase 
site. Thus these differences in the sites of action between H7 
and sphingosine may account for the depression of the response 
of the rat SCG to PDBu by sphingosine (Grove et al., 1990) but 
not by H7 (Tables 5.10 & 5.11). Thus the results presented here 
(Tables 5.10 & 5.11) suggest the interaction of adenosine with 
muscarine and PDBu is at a site distinct to the ATP binding site 
of PKC. Adenosine may alter the activation by PKC at the 
regulatory site although this seems unlikely as TFP has been 
shown to antagonise the binding of Ca2+ to the regulatory domain 
of PKC (Huang, 1989) but did not alter the hyperpolarisation of
the rat SCG by adenosine (Table 4.3).
Tumour-promoting phorbol esters have been reported to augment 
drug and neurotransmitter-induced second messenger production, 
e.g. cAMP, by an unknown mechanism in a variety of tissues 
including brain (for references see Karbon et al., 1986). 
However, it is unlikely that the enhanced response of the rat SCG 
to adenosine in the presence of PDBu is due to an increase in 
cAMP as reported for the effects of 2CA on rat brain slices 
(Karbon et a l . , 1986 ) as the alteration of cyclic nucleotide
metabolism in PSS did not enhance the response to adenosine.
In addition it is known that PKC inhibitors are not completely 
specific in that all of them are reported to inhibit other PKs, 
e.g. H7 also inhibits cAMP dependent PK at 3 uM and cAMP 
dependent PK at 6 uM (Hidaka, Inagaki, Kawamoto & Sasaki, 19 84), 
and polymixin B inhibits both PKC and Ca2+/CaM dependent PK but 
not the cyclic nucleotide dependent PKs. The inactivity of H7 on 
the response to adenosine (Tables 5.10 & 5.11) further supports 
the hypothesis that cAMP is not involved in the response to 
adenosine as 50 uM H7 would be expected to inhibit PKA.
The role of arachidonic acid on the response of the SCG to
adenosine.
It is possible that the G-protein that couples muscarinic 
receptors to PLC second messenger cascade may also couple in an
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independent manner, to the suppression of Im, perhaps via a 
direct mechanism. Alternatively the suppression of Im in the rat 
SCG could occur via DAG which is hydrolysed by DAG-lipase to form 
monoacylglycerol (MAG) and AA (Irvine, 1982). In support of this 
idea is the ability of A9L cells to release AA upon stimulation 
of Ml receptors (Irvine, 1982) and the activation of muscarinic 
receptors of some cell lines (De George, Morell, McCarthy & La 
Petina, 1986). Recently the products of AA metabolism, i.e. 
prostaglandins (PG) and leukotrienes (LT) (Fig. 5.15) have been 
found to modulate K+ channels (Higashida & Brown, 1986; Kim & 
Clapham, 1989; Kim et al., 1989; Kurachi et al., 1989a,b).
A second pathway for the synthesis of AA is via the hydrolysis 
of phospholipids by PLA2 to release lysophospholipid and free 
fatty acid, usually AA, which can directly activate or inhibit 
PKC (Huang, 1989). In addition AA in neurons can be metabolised 
by lipoxygenase, cyclo-oxygenase or epoxygenase enzymes to form 
LTs, hydroxyeicosatetraenoic acids (HETEs), PGs, thromboxanes 
(TXs) and epoxides respectively (Axelrod, Burch & Jelsema, 1988) 
(Fig. 5.15).
Most electrophysiological effects of adenosine so far identified 
appear to result from its ability to alter cAMP or PIT metabolism 
and arachidonate pathway products do not appear to be a major 
second messenger system for adenosine. In fact one reason for 
postulating separate receptors for adenosine and ATP arose from 
the ability of ATP rather its metabolically stable, phosphate 
modified analogues to stimulate the synthesis and release of PGs 
(Brown & Burnstock, 1981b; Needleman, Minkes & Douglas, 1974). 
Recently this dogma has been challenged by two reports of the 
activation of PG synthesis by adenosine in guinea-pig atria 
(Caparrota, Fassina, Froldi & Poja, 1987) and the rabbit heart 
(Karwatowska-Prokocsuk, Ciabattoni & Wennmalm, 1988).
Both intact and homogenated rat SCG have the ability to 
synthesise PGs. Ganglia spontaneously released PGE and 
indomethacin inhibited the synthesis of PGE with an IC50 for rat
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SCG homogenates of 11 uM (Webb, Saelens & Halushaka, 1978). 
Homogenates of rat SCG have also been reported to produce PGE2 
and 6-keto-PGFla (Gonzales, Goldyne, Taiwo & Levine, 1989). Given 
the ability of the rat SCG to synthesise PGs, the interaction of 
adenosine with the LT and PG pathways of the rat SCG was tested.
At 50 uM indomethacin produced a small non-significant rightward 
shift in the CRC to adenosine (Fig. 5.16). At this concentration, 
indomethacin is likely to be supramaximal for the inhibition of 
PG synthesis as it was reported to inhibit the formation of PGs 
in intact rat SCG at 55 uM (Webb et al., 1978). Thus it appears 
PGs are not involved in the response of the ganglion to 
adenosine. If PLA2 activation is necessary for the 
hyperpolarisation to adenosine then the effect of a PLA2 
inhibitor such as nordihydroguaiaretic acid (NDGA) should be to 
decrease the response to adenosine. In combination with 
indomethacin to inhibit PG synthesis, NDGA produced a significant 
antagonism of the hyperpolarisation of the rat SCG to adenosine 
(Fig 5.16), suggesting either the activation of PLA2 and/or the 
lipoxygenase pathway may mediate a significant part of the 
response to adenosine.
The results reported here appear to be similar to those effects 
on the opening of S-channels of Aplysia sensory neurones. The 
opening of K+ channels in Aplysia neurones was imitated by 
exogenous AA and blocked by inhibitors of phospholipase and 
lipoxygenase, but not by indomethacin (Piomelli, Volterra, Dale, 
Siegelbaum, Kandel, Schwartz & Belardetti, 1987). Other similar 
actions of AA metabolites have been reported, i.e. some 
lipoxygenase products have been found to be intracellular 
modulators of G-protein-gated muscarinic K+ channels of 
guinea-pig atrial cells (Kurachi et al., 1989a,b) and neonatal 
rat atrial cells (Kim & Clapham, 1989; Kim et al., 1989 ) and thus 
the interaction of muscarine and adenosine on the rat SCG may 
occur via one of these secondary messengers.
Given the broad spectrum of actions of PGs and LTs the results
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reported here must be considered as preliminary findings and 
suitable controls will need to be included before any specific 
claims can be made for the role of LTs in the actions of 
adenosine on the rat SCG. However, a recent report has suggested 
that the Al receptors of rat striatal glial cells may be coupled 
to the PLA2-PG synthesis pathway (Caciacli, Ciccarelli, Di Iorio, 
Tacconelli & Ballerni, 1989) and a similar coupling of adenosine 
receptors to the PLA2 secondary messenger system may occur in rat 
SCG neurones.
With these caveates it is proposed that adenosine may increase 
the production of arachidonic acid and the production of 
lipoxygenase products which can then activate K+ channels to 
hyperpolarise the rat SCG (Fig 7). It is hypothesised that 
muscarinic depolarisation augments the response to adenosine due 
to an increased activity of PLC that can increase the 
concentration of DAG and AA. An increase in free AA may be 
sufficient to inhibit the activation of PKC and cause a 
subsequent depression of the muscarinic response. To determine 
whether the 5-lipoxygenase pathway is involved in the response 
of the rat SCG to adenosine, the effect of a specific inhibitor 
of LT synthesis such as nafazatrom could be tested.
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CONCLUSION.
There are many potential interactions between purines and 
responses to cholinomimetics which may provide the capacity for 
the modulation of both central and peripheral neurones (Table 
5.12). The results presented in this chapter suggest that 
adenosine selectively depressed the response of the rat SCG to 
muscarinic agonists via a reduction of the Ml-mediated 
depolarisation and that these actions were competitive and 
readily reversible. Furthermore, the results indicate there was 
an adenosine sensitive and adenosine insensitive component to the 
response to muscarine and may reflect the multiple actions of 
muscarine reported (Mochida & Kobayashi, 1986a,b).
Many agonists that are reported to increase intracellular cAMP 
depolarised the rat SCG but did not alter the response to 
adenosine suggesting a change in cAMP is not responsible for the 
potentiation of the hyperpolarisation to adenosine in the 
presence of muscarinic agents. The potential for an interaction 
of adenosine at a number of intracellular sites has been reviewed 
and it is suggested that adenosine may alter the activity of 
these sites to counteract the inhibition of Im by muscarine 
possibly via an interaction with PKC. Whatever the mechanism of 
interaction between muscarine and adenosine the ability of 
muscarine and PDBu to enhance the response to adenosine during 
the persistent depolarisation to muscarine, suggests the effector 
mechanism is beyond the level of the muscarinic receptor and is 
unlikely to be a depletable secondary messenger.
From the experimental data obtained in chapters 4 and here it is 
proposed that opposing changes in gK underlie the depression of 
muscarinic responses by adenosine. This may occur via a direct 
action of adenosine on G-proteins to activate a K+ channels (Fig 
7), as reported for the heart (Pffaninger et al., 1988a,b) or via 
a secondary messenger/s to alter Im. It is known that muscarine 
depolarises the rat SCG via a G-protein that is insensitive to 
pertussis toxin (Brown, Marrion & Smart, 1989, Newberry & 
Gilbert, 1989b) and the actions of several compounds that
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hyperpolarise the rat SCG, including adenosine were antagonised 
by treatment with PTX (Newberry & Gilbert, 1989b) . However the 
specific G-proteins responsible for each of these effect have not 
been characterised and their interaction has not been studied. 
Intracellular recording techniques were made by a similar method 
to that of Henon & McAfee ( 1983a) on intact ganglia, but the 
actions of adenosine were inconsistent as reported by Henon & 
McAfee (1983a). Therefore to address the role of intracellular 
messengers and G-protein coupling in these responses, it is 
recommended that primary cultured SCG neurones are studied by a 
patch clamp technique.
Muscarine and MeF are known to augment and produce a prolonged 
response to submaximal preganglionic stimulation (for references 
see Brown et al. , 1980). The ability of adenosine to selectively 
depress the depolarising response to muscarine would therefore 
be predicted to depress muscarinic facilitation of synaptic 
transmission in vivo. In addition the ability of muscarine to 
potentiate subthreshold responses to adenosine should result in 
a potentiation of adenosine-induced hyperpolarisations of the rat 
SCG in vivo.
